data_1spf_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1spf _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.534 0.358 0 N-CA-C 108.69 -0.856 . . . . 4.0700000000000003 108.69 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 10.2 tp -55.23 -45.58 75.97 Favored 'General case' 0 N--CA 1.453 -0.309 0 O-C-N 121.873 -0.517 . . . . 3.21 111.149 176.081 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 89.7 t -55.12 -48.82 75.72 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 O-C-N 122.199 -0.313 . . . . 1.53 110.156 174.544 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 55.3 t -56.54 -46.79 82.58 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 CA-C-N 118.612 0.642 . . . . 1.6899999999999999 110.182 177.119 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 72.3 t -54.52 -50.46 58.32 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 CA-C-N 118.771 0.714 . . . . 2.1800000000000002 110.451 175.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 73.0 t -56.27 -44.34 79.25 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 O-C-N 121.636 -0.665 . . . . 1.96 110.843 177.537 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 46.4 t -60.04 -48.11 89.21 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.177 0 N-CA-C 108.904 -0.776 . . . . 1.6799999999999999 108.904 178.262 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 41.9 t -54.02 -50.19 55.64 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 C-N-CA 123.203 0.601 . . . . 1.8 110.486 176.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 46.9 t -56.96 -46.69 83.98 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 C-N-CA 123.4 0.68 . . . . 2.04 110.79 177.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -59.38 -46.93 87.31 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 123.352 0.661 . . . . 1.5700000000000001 109.39 177.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 13.7 t -61.32 -40.76 87.24 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.795 0 C-N-CA 123.881 0.873 . . . . 1.6699999999999999 109.951 179.291 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 3.2 t -62.0 -47.64 92.24 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.359 0 O-C-N 121.56 -0.713 . . . . 1.77 110.028 174.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 1.4 t -55.36 -40.66 58.28 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 CA-C-N 119.115 0.87 . . . . 1.76 111.407 173.262 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.4 t -63.9 -46.11 95.09 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.235 0 N-CA-C 108.349 -0.982 . . . . 1.76 108.349 178.363 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 10.8 mt -59.34 -42.61 87.93 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 N-CA-C 108.92 -0.771 . . . . 1.6799999999999999 108.92 178.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 39.6 t -63.37 -52.79 53.76 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 N-CA-C 109.423 -0.584 . . . . 1.6499999999999999 109.423 -179.673 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -52.27 -47.27 56.2 Favored Glycine 0 CA--C 1.53 1.009 0 N-CA-C 111.527 -0.629 . . . . 0.37 111.527 175.363 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -56.88 -49.83 74.33 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 123.446 0.698 . . . . 1.5900000000000001 110.46 178.231 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 11.2 tp -59.46 -44.63 92.93 Favored 'General case' 0 N--CA 1.44 -0.939 0 C-N-CA 123.776 0.83 . . . . 1.78 109.465 178.409 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 85.3 mt . . . . . 0 CA--C 1.533 0.302 0 O-C-N 121.431 -0.793 . . . . 2.52 111.23 178.01 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.8 tm? . . . . . 0 N--CA 1.451 -0.4 0 N-CA-C 107.839 -1.171 . . . . 3.4900000000000002 107.839 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -55.48 -45.89 76.95 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-O 120.835 0.35 . . . . 3.5099999999999998 110.639 176.831 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 64.4 t -56.15 -49.94 73.25 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 O-C-N 121.946 -0.471 . . . . 1.9399999999999999 109.77 174.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 38.1 t -55.77 -45.79 79.58 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 CA-C-N 118.404 0.547 . . . . 1.73 110.322 177.447 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 54.2 t -55.72 -51.17 62.11 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.375 0 CA-C-N 119.158 0.89 . . . . 1.6599999999999999 110.314 177.113 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 73.3 t -56.22 -45.18 80.98 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 O-C-N 121.791 -0.568 . . . . 1.54 110.903 177.341 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 54.8 t -60.87 -46.4 96.41 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 N-CA-C 109.152 -0.684 . . . . 1.52 109.152 179.504 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 47.8 t -55.19 -49.01 75.62 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 C-N-CA 123.481 0.712 . . . . 1.5700000000000001 110.278 176.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 46.2 t -57.08 -46.85 84.46 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 O-C-N 121.815 -0.553 . . . . 1.55 110.635 177.244 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.13 -47.35 83.59 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 123.265 0.626 . . . . 1.6299999999999999 109.524 177.135 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 11.7 t -62.38 -40.8 89.31 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.814 0 C-N-CA 124.033 0.933 . . . . 1.6699999999999999 109.939 -179.093 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 5.1 t -62.63 -47.98 90.37 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.411 0 O-C-N 121.649 -0.657 . . . . 1.6299999999999999 109.654 175.273 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 1.5 t -55.09 -40.35 54.32 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.585 0 CA-C-N 119.051 0.842 . . . . 1.6499999999999999 111.144 173.453 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.4 t -65.32 -45.48 93.3 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.249 0 N-CA-C 108.687 -0.857 . . . . 1.74 108.687 179.025 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 11.2 mt -59.85 -44.55 94.44 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.525 0 N-CA-C 108.566 -0.902 . . . . 1.8200000000000001 108.566 178.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 38.8 t -63.97 -51.77 65.02 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 N-CA-C 109.371 -0.603 . . . . 1.73 109.371 -177.49 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -54.0 -49.81 57.51 Favored Glycine 0 CA--C 1.528 0.868 0 N-CA-C 111.063 -0.815 . . . . 0.29999999999999999 111.063 175.028 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -56.01 -41.9 75.61 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 123.305 0.642 . . . . 1.6699999999999999 111.313 179.465 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 10.7 tp -61.2 -58.09 9.75 Favored 'General case' 0 N--CA 1.439 -0.987 0 N-CA-C 108.338 -0.986 . . . . 1.8 108.338 174.054 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 75.6 mt . . . . . 0 CA--C 1.53 0.207 0 C-N-CA 123.823 0.849 . . . . 2.73 112.497 -173.981 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.1 tt . . . . . 0 N--CA 1.453 -0.301 0 N-CA-C 108.09 -1.078 . . . . 3.23 108.09 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 11.0 tp -54.41 -46.0 73.06 Favored 'General case' 0 N--CA 1.454 -0.255 0 O-C-N 121.922 -0.486 . . . . 3.1600000000000001 111.245 174.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 79.9 t -57.81 -47.64 85.57 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 O-C-N 122.16 -0.337 . . . . 1.79 110.241 174.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 49.6 t -55.68 -44.83 78.38 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 O-C-N 121.718 -0.614 . . . . 1.75 110.218 176.371 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 68.7 t -56.35 -49.33 77.36 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 CA-C-N 119.203 0.911 . . . . 1.75 110.472 175.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 76.4 t -55.24 -45.15 77.47 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 O-C-N 121.564 -0.71 . . . . 1.5800000000000001 110.704 176.151 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 70.1 t -60.17 -46.19 94.92 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.191 0 N-CA-C 109.163 -0.68 . . . . 1.6200000000000001 109.163 177.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 41.1 t -54.7 -48.58 72.14 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 C-N-CA 123.471 0.709 . . . . 1.76 110.572 177.084 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 53.9 t -56.47 -46.97 82.4 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 CA-C-N 118.673 0.669 . . . . 1.6599999999999999 110.598 177.12 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -59.08 -47.29 85.81 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 109.514 -0.551 . . . . 1.54 109.514 177.104 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 15.9 t -61.67 -38.49 80.46 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.878 0 C-N-CA 124.145 0.978 . . . . 1.5700000000000001 110.179 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 2.9 t -62.64 -49.45 83.72 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.334 0 C-N-CA 123.616 0.767 . . . . 1.99 109.562 174.417 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 1.3 t -54.25 -41.49 52.37 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 CA-C-N 119.207 0.912 . . . . 1.7 111.384 173.369 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.4 t -64.33 -44.76 97.29 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 N-CA-C 108.706 -0.85 . . . . 1.71 108.706 179.013 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 11.3 mt -59.85 -43.04 91.08 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 N-CA-C 108.627 -0.879 . . . . 1.75 108.627 178.259 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 39.5 t -61.71 -57.57 11.5 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 N-CA-C 108.809 -0.812 . . . . 1.72 108.809 -179.273 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -53.01 -45.18 62.27 Favored Glycine 0 CA--C 1.533 1.18 0 C-N-CA 120.972 -0.632 . . . . 0.47999999999999998 111.936 176.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -60.55 -32.73 71.78 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 124.135 0.974 . . . . 1.6399999999999999 111.868 179.243 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 13.2 tp -70.12 -60.33 2.35 Favored 'General case' 0 N--CA 1.435 -1.209 0 N-CA-C 107.49 -1.3 . . . . 1.8300000000000001 107.49 172.519 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 5.3 mp . . . . . 0 C--N 1.341 0.237 0 N-CA-C 113.412 0.893 . . . . 3.73 113.412 -171.928 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.3 tt . . . . . 0 N--CA 1.455 -0.209 0 N-CA-C 108.275 -1.009 . . . . 2.98 108.275 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 10.8 tp -56.51 -45.97 80.78 Favored 'General case' 0 N--CA 1.454 -0.272 0 O-C-N 121.868 -0.52 . . . . 3.3599999999999999 111.477 176.279 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 99.4 t -56.65 -48.03 81.35 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 N-CA-C 109.777 -0.453 . . . . 1.78 109.777 174.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 44.3 t -56.47 -45.76 82.01 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.291 0 CA-C-O 118.65 -0.691 . . . . 2.0299999999999998 110.058 177.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 55.9 t -54.25 -51.41 48.2 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 CA-C-N 119.572 1.078 . . . . 2.2000000000000002 110.467 176.422 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 97.8 t -57.29 -45.78 85.08 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 O-C-N 121.547 -0.721 . . . . 1.8100000000000001 111.011 177.354 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 53.7 t -59.92 -42.74 90.36 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 N-CA-C 109.382 -0.599 . . . . 2.0600000000000001 109.382 179.341 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 30.1 t -54.5 -47.42 71.18 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 C-N-CA 123.711 0.804 . . . . 2.48 110.377 177.3 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 72.8 t -59.1 -46.41 91.93 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 CA-C-N 118.829 0.741 . . . . 2.04 110.395 178.178 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -58.93 -46.1 88.77 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 123.216 0.606 . . . . 1.6000000000000001 109.856 177.167 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.4 t -62.54 -40.51 88.52 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.898 0 C-N-CA 124.559 1.144 . . . . 2.1400000000000001 109.84 -179.486 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 5.0 t -62.51 -48.79 86.57 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.402 0 CA-C-N 118.776 0.716 . . . . 2.0899999999999999 109.65 175.042 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 1.4 t -54.58 -39.88 47.93 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 CA-C-N 118.734 0.697 . . . . 1.72 111.38 173.611 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.4 t -66.45 -45.01 90.18 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 N-CA-C 108.891 -0.781 . . . . 1.6399999999999999 108.891 179.131 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 11.8 mt -59.01 -44.99 92.5 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 N-CA-C 108.334 -0.987 . . . . 1.97 108.334 178.568 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 42.7 t -64.24 -53.46 43.11 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 N-CA-C 109.48 -0.563 . . . . 1.78 109.48 -177.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -54.71 -44.31 80.05 Favored Glycine 0 CA--C 1.527 0.844 0 N-CA-C 111.568 -0.613 . . . . 0.62 111.568 176.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -60.98 -45.02 96.5 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 117.686 0.743 . . . . 1.5800000000000001 111.013 178.122 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 9.7 tp -56.93 -53.45 57.89 Favored 'General case' 0 N--CA 1.441 -0.917 0 N-CA-C 108.303 -0.999 . . . . 1.75 108.303 175.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 85.5 mt . . . . . 0 CA--C 1.533 0.291 0 C-N-CA 122.804 0.442 . . . . 3.1499999999999999 111.789 -177.837 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 9.3 tt . . . . . 0 N--CA 1.455 -0.213 0 N-CA-C 108.895 -0.78 . . . . 3.4399999999999999 108.895 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 10.5 tp -56.61 -46.07 81.1 Favored 'General case' 0 N--CA 1.453 -0.295 0 O-C-N 122.228 -0.295 . . . . 3.4500000000000002 111.476 176.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 72.7 t -54.26 -50.16 58.14 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 N-CA-C 109.75 -0.463 . . . . 2.3500000000000001 109.75 174.336 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 40.6 t -58.49 -46.37 89.75 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.224 0 CA-C-O 118.681 -0.676 . . . . 2.0099999999999998 110.454 179.452 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 53.1 t -53.37 -53.33 24.76 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 CA-C-N 119.394 0.997 . . . . 1.98 109.93 176.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 69.8 t -58.1 -46.07 88.3 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 O-C-N 122.036 -0.415 . . . . 1.74 110.974 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 48.5 t -61.44 -46.86 95.71 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 N-CA-C 109.008 -0.738 . . . . 1.72 109.008 -178.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 43.1 t -54.14 -49.94 58.47 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 C-N-CA 123.566 0.746 . . . . 1.71 110.038 176.414 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 44.4 t -58.28 -48.13 85.68 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 CA-C-N 118.71 0.687 . . . . 1.72 110.864 179.166 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -59.09 -47.2 86.13 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 109.379 -0.6 . . . . 1.8 109.379 178.829 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 15.5 t -62.63 -39.59 85.21 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.985 0 C-N-CA 124.037 0.935 . . . . 1.6599999999999999 109.929 -179.264 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 3.8 t -63.83 -47.52 90.47 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.482 0 CA-C-N 118.871 0.76 . . . . 1.71 109.6 175.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 1.4 t -54.76 -41.6 57.46 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.602 0 CA-C-N 119.061 0.846 . . . . 1.6399999999999999 111.225 173.207 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.4 t -65.09 -46.33 91.57 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.171 0 N-CA-C 108.648 -0.871 . . . . 1.5700000000000001 108.648 179.746 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 13.1 mt -59.82 -43.52 92.01 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 N-CA-C 108.421 -0.955 . . . . 1.8700000000000001 108.421 179.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 27.3 t -62.99 -54.87 28.02 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 N-CA-C 109.061 -0.718 . . . . 1.7 109.061 -178.685 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -52.33 -45.96 57.86 Favored Glycine 0 CA--C 1.529 0.961 0 N-CA-C 111.541 -0.624 . . . . 0.38 111.541 176.14 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -61.87 -41.96 98.49 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 122.959 0.504 . . . . 1.75 111.54 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 11.6 tp -63.56 -46.28 86.62 Favored 'General case' 0 N--CA 1.44 -0.928 0 N-CA-C 108.669 -0.863 . . . . 2.02 108.669 176.23 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 82.8 mt . . . . . 0 CA--C 1.53 0.204 0 O-C-N 122.061 -0.399 . . . . 3.0 111.182 -178.12 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.1 tm? . . . . . 0 CA--C 1.527 0.071 0 N-CA-C 109.005 -0.739 . . . . 3.8199999999999998 109.005 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 1.7 tt -57.61 -46.28 84.3 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-O 121.283 0.563 . . . . 3.79 110.225 176.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 48.0 t -58.19 -46.13 88.66 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 N-CA-C 109.618 -0.512 . . . . 1.53 109.618 176.501 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 68.6 t -57.01 -46.44 84.1 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 CA-C-O 118.515 -0.755 . . . . 2.1400000000000001 109.766 176.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 54.5 t -55.36 -50.35 65.98 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 CA-C-N 119.803 1.183 . . . . 2.0 110.144 177.317 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 81.1 t -56.14 -46.58 81.11 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 O-C-N 121.841 -0.537 . . . . 1.6799999999999999 110.929 177.389 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 54.3 t -60.37 -45.53 96.45 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 N-CA-C 109.212 -0.662 . . . . 1.8200000000000001 109.212 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 51.0 t -55.15 -49.7 69.94 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 C-N-CA 123.674 0.79 . . . . 2.1299999999999999 110.052 176.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 49.0 t -57.86 -47.21 86.77 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 CA-C-N 118.501 0.591 . . . . 2.1499999999999999 110.553 178.552 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -58.63 -47.13 85.42 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 123.123 0.569 . . . . 1.76 109.466 177.79 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 11.9 t -62.77 -39.72 85.93 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.898 0 C-N-CA 124.238 1.015 . . . . 1.8500000000000001 109.96 -178.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 5.6 t -63.29 -48.49 87.15 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 CA-C-N 118.77 0.714 . . . . 1.8799999999999999 109.687 175.205 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 1.4 t -54.28 -41.1 50.72 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 CA-C-N 118.844 0.747 . . . . 1.78 111.232 173.195 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.4 t -65.81 -45.08 92.52 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.278 0 N-CA-C 108.646 -0.872 . . . . 1.71 108.646 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 11.6 mt -58.96 -45.35 92.1 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.603 0 N-CA-C 108.191 -1.04 . . . . 1.74 108.191 178.489 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 38.4 t -63.77 -52.99 50.16 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 N-CA-C 109.697 -0.483 . . . . 1.6699999999999999 109.697 -176.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -54.9 -48.55 66.28 Favored Glycine 0 CA--C 1.528 0.849 0 N-CA-C 111.354 -0.698 . . . . 0.38 111.354 175.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -57.1 -41.21 78.49 Favored 'General case' 0 N--CA 1.455 -0.225 0 O-C-N 122.105 -0.644 . . . . 1.5600000000000001 111.211 178.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 12.6 tp -66.73 -52.41 44.73 Favored 'General case' 0 N--CA 1.438 -1.069 0 C-N-CA 123.886 0.874 . . . . 1.8600000000000001 109.11 178.756 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . 0.298 3.6 pp . . . . . 0 CA--C 1.532 0.254 0 CA-C-N 119.11 0.868 . . . . 4.2000000000000002 112.685 -175.285 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 9.9 tt . . . . . 0 N--CA 1.45 -0.451 0 N-CA-C 108.413 -0.958 . . . . 2.98 108.413 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 10.9 tp -56.04 -45.85 79.08 Favored 'General case' 0 N--CA 1.454 -0.239 0 O-C-N 122.223 -0.298 . . . . 2.96 111.232 174.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 93.5 t -56.66 -49.75 76.74 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 N-CA-C 110.185 -0.302 . . . . 1.47 110.185 174.567 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 54.8 t -55.29 -46.0 77.98 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 O-C-N 121.87 -0.519 . . . . 1.75 110.039 177.166 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 54.3 t -56.17 -47.87 80.09 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 CA-C-N 118.833 0.742 . . . . 1.96 110.222 177.084 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 76.0 t -54.9 -45.37 75.45 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 CA-C-N 118.683 0.674 . . . . 1.71 110.78 175.13 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 87.2 t -60.23 -47.3 92.76 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.182 0 N-CA-C 109.28 -0.637 . . . . 1.8200000000000001 109.28 178.579 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 53.1 t -55.12 -49.09 74.73 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 C-N-CA 123.48 0.712 . . . . 1.76 110.406 177.531 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 41.8 t -56.98 -46.23 83.94 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 C-N-CA 123.485 0.714 . . . . 1.8999999999999999 110.22 177.3 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -58.59 -47.4 84.43 Favored 'General case' 0 N--CA 1.45 -0.425 0 N-CA-C 109.363 -0.606 . . . . 1.99 109.363 177.148 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.7 t -62.12 -41.3 90.69 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.829 0 O-C-N 121.316 -0.865 . . . . 1.8600000000000001 110.045 -179.482 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 4.3 t -62.91 -47.11 94.38 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 O-C-N 121.512 -0.742 . . . . 1.6499999999999999 109.83 175.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 2.1 t -56.86 -37.69 55.21 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.707 0 CA-C-N 118.812 0.733 . . . . 1.8899999999999999 110.957 173.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.4 t -66.64 -46.9 84.87 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.245 0 N-CA-C 108.447 -0.946 . . . . 1.9199999999999999 108.447 178.034 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 10.7 mt -58.28 -45.89 89.08 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 N-CA-C 108.569 -0.9 . . . . 1.6000000000000001 108.569 179.283 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 43.6 t -65.65 -50.95 68.22 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 N-CA-C 109.382 -0.599 . . . . 1.74 109.382 -176.723 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -53.08 -49.0 57.47 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 111.101 -0.799 . . . . 0.42999999999999999 111.101 176.06 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -57.54 -47.86 80.86 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.507 0.723 . . . . 1.6200000000000001 110.643 178.273 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 10.8 tp -59.04 -46.94 86.95 Favored 'General case' 0 N--CA 1.441 -0.908 0 C-N-CA 123.679 0.792 . . . . 1.8 109.695 178.188 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . 0.307 0.1 OUTLIER . . . . . 0 CA--C 1.54 0.56 0 O-C-N 121.592 -0.692 . . . . 4.3200000000000003 110.732 -178.555 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 9.1 tt . . . . . 0 C--O 1.224 -0.262 0 N-CA-C 108.972 -0.751 . . . . 3.04 108.972 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 10.7 tp -52.84 -45.55 67.38 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-O 121.031 0.443 . . . . 3.0 111.464 171.448 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 39.7 t -61.65 -44.28 98.43 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 N-CA-C 109.511 -0.551 . . . . 2.1000000000000001 109.511 176.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 90.3 t -55.53 -46.86 79.12 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 O-C-N 121.999 -0.438 . . . . 2.0 110.051 175.026 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 67.3 t -56.06 -49.14 77.31 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 CA-C-N 118.808 0.731 . . . . 1.6200000000000001 109.809 176.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 75.1 t -56.36 -44.49 80.04 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 O-C-N 121.827 -0.546 . . . . 1.54 111.013 177.114 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 56.0 t -61.03 -47.79 92.0 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.139 0 O-C-N 121.661 -0.65 . . . . 1.6799999999999999 109.26 178.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 54.7 t -54.78 -48.98 72.56 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 C-N-CA 123.312 0.645 . . . . 1.95 110.199 176.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 38.1 t -57.13 -46.4 84.56 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 C-N-CA 123.568 0.747 . . . . 1.8400000000000001 110.544 177.445 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -59.01 -48.08 82.87 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 123.424 0.69 . . . . 1.71 109.361 177.802 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 16.1 t -61.87 -40.98 89.02 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.848 0 O-C-N 121.387 -0.82 . . . . 1.8700000000000001 109.954 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 4.2 t -62.91 -45.89 97.71 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.507 0 O-C-N 121.543 -0.723 . . . . 1.98 109.84 175.491 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 1.6 t -56.42 -40.26 66.22 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.631 0 CA-C-N 119.296 0.953 . . . . 1.8 110.927 173.556 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.4 t -63.57 -48.42 86.94 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 N-CA-C 108.345 -0.983 . . . . 1.51 108.345 177.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 11.2 mt -59.43 -42.46 87.75 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 N-CA-C 109.053 -0.721 . . . . 1.9399999999999999 109.053 -179.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 32.4 t -65.06 -50.37 74.86 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 N-CA-C 109.162 -0.681 . . . . 1.77 109.162 -178.477 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -52.1 -46.39 56.28 Favored Glycine 0 CA--C 1.53 0.981 0 N-CA-C 111.463 -0.655 . . . . 0.32000000000000001 111.463 173.641 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -59.24 -51.15 71.23 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 121.256 0.55 . . . . 1.7 110.587 178.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 9.2 tp -54.53 -46.6 73.58 Favored 'General case' 0 N--CA 1.443 -0.817 0 C-N-CA 123.973 0.909 . . . . 2.0099999999999998 109.594 175.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 64.7 mt . . . . . 0 CA--C 1.53 0.19 0 O-C-N 121.808 -0.557 . . . . 3.0 111.536 -178.789 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 68.9 tp . . . . . 0 N--CA 1.454 -0.275 0 N-CA-C 108.553 -0.906 . . . . 3.21 108.553 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -57.58 -46.09 84.44 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-O 120.91 0.386 . . . . 3.3399999999999999 110.151 177.567 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 75.7 t -55.56 -49.32 74.44 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 O-C-N 121.967 -0.458 . . . . 1.6000000000000001 110.234 173.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 32.4 t -56.12 -46.04 80.88 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.204 0 CA-C-O 118.896 -0.573 . . . . 1.79 110.089 178.348 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 55.1 t -54.92 -51.91 48.52 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.426 0 CA-C-N 119.273 0.942 . . . . 1.5800000000000001 109.924 177.073 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 70.8 t -56.24 -45.76 81.2 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 O-C-N 121.908 -0.495 . . . . 1.8600000000000001 110.922 177.709 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 52.7 t -60.47 -46.22 95.66 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.309 0 N-CA-C 109.083 -0.71 . . . . 1.73 109.083 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 48.7 t -55.48 -49.5 72.94 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 C-N-CA 123.605 0.762 . . . . 1.5600000000000001 110.119 176.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 52.3 t -58.05 -46.98 87.93 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 CA-C-N 118.465 0.575 . . . . 1.8200000000000001 110.619 178.051 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -59.06 -46.83 87.25 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 123.382 0.673 . . . . 1.77 109.488 178.017 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 10.6 t -62.08 -40.6 88.04 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.855 0 C-N-CA 124.353 1.061 . . . . 1.5900000000000001 109.909 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 3.5 t -62.32 -48.03 90.29 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.404 0 CA-C-N 118.696 0.68 . . . . 1.6299999999999999 109.685 175.048 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 1.4 t -55.59 -40.63 60.43 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 O-C-N 121.375 -0.828 . . . . 1.74 111.329 173.655 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.4 t -64.63 -44.86 96.69 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.215 0 N-CA-C 108.541 -0.911 . . . . 1.47 108.541 178.599 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 11.5 mt -60.01 -43.67 93.06 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 N-CA-C 108.607 -0.886 . . . . 1.6299999999999999 108.607 178.473 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 39.6 t -62.95 -53.83 41.58 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 N-CA-C 109.262 -0.644 . . . . 1.6000000000000001 109.262 -178.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -53.19 -47.11 61.86 Favored Glycine 0 CA--C 1.53 1.006 0 N-CA-C 111.572 -0.611 . . . . 0.28000000000000003 111.572 175.432 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -60.34 -40.16 89.68 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 123.503 0.721 . . . . 1.6599999999999999 111.204 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 11.1 tp -63.42 -52.88 59.68 Favored 'General case' 0 N--CA 1.439 -0.991 0 N-CA-C 108.175 -1.046 . . . . 1.8 108.175 174.607 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 79.0 mt . . . . . 0 CA--C 1.531 0.216 0 C-N-CA 123.423 0.689 . . . . 2.6299999999999999 111.981 -177.054 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 59.9 tp . . . . . 0 N--CA 1.45 -0.453 0 N-CA-C 108.358 -0.979 . . . . 3.2799999999999998 108.358 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 10.9 tp -55.58 -46.02 77.29 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 117.9 0.318 . . . . 3.1600000000000001 111.186 176.394 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 75.2 t -55.18 -51.38 55.77 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 N-CA-C 110.221 -0.289 . . . . 2.0 110.221 174.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 50.6 t -56.01 -46.03 80.5 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 O-C-N 121.725 -0.61 . . . . 2.0800000000000001 110.339 177.336 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 55.0 t -55.68 -47.03 79.65 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 CA-C-N 118.766 0.712 . . . . 2.0099999999999998 110.179 177.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 70.6 t -55.44 -45.49 78.29 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 CA-C-N 118.834 0.743 . . . . 1.74 110.75 175.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 86.8 t -60.47 -47.75 91.32 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 N-CA-C 109.385 -0.598 . . . . 1.8 109.385 178.676 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 64.0 t -54.81 -48.61 73.33 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 C-N-CA 123.395 0.678 . . . . 1.99 110.495 177.454 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 39.8 t -57.34 -45.71 85.26 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 C-N-CA 123.574 0.749 . . . . 1.8899999999999999 110.248 177.447 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.6 -47.66 83.56 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 109.469 -0.567 . . . . 2.0600000000000001 109.469 177.075 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 16.6 t -61.93 -41.95 92.84 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.774 0 O-C-N 121.42 -0.8 . . . . 1.95 110.103 -179.588 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 5.9 t -62.24 -46.06 97.31 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 O-C-N 121.565 -0.71 . . . . 1.8600000000000001 109.869 175.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 1.6 t -56.79 -39.48 64.57 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.644 0 CA-C-N 119.152 0.887 . . . . 1.78 110.931 173.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.4 t -64.25 -46.97 91.82 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.188 0 N-CA-C 108.509 -0.923 . . . . 1.8200000000000001 108.509 177.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 10.2 mt -59.5 -44.11 92.22 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 N-CA-C 108.951 -0.759 . . . . 1.8400000000000001 108.951 179.328 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 39.5 t -64.51 -49.74 79.23 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 N-CA-C 109.164 -0.68 . . . . 1.8400000000000001 109.164 -177.543 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -51.37 -52.78 31.0 Favored Glycine 0 CA--C 1.527 0.81 0 N-CA-C 110.619 -0.992 . . . . 0.53000000000000003 110.619 173.479 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -55.18 -43.98 74.85 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 122.966 0.506 . . . . 1.8 111.176 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 10.7 tp -62.11 -46.51 88.73 Favored 'General case' 0 N--CA 1.442 -0.848 0 C-N-CA 124.012 0.925 . . . . 1.8700000000000001 109.617 176.327 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 65.5 mt . . . . . 0 CA--C 1.531 0.22 0 CA-C-N 118.287 0.494 . . . . 2.8199999999999998 111.532 -178.102 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 9.5 tt . . . . . 0 N--CA 1.454 -0.247 0 N-CA-C 108.346 -0.983 . . . . 3.2400000000000002 108.346 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 1.3 tt -56.23 -46.22 79.63 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-O 121.017 0.437 . . . . 3.25 110.4 175.313 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 84.6 t -56.53 -48.01 81.0 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 O-C-N 121.835 -0.541 . . . . 1.54 110.308 175.391 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 41.5 t -56.19 -45.99 81.1 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.185 0 O-C-N 121.758 -0.589 . . . . 1.7 109.885 177.11 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 54.0 t -54.89 -50.13 64.51 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 CA-C-N 119.29 0.95 . . . . 1.75 110.207 176.376 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 73.0 t -56.2 -45.87 81.12 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 O-C-N 121.743 -0.598 . . . . 1.6399999999999999 111.007 177.32 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 56.7 t -60.2 -47.32 92.59 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 N-CA-C 109.176 -0.676 . . . . 1.6000000000000001 109.176 179.509 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 51.0 t -54.81 -49.34 70.06 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 C-N-CA 123.591 0.756 . . . . 1.6699999999999999 110.109 177.233 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 42.8 t -57.54 -46.68 86.13 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 O-C-N 121.817 -0.552 . . . . 1.73 110.528 177.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -58.5 -47.51 83.85 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 123.248 0.619 . . . . 1.71 109.491 177.72 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 14.4 t -62.29 -41.18 90.57 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.842 0 C-N-CA 123.868 0.867 . . . . 1.6799999999999999 109.958 -179.399 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 5.2 t -62.69 -47.16 94.22 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.49 0 O-C-N 121.605 -0.685 . . . . 1.6000000000000001 109.766 175.652 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 1.6 t -56.01 -39.7 59.35 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.643 0 CA-C-N 118.949 0.795 . . . . 1.52 111.211 173.62 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.4 t -65.09 -45.84 93.05 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.191 0 N-CA-C 108.517 -0.919 . . . . 1.72 108.517 178.357 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 11.3 mt -59.93 -43.85 93.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 N-CA-C 108.729 -0.841 . . . . 1.5900000000000001 108.729 179.104 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 39.7 t -64.14 -51.4 69.34 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 N-CA-C 109.301 -0.629 . . . . 1.6100000000000001 109.301 -178.242 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -53.13 -49.6 55.19 Favored Glycine 0 CA--C 1.528 0.87 0 N-CA-C 110.905 -0.878 . . . . 0.28000000000000003 110.905 175.231 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -56.98 -45.43 82.92 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 123.049 0.539 . . . . 1.6000000000000001 111.079 178.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 10.0 tp -58.79 -50.01 75.54 Favored 'General case' 0 N--CA 1.442 -0.853 0 C-N-CA 124.004 0.922 . . . . 1.73 109.221 176.696 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 72.9 mt . . . . . 0 CA--C 1.532 0.269 0 CA-C-N 118.033 0.379 . . . . 2.5499999999999998 111.115 -178.996 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.1 tm? . . . . . 0 N--CA 1.455 -0.197 0 N-CA-C 108.348 -0.982 . . . . 3.2999999999999998 108.348 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 1.3 tt -57.81 -46.11 85.14 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-O 121.032 0.444 . . . . 3.2000000000000002 110.314 177.028 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 58.4 t -57.44 -48.09 83.51 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 O-C-N 122.022 -0.424 . . . . 1.77 109.869 176.315 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 48.2 t -56.47 -45.89 82.05 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.232 0 CA-C-O 118.871 -0.585 . . . . 1.6200000000000001 110.074 176.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 48.3 t -55.31 -50.47 64.68 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 CA-C-N 119.379 0.99 . . . . 1.8100000000000001 110.182 176.528 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 71.3 t -55.84 -46.17 79.95 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 O-C-N 121.812 -0.555 . . . . 1.5 110.834 177.732 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 56.0 t -60.41 -47.01 94.32 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.227 0 N-CA-C 109.196 -0.668 . . . . 1.5900000000000001 109.196 179.508 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 47.7 t -55.36 -48.43 76.85 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 C-N-CA 123.708 0.803 . . . . 1.72 110.358 177.322 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 44.5 t -57.75 -46.97 86.86 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 CA-C-N 118.603 0.638 . . . . 1.55 110.417 177.602 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -59.1 -47.27 85.86 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 109.456 -0.572 . . . . 1.8 109.456 177.681 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 15.5 t -61.89 -39.48 83.7 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.886 0 C-N-CA 124.007 0.923 . . . . 1.6599999999999999 110.095 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 3.3 t -62.63 -48.2 89.33 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.38 0 C-N-CA 123.419 0.688 . . . . 1.6499999999999999 109.691 174.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 1.4 t -55.12 -41.07 57.93 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 CA-C-N 119.176 0.898 . . . . 1.74 111.415 173.216 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.4 t -63.97 -45.33 97.1 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.198 0 N-CA-C 108.549 -0.908 . . . . 1.6499999999999999 108.549 178.566 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 11.8 mt -60.09 -42.01 88.45 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 N-CA-C 108.719 -0.845 . . . . 1.74 108.719 178.722 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 40.4 t -62.62 -55.7 22.18 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 N-CA-C 109.074 -0.713 . . . . 1.6899999999999999 109.074 179.486 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -52.47 -45.41 59.07 Favored Glycine 0 CA--C 1.531 1.089 0 N-CA-C 111.719 -0.553 . . . . 0.31 111.719 177.11 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -56.46 -47.57 78.87 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 123.427 0.691 . . . . 1.6200000000000001 110.566 175.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 8.5 tp -58.18 -49.96 75.2 Favored 'General case' 0 N--CA 1.441 -0.899 0 C-N-CA 123.947 0.899 . . . . 1.8799999999999999 109.142 178.699 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 5.5 mp . . . . . 0 CA--C 1.534 0.365 0 CA-C-N 119.27 0.941 . . . . 3.21 112.142 174.389 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 37.4 tp . . . . . 0 N--CA 1.454 -0.238 0 N-CA-C 108.778 -0.823 . . . . 3.1800000000000002 108.778 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 1.6 tt -56.8 -46.25 81.7 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-O 121.132 0.491 . . . . 3.5099999999999998 110.3 176.218 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 40.6 t -59.0 -47.02 91.25 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 N-CA-C 109.412 -0.588 . . . . 1.74 109.412 176.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 57.4 t -56.66 -46.15 82.81 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.219 0 CA-C-O 118.821 -0.609 . . . . 1.8100000000000001 110.104 176.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 54.1 t -55.93 -50.57 68.33 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.441 0 CA-C-N 119.35 0.977 . . . . 2.04 109.773 177.506 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 77.3 t -56.23 -46.36 81.38 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 O-C-N 121.987 -0.446 . . . . 1.6599999999999999 110.889 177.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 54.7 t -60.94 -46.87 95.7 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 N-CA-C 109.104 -0.702 . . . . 1.6899999999999999 109.104 -179.576 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 48.5 t -54.62 -49.79 64.53 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.426 0 C-N-CA 123.421 0.688 . . . . 1.6599999999999999 110.179 176.755 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 46.2 t -58.63 -46.85 90.07 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.425 0 CA-C-N 118.395 0.543 . . . . 1.6100000000000001 110.588 179.014 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -59.39 -47.36 85.73 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 109.296 -0.631 . . . . 1.72 109.296 178.318 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.8 t -62.06 -40.05 86.01 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.9 0 C-N-CA 123.977 0.911 . . . . 1.5900000000000001 109.997 -179.814 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 3.5 t -62.99 -47.98 90.2 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.412 0 CA-C-N 118.702 0.683 . . . . 1.6200000000000001 109.83 175.248 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 1.5 t -55.27 -40.63 57.3 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 CA-C-N 118.98 0.809 . . . . 1.5800000000000001 111.048 173.851 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.4 t -65.67 -45.96 90.6 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 N-CA-C 108.674 -0.862 . . . . 1.4299999999999999 108.674 179.215 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 12.3 mt -58.86 -44.57 90.89 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 N-CA-C 108.282 -1.007 . . . . 1.5600000000000001 108.282 179.133 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 39.3 t -64.1 -54.46 31.14 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 N-CA-C 109.511 -0.552 . . . . 1.6100000000000001 109.511 -177.457 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -55.18 -47.48 73.98 Favored Glycine 0 CA--C 1.529 0.939 0 N-CA-C 111.439 -0.665 . . . . 0.34999999999999998 111.439 177.349 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -57.72 -42.59 84.13 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 123.317 0.647 . . . . 1.77 111.282 178.281 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 11.6 tp -63.08 -53.06 59.57 Favored 'General case' 0 N--CA 1.439 -1.009 0 N-CA-C 108.291 -1.003 . . . . 1.95 108.291 177.257 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 84.3 mt . . . . . 0 CA--C 1.533 0.296 0 CA-C-N 118.361 0.528 . . . . 3.1099999999999999 111.41 -177.825 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.4 tm? . . . . . 0 CA--C 1.531 0.236 0 N-CA-C 108.894 -0.78 . . . . 3.29 108.894 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -56.09 -46.0 79.21 Favored 'General case' 0 CA--C 1.533 0.3 0 O-C-N 121.891 -0.506 . . . . 3.29 110.251 174.886 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 85.3 t -56.16 -48.43 79.25 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 O-C-N 121.814 -0.554 . . . . 1.73 110.136 174.734 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 44.7 t -54.78 -47.05 74.82 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 CA-C-N 118.617 0.644 . . . . 1.78 109.822 176.293 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 50.3 t -55.02 -48.44 75.83 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 CA-C-N 119.028 0.831 . . . . 1.74 110.754 176.167 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 70.6 t -55.42 -44.99 78.03 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 O-C-N 121.447 -0.783 . . . . 1.76 110.71 175.385 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 87.0 t -60.4 -46.18 95.54 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.22 0 N-CA-C 109.073 -0.714 . . . . 1.74 109.073 178.362 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 72.4 t -55.02 -49.5 70.97 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 C-N-CA 123.218 0.607 . . . . 1.8300000000000001 110.069 177.09 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 46.5 t -56.93 -47.85 82.53 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 O-C-N 121.798 -0.564 . . . . 1.5 110.671 177.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -58.34 -47.57 83.36 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 123.23 0.612 . . . . 1.6499999999999999 109.354 177.732 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 14.2 t -62.61 -39.62 85.31 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.92 0 C-N-CA 124.162 0.985 . . . . 1.54 110.066 -179.209 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 3.6 t -63.44 -48.25 87.99 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 CA-C-N 118.742 0.701 . . . . 1.6499999999999999 109.56 175.472 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 1.5 t -55.43 -40.5 58.23 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.617 0 CA-C-N 118.909 0.777 . . . . 1.6599999999999999 110.953 173.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.4 t -66.17 -45.06 91.19 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.237 0 N-CA-C 108.746 -0.835 . . . . 1.6899999999999999 108.746 179.319 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 12.5 mt -59.05 -44.86 92.35 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.576 0 N-CA-C 108.285 -1.005 . . . . 1.7 108.285 178.598 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 40.2 t -63.73 -55.4 22.74 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 N-CA-C 109.347 -0.612 . . . . 1.5800000000000001 109.347 -177.672 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -53.34 -47.51 61.95 Favored Glycine 0 CA--C 1.529 0.941 0 N-CA-C 111.428 -0.669 . . . . 0.32000000000000001 111.428 176.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -57.89 -43.41 86.1 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 123.323 0.649 . . . . 1.73 111.142 178.6 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 13.5 tp -67.04 -45.28 77.93 Favored 'General case' 0 N--CA 1.439 -1.008 0 C-N-CA 123.698 0.799 . . . . 2.04 109.156 178.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 84.1 mt . . . . . 0 CA--C 1.533 0.311 0 CA-C-N 119.087 0.858 . . . . 2.7400000000000002 110.562 176.692 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.452 -0.36 0 N-CA-C 108.16 -1.052 . . . . 4.0 108.16 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 10.6 tp -55.33 -45.83 76.38 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 122.648 0.379 . . . . 2.9199999999999999 111.259 175.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 74.0 t -54.97 -50.15 65.06 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 N-CA-C 109.989 -0.375 . . . . 1.95 109.989 174.441 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 42.2 t -56.54 -47.33 82.12 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 CA-C-N 118.43 0.559 . . . . 1.74 110.185 178.083 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 61.5 t -54.55 -51.18 52.74 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 CA-C-N 119.032 0.833 . . . . 1.53 110.268 177.149 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 60.7 t -56.52 -44.87 81.65 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 O-C-N 121.819 -0.55 . . . . 1.73 110.825 177.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 53.8 t -60.83 -47.4 93.46 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.267 0 N-CA-C 109.033 -0.729 . . . . 1.6299999999999999 109.033 179.27 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 55.4 t -54.27 -50.29 57.31 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 C-N-CA 123.32 0.648 . . . . 1.6100000000000001 110.148 176.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 43.1 t -57.73 -46.97 86.8 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 C-N-CA 123.052 0.541 . . . . 1.6299999999999999 110.811 178.495 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -59.34 -46.99 87.08 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 123.382 0.673 . . . . 1.6399999999999999 109.328 178.123 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 15.5 t -61.89 -40.73 88.14 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.882 0 C-N-CA 124.077 0.951 . . . . 1.6799999999999999 109.898 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 4.1 t -62.24 -47.79 91.42 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.396 0 O-C-N 121.554 -0.716 . . . . 1.6799999999999999 109.78 174.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 1.4 t -55.86 -39.87 58.93 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 CA-C-N 119.137 0.88 . . . . 1.6399999999999999 111.459 173.587 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.4 t -64.74 -45.09 96.21 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 N-CA-C 108.492 -0.929 . . . . 1.4399999999999999 108.492 178.111 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 11.3 mt -60.14 -42.85 91.52 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 N-CA-C 108.725 -0.843 . . . . 1.53 108.725 178.674 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 40.5 t -63.1 -52.67 56.04 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 N-CA-C 109.294 -0.632 . . . . 1.5900000000000001 109.294 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -53.07 -46.49 61.69 Favored Glycine 0 CA--C 1.529 0.968 0 N-CA-C 111.551 -0.62 . . . . 0.32000000000000001 111.551 175.858 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -57.47 -49.12 77.29 Favored 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 123.409 0.684 . . . . 1.6299999999999999 110.406 177.476 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 10.3 tp -58.88 -46.17 88.44 Favored 'General case' 0 N--CA 1.44 -0.935 0 C-N-CA 123.739 0.816 . . . . 1.7 109.206 178.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 84.9 mt . . . . . 0 CA--C 1.533 0.314 0 O-C-N 121.792 -0.568 . . . . 2.73 111.169 178.737 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 47.8 tp . . . . . 0 N--CA 1.454 -0.233 0 N-CA-C 109.233 -0.654 . . . . 3.3700000000000001 109.233 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -57.53 -46.13 84.23 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-O 121.26 0.553 . . . . 3.4199999999999999 110.231 175.372 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 43.6 t -60.46 -45.15 97.3 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 N-CA-C 109.384 -0.599 . . . . 1.8300000000000001 109.384 176.571 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 72.2 t -56.32 -45.82 81.53 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.217 0 CA-C-O 118.876 -0.583 . . . . 1.71 110.132 175.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 55.5 t -56.44 -48.98 79.21 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 CA-C-N 119.504 1.047 . . . . 1.8400000000000001 110.102 177.125 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 69.9 t -55.76 -45.75 79.51 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 O-C-N 121.786 -0.571 . . . . 1.5800000000000001 110.905 176.449 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 53.2 t -60.23 -46.87 94.13 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.18 0 N-CA-C 109.248 -0.649 . . . . 1.54 109.248 178.841 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 48.9 t -54.48 -49.42 65.81 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 C-N-CA 123.7 0.8 . . . . 1.6399999999999999 110.118 177.145 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 42.2 t -57.01 -47.19 83.93 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 CA-C-N 118.435 0.561 . . . . 1.8200000000000001 110.537 177.744 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.19 -47.44 83.43 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 123.053 0.541 . . . . 1.76 109.553 177.546 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 16.0 t -62.94 -40.4 88.78 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.893 0 C-N-CA 123.909 0.884 . . . . 1.6699999999999999 110.049 -178.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 7.5 t -63.55 -47.13 92.9 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.48 0 O-C-N 121.542 -0.724 . . . . 1.5700000000000001 109.503 175.841 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 1.4 t -54.69 -41.37 55.62 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.579 0 CA-C-N 119.107 0.867 . . . . 1.6299999999999999 111.212 172.805 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.4 t -64.51 -45.7 94.9 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.19 0 N-CA-C 108.627 -0.879 . . . . 1.76 108.627 179.249 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 11.1 mt -59.89 -43.99 93.35 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 N-CA-C 108.75 -0.833 . . . . 1.75 108.75 178.689 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 37.4 t -64.89 -49.74 78.43 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.266 0 N-CA-C 109.535 -0.543 . . . . 1.7 109.535 -176.814 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -55.77 -50.33 61.5 Favored Glycine 0 CA--C 1.528 0.897 0 N-CA-C 111.128 -0.789 . . . . 0.41999999999999998 111.128 174.229 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -55.15 -42.3 72.92 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 117.325 0.563 . . . . 1.6100000000000001 111.048 178.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 10.2 tp -59.87 -62.36 1.93 Allowed 'General case' 0 N--CA 1.439 -1.023 0 N-CA-C 108.512 -0.921 . . . . 1.6899999999999999 108.512 175.052 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . 0.269 2.9 pp . . . . . 0 N--CA 1.465 0.319 0 CA-C-N 119.223 0.92 . . . . 4.2300000000000004 113.267 -170.357 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.9 tt . . . . . 0 CA--C 1.534 0.358 0 N-CA-C 108.288 -1.005 . . . . 3.3700000000000001 108.288 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.24 -46.06 79.75 Favored 'General case' 0 CA--C 1.535 0.396 0 O-C-N 121.927 -0.483 . . . . 3.71 110.369 176.062 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 89.2 t -55.89 -47.24 80.05 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 O-C-N 121.58 -0.7 . . . . 1.72 110.591 174.655 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 51.1 t -56.27 -45.96 81.36 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.19 0 O-C-N 121.507 -0.745 . . . . 1.72 109.892 176.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 73.0 t -53.74 -50.0 54.06 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 CA-C-N 119.246 0.93 . . . . 1.6799999999999999 110.483 174.689 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 93.2 t -55.5 -45.1 78.38 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 O-C-N 121.696 -0.627 . . . . 1.6200000000000001 111.085 176.692 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 73.8 t -60.42 -46.17 95.61 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.159 0 O-C-N 121.597 -0.689 . . . . 1.6899999999999999 109.25 178.77 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 53.0 t -55.84 -48.01 78.84 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 C-N-CA 123.407 0.683 . . . . 1.6599999999999999 110.36 177.271 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 47.0 t -56.5 -46.45 82.32 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 O-C-N 121.765 -0.585 . . . . 1.51 110.524 176.4 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -58.92 -46.69 87.35 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 123.076 0.55 . . . . 1.76 109.63 176.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 13.5 t -61.62 -40.59 87.17 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.839 0 O-C-N 121.255 -0.903 . . . . 1.5800000000000001 110.063 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 5.4 t -62.08 -47.95 90.77 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.416 0 O-C-N 121.511 -0.743 . . . . 1.6200000000000001 109.841 174.808 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 1.4 t -54.94 -40.76 54.74 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 CA-C-N 119.088 0.858 . . . . 1.5800000000000001 111.493 173.065 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.4 t -63.88 -45.24 97.54 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.179 0 N-CA-C 108.472 -0.936 . . . . 1.76 108.472 178.535 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 10.1 mt -59.42 -43.74 91.11 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 N-CA-C 108.831 -0.803 . . . . 1.9299999999999999 108.831 177.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 40.9 t -63.36 -52.37 59.2 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 N-CA-C 109.489 -0.56 . . . . 1.6799999999999999 109.489 -178.444 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -52.74 -50.46 49.46 Favored Glycine 0 CA--C 1.528 0.871 0 N-CA-C 111.007 -0.837 . . . . 0.34000000000000002 111.007 174.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -55.24 -44.67 75.7 Favored 'General case' 0 CA--C 1.53 0.182 0 O-C-N 122.284 -0.539 . . . . 1.5800000000000001 111.075 179.198 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 11.0 tp -61.26 -50.64 72.22 Favored 'General case' 0 N--CA 1.442 -0.869 0 C-N-CA 123.599 0.76 . . . . 1.9299999999999999 108.959 176.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 73.7 mt . . . . . 0 CA--C 1.532 0.265 0 CA-C-N 118.264 0.484 . . . . 2.4700000000000002 111.642 -179.148 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.6 tt . . . . . 0 CA--C 1.534 0.354 0 N-CA-C 108.566 -0.902 . . . . 3.3100000000000001 108.566 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -55.76 -45.82 77.99 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.223 0.609 . . . . 3.8999999999999999 110.344 176.403 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 96.3 t -55.75 -48.76 77.57 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 O-C-N 121.813 -0.554 . . . . 1.78 110.398 174.811 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 55.5 t -55.77 -47.37 79.49 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 O-C-N 121.659 -0.65 . . . . 1.9099999999999999 109.935 176.646 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 72.0 t -54.29 -49.67 61.97 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 CA-C-N 118.783 0.719 . . . . 1.8700000000000001 110.389 176.247 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 73.5 t -56.0 -44.7 79.18 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 O-C-N 121.641 -0.662 . . . . 1.6599999999999999 110.864 177.164 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 54.6 t -59.9 -48.09 89.07 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.168 0 N-CA-C 109.067 -0.716 . . . . 1.6599999999999999 109.067 178.329 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 60.1 t -55.19 -48.92 75.77 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 C-N-CA 122.943 0.497 . . . . 2.1699999999999999 110.32 177.315 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 42.2 t -56.74 -45.76 82.98 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 C-N-CA 123.632 0.773 . . . . 1.8100000000000001 110.601 177.237 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.25 -47.91 83.6 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 123.402 0.681 . . . . 1.8200000000000001 109.405 177.455 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 20.3 t -61.51 -40.88 87.99 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.838 0 O-C-N 121.484 -0.76 . . . . 2.02 110.0 179.481 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 4.1 t -62.0 -45.8 97.9 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.39 0 C-N-CA 123.556 0.742 . . . . 1.75 109.887 175.029 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 1.4 t -57.26 -40.46 73.9 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 CA-C-N 119.437 1.017 . . . . 1.51 111.34 173.329 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.4 t -62.87 -45.3 99.21 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 N-CA-C 108.398 -0.964 . . . . 1.8100000000000001 108.398 177.339 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 10.9 mt -61.22 -41.37 89.33 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 N-CA-C 109.232 -0.655 . . . . 1.72 109.232 178.675 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 32.9 t -62.74 -50.3 80.27 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.277 0 N-CA-C 108.957 -0.757 . . . . 1.77 108.957 179.071 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -52.65 -47.23 58.34 Favored Glycine 0 CA--C 1.53 1.021 0 N-CA-C 111.527 -0.629 . . . . 0.34000000000000002 111.527 173.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -57.01 -49.58 75.35 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 123.224 0.61 . . . . 1.7 110.551 177.583 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 10.4 tp -58.6 -45.63 88.72 Favored 'General case' 0 N--CA 1.441 -0.909 0 C-N-CA 124.351 1.06 . . . . 2.1400000000000001 109.216 178.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 66.4 mt . . . . . 0 CA--C 1.533 0.311 0 O-C-N 121.713 -0.617 . . . . 2.6400000000000001 111.017 177.871 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.4 tt . . . . . 0 N--CA 1.452 -0.336 0 N-CA-C 108.107 -1.072 . . . . 2.9700000000000002 108.107 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 10.3 tp -55.39 -45.89 76.58 Favored 'General case' 0 N--CA 1.453 -0.293 0 O-C-N 121.81 -0.556 . . . . 3.0899999999999999 111.375 174.579 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 94.3 t -56.15 -49.13 77.67 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 N-CA-C 110.068 -0.345 . . . . 1.6699999999999999 110.068 174.623 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 49.2 t -56.07 -46.5 80.85 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 O-C-N 121.796 -0.565 . . . . 1.76 110.195 177.502 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 53.1 t -54.64 -50.55 58.76 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 CA-C-N 118.952 0.796 . . . . 1.6399999999999999 110.043 176.433 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 78.7 t -55.6 -45.23 78.78 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 O-C-N 121.859 -0.526 . . . . 1.5600000000000001 110.8 177.142 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 61.9 t -60.15 -47.47 91.9 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.136 0 N-CA-C 109.191 -0.67 . . . . 1.52 109.191 178.829 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 55.7 t -55.15 -49.16 74.27 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 C-N-CA 123.487 0.715 . . . . 1.8500000000000001 110.25 177.548 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 46.1 t -57.43 -46.25 85.7 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 C-N-CA 123.246 0.618 . . . . 1.9399999999999999 110.473 177.631 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -59.06 -47.25 85.91 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 123.204 0.602 . . . . 1.55 109.422 177.374 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 14.2 t -61.61 -41.11 89.01 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.821 0 C-N-CA 123.814 0.846 . . . . 1.79 110.003 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 4.1 t -62.24 -47.14 94.48 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 O-C-N 121.541 -0.724 . . . . 1.5700000000000001 109.852 175.172 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 1.4 t -56.11 -39.97 61.74 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.6 0 CA-C-N 119.085 0.857 . . . . 1.6799999999999999 111.349 173.418 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.4 t -64.03 -46.0 95.1 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.203 0 N-CA-C 108.411 -0.959 . . . . 1.6200000000000001 108.411 177.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 10.6 mt -59.95 -43.0 91.34 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 N-CA-C 108.825 -0.806 . . . . 1.73 108.825 178.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 39.2 t -61.71 -54.71 31.05 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 N-CA-C 108.933 -0.766 . . . . 1.5800000000000001 108.933 179.827 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -52.59 -45.17 59.93 Favored Glycine 0 CA--C 1.53 0.985 0 N-CA-C 111.703 -0.559 . . . . 0.32000000000000001 111.703 176.535 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -57.77 -44.78 86.41 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 123.498 0.719 . . . . 1.6399999999999999 110.712 177.274 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 9.7 tp -60.9 -51.97 67.04 Favored 'General case' 0 N--CA 1.439 -0.983 0 C-N-CA 124.014 0.926 . . . . 1.9099999999999999 109.235 177.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 5.5 mp . . . . . 0 CA--C 1.533 0.303 0 CA-C-N 119.231 0.923 . . . . 3.3399999999999999 112.14 175.546 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 63.2 tp . . . . . 0 N--CA 1.451 -0.395 0 N-CA-C 108.6 -0.889 . . . . 3.3300000000000001 108.6 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 1.6 tt -58.42 -46.13 87.07 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-O 120.984 0.421 . . . . 3.6600000000000001 110.469 178.498 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 71.4 t -55.8 -49.39 74.93 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 N-CA-C 109.863 -0.421 . . . . 1.96 109.863 174.684 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 25.5 t -57.0 -45.61 83.86 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.365 0 CA-C-O 118.505 -0.759 . . . . 1.96 110.252 178.514 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 49.3 t -54.2 -52.11 41.06 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 CA-C-N 119.693 1.133 . . . . 1.8899999999999999 110.008 177.277 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 85.1 t -57.41 -47.18 85.3 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 O-C-N 121.949 -0.469 . . . . 1.76 111.004 178.67 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 57.3 t -60.66 -45.35 97.64 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 N-CA-C 109.219 -0.66 . . . . 1.6599999999999999 109.219 -179.132 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 46.8 t -55.68 -48.79 77.33 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 C-N-CA 124.069 0.948 . . . . 1.8500000000000001 110.099 177.076 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 44.2 t -57.88 -47.71 85.63 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 CA-C-N 118.779 0.718 . . . . 1.6599999999999999 110.601 177.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -59.23 -46.65 87.89 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 109.551 -0.537 . . . . 1.8999999999999999 109.551 178.327 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.5 t -62.55 -39.36 84.25 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.923 0 C-N-CA 124.442 1.097 . . . . 1.74 110.04 -179.682 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 3.4 t -63.23 -48.92 85.26 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.391 0 CA-C-N 118.963 0.801 . . . . 1.78 109.569 175.285 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 1.3 t -53.99 -41.84 51.57 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 CA-C-N 118.881 0.764 . . . . 1.77 111.286 173.242 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.4 t -65.43 -44.45 94.39 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.266 0 N-CA-C 108.667 -0.864 . . . . 1.9399999999999999 108.667 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 12.3 mt -59.34 -44.29 92.06 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.57 0 N-CA-C 108.379 -0.971 . . . . 1.6100000000000001 108.379 178.117 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 39.2 t -64.36 -52.95 49.03 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 N-CA-C 109.568 -0.53 . . . . 1.6499999999999999 109.568 -177.159 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -55.22 -48.24 69.81 Favored Glycine 0 CA--C 1.529 0.934 0 N-CA-C 111.512 -0.635 . . . . 0.33000000000000002 111.512 175.846 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -55.56 -44.98 77.35 Favored 'General case' 0 N--CA 1.454 -0.226 0 O-C-N 122.15 -0.618 . . . . 1.77 110.592 177.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 11.9 tp -62.92 -53.9 46.92 Favored 'General case' 0 N--CA 1.437 -1.102 0 C-N-CA 123.613 0.765 . . . . 1.95 109.045 179.187 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . 0.305 3.1 pp . . . . . 0 CA--C 1.531 0.239 0 CA-C-N 119.375 0.989 . . . . 4.2800000000000002 112.568 -175.121 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 3.9 mm? . . . . . 0 N--CA 1.474 0.758 0 N-CA-C 105.083 -2.192 . . . . 19.359999999999999 105.083 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 7.5 ptm180 48.49 -176.25 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.969 1.707 . . . . 17.920000000000002 112.846 -169.477 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 47.8 pt -74.27 140.07 76.0 Favored Pre-proline 0 N--CA 1.448 -0.545 0 N-CA-C 106.811 -1.551 . . . . 14.710000000000001 106.811 163.332 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -64.65 -66.28 0.05 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.007 0 C-N-CA 121.653 1.569 . . . . 9.6899999999999995 109.951 -176.323 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 48.6 t -163.72 63.77 0.16 Allowed 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 106.276 -1.75 . . . . 10.359999999999999 106.276 -179.253 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 46.0 t 88.24 134.59 0.04 OUTLIER Pre-proline 0 CA--C 1.533 0.315 0 C-N-CA 128.587 2.755 . . . . 9.7300000000000004 108.351 -164.381 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -61.47 136.44 63.44 Favored 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 121.667 1.578 . . . . 6.8600000000000003 110.894 177.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.4 t -80.72 -133.25 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 C-N-CA 125.69 1.596 . . . . 6.25 108.608 -178.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 14.7 p-10 -46.45 -27.78 1.19 Allowed 'General case' 0 CA--C 1.539 0.534 0 O-C-N 120.858 -1.151 . . . . 4.5099999999999998 113.409 174.27 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -54.03 -35.32 61.84 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 123.882 0.873 . . . . 4.04 110.182 174.624 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 55.4 tptt -58.29 -54.2 49.73 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 123.098 0.559 . . . . 5.3399999999999999 109.785 175.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 38.1 ptt180 -69.52 -26.37 64.49 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 119.567 -0.853 . . . . 7.04 111.339 -177.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -59.04 -51.0 71.96 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 108.69 -0.856 . . . . 4.0700000000000003 108.69 168.615 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 10.2 tp -55.23 -45.58 75.97 Favored 'General case' 0 N--CA 1.453 -0.309 0 O-C-N 121.873 -0.517 . . . . 3.21 111.149 176.081 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 89.7 t -55.12 -48.82 75.72 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 O-C-N 122.199 -0.313 . . . . 1.53 110.156 174.544 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 55.3 t -56.54 -46.79 82.58 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 CA-C-N 118.612 0.642 . . . . 1.6899999999999999 110.182 177.119 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 72.3 t -54.52 -50.46 58.32 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 CA-C-N 118.771 0.714 . . . . 2.1800000000000002 110.451 175.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 73.0 t -56.27 -44.34 79.25 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 O-C-N 121.636 -0.665 . . . . 1.96 110.843 177.537 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 46.4 t -60.04 -48.11 89.21 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.177 0 N-CA-C 108.904 -0.776 . . . . 1.6799999999999999 108.904 178.262 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 41.9 t -54.02 -50.19 55.64 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 C-N-CA 123.203 0.601 . . . . 1.8 110.486 176.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 46.9 t -56.96 -46.69 83.98 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 C-N-CA 123.4 0.68 . . . . 2.04 110.79 177.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -59.38 -46.93 87.31 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 123.352 0.661 . . . . 1.5700000000000001 109.39 177.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 13.7 t -61.32 -40.76 87.24 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.795 0 C-N-CA 123.881 0.873 . . . . 1.6699999999999999 109.951 179.291 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 3.2 t -62.0 -47.64 92.24 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.359 0 O-C-N 121.56 -0.713 . . . . 1.77 110.028 174.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 1.4 t -55.36 -40.66 58.28 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 CA-C-N 119.115 0.87 . . . . 1.76 111.407 173.262 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.4 t -63.9 -46.11 95.09 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.235 0 N-CA-C 108.349 -0.982 . . . . 1.76 108.349 178.363 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 10.8 mt -59.34 -42.61 87.93 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 N-CA-C 108.92 -0.771 . . . . 1.6799999999999999 108.92 178.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 39.6 t -63.37 -52.79 53.76 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 N-CA-C 109.423 -0.584 . . . . 1.6499999999999999 109.423 -179.673 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -52.27 -47.27 56.2 Favored Glycine 0 CA--C 1.53 1.009 0 N-CA-C 111.527 -0.629 . . . . 0.37 111.527 175.363 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -56.88 -49.83 74.33 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 123.446 0.698 . . . . 1.5900000000000001 110.46 178.231 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 11.2 tp -59.46 -44.63 92.93 Favored 'General case' 0 N--CA 1.44 -0.939 0 C-N-CA 123.776 0.83 . . . . 1.78 109.465 178.409 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 85.3 mt -61.3 -39.78 91.71 Favored 'General case' 0 CA--C 1.533 0.302 0 O-C-N 121.431 -0.793 . . . . 2.52 111.23 178.01 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 16.9 tpt -63.65 -44.38 94.02 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 118.145 0.43 . . . . 5.8700000000000001 110.354 173.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -179.9 -67.6 0.07 OUTLIER Glycine 0 CA--C 1.528 0.864 0 N-CA-C 111.022 -0.831 . . . . 3.52 111.022 176.247 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 3.1 mm? . . . . . 0 N--CA 1.447 -0.589 0 N-CA-C 104.108 -2.553 . . . . 7.0499999999999998 104.108 175.317 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.473 0.692 0 CA-C-O 118.198 -0.906 . . . . 17.350000000000001 108.575 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 62.8 ttm-85 -153.83 91.47 1.46 Allowed 'General case' 0 N--CA 1.455 -0.183 0 N-CA-C 107.608 -1.256 . . . . 17.399999999999999 107.608 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 42.9 mm -117.37 82.09 14.56 Favored Pre-proline 0 CA--C 1.538 0.512 0 C-N-CA 124.344 1.058 . . . . 12.49 108.689 -175.015 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -79.39 -38.41 0.41 Allowed 'Trans proline' 0 N--CA 1.456 -0.705 0 C-N-CA 122.59 2.193 . . . . 8.8200000000000003 111.001 179.496 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 96.8 m 64.37 19.68 11.88 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 125.637 1.575 . . . . 8.75 111.298 -177.345 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 11.6 t -53.84 -55.08 39.54 Favored Pre-proline 0 CA--C 1.537 0.462 0 C-N-CA 124.226 1.01 . . . . 8.0800000000000001 112.642 -174.665 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -79.07 7.45 4.36 Favored 'Trans proline' 0 CA--C 1.539 0.773 0 C-N-CA 121.776 1.65 . . . . 4.7999999999999998 113.121 177.502 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.4 t -107.16 -133.33 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 C-N-CA 125.493 1.517 . . . . 3.8100000000000001 107.747 -174.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 53.2 p-10 -42.23 -39.57 2.11 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.951 1.3 . . . . 4.4699999999999998 114.161 179.322 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -57.95 -49.14 77.81 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 119.243 0.929 . . . . 4.2300000000000004 109.569 174.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 3.3 tmtm? -59.79 -48.19 82.67 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 108.804 -0.813 . . . . 4.8799999999999999 108.804 177.033 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 39.9 ttt-85 -66.46 -26.86 67.4 Favored 'General case' 0 N--CA 1.448 -0.529 0 O-C-N 122.171 -0.331 . . . . 6.1600000000000001 111.673 -176.107 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -67.57 -50.35 58.87 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 107.839 -1.171 . . . . 3.4900000000000002 107.839 173.177 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -55.48 -45.89 76.95 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-O 120.835 0.35 . . . . 3.5099999999999998 110.639 176.831 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 64.4 t -56.15 -49.94 73.25 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 O-C-N 121.946 -0.471 . . . . 1.9399999999999999 109.77 174.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 38.1 t -55.77 -45.79 79.58 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 CA-C-N 118.404 0.547 . . . . 1.73 110.322 177.447 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 54.2 t -55.72 -51.17 62.11 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.375 0 CA-C-N 119.158 0.89 . . . . 1.6599999999999999 110.314 177.113 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 73.3 t -56.22 -45.18 80.98 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 O-C-N 121.791 -0.568 . . . . 1.54 110.903 177.341 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 54.8 t -60.87 -46.4 96.41 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 N-CA-C 109.152 -0.684 . . . . 1.52 109.152 179.504 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 47.8 t -55.19 -49.01 75.62 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 C-N-CA 123.481 0.712 . . . . 1.5700000000000001 110.278 176.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 46.2 t -57.08 -46.85 84.46 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 O-C-N 121.815 -0.553 . . . . 1.55 110.635 177.244 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.13 -47.35 83.59 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 123.265 0.626 . . . . 1.6299999999999999 109.524 177.135 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 11.7 t -62.38 -40.8 89.31 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.814 0 C-N-CA 124.033 0.933 . . . . 1.6699999999999999 109.939 -179.093 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 5.1 t -62.63 -47.98 90.37 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.411 0 O-C-N 121.649 -0.657 . . . . 1.6299999999999999 109.654 175.273 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 1.5 t -55.09 -40.35 54.32 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.585 0 CA-C-N 119.051 0.842 . . . . 1.6499999999999999 111.144 173.453 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.4 t -65.32 -45.48 93.3 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.249 0 N-CA-C 108.687 -0.857 . . . . 1.74 108.687 179.025 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 11.2 mt -59.85 -44.55 94.44 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.525 0 N-CA-C 108.566 -0.902 . . . . 1.8200000000000001 108.566 178.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 38.8 t -63.97 -51.77 65.02 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 N-CA-C 109.371 -0.603 . . . . 1.73 109.371 -177.49 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -54.0 -49.81 57.51 Favored Glycine 0 CA--C 1.528 0.868 0 N-CA-C 111.063 -0.815 . . . . 0.29999999999999999 111.063 175.028 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -56.01 -41.9 75.61 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 123.305 0.642 . . . . 1.6699999999999999 111.313 179.465 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 10.7 tp -61.2 -58.09 9.75 Favored 'General case' 0 N--CA 1.439 -0.987 0 N-CA-C 108.338 -0.986 . . . . 1.8 108.338 174.054 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 75.6 mt -56.5 -36.7 69.46 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 123.823 0.849 . . . . 2.73 112.497 -173.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 50.7 mtt -57.67 -29.7 64.84 Favored 'General case' 0 CA--C 1.535 0.382 0 O-C-N 121.914 -0.491 . . . . 4.7400000000000002 111.422 175.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -90.56 -68.23 1.2 Allowed Glycine 0 CA--C 1.529 0.962 0 C-N-CA 124.226 0.917 . . . . 4.21 111.134 173.143 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 3.6 mm? . . . . . 0 N--CA 1.451 -0.377 0 C-N-CA 126.054 1.742 . . . . 9.1600000000000001 107.226 -174.686 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.472 0.663 0 CA-C-O 117.381 -1.295 . . . . 19.77 108.65 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . 0.252 0.0 OUTLIER 38.66 98.84 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 127.646 2.378 . . . . 17.77 115.215 -175.937 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 16.8 mm 33.94 73.26 0.6 Allowed Pre-proline 0 CA--C 1.543 0.695 0 C-N-CA 125.569 1.547 . . . . 15.039999999999999 113.108 159.625 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -75.54 157.99 40.28 Favored 'Trans proline' 0 N--CA 1.452 -0.917 0 C-N-CA 122.561 2.174 . . . . 10.99 109.268 174.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 20.7 p -152.52 15.79 0.6 Allowed 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 112.624 0.602 . . . . 8.6099999999999994 112.624 178.255 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 52.1 t -121.9 97.26 46.25 Favored Pre-proline 0 CA--C 1.532 0.265 0 C-N-CA 123.528 0.731 . . . . 8.3800000000000008 109.629 -178.206 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -79.98 57.22 6.4 Favored 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 122.872 2.381 . . . . 4.3399999999999999 110.893 -175.188 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 10.4 p -96.13 -136.05 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 N-CA-C 106.17 -1.789 . . . . 6.0099999999999998 106.17 163.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 51.68 -88.97 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 126.178 1.791 . . . . 5.29 112.087 169.174 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 6.2 tt -53.97 -45.18 71.3 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 125.465 1.506 . . . . 4.21 108.529 175.223 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 50.4 tttp -59.04 -42.7 90.88 Favored 'General case' 0 CA--C 1.534 0.355 0 O-C-N 121.756 -0.59 . . . . 4.4000000000000004 110.403 176.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.58 -26.88 64.68 Favored 'General case' 0 N--CA 1.452 -0.326 0 O-C-N 121.759 -0.588 . . . . 7.8899999999999997 110.636 179.096 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.1 tt -64.87 -48.23 75.01 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 108.09 -1.078 . . . . 3.23 108.09 171.649 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 11.0 tp -54.41 -46.0 73.06 Favored 'General case' 0 N--CA 1.454 -0.255 0 O-C-N 121.922 -0.486 . . . . 3.1600000000000001 111.245 174.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 79.9 t -57.81 -47.64 85.57 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 O-C-N 122.16 -0.337 . . . . 1.79 110.241 174.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 49.6 t -55.68 -44.83 78.38 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 O-C-N 121.718 -0.614 . . . . 1.75 110.218 176.371 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 68.7 t -56.35 -49.33 77.36 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 CA-C-N 119.203 0.911 . . . . 1.75 110.472 175.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 76.4 t -55.24 -45.15 77.47 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 O-C-N 121.564 -0.71 . . . . 1.5800000000000001 110.704 176.151 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 70.1 t -60.17 -46.19 94.92 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.191 0 N-CA-C 109.163 -0.68 . . . . 1.6200000000000001 109.163 177.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 41.1 t -54.7 -48.58 72.14 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 C-N-CA 123.471 0.709 . . . . 1.76 110.572 177.084 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 53.9 t -56.47 -46.97 82.4 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 CA-C-N 118.673 0.669 . . . . 1.6599999999999999 110.598 177.12 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -59.08 -47.29 85.81 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 109.514 -0.551 . . . . 1.54 109.514 177.104 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 15.9 t -61.67 -38.49 80.46 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.878 0 C-N-CA 124.145 0.978 . . . . 1.5700000000000001 110.179 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 2.9 t -62.64 -49.45 83.72 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.334 0 C-N-CA 123.616 0.767 . . . . 1.99 109.562 174.417 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 1.3 t -54.25 -41.49 52.37 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 CA-C-N 119.207 0.912 . . . . 1.7 111.384 173.369 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.4 t -64.33 -44.76 97.29 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 N-CA-C 108.706 -0.85 . . . . 1.71 108.706 179.013 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 11.3 mt -59.85 -43.04 91.08 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 N-CA-C 108.627 -0.879 . . . . 1.75 108.627 178.259 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 39.5 t -61.71 -57.57 11.5 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 N-CA-C 108.809 -0.812 . . . . 1.72 108.809 -179.273 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -53.01 -45.18 62.27 Favored Glycine 0 CA--C 1.533 1.18 0 C-N-CA 120.972 -0.632 . . . . 0.47999999999999998 111.936 176.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -60.55 -32.73 71.78 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 124.135 0.974 . . . . 1.6399999999999999 111.868 179.243 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 13.2 tp -70.12 -60.33 2.35 Favored 'General case' 0 N--CA 1.435 -1.209 0 N-CA-C 107.49 -1.3 . . . . 1.8300000000000001 107.49 172.519 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 5.3 mp -57.65 -35.49 70.59 Favored 'General case' 0 C--N 1.341 0.237 0 N-CA-C 113.412 0.893 . . . . 3.73 113.412 -171.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 28.1 ptm -61.05 -25.58 67.02 Favored 'General case' 0 CA--C 1.537 0.457 0 O-C-N 121.459 -0.775 . . . . 5.0599999999999996 111.941 176.233 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -91.01 -61.97 1.25 Allowed Glycine 0 CA--C 1.528 0.874 0 C-N-CA 124.625 1.107 . . . . 3.6000000000000001 111.002 175.353 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 76.1 mt . . . . . 0 N--CA 1.446 -0.649 0 C-N-CA 125.767 1.627 . . . . 8.6300000000000008 107.705 -173.167 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 10.7 mp . . . . . 0 N--CA 1.475 0.812 0 N-CA-C 106.219 -1.771 . . . . 19.199999999999999 106.219 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 55.8 mmm-85 -146.67 80.79 1.55 Allowed 'General case' 0 C--O 1.224 -0.248 0 C-N-CA 124.108 0.963 . . . . 23.84 108.593 177.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 3.8 mp 47.18 73.29 1.02 Allowed Pre-proline 0 CA--C 1.544 0.728 0 C-N-CA 125.007 1.323 . . . . 18.23 111.51 173.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -66.37 -25.43 49.08 Favored 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 122.261 1.974 . . . . 13.01 112.327 -177.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER 66.16 14.52 9.68 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 126.181 1.792 . . . . 12.58 112.847 172.206 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 48.7 m -83.82 -54.12 0.52 Allowed Pre-proline 0 CA--C 1.535 0.395 0 C-N-CA 124.937 1.295 . . . . 8.4199999999999999 112.644 -174.212 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -70.21 -36.81 8.98 Favored 'Trans proline' 0 N--CA 1.459 -0.513 0 C-N-CA 121.319 1.346 . . . . 5.9500000000000002 110.315 172.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 5.6 t -60.33 156.05 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 N-CA-C 107.648 -1.241 . . . . 5.1900000000000004 107.648 167.183 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 29.5 m-80 72.12 -46.69 0.65 Allowed 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 125.85 1.66 . . . . 5.0800000000000001 111.916 -176.41 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -66.76 -47.97 70.56 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 108.419 -0.956 . . . . 5.5300000000000002 108.419 175.079 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -57.78 -40.77 80.6 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-O 121.216 0.531 . . . . 4.75 110.163 174.411 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 43.0 ttt85 -67.28 -26.41 66.53 Favored 'General case' 0 N--CA 1.44 -0.931 0 O-C-N 122.116 -0.365 . . . . 7.2400000000000002 111.592 179.246 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.3 tt -60.07 -48.75 80.4 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 108.275 -1.009 . . . . 2.98 108.275 173.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 10.8 tp -56.51 -45.97 80.78 Favored 'General case' 0 N--CA 1.454 -0.272 0 O-C-N 121.868 -0.52 . . . . 3.3599999999999999 111.477 176.279 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 99.4 t -56.65 -48.03 81.35 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 N-CA-C 109.777 -0.453 . . . . 1.78 109.777 174.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 44.3 t -56.47 -45.76 82.01 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.291 0 CA-C-O 118.65 -0.691 . . . . 2.0299999999999998 110.058 177.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 55.9 t -54.25 -51.41 48.2 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 CA-C-N 119.572 1.078 . . . . 2.2000000000000002 110.467 176.422 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 97.8 t -57.29 -45.78 85.08 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 O-C-N 121.547 -0.721 . . . . 1.8100000000000001 111.011 177.354 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 53.7 t -59.92 -42.74 90.36 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 N-CA-C 109.382 -0.599 . . . . 2.0600000000000001 109.382 179.341 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 30.1 t -54.5 -47.42 71.18 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 C-N-CA 123.711 0.804 . . . . 2.48 110.377 177.3 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 72.8 t -59.1 -46.41 91.93 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 CA-C-N 118.829 0.741 . . . . 2.04 110.395 178.178 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -58.93 -46.1 88.77 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 123.216 0.606 . . . . 1.6000000000000001 109.856 177.167 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.4 t -62.54 -40.51 88.52 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.898 0 C-N-CA 124.559 1.144 . . . . 2.1400000000000001 109.84 -179.486 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 5.0 t -62.51 -48.79 86.57 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.402 0 CA-C-N 118.776 0.716 . . . . 2.0899999999999999 109.65 175.042 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 1.4 t -54.58 -39.88 47.93 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 CA-C-N 118.734 0.697 . . . . 1.72 111.38 173.611 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.4 t -66.45 -45.01 90.18 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 N-CA-C 108.891 -0.781 . . . . 1.6399999999999999 108.891 179.131 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 11.8 mt -59.01 -44.99 92.5 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 N-CA-C 108.334 -0.987 . . . . 1.97 108.334 178.568 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 42.7 t -64.24 -53.46 43.11 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 N-CA-C 109.48 -0.563 . . . . 1.78 109.48 -177.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -54.71 -44.31 80.05 Favored Glycine 0 CA--C 1.527 0.844 0 N-CA-C 111.568 -0.613 . . . . 0.62 111.568 176.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -60.98 -45.02 96.5 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 117.686 0.743 . . . . 1.5800000000000001 111.013 178.122 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 9.7 tp -56.93 -53.45 57.89 Favored 'General case' 0 N--CA 1.441 -0.917 0 N-CA-C 108.303 -0.999 . . . . 1.75 108.303 175.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 85.5 mt -61.18 -37.64 83.64 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 122.804 0.442 . . . . 3.1499999999999999 111.789 -177.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 47.4 ttm -60.51 -34.45 74.11 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.067 0.547 . . . . 4.1699999999999999 110.13 174.032 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -69.85 -66.23 2.29 Favored Glycine 0 CA--C 1.529 0.913 0 N-CA-C 110.967 -0.853 . . . . 2.8999999999999999 110.967 172.629 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 3.4 pp . . . . . 0 N--CA 1.436 -1.145 0 C-N-CA 125.601 1.56 . . . . 8.4199999999999999 110.181 -169.38 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 65.2 mt . . . . . 0 N--CA 1.475 0.811 0 N-CA-C 107.918 -1.141 . . . . 18.960000000000001 107.918 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 55.0 ttt85 -161.89 156.93 23.18 Favored 'General case' 0 N--CA 1.455 -0.182 0 N-CA-C 106.749 -1.574 . . . . 15.74 106.749 178.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 64.7 mt -73.92 126.63 89.26 Favored Pre-proline 0 CA--C 1.538 0.499 0 N-CA-C 106.758 -1.571 . . . . 12.800000000000001 106.758 169.565 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -75.21 177.65 8.34 Favored 'Trans proline' 0 N--CA 1.454 -0.822 0 C-N-CA 122.679 2.252 . . . . 11.26 110.423 -178.655 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 78.6 m 64.2 48.18 2.99 Favored 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 124.254 1.022 . . . . 10.77 109.781 176.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 40.3 t -109.2 87.43 4.89 Favored Pre-proline 0 CA--C 1.535 0.388 0 C-N-CA 124.523 1.129 . . . . 5.4400000000000004 110.516 -178.49 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -77.26 63.88 7.83 Favored 'Trans proline' 0 CA--C 1.535 0.562 0 C-N-CA 123.386 2.724 . . . . 4.0800000000000001 111.518 -174.549 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 12.7 p -80.27 -133.63 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 C-N-CA 125.109 1.364 . . . . 5.3899999999999997 109.788 179.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 66.9 m-80 -55.51 -21.36 16.35 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.096 0.958 . . . . 4.0599999999999996 113.562 -174.075 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.7 pp -54.37 -29.31 48.07 Favored 'General case' 0 CA--C 1.536 0.418 0 O-C-N 121.3 -0.875 . . . . 5.0999999999999996 111.133 171.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 3.0 ttmp? -57.7 -56.55 20.52 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 123.685 0.794 . . . . 5.8399999999999999 109.409 172.424 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 7.4 ptp180 -67.83 -26.59 66.13 Favored 'General case' 0 C--N 1.34 0.169 0 C-N-CA 120.318 -0.553 . . . . 6.8700000000000001 111.144 -178.027 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 9.3 tt -62.45 -50.86 69.77 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 108.895 -0.78 . . . . 3.4399999999999999 108.895 173.072 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 10.5 tp -56.61 -46.07 81.1 Favored 'General case' 0 N--CA 1.453 -0.295 0 O-C-N 122.228 -0.295 . . . . 3.4500000000000002 111.476 176.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 72.7 t -54.26 -50.16 58.14 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 N-CA-C 109.75 -0.463 . . . . 2.3500000000000001 109.75 174.336 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 40.6 t -58.49 -46.37 89.75 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.224 0 CA-C-O 118.681 -0.676 . . . . 2.0099999999999998 110.454 179.452 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 53.1 t -53.37 -53.33 24.76 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 CA-C-N 119.394 0.997 . . . . 1.98 109.93 176.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 69.8 t -58.1 -46.07 88.3 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 O-C-N 122.036 -0.415 . . . . 1.74 110.974 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 48.5 t -61.44 -46.86 95.71 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 N-CA-C 109.008 -0.738 . . . . 1.72 109.008 -178.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 43.1 t -54.14 -49.94 58.47 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 C-N-CA 123.566 0.746 . . . . 1.71 110.038 176.414 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 44.4 t -58.28 -48.13 85.68 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 CA-C-N 118.71 0.687 . . . . 1.72 110.864 179.166 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -59.09 -47.2 86.13 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 109.379 -0.6 . . . . 1.8 109.379 178.829 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 15.5 t -62.63 -39.59 85.21 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.985 0 C-N-CA 124.037 0.935 . . . . 1.6599999999999999 109.929 -179.264 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 3.8 t -63.83 -47.52 90.47 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.482 0 CA-C-N 118.871 0.76 . . . . 1.71 109.6 175.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 1.4 t -54.76 -41.6 57.46 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.602 0 CA-C-N 119.061 0.846 . . . . 1.6399999999999999 111.225 173.207 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.4 t -65.09 -46.33 91.57 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.171 0 N-CA-C 108.648 -0.871 . . . . 1.5700000000000001 108.648 179.746 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 13.1 mt -59.82 -43.52 92.01 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 N-CA-C 108.421 -0.955 . . . . 1.8700000000000001 108.421 179.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 27.3 t -62.99 -54.87 28.02 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 N-CA-C 109.061 -0.718 . . . . 1.7 109.061 -178.685 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -52.33 -45.96 57.86 Favored Glycine 0 CA--C 1.529 0.961 0 N-CA-C 111.541 -0.624 . . . . 0.38 111.541 176.14 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -61.87 -41.96 98.49 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 122.959 0.504 . . . . 1.75 111.54 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 11.6 tp -63.56 -46.28 86.62 Favored 'General case' 0 N--CA 1.44 -0.928 0 N-CA-C 108.669 -0.863 . . . . 2.02 108.669 176.23 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 82.8 mt -62.7 -47.52 83.27 Favored 'General case' 0 CA--C 1.53 0.204 0 O-C-N 122.061 -0.399 . . . . 3.0 111.182 -178.12 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 14.0 ptt? -66.79 -36.8 83.23 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 118.3 0.5 . . . . 5.0099999999999998 110.394 177.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.17 76.32 1.22 Allowed Glycine 0 C--N 1.338 0.66 0 N-CA-C 109.984 -1.246 . . . . 3.3399999999999999 109.984 -178.608 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.536 0.414 0 CA-C-O 117.82 -1.086 . . . . 8.4800000000000004 111.384 161.342 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 68.5 tp . . . . . 0 N--CA 1.475 0.777 0 N-CA-C 108.688 -0.856 . . . . 16.989999999999998 108.688 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 30.1 ptt180 -79.59 64.26 4.41 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 118.472 0.578 . . . . 17.75 111.979 -173.407 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 16.0 mm 41.51 71.92 1.21 Allowed Pre-proline 0 CA--C 1.543 0.709 0 C-N-CA 125.933 1.693 . . . . 12.83 112.388 167.203 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -62.94 115.49 2.98 Favored 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 122.148 1.899 . . . . 9.9199999999999999 110.186 -178.613 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 23.6 p -125.87 34.72 4.83 Favored 'General case' 0 CA--C 1.529 0.135 0 C-N-CA 126.042 1.737 . . . . 7.5700000000000003 109.114 -172.168 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 46.2 t 57.83 72.04 0.96 Allowed Pre-proline 0 CA--C 1.535 0.399 0 C-N-CA 124.914 1.285 . . . . 7.7300000000000004 109.771 -167.261 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_endo -80.11 -176.8 3.4 Favored 'Trans proline' 0 N--CA 1.45 -1.048 0 C-N-CA 122.788 2.326 . . . . 7.71 111.428 -173.504 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.9 p -52.1 155.49 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 CA-C-O 122.876 1.322 . . . . 6.0899999999999999 111.064 170.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 13.7 t30 68.16 -46.37 0.52 Allowed 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 127.371 2.268 . . . . 4.9699999999999998 112.96 -172.499 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.4 tt -63.57 -54.49 35.27 Favored 'General case' 0 N--CA 1.446 -0.631 0 N-CA-C 107.86 -1.163 . . . . 4.0899999999999999 107.86 174.555 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 33.4 ttmt -57.26 -44.83 84.26 Favored 'General case' 0 N--CA 1.453 -0.288 0 O-C-N 121.989 -0.444 . . . . 5.46 110.308 176.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 1.2 ptt85 -65.22 -26.21 68.03 Favored 'General case' 0 C--O 1.224 -0.245 0 CA-C-O 119.521 -0.276 . . . . 7.5499999999999998 111.49 -178.311 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -58.76 -44.21 90.53 Favored 'General case' 0 C--N 1.333 -0.11 0 N-CA-C 109.005 -0.739 . . . . 3.8199999999999998 109.005 179.129 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 1.7 tt -57.61 -46.28 84.3 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-O 121.283 0.563 . . . . 3.79 110.225 176.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 48.0 t -58.19 -46.13 88.66 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 N-CA-C 109.618 -0.512 . . . . 1.53 109.618 176.501 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 68.6 t -57.01 -46.44 84.1 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 CA-C-O 118.515 -0.755 . . . . 2.1400000000000001 109.766 176.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 54.5 t -55.36 -50.35 65.98 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 CA-C-N 119.803 1.183 . . . . 2.0 110.144 177.317 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 81.1 t -56.14 -46.58 81.11 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 O-C-N 121.841 -0.537 . . . . 1.6799999999999999 110.929 177.389 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 54.3 t -60.37 -45.53 96.45 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 N-CA-C 109.212 -0.662 . . . . 1.8200000000000001 109.212 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 51.0 t -55.15 -49.7 69.94 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 C-N-CA 123.674 0.79 . . . . 2.1299999999999999 110.052 176.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 49.0 t -57.86 -47.21 86.77 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 CA-C-N 118.501 0.591 . . . . 2.1499999999999999 110.553 178.552 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -58.63 -47.13 85.42 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 123.123 0.569 . . . . 1.76 109.466 177.79 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 11.9 t -62.77 -39.72 85.93 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.898 0 C-N-CA 124.238 1.015 . . . . 1.8500000000000001 109.96 -178.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 5.6 t -63.29 -48.49 87.15 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 CA-C-N 118.77 0.714 . . . . 1.8799999999999999 109.687 175.205 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 1.4 t -54.28 -41.1 50.72 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 CA-C-N 118.844 0.747 . . . . 1.78 111.232 173.195 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.4 t -65.81 -45.08 92.52 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.278 0 N-CA-C 108.646 -0.872 . . . . 1.71 108.646 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 11.6 mt -58.96 -45.35 92.1 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.603 0 N-CA-C 108.191 -1.04 . . . . 1.74 108.191 178.489 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 38.4 t -63.77 -52.99 50.16 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 N-CA-C 109.697 -0.483 . . . . 1.6699999999999999 109.697 -176.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -54.9 -48.55 66.28 Favored Glycine 0 CA--C 1.528 0.849 0 N-CA-C 111.354 -0.698 . . . . 0.38 111.354 175.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -57.1 -41.21 78.49 Favored 'General case' 0 N--CA 1.455 -0.225 0 O-C-N 122.105 -0.644 . . . . 1.5600000000000001 111.211 178.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 12.6 tp -66.73 -52.41 44.73 Favored 'General case' 0 N--CA 1.438 -1.069 0 C-N-CA 123.886 0.874 . . . . 1.8600000000000001 109.11 178.756 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . 0.298 3.6 pp -68.27 -34.29 75.91 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 119.11 0.868 . . . . 4.2000000000000002 112.685 -175.285 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 73.7 mtm -68.03 -42.98 79.8 Favored 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 110.004 -0.369 . . . . 4.3799999999999999 110.004 171.394 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 94.4 72.48 1.17 Allowed Glycine 0 CA--C 1.524 0.6 0 N-CA-C 109.598 -1.401 . . . . 3.48 109.598 -178.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 2.3 pt? . . . . . 0 CA--C 1.533 0.325 0 CA-C-O 118.296 -0.859 . . . . 9.2799999999999994 111.483 168.954 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 1.7 tm? . . . . . 0 N--CA 1.474 0.775 0 N-CA-C 107.835 -1.172 . . . . 18.859999999999999 107.835 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.18 68.6 0.87 Allowed 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.817 1.247 . . . . 18.300000000000001 108.581 179.591 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.7 mp -104.47 105.3 49.34 Favored Pre-proline 0 CA--C 1.533 0.31 0 N-CA-C 105.915 -1.883 . . . . 13.609999999999999 105.915 171.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -78.23 -53.9 0.06 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.879 0 C-N-CA 121.833 1.689 . . . . 9.6500000000000004 109.717 175.332 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 25.5 p -156.97 23.89 0.32 Allowed 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 124.43 1.092 . . . . 7.5300000000000002 111.127 -172.263 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 29.5 t -53.81 -51.62 75.05 Favored Pre-proline 0 CA--C 1.54 0.574 0 N-CA-C 113.837 1.051 . . . . 7.2800000000000002 113.837 -172.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -71.85 75.92 2.09 Favored 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 122.044 1.829 . . . . 4.4199999999999999 110.301 176.5 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 10.1 p -95.36 -135.36 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 C-N-CA 125.401 1.48 . . . . 5.9699999999999998 109.897 -176.227 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -54.05 -34.37 59.86 Favored 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 124.331 1.052 . . . . 4.8700000000000001 110.642 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 10.0 tt -54.47 -39.12 67.16 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 124.027 0.931 . . . . 4.9100000000000001 109.906 177.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 28.1 tptp -63.67 -42.87 97.99 Favored 'General case' 0 N--CA 1.451 -0.4 0 O-C-N 121.936 -0.478 . . . . 4.9199999999999999 109.879 179.472 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 10.6 mpt_? -74.11 -26.77 60.54 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 109.884 -0.413 . . . . 11.1 109.884 -178.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 9.9 tt -64.18 -45.36 88.71 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 108.413 -0.958 . . . . 2.98 108.413 172.222 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 10.9 tp -56.04 -45.85 79.08 Favored 'General case' 0 N--CA 1.454 -0.239 0 O-C-N 122.223 -0.298 . . . . 2.96 111.232 174.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 93.5 t -56.66 -49.75 76.74 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 N-CA-C 110.185 -0.302 . . . . 1.47 110.185 174.567 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 54.8 t -55.29 -46.0 77.98 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 O-C-N 121.87 -0.519 . . . . 1.75 110.039 177.166 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 54.3 t -56.17 -47.87 80.09 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 CA-C-N 118.833 0.742 . . . . 1.96 110.222 177.084 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 76.0 t -54.9 -45.37 75.45 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 CA-C-N 118.683 0.674 . . . . 1.71 110.78 175.13 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 87.2 t -60.23 -47.3 92.76 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.182 0 N-CA-C 109.28 -0.637 . . . . 1.8200000000000001 109.28 178.579 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 53.1 t -55.12 -49.09 74.73 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 C-N-CA 123.48 0.712 . . . . 1.76 110.406 177.531 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 41.8 t -56.98 -46.23 83.94 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 C-N-CA 123.485 0.714 . . . . 1.8999999999999999 110.22 177.3 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -58.59 -47.4 84.43 Favored 'General case' 0 N--CA 1.45 -0.425 0 N-CA-C 109.363 -0.606 . . . . 1.99 109.363 177.148 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.7 t -62.12 -41.3 90.69 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.829 0 O-C-N 121.316 -0.865 . . . . 1.8600000000000001 110.045 -179.482 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 4.3 t -62.91 -47.11 94.38 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 O-C-N 121.512 -0.742 . . . . 1.6499999999999999 109.83 175.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 2.1 t -56.86 -37.69 55.21 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.707 0 CA-C-N 118.812 0.733 . . . . 1.8899999999999999 110.957 173.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.4 t -66.64 -46.9 84.87 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.245 0 N-CA-C 108.447 -0.946 . . . . 1.9199999999999999 108.447 178.034 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 10.7 mt -58.28 -45.89 89.08 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 N-CA-C 108.569 -0.9 . . . . 1.6000000000000001 108.569 179.283 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 43.6 t -65.65 -50.95 68.22 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 N-CA-C 109.382 -0.599 . . . . 1.74 109.382 -176.723 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -53.08 -49.0 57.47 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 111.101 -0.799 . . . . 0.42999999999999999 111.101 176.06 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -57.54 -47.86 80.86 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.507 0.723 . . . . 1.6200000000000001 110.643 178.273 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 10.8 tp -59.04 -46.94 86.95 Favored 'General case' 0 N--CA 1.441 -0.908 0 C-N-CA 123.679 0.792 . . . . 1.8 109.695 178.188 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . 0.307 0.1 OUTLIER -66.67 -40.25 88.51 Favored 'General case' 0 CA--C 1.54 0.56 0 O-C-N 121.592 -0.692 . . . . 4.3200000000000003 110.732 -178.555 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 28.1 ttt -63.98 -37.24 86.71 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 123.954 0.902 . . . . 4.2999999999999998 110.688 176.366 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 86.34 59.09 1.87 Allowed Glycine 0 CA--C 1.524 0.639 0 N-CA-C 108.358 -1.897 . . . . 3.1200000000000001 108.358 -168.697 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.45 -0.444 0 N-CA-C 105.602 -1.999 . . . . 10.18 105.602 178.427 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.473 0.692 0 CA-C-O 119.211 -0.423 . . . . 21.190000000000001 109.92 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 90.2 mmt-85 -145.18 171.71 14.15 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 105.377 -2.083 . . . . 21.239999999999998 105.377 165.109 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.5 pp -73.79 145.04 83.71 Favored Pre-proline 0 CA--C 1.535 0.401 0 N-CA-C 109.568 -0.53 . . . . 14.779999999999999 109.568 -178.611 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_endo -73.27 141.06 31.59 Favored 'Trans proline' 0 N--CA 1.453 -0.909 0 C-N-CA 122.628 2.219 . . . . 11.98 110.031 179.231 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -155.93 54.35 0.59 Allowed 'General case' 0 C--O 1.226 -0.177 0 N-CA-C 107.699 -1.223 . . . . 9.3699999999999992 107.699 176.557 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 10.1 t -54.17 -53.39 59.31 Favored Pre-proline 0 CA--C 1.541 0.601 0 N-CA-C 113.62 0.97 . . . . 6.4500000000000002 113.62 -177.062 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -77.99 54.97 5.11 Favored 'Trans proline' 0 CA--C 1.54 0.779 0 C-N-CA 122.229 1.953 . . . . 4.9299999999999997 112.577 -174.372 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.5 t -59.83 149.0 7.13 Favored 'Isoleucine or valine' 0 C--N 1.339 0.126 0 N-CA-C 108.039 -1.097 . . . . 4.6100000000000003 108.039 171.53 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 40.2 m-80 63.5 -46.3 0.24 Allowed 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 127.026 2.13 . . . . 3.6699999999999999 113.744 -170.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 86.9 mt -64.12 -47.36 80.31 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 119.411 1.005 . . . . 4.0800000000000001 109.482 -177.01 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 2.2 tmtm? -60.82 -37.01 80.54 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.491 -0.322 . . . . 4.6900000000000004 110.777 -174.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.05 -26.56 26.93 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 122.847 0.459 . . . . 7.7000000000000002 111.918 177.768 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 9.1 tt -60.52 -39.71 88.82 Favored 'General case' 0 C--O 1.224 -0.262 0 N-CA-C 108.972 -0.751 . . . . 3.04 108.972 172.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 10.7 tp -52.84 -45.55 67.38 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-O 121.031 0.443 . . . . 3.0 111.464 171.448 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 39.7 t -61.65 -44.28 98.43 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 N-CA-C 109.511 -0.551 . . . . 2.1000000000000001 109.511 176.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 90.3 t -55.53 -46.86 79.12 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 O-C-N 121.999 -0.438 . . . . 2.0 110.051 175.026 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 67.3 t -56.06 -49.14 77.31 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 CA-C-N 118.808 0.731 . . . . 1.6200000000000001 109.809 176.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 75.1 t -56.36 -44.49 80.04 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 O-C-N 121.827 -0.546 . . . . 1.54 111.013 177.114 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 56.0 t -61.03 -47.79 92.0 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.139 0 O-C-N 121.661 -0.65 . . . . 1.6799999999999999 109.26 178.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 54.7 t -54.78 -48.98 72.56 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 C-N-CA 123.312 0.645 . . . . 1.95 110.199 176.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 38.1 t -57.13 -46.4 84.56 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 C-N-CA 123.568 0.747 . . . . 1.8400000000000001 110.544 177.445 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -59.01 -48.08 82.87 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 123.424 0.69 . . . . 1.71 109.361 177.802 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 16.1 t -61.87 -40.98 89.02 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.848 0 O-C-N 121.387 -0.82 . . . . 1.8700000000000001 109.954 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 4.2 t -62.91 -45.89 97.71 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.507 0 O-C-N 121.543 -0.723 . . . . 1.98 109.84 175.491 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 1.6 t -56.42 -40.26 66.22 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.631 0 CA-C-N 119.296 0.953 . . . . 1.8 110.927 173.556 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.4 t -63.57 -48.42 86.94 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 N-CA-C 108.345 -0.983 . . . . 1.51 108.345 177.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 11.2 mt -59.43 -42.46 87.75 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 N-CA-C 109.053 -0.721 . . . . 1.9399999999999999 109.053 -179.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 32.4 t -65.06 -50.37 74.86 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 N-CA-C 109.162 -0.681 . . . . 1.77 109.162 -178.477 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -52.1 -46.39 56.28 Favored Glycine 0 CA--C 1.53 0.981 0 N-CA-C 111.463 -0.655 . . . . 0.32000000000000001 111.463 173.641 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -59.24 -51.15 71.23 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 121.256 0.55 . . . . 1.7 110.587 178.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 9.2 tp -54.53 -46.6 73.58 Favored 'General case' 0 N--CA 1.443 -0.817 0 C-N-CA 123.973 0.909 . . . . 2.0099999999999998 109.594 175.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 64.7 mt -63.17 -45.33 92.36 Favored 'General case' 0 CA--C 1.53 0.19 0 O-C-N 121.808 -0.557 . . . . 3.0 111.536 -178.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 18.8 ptt? -65.99 -35.92 81.89 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 118.837 0.744 . . . . 5.1799999999999997 110.524 178.398 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 173.02 -47.67 0.16 Allowed Glycine 0 CA--C 1.526 0.756 0 CA-C-N 117.836 0.289 . . . . 3.23 112.513 174.075 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 3.2 tm? . . . . . 0 N--CA 1.45 -0.427 0 N-CA-C 104.58 -2.378 . . . . 8.0999999999999996 104.58 -175.188 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 4.3 mm? . . . . . 0 N--CA 1.475 0.791 0 N-CA-C 106.706 -1.59 . . . . 21.890000000000001 106.706 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.18 55.33 0.76 Allowed 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 107.991 -1.115 . . . . 17.969999999999999 107.991 -179.215 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 41.3 pt -73.85 148.0 86.85 Favored Pre-proline 0 CA--C 1.538 0.499 0 C-N-CA 123.325 0.65 . . . . 13.94 111.219 -169.322 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_endo -63.26 -71.0 0.03 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.75 0 C-N-CA 122.376 2.05 . . . . 9.9700000000000006 111.597 -173.548 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 32.0 p -158.15 44.83 0.32 Allowed 'General case' 0 C--N 1.332 -0.173 0 C-N-CA 124.024 0.93 . . . . 7.2699999999999996 109.52 -167.209 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 38.0 t 62.0 88.09 0.12 Allowed Pre-proline 0 CA--C 1.535 0.397 0 C-N-CA 124.606 1.162 . . . . 8.6600000000000001 110.139 -169.345 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -73.57 74.38 3.25 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 123.312 2.675 . . . . 4.7599999999999998 110.856 -173.277 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.8 p -55.79 153.95 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 CA-C-O 122.693 1.235 . . . . 4.5800000000000001 110.847 174.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 35.5 t30 64.8 -46.58 0.33 Allowed 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 127.769 2.427 . . . . 5.1600000000000001 113.218 -168.469 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -66.4 -48.33 70.43 Favored 'General case' 0 N--CA 1.453 -0.325 0 C-N-CA 123.588 0.755 . . . . 4.7699999999999996 109.061 -178.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 9.4 tmtt? -57.63 -51.45 69.46 Favored 'General case' 0 C--O 1.233 0.192 0 N-CA-C 108.57 -0.9 . . . . 5.2599999999999998 108.57 -179.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 10.4 ptm180 -69.77 -26.33 64.24 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 120.026 -0.67 . . . . 6.1799999999999997 112.469 -177.507 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 68.9 tp -63.64 -48.4 77.41 Favored 'General case' 0 N--CA 1.454 -0.275 0 N-CA-C 108.553 -0.906 . . . . 3.21 108.553 172.548 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -57.58 -46.09 84.44 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-O 120.91 0.386 . . . . 3.3399999999999999 110.151 177.567 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 75.7 t -55.56 -49.32 74.44 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 O-C-N 121.967 -0.458 . . . . 1.6000000000000001 110.234 173.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 32.4 t -56.12 -46.04 80.88 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.204 0 CA-C-O 118.896 -0.573 . . . . 1.79 110.089 178.348 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 55.1 t -54.92 -51.91 48.52 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.426 0 CA-C-N 119.273 0.942 . . . . 1.5800000000000001 109.924 177.073 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 70.8 t -56.24 -45.76 81.2 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 O-C-N 121.908 -0.495 . . . . 1.8600000000000001 110.922 177.709 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 52.7 t -60.47 -46.22 95.66 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.309 0 N-CA-C 109.083 -0.71 . . . . 1.73 109.083 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 48.7 t -55.48 -49.5 72.94 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 C-N-CA 123.605 0.762 . . . . 1.5600000000000001 110.119 176.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 52.3 t -58.05 -46.98 87.93 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 CA-C-N 118.465 0.575 . . . . 1.8200000000000001 110.619 178.051 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -59.06 -46.83 87.25 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 123.382 0.673 . . . . 1.77 109.488 178.017 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 10.6 t -62.08 -40.6 88.04 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.855 0 C-N-CA 124.353 1.061 . . . . 1.5900000000000001 109.909 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 3.5 t -62.32 -48.03 90.29 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.404 0 CA-C-N 118.696 0.68 . . . . 1.6299999999999999 109.685 175.048 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 1.4 t -55.59 -40.63 60.43 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 O-C-N 121.375 -0.828 . . . . 1.74 111.329 173.655 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.4 t -64.63 -44.86 96.69 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.215 0 N-CA-C 108.541 -0.911 . . . . 1.47 108.541 178.599 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 11.5 mt -60.01 -43.67 93.06 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 N-CA-C 108.607 -0.886 . . . . 1.6299999999999999 108.607 178.473 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 39.6 t -62.95 -53.83 41.58 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 N-CA-C 109.262 -0.644 . . . . 1.6000000000000001 109.262 -178.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -53.19 -47.11 61.86 Favored Glycine 0 CA--C 1.53 1.006 0 N-CA-C 111.572 -0.611 . . . . 0.28000000000000003 111.572 175.432 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -60.34 -40.16 89.68 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 123.503 0.721 . . . . 1.6599999999999999 111.204 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 11.1 tp -63.42 -52.88 59.68 Favored 'General case' 0 N--CA 1.439 -0.991 0 N-CA-C 108.175 -1.046 . . . . 1.8 108.175 174.607 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 79.0 mt -55.91 -42.18 75.67 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 123.423 0.689 . . . . 2.6299999999999999 111.981 -177.054 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 17.6 ptp -77.35 -13.68 59.88 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 112.371 0.508 . . . . 4.25 112.371 176.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -101.25 -40.94 2.69 Favored Glycine 0 CA--C 1.527 0.821 0 C-N-CA 124.356 0.979 . . . . 2.3999999999999999 113.512 -166.282 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.6 pt? . . . . . 0 CA--C 1.532 0.276 0 CA-C-O 117.588 -1.196 . . . . 9.5899999999999999 112.304 -176.192 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 3.0 pp . . . . . 0 N--CA 1.476 0.831 0 CA-C-O 117.824 -1.084 . . . . 16.739999999999998 108.635 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -157.65 60.52 0.48 Allowed 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 119.05 0.841 . . . . 17.98 110.285 -179.522 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 41.1 mm -116.99 89.41 29.76 Favored Pre-proline 0 CA--C 1.538 0.485 0 N-CA-C 108.027 -1.101 . . . . 13.380000000000001 108.027 -178.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -78.0 70.14 7.18 Favored 'Trans proline' 0 N--CA 1.455 -0.736 0 C-N-CA 122.639 2.226 . . . . 10.9 110.295 -174.312 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.8 m -145.91 47.98 1.24 Allowed 'General case' 0 N--CA 1.463 0.192 0 C-N-CA 124.172 0.989 . . . . 7.5800000000000001 109.074 179.394 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 7.9 t -59.53 -57.78 24.37 Favored Pre-proline 0 CA--C 1.541 0.627 0 CA-C-O 118.429 -0.796 . . . . 7.5199999999999996 112.447 173.62 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_endo -78.67 62.21 8.24 Favored 'Trans proline' 0 CA--C 1.537 0.664 0 C-N-CA 122.382 2.055 . . . . 4.2699999999999996 111.215 -178.164 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 12.1 p -86.21 -133.56 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 C-N-CA 125.502 1.521 . . . . 5.9199999999999999 108.66 175.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 7.4 m120 -35.21 -40.87 0.15 Allowed 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 126.818 2.047 . . . . 3.54 114.024 179.325 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -54.02 -40.84 67.39 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 125.159 1.383 . . . . 4.79 110.13 -178.582 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 82.7 tttt -57.9 -53.22 60.64 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 123.193 0.597 . . . . 4.3899999999999997 109.447 176.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 66.3 ttt-85 -67.95 -26.89 66.18 Favored 'General case' 0 N--CA 1.442 -0.832 0 O-C-N 121.914 -0.491 . . . . 5.7699999999999996 111.376 -177.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 59.9 tp -65.43 -49.01 70.79 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 108.358 -0.979 . . . . 3.2799999999999998 108.358 173.218 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 10.9 tp -55.58 -46.02 77.29 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 117.9 0.318 . . . . 3.1600000000000001 111.186 176.394 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 75.2 t -55.18 -51.38 55.77 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 N-CA-C 110.221 -0.289 . . . . 2.0 110.221 174.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 50.6 t -56.01 -46.03 80.5 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 O-C-N 121.725 -0.61 . . . . 2.0800000000000001 110.339 177.336 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 55.0 t -55.68 -47.03 79.65 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 CA-C-N 118.766 0.712 . . . . 2.0099999999999998 110.179 177.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 70.6 t -55.44 -45.49 78.29 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 CA-C-N 118.834 0.743 . . . . 1.74 110.75 175.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 86.8 t -60.47 -47.75 91.32 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 N-CA-C 109.385 -0.598 . . . . 1.8 109.385 178.676 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 64.0 t -54.81 -48.61 73.33 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 C-N-CA 123.395 0.678 . . . . 1.99 110.495 177.454 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 39.8 t -57.34 -45.71 85.26 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 C-N-CA 123.574 0.749 . . . . 1.8899999999999999 110.248 177.447 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.6 -47.66 83.56 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 109.469 -0.567 . . . . 2.0600000000000001 109.469 177.075 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 16.6 t -61.93 -41.95 92.84 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.774 0 O-C-N 121.42 -0.8 . . . . 1.95 110.103 -179.588 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 5.9 t -62.24 -46.06 97.31 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 O-C-N 121.565 -0.71 . . . . 1.8600000000000001 109.869 175.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 1.6 t -56.79 -39.48 64.57 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.644 0 CA-C-N 119.152 0.887 . . . . 1.78 110.931 173.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.4 t -64.25 -46.97 91.82 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.188 0 N-CA-C 108.509 -0.923 . . . . 1.8200000000000001 108.509 177.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 10.2 mt -59.5 -44.11 92.22 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 N-CA-C 108.951 -0.759 . . . . 1.8400000000000001 108.951 179.328 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 39.5 t -64.51 -49.74 79.23 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 N-CA-C 109.164 -0.68 . . . . 1.8400000000000001 109.164 -177.543 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -51.37 -52.78 31.0 Favored Glycine 0 CA--C 1.527 0.81 0 N-CA-C 110.619 -0.992 . . . . 0.53000000000000003 110.619 173.479 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -55.18 -43.98 74.85 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 122.966 0.506 . . . . 1.8 111.176 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 10.7 tp -62.11 -46.51 88.73 Favored 'General case' 0 N--CA 1.442 -0.848 0 C-N-CA 124.012 0.925 . . . . 1.8700000000000001 109.617 176.327 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 65.5 mt -62.23 -50.26 72.45 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 118.287 0.494 . . . . 2.8199999999999998 111.532 -178.102 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 4.9 mpp? -63.48 -39.71 95.19 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 118.494 0.588 . . . . 4.96 110.606 174.706 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 90.06 56.33 1.84 Allowed Glycine 0 CA--C 1.525 0.663 0 N-CA-C 109.164 -1.574 . . . . 2.6499999999999999 109.164 -173.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 19.8 tp . . . . . 0 CA--C 1.534 0.331 0 C-N-CA 126.219 1.808 . . . . 9.0899999999999999 110.089 -172.621 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 1.2 pt? . . . . . 0 N--CA 1.478 0.967 0 N-CA-C 113.104 0.779 . . . . 19.899999999999999 113.104 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -77.86 66.53 3.54 Favored 'General case' 0 CA--C 1.538 0.485 0 O-C-N 121.135 -0.978 . . . . 18.640000000000001 111.272 -176.777 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 55.8 mt -114.58 90.6 22.09 Favored Pre-proline 0 CA--C 1.54 0.573 0 C-N-CA 124.926 1.291 . . . . 14.27 108.765 -174.398 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -73.61 75.76 2.96 Favored 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 122.909 2.406 . . . . 11.02 110.089 -179.1 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 31.5 p -113.41 30.21 7.4 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 125.681 1.592 . . . . 8.4700000000000006 111.021 -176.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 26.1 m -53.12 104.12 0.41 Allowed Pre-proline 0 CA--C 1.532 0.28 0 C-N-CA 127.083 2.153 . . . . 7.9199999999999999 109.722 -168.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -84.95 67.66 6.14 Favored 'Trans proline' 0 N--CA 1.45 -1.037 0 C-N-CA 123.111 2.541 . . . . 4.4800000000000004 109.678 -166.575 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.2 t -79.62 -133.83 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 C-N-CA 123.671 0.789 . . . . 3.8500000000000001 109.933 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -62.64 -11.78 19.2 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 114.459 1.281 . . . . 5.9100000000000001 114.459 -160.423 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -55.17 -48.25 74.03 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 119.489 1.04 . . . . 4.1900000000000004 108.868 166.77 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 23.0 tptm -58.67 -47.4 84.6 Favored 'General case' 0 N--CA 1.451 -0.383 0 O-C-N 121.71 -0.619 . . . . 4.2000000000000002 109.577 175.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 35.1 mtp-105 -65.58 -26.49 67.87 Favored 'General case' 0 C--O 1.224 -0.243 0 N-CA-C 111.982 0.364 . . . . 5.4100000000000001 111.982 -178.249 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 9.5 tt -63.45 -47.8 80.36 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 108.346 -0.983 . . . . 3.2400000000000002 108.346 173.334 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 1.3 tt -56.23 -46.22 79.63 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-O 121.017 0.437 . . . . 3.25 110.4 175.313 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 84.6 t -56.53 -48.01 81.0 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 O-C-N 121.835 -0.541 . . . . 1.54 110.308 175.391 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 41.5 t -56.19 -45.99 81.1 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.185 0 O-C-N 121.758 -0.589 . . . . 1.7 109.885 177.11 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 54.0 t -54.89 -50.13 64.51 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 CA-C-N 119.29 0.95 . . . . 1.75 110.207 176.376 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 73.0 t -56.2 -45.87 81.12 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 O-C-N 121.743 -0.598 . . . . 1.6399999999999999 111.007 177.32 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 56.7 t -60.2 -47.32 92.59 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 N-CA-C 109.176 -0.676 . . . . 1.6000000000000001 109.176 179.509 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 51.0 t -54.81 -49.34 70.06 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 C-N-CA 123.591 0.756 . . . . 1.6699999999999999 110.109 177.233 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 42.8 t -57.54 -46.68 86.13 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 O-C-N 121.817 -0.552 . . . . 1.73 110.528 177.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -58.5 -47.51 83.85 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 123.248 0.619 . . . . 1.71 109.491 177.72 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 14.4 t -62.29 -41.18 90.57 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.842 0 C-N-CA 123.868 0.867 . . . . 1.6799999999999999 109.958 -179.399 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 5.2 t -62.69 -47.16 94.22 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.49 0 O-C-N 121.605 -0.685 . . . . 1.6000000000000001 109.766 175.652 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 1.6 t -56.01 -39.7 59.35 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.643 0 CA-C-N 118.949 0.795 . . . . 1.52 111.211 173.62 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.4 t -65.09 -45.84 93.05 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.191 0 N-CA-C 108.517 -0.919 . . . . 1.72 108.517 178.357 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 11.3 mt -59.93 -43.85 93.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 N-CA-C 108.729 -0.841 . . . . 1.5900000000000001 108.729 179.104 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 39.7 t -64.14 -51.4 69.34 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 N-CA-C 109.301 -0.629 . . . . 1.6100000000000001 109.301 -178.242 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -53.13 -49.6 55.19 Favored Glycine 0 CA--C 1.528 0.87 0 N-CA-C 110.905 -0.878 . . . . 0.28000000000000003 110.905 175.231 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -56.98 -45.43 82.92 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 123.049 0.539 . . . . 1.6000000000000001 111.079 178.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 10.0 tp -58.79 -50.01 75.54 Favored 'General case' 0 N--CA 1.442 -0.853 0 C-N-CA 124.004 0.922 . . . . 1.73 109.221 176.696 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 72.9 mt -61.27 -41.49 97.03 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 118.033 0.379 . . . . 2.5499999999999998 111.115 -178.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 75.3 mtp -64.08 -49.68 71.32 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 123.36 0.664 . . . . 3.77 110.676 177.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 140.45 88.26 0.14 Allowed Glycine 0 CA--C 1.523 0.588 0 N-CA-C 108.888 -1.685 . . . . 3.3999999999999999 108.888 -172.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.6 pp . . . . . 0 CA--C 1.534 0.355 0 CA-C-O 117.907 -1.044 . . . . 7.4900000000000002 111.102 168.9 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.473 0.724 0 CA-C-O 117.95 -1.024 . . . . 25.16 108.342 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 2.2 ptt85 -159.31 58.74 0.4 Allowed 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 118.746 0.703 . . . . 21.140000000000001 109.992 175.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -74.33 150.0 87.07 Favored Pre-proline 0 CA--C 1.538 0.488 0 C-N-CA 123.514 0.725 . . . . 16.260000000000002 109.352 175.26 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -67.18 -35.11 25.91 Favored 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 122.383 2.056 . . . . 13.1 111.982 -178.312 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 9.1 t 64.71 47.96 2.65 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-O 122.393 1.092 . . . . 10.859999999999999 110.322 176.46 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 32.8 t -149.79 -65.37 0.02 OUTLIER Pre-proline 0 CA--C 1.534 0.359 0 CA-C-N 114.966 -1.015 . . . . 6.3200000000000003 111.594 177.62 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -73.43 67.83 4.41 Favored 'Trans proline' 0 CA--C 1.538 0.695 0 C-N-CA 122.471 2.114 . . . . 4.1100000000000003 110.62 175.092 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 20.1 t -120.58 163.19 18.42 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.187 0 C-N-CA 126.21 1.804 . . . . 4.3700000000000001 106.942 176.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 58.0 t30 70.11 -45.88 0.59 Allowed 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 126.638 1.975 . . . . 3.8999999999999999 113.74 -179.755 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 8.7 tt -66.6 -50.2 63.83 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 124.293 1.037 . . . . 4.1799999999999997 109.088 170.542 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.06 -38.42 79.38 Favored 'General case' 0 CA--C 1.531 0.238 0 O-C-N 121.489 -0.757 . . . . 4.2800000000000002 111.106 -169.336 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 40.1 ptt85 -65.5 -25.95 67.7 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 116.303 -0.408 . . . . 8.0199999999999996 111.952 178.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -62.13 -45.85 91.63 Favored 'General case' 0 N--CA 1.455 -0.197 0 N-CA-C 108.348 -0.982 . . . . 3.2999999999999998 108.348 178.269 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 1.3 tt -57.81 -46.11 85.14 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-O 121.032 0.444 . . . . 3.2000000000000002 110.314 177.028 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 58.4 t -57.44 -48.09 83.51 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 O-C-N 122.022 -0.424 . . . . 1.77 109.869 176.315 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 48.2 t -56.47 -45.89 82.05 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.232 0 CA-C-O 118.871 -0.585 . . . . 1.6200000000000001 110.074 176.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 48.3 t -55.31 -50.47 64.68 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 CA-C-N 119.379 0.99 . . . . 1.8100000000000001 110.182 176.528 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 71.3 t -55.84 -46.17 79.95 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 O-C-N 121.812 -0.555 . . . . 1.5 110.834 177.732 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 56.0 t -60.41 -47.01 94.32 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.227 0 N-CA-C 109.196 -0.668 . . . . 1.5900000000000001 109.196 179.508 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 47.7 t -55.36 -48.43 76.85 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 C-N-CA 123.708 0.803 . . . . 1.72 110.358 177.322 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 44.5 t -57.75 -46.97 86.86 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 CA-C-N 118.603 0.638 . . . . 1.55 110.417 177.602 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -59.1 -47.27 85.86 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 109.456 -0.572 . . . . 1.8 109.456 177.681 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 15.5 t -61.89 -39.48 83.7 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.886 0 C-N-CA 124.007 0.923 . . . . 1.6599999999999999 110.095 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 3.3 t -62.63 -48.2 89.33 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.38 0 C-N-CA 123.419 0.688 . . . . 1.6499999999999999 109.691 174.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 1.4 t -55.12 -41.07 57.93 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 CA-C-N 119.176 0.898 . . . . 1.74 111.415 173.216 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.4 t -63.97 -45.33 97.1 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.198 0 N-CA-C 108.549 -0.908 . . . . 1.6499999999999999 108.549 178.566 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 11.8 mt -60.09 -42.01 88.45 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 N-CA-C 108.719 -0.845 . . . . 1.74 108.719 178.722 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 40.4 t -62.62 -55.7 22.18 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 N-CA-C 109.074 -0.713 . . . . 1.6899999999999999 109.074 179.486 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -52.47 -45.41 59.07 Favored Glycine 0 CA--C 1.531 1.089 0 N-CA-C 111.719 -0.553 . . . . 0.31 111.719 177.11 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -56.46 -47.57 78.87 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 123.427 0.691 . . . . 1.6200000000000001 110.566 175.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 8.5 tp -58.18 -49.96 75.2 Favored 'General case' 0 N--CA 1.441 -0.899 0 C-N-CA 123.947 0.899 . . . . 1.8799999999999999 109.142 178.699 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 5.5 mp -56.01 -44.45 78.7 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 119.27 0.941 . . . . 3.21 112.142 174.389 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 43.8 tpp -64.57 -32.09 73.58 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 118.253 0.479 . . . . 4.6200000000000001 111.557 178.329 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 99.37 44.94 2.25 Favored Glycine 0 CA--C 1.528 0.9 0 C-N-CA 125.797 1.665 . . . . 3.0899999999999999 111.007 -177.782 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 5.3 mp . . . . . 0 N--CA 1.449 -0.52 0 N-CA-C 106.315 -1.735 . . . . 9.2400000000000002 106.315 170.519 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 2.8 tm? . . . . . 0 N--CA 1.474 0.742 0 N-CA-C 105.708 -1.96 . . . . 21.690000000000001 105.708 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 80.5 mtp180 -129.86 147.0 51.58 Favored 'General case' 0 N--CA 1.457 -0.116 0 N-CA-C 106.784 -1.562 . . . . 22.359999999999999 106.784 175.601 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 11.1 pt -118.69 71.36 10.07 Favored Pre-proline 0 CA--C 1.538 0.489 0 C-N-CA 124.951 1.3 . . . . 16.620000000000001 110.385 -173.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -66.12 132.24 29.28 Favored 'Trans proline' 0 N--CA 1.452 -0.936 0 C-N-CA 121.237 1.292 . . . . 12.699999999999999 109.026 175.037 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 15.8 p -103.7 15.45 28.79 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 123.726 0.81 . . . . 10.35 110.89 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 84.1 m -112.14 85.2 6.48 Favored Pre-proline 0 N--CA 1.455 -0.217 0 C-N-CA 125.082 1.353 . . . . 8.6300000000000008 108.584 -175.496 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -66.65 -47.41 2.85 Favored 'Trans proline' 0 N--CA 1.454 -0.838 0 C-N-CA 121.423 1.415 . . . . 5.3300000000000001 109.342 172.789 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 14.3 t -62.02 158.07 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 N-CA-C 108.336 -0.987 . . . . 4.0199999999999996 108.336 169.678 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 67.1 m-80 69.5 -35.4 0.31 Allowed 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 125.883 1.673 . . . . 4.7800000000000002 114.084 -173.447 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 10.8 mp -82.41 -44.41 16.11 Favored 'General case' 0 CA--C 1.528 0.103 0 CA-C-N 118.818 0.735 . . . . 5.29 110.483 171.2 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.06 -33.81 73.9 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 119.793 1.179 . . . . 6.6200000000000001 110.922 -173.571 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 25.0 ptt180 -64.15 -26.24 68.44 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 112.133 0.42 . . . . 8.2599999999999998 112.133 176.122 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 37.4 tp -63.52 -43.3 97.57 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 108.778 -0.823 . . . . 3.1800000000000002 108.778 -174.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 1.6 tt -56.8 -46.25 81.7 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-O 121.132 0.491 . . . . 3.5099999999999998 110.3 176.218 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 40.6 t -59.0 -47.02 91.25 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 N-CA-C 109.412 -0.588 . . . . 1.74 109.412 176.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 57.4 t -56.66 -46.15 82.81 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.219 0 CA-C-O 118.821 -0.609 . . . . 1.8100000000000001 110.104 176.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 54.1 t -55.93 -50.57 68.33 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.441 0 CA-C-N 119.35 0.977 . . . . 2.04 109.773 177.506 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 77.3 t -56.23 -46.36 81.38 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 O-C-N 121.987 -0.446 . . . . 1.6599999999999999 110.889 177.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 54.7 t -60.94 -46.87 95.7 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 N-CA-C 109.104 -0.702 . . . . 1.6899999999999999 109.104 -179.576 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 48.5 t -54.62 -49.79 64.53 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.426 0 C-N-CA 123.421 0.688 . . . . 1.6599999999999999 110.179 176.755 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 46.2 t -58.63 -46.85 90.07 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.425 0 CA-C-N 118.395 0.543 . . . . 1.6100000000000001 110.588 179.014 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -59.39 -47.36 85.73 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 109.296 -0.631 . . . . 1.72 109.296 178.318 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.8 t -62.06 -40.05 86.01 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.9 0 C-N-CA 123.977 0.911 . . . . 1.5900000000000001 109.997 -179.814 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 3.5 t -62.99 -47.98 90.2 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.412 0 CA-C-N 118.702 0.683 . . . . 1.6200000000000001 109.83 175.248 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 1.5 t -55.27 -40.63 57.3 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 CA-C-N 118.98 0.809 . . . . 1.5800000000000001 111.048 173.851 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.4 t -65.67 -45.96 90.6 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 N-CA-C 108.674 -0.862 . . . . 1.4299999999999999 108.674 179.215 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 12.3 mt -58.86 -44.57 90.89 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 N-CA-C 108.282 -1.007 . . . . 1.5600000000000001 108.282 179.133 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 39.3 t -64.1 -54.46 31.14 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 N-CA-C 109.511 -0.552 . . . . 1.6100000000000001 109.511 -177.457 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -55.18 -47.48 73.98 Favored Glycine 0 CA--C 1.529 0.939 0 N-CA-C 111.439 -0.665 . . . . 0.34999999999999998 111.439 177.349 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -57.72 -42.59 84.13 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 123.317 0.647 . . . . 1.77 111.282 178.281 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 11.6 tp -63.08 -53.06 59.57 Favored 'General case' 0 N--CA 1.439 -1.009 0 N-CA-C 108.291 -1.003 . . . . 1.95 108.291 177.257 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 84.3 mt -58.13 -38.13 75.93 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 118.361 0.528 . . . . 3.1099999999999999 111.41 -177.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 38.2 ttm -83.68 6.8 19.67 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 123.557 0.743 . . . . 4.5099999999999998 111.901 177.428 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -121.95 -61.12 0.22 Allowed Glycine 0 CA--C 1.528 0.852 0 C-N-CA 125.151 1.358 . . . . 2.4900000000000002 112.497 -170.161 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 85.0 mt . . . . . 0 N--CA 1.447 -0.596 0 C-N-CA 125.069 1.348 . . . . 7.4400000000000004 107.816 -170.271 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 11.1 mp . . . . . 0 N--CA 1.476 0.853 0 N-CA-C 106.691 -1.596 . . . . 21.73 106.691 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 3.2 mpt_? -120.13 158.93 25.87 Favored 'General case' 0 CA--C 1.53 0.204 0 N-CA-C 105.81 -1.922 . . . . 26.109999999999999 105.81 161.417 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 24.6 mm 50.07 68.72 3.17 Favored Pre-proline 0 CA--C 1.541 0.614 0 C-N-CA 124.831 1.252 . . . . 18.510000000000002 110.938 -178.157 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -75.04 64.72 6.1 Favored 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 123.109 2.539 . . . . 14.800000000000001 109.5 176.565 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.3 m -158.48 57.23 0.45 Allowed 'General case' 0 C--O 1.227 -0.086 0 C-N-CA 126.149 1.78 . . . . 12.619999999999999 106.375 -174.548 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 46.8 t 56.07 71.69 1.16 Allowed Pre-proline 0 CA--C 1.536 0.439 0 C-N-CA 124.77 1.228 . . . . 6.2199999999999998 111.585 178.786 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -75.78 70.17 5.9 Favored 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 123.22 2.613 . . . . 4.7699999999999996 112.145 -170.486 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 8.5 p -115.37 -133.27 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 C-N-CA 126.061 1.744 . . . . 4.8700000000000001 109.739 177.365 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 20.0 p-10 -39.45 -45.88 1.59 Allowed 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.781 1.232 . . . . 5.0199999999999996 112.614 176.154 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 89.3 mt -58.06 -39.85 79.51 Favored 'General case' 0 C--O 1.227 -0.113 0 C-N-CA 124.135 0.974 . . . . 3.71 110.266 178.81 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.26 -51.27 64.43 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 123.371 0.669 . . . . 5.79 109.354 -179.725 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 14.5 ptm180 -68.45 -26.42 65.5 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 119.223 -0.991 . . . . 5.5999999999999996 111.869 179.532 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -63.46 -47.34 82.23 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 108.894 -0.78 . . . . 3.29 108.894 171.206 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -56.09 -46.0 79.21 Favored 'General case' 0 CA--C 1.533 0.3 0 O-C-N 121.891 -0.506 . . . . 3.29 110.251 174.886 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 85.3 t -56.16 -48.43 79.25 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 O-C-N 121.814 -0.554 . . . . 1.73 110.136 174.734 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 44.7 t -54.78 -47.05 74.82 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 CA-C-N 118.617 0.644 . . . . 1.78 109.822 176.293 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 50.3 t -55.02 -48.44 75.83 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 CA-C-N 119.028 0.831 . . . . 1.74 110.754 176.167 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 70.6 t -55.42 -44.99 78.03 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 O-C-N 121.447 -0.783 . . . . 1.76 110.71 175.385 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 87.0 t -60.4 -46.18 95.54 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.22 0 N-CA-C 109.073 -0.714 . . . . 1.74 109.073 178.362 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 72.4 t -55.02 -49.5 70.97 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 C-N-CA 123.218 0.607 . . . . 1.8300000000000001 110.069 177.09 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 46.5 t -56.93 -47.85 82.53 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 O-C-N 121.798 -0.564 . . . . 1.5 110.671 177.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -58.34 -47.57 83.36 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 123.23 0.612 . . . . 1.6499999999999999 109.354 177.732 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 14.2 t -62.61 -39.62 85.31 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.92 0 C-N-CA 124.162 0.985 . . . . 1.54 110.066 -179.209 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 3.6 t -63.44 -48.25 87.99 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 CA-C-N 118.742 0.701 . . . . 1.6499999999999999 109.56 175.472 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 1.5 t -55.43 -40.5 58.23 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.617 0 CA-C-N 118.909 0.777 . . . . 1.6599999999999999 110.953 173.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.4 t -66.17 -45.06 91.19 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.237 0 N-CA-C 108.746 -0.835 . . . . 1.6899999999999999 108.746 179.319 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 12.5 mt -59.05 -44.86 92.35 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.576 0 N-CA-C 108.285 -1.005 . . . . 1.7 108.285 178.598 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 40.2 t -63.73 -55.4 22.74 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 N-CA-C 109.347 -0.612 . . . . 1.5800000000000001 109.347 -177.672 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -53.34 -47.51 61.95 Favored Glycine 0 CA--C 1.529 0.941 0 N-CA-C 111.428 -0.669 . . . . 0.32000000000000001 111.428 176.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -57.89 -43.41 86.1 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 123.323 0.649 . . . . 1.73 111.142 178.6 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 13.5 tp -67.04 -45.28 77.93 Favored 'General case' 0 N--CA 1.439 -1.008 0 C-N-CA 123.698 0.799 . . . . 2.04 109.156 178.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 84.1 mt -58.03 -42.09 84.61 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 119.087 0.858 . . . . 2.7400000000000002 110.562 176.692 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 27.6 ttt -69.46 -42.03 75.42 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 123.041 0.536 . . . . 4.7800000000000002 111.779 178.8 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -126.11 50.89 0.86 Allowed Glycine 0 CA--C 1.526 0.759 0 C-N-CA 125.794 1.664 . . . . 3.1600000000000001 111.663 -168.181 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 66.2 mt . . . . . 0 CA--C 1.532 0.265 0 C-N-CA 125.613 1.565 . . . . 9.4900000000000002 110.743 166.531 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.473 0.689 0 N-CA-C 107.168 -1.419 . . . . 19.109999999999999 107.168 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 65.21 175.21 0.21 Allowed 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 106.943 -1.502 . . . . 22.25 106.943 -158.138 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.2 mp 54.2 78.55 0.38 Allowed Pre-proline 0 CA--C 1.543 0.688 0 C-N-CA 124.665 1.186 . . . . 17.710000000000001 109.564 -176.62 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -76.53 67.09 7.24 Favored 'Trans proline' 0 N--CA 1.456 -0.709 0 C-N-CA 122.931 2.421 . . . . 15.640000000000001 109.908 -177.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 23.7 t -104.25 28.43 6.86 Favored 'General case' 0 C--O 1.224 -0.27 0 C-N-CA 125.215 1.406 . . . . 11.75 109.246 -178.577 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 13.2 t -55.52 -49.79 90.61 Favored Pre-proline 0 CA--C 1.543 0.689 0 N-CA-C 114.178 1.177 . . . . 7.9400000000000004 114.178 173.544 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -79.26 65.38 8.87 Favored 'Trans proline' 0 CA--C 1.537 0.658 0 C-N-CA 122.015 1.81 . . . . 6.7999999999999998 112.912 -165.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.1 t -93.92 -133.66 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 C-N-CA 124.076 0.95 . . . . 4.7999999999999998 109.928 177.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -68.19 31.44 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 127.102 2.161 . . . . 4.2599999999999998 115.792 -167.261 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -114.36 -57.7 2.24 Favored 'General case' 0 N--CA 1.444 -0.736 0 C-N-CA 126.728 2.011 . . . . 4.4299999999999997 105.634 159.462 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 3.6 tmtm? -57.63 -52.1 66.81 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 123.302 0.641 . . . . 5.0300000000000002 109.642 175.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 26.8 mmm180 -64.92 -26.42 68.3 Favored 'General case' 0 N--CA 1.452 -0.328 0 O-C-N 122.288 -0.258 . . . . 8.2400000000000002 111.301 179.698 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.63 -51.02 64.81 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 108.16 -1.052 . . . . 4.0 108.16 173.098 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 10.6 tp -55.33 -45.83 76.38 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 122.648 0.379 . . . . 2.9199999999999999 111.259 175.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 74.0 t -54.97 -50.15 65.06 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 N-CA-C 109.989 -0.375 . . . . 1.95 109.989 174.441 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 42.2 t -56.54 -47.33 82.12 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 CA-C-N 118.43 0.559 . . . . 1.74 110.185 178.083 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 61.5 t -54.55 -51.18 52.74 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 CA-C-N 119.032 0.833 . . . . 1.53 110.268 177.149 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 60.7 t -56.52 -44.87 81.65 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 O-C-N 121.819 -0.55 . . . . 1.73 110.825 177.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 53.8 t -60.83 -47.4 93.46 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.267 0 N-CA-C 109.033 -0.729 . . . . 1.6299999999999999 109.033 179.27 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 55.4 t -54.27 -50.29 57.31 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 C-N-CA 123.32 0.648 . . . . 1.6100000000000001 110.148 176.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 43.1 t -57.73 -46.97 86.8 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 C-N-CA 123.052 0.541 . . . . 1.6299999999999999 110.811 178.495 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -59.34 -46.99 87.08 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 123.382 0.673 . . . . 1.6399999999999999 109.328 178.123 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 15.5 t -61.89 -40.73 88.14 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.882 0 C-N-CA 124.077 0.951 . . . . 1.6799999999999999 109.898 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 4.1 t -62.24 -47.79 91.42 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.396 0 O-C-N 121.554 -0.716 . . . . 1.6799999999999999 109.78 174.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 1.4 t -55.86 -39.87 58.93 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 CA-C-N 119.137 0.88 . . . . 1.6399999999999999 111.459 173.587 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.4 t -64.74 -45.09 96.21 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 N-CA-C 108.492 -0.929 . . . . 1.4399999999999999 108.492 178.111 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 11.3 mt -60.14 -42.85 91.52 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 N-CA-C 108.725 -0.843 . . . . 1.53 108.725 178.674 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 40.5 t -63.1 -52.67 56.04 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 N-CA-C 109.294 -0.632 . . . . 1.5900000000000001 109.294 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -53.07 -46.49 61.69 Favored Glycine 0 CA--C 1.529 0.968 0 N-CA-C 111.551 -0.62 . . . . 0.32000000000000001 111.551 175.858 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -57.47 -49.12 77.29 Favored 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 123.409 0.684 . . . . 1.6299999999999999 110.406 177.476 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 10.3 tp -58.88 -46.17 88.44 Favored 'General case' 0 N--CA 1.44 -0.935 0 C-N-CA 123.739 0.816 . . . . 1.7 109.206 178.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 84.9 mt -61.7 -42.54 99.08 Favored 'General case' 0 CA--C 1.533 0.314 0 O-C-N 121.792 -0.568 . . . . 2.73 111.169 178.737 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 47.9 tpp -63.73 -38.61 91.74 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 123.073 0.549 . . . . 4.7400000000000002 110.825 176.312 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 101.85 57.36 0.82 Allowed Glycine 0 CA--C 1.527 0.806 0 C-N-CA 125.709 1.623 . . . . 3.0499999999999998 109.604 -173.027 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 60.5 tp . . . . . 0 N--CA 1.45 -0.437 0 C-N-CA 126.118 1.767 . . . . 9.6600000000000001 106.396 178.235 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 1.3 pt? . . . . . 0 N--CA 1.481 1.105 0 N-CA-C 114.052 1.13 . . . . 24.379999999999999 114.052 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 96.3 mtm-85 -152.02 171.25 18.13 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 105.09 -2.189 . . . . 24.149999999999999 105.09 172.681 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.9 mp 46.9 74.31 0.83 Allowed Pre-proline 0 CA--C 1.542 0.64 0 C-N-CA 125.429 1.492 . . . . 16.16 111.851 -179.316 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -75.12 -151.81 0.04 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.856 0 C-N-CA 122.237 1.958 . . . . 13.220000000000001 108.0 164.673 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 17.4 p -103.57 26.49 8.42 Favored 'General case' 0 N--CA 1.464 0.243 0 O-C-N 120.937 -1.102 . . . . 11.49 109.489 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 33.5 t -144.61 92.13 6.03 Favored Pre-proline 0 CA--C 1.531 0.219 0 C-N-CA 125.39 1.476 . . . . 8.6600000000000001 108.556 175.153 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -72.23 -31.87 11.26 Favored 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 122.411 2.074 . . . . 5.8799999999999999 110.942 179.626 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.4 t -58.9 151.23 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.23 0 N-CA-C 108.368 -0.975 . . . . 3.8599999999999999 108.368 174.168 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 69.2 m-20 68.36 -46.35 0.53 Allowed 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 126.493 1.917 . . . . 4.2199999999999998 112.585 -172.813 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -63.14 -41.61 99.32 Favored 'General case' 0 C--N 1.332 -0.162 0 C-N-CA 123.618 0.767 . . . . 5.0800000000000001 109.438 176.556 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 2.5 tmtp? -55.27 -47.52 75.36 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 108.928 -0.768 . . . . 3.7999999999999998 108.928 172.25 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.8 -26.6 66.16 Favored 'General case' 0 CA--C 1.533 0.307 0 O-C-N 122.1 -0.375 . . . . 6.9000000000000004 111.378 -178.56 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 47.8 tp -61.45 -39.06 89.46 Favored 'General case' 0 C--N 1.33 -0.251 0 O-C-N 121.534 -0.728 . . . . 3.3700000000000001 109.233 178.066 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -57.53 -46.13 84.23 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-O 121.26 0.553 . . . . 3.4199999999999999 110.231 175.372 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 43.6 t -60.46 -45.15 97.3 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 N-CA-C 109.384 -0.599 . . . . 1.8300000000000001 109.384 176.571 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 72.2 t -56.32 -45.82 81.53 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.217 0 CA-C-O 118.876 -0.583 . . . . 1.71 110.132 175.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 55.5 t -56.44 -48.98 79.21 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 CA-C-N 119.504 1.047 . . . . 1.8400000000000001 110.102 177.125 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 69.9 t -55.76 -45.75 79.51 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 O-C-N 121.786 -0.571 . . . . 1.5800000000000001 110.905 176.449 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 53.2 t -60.23 -46.87 94.13 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.18 0 N-CA-C 109.248 -0.649 . . . . 1.54 109.248 178.841 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 48.9 t -54.48 -49.42 65.81 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 C-N-CA 123.7 0.8 . . . . 1.6399999999999999 110.118 177.145 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 42.2 t -57.01 -47.19 83.93 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 CA-C-N 118.435 0.561 . . . . 1.8200000000000001 110.537 177.744 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.19 -47.44 83.43 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 123.053 0.541 . . . . 1.76 109.553 177.546 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 16.0 t -62.94 -40.4 88.78 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.893 0 C-N-CA 123.909 0.884 . . . . 1.6699999999999999 110.049 -178.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 7.5 t -63.55 -47.13 92.9 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.48 0 O-C-N 121.542 -0.724 . . . . 1.5700000000000001 109.503 175.841 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 1.4 t -54.69 -41.37 55.62 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.579 0 CA-C-N 119.107 0.867 . . . . 1.6299999999999999 111.212 172.805 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.4 t -64.51 -45.7 94.9 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.19 0 N-CA-C 108.627 -0.879 . . . . 1.76 108.627 179.249 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 11.1 mt -59.89 -43.99 93.35 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 N-CA-C 108.75 -0.833 . . . . 1.75 108.75 178.689 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 37.4 t -64.89 -49.74 78.43 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.266 0 N-CA-C 109.535 -0.543 . . . . 1.7 109.535 -176.814 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -55.77 -50.33 61.5 Favored Glycine 0 CA--C 1.528 0.897 0 N-CA-C 111.128 -0.789 . . . . 0.41999999999999998 111.128 174.229 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -55.15 -42.3 72.92 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 117.325 0.563 . . . . 1.6100000000000001 111.048 178.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 10.2 tp -59.87 -62.36 1.93 Allowed 'General case' 0 N--CA 1.439 -1.023 0 N-CA-C 108.512 -0.921 . . . . 1.6899999999999999 108.512 175.052 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . 0.269 2.9 pp -65.7 -27.92 68.69 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 119.223 0.92 . . . . 4.2300000000000004 113.267 -170.357 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 60.8 mtt -61.49 -32.31 72.33 Favored 'General case' 0 CA--C 1.534 0.333 0 O-C-N 121.919 -0.488 . . . . 4.7400000000000002 110.923 171.037 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -83.75 -65.73 1.54 Allowed Glycine 0 CA--C 1.528 0.884 0 N-CA-C 111.074 -0.811 . . . . 3.54 111.074 176.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 2.2 pt? . . . . . 0 N--CA 1.432 -1.329 0 C-N-CA 125.749 1.619 . . . . 8.4199999999999999 110.114 -166.216 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 67.3 mt . . . . . 0 N--CA 1.474 0.757 0 N-CA-C 106.84 -1.541 . . . . 21.710000000000001 106.84 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 58.0 ttt180 -150.3 129.59 12.85 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 107.629 -1.248 . . . . 17.829999999999998 107.629 -179.346 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -74.2 145.28 82.93 Favored Pre-proline 0 N--CA 1.45 -0.449 0 N-CA-C 109.604 -0.517 . . . . 13.99 109.604 176.847 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -77.15 60.35 6.9 Favored 'Trans proline' 0 N--CA 1.457 -0.67 0 C-N-CA 123.237 2.625 . . . . 13.220000000000001 109.903 178.405 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -170.1 58.83 0.04 OUTLIER 'General case' 0 CA--C 1.529 0.166 0 N-CA-C 107.618 -1.252 . . . . 10.4 107.618 -174.756 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 44.8 t -160.58 101.7 1.34 Allowed Pre-proline 0 CA--C 1.532 0.286 0 CA-C-O 118.599 -0.715 . . . . 6.3399999999999999 110.214 -177.67 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -82.54 -5.4 11.7 Favored 'Trans proline' 0 CA--C 1.536 0.606 0 C-N-CA 123.308 2.672 . . . . 3.9399999999999999 112.437 178.447 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 9.5 t -60.61 153.34 4.92 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 N-CA-C 108.455 -0.942 . . . . 3.96 108.455 -179.517 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . 0.368 17.1 p30 59.69 -45.87 0.08 Allowed 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 127.367 2.267 . . . . 4.21 115.031 -166.401 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 7.9 mp -57.12 -39.08 74.43 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 119.498 1.044 . . . . 4.9299999999999997 110.443 175.331 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 3.2 tmtp? -57.76 -51.14 70.79 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 108.526 -0.916 . . . . 4.0999999999999996 108.526 178.712 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 7.5 ptm180 -70.39 -25.83 63.42 Favored 'General case' 0 C--O 1.224 -0.245 0 C-N-CA 119.907 -0.717 . . . . 6.1100000000000003 112.204 -179.627 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.9 tt -57.28 -49.68 75.3 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 108.288 -1.005 . . . . 3.3700000000000001 108.288 169.703 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.24 -46.06 79.75 Favored 'General case' 0 CA--C 1.535 0.396 0 O-C-N 121.927 -0.483 . . . . 3.71 110.369 176.062 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 89.2 t -55.89 -47.24 80.05 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 O-C-N 121.58 -0.7 . . . . 1.72 110.591 174.655 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 51.1 t -56.27 -45.96 81.36 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.19 0 O-C-N 121.507 -0.745 . . . . 1.72 109.892 176.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 73.0 t -53.74 -50.0 54.06 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 CA-C-N 119.246 0.93 . . . . 1.6799999999999999 110.483 174.689 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 93.2 t -55.5 -45.1 78.38 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 O-C-N 121.696 -0.627 . . . . 1.6200000000000001 111.085 176.692 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 73.8 t -60.42 -46.17 95.61 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.159 0 O-C-N 121.597 -0.689 . . . . 1.6899999999999999 109.25 178.77 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 53.0 t -55.84 -48.01 78.84 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 C-N-CA 123.407 0.683 . . . . 1.6599999999999999 110.36 177.271 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 47.0 t -56.5 -46.45 82.32 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 O-C-N 121.765 -0.585 . . . . 1.51 110.524 176.4 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -58.92 -46.69 87.35 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 123.076 0.55 . . . . 1.76 109.63 176.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 13.5 t -61.62 -40.59 87.17 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.839 0 O-C-N 121.255 -0.903 . . . . 1.5800000000000001 110.063 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 5.4 t -62.08 -47.95 90.77 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.416 0 O-C-N 121.511 -0.743 . . . . 1.6200000000000001 109.841 174.808 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 1.4 t -54.94 -40.76 54.74 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 CA-C-N 119.088 0.858 . . . . 1.5800000000000001 111.493 173.065 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.4 t -63.88 -45.24 97.54 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.179 0 N-CA-C 108.472 -0.936 . . . . 1.76 108.472 178.535 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 10.1 mt -59.42 -43.74 91.11 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 N-CA-C 108.831 -0.803 . . . . 1.9299999999999999 108.831 177.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 40.9 t -63.36 -52.37 59.2 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 N-CA-C 109.489 -0.56 . . . . 1.6799999999999999 109.489 -178.444 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -52.74 -50.46 49.46 Favored Glycine 0 CA--C 1.528 0.871 0 N-CA-C 111.007 -0.837 . . . . 0.34000000000000002 111.007 174.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -55.24 -44.67 75.7 Favored 'General case' 0 CA--C 1.53 0.182 0 O-C-N 122.284 -0.539 . . . . 1.5800000000000001 111.075 179.198 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 11.0 tp -61.26 -50.64 72.22 Favored 'General case' 0 N--CA 1.442 -0.869 0 C-N-CA 123.599 0.76 . . . . 1.9299999999999999 108.959 176.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 73.7 mt -57.59 -41.97 82.25 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 118.264 0.484 . . . . 2.4700000000000002 111.642 -179.148 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -71.06 -35.62 71.97 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 122.441 0.296 . . . . 5.5300000000000002 111.314 176.234 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -80.46 -34.33 29.05 Favored Glycine 0 CA--C 1.53 0.978 0 CA-C-O 118.893 -0.948 . . . . 2.5600000000000001 113.987 -171.071 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 4.4 pp . . . . . 0 CA--C 1.531 0.214 0 CA-C-N 117.973 0.886 . . . . 9.9499999999999993 112.595 -175.323 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 63.2 tp . . . . . 0 N--CA 1.474 0.76 0 N-CA-C 106.728 -1.582 . . . . 16.620000000000001 106.728 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 22.5 ptt-85 -157.02 175.7 13.74 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 106.945 -1.502 . . . . 19.420000000000002 106.945 171.058 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 15.4 mt 64.56 126.38 0.02 OUTLIER Pre-proline 0 CA--C 1.543 0.674 0 C-N-CA 127.349 2.26 . . . . 13.67 112.16 179.686 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -77.96 57.21 6.01 Favored 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 122.622 2.215 . . . . 12.17 111.137 -178.78 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 27.3 t -129.52 46.4 2.65 Favored 'General case' 0 CA--C 1.529 0.135 0 CA-C-O 122.954 1.359 . . . . 8.6999999999999993 107.439 174.03 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 28.6 t -158.93 -57.41 0.02 OUTLIER Pre-proline 0 CA--C 1.532 0.277 0 C-N-CA 126.398 1.879 . . . . 8.0500000000000007 109.083 -179.572 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -72.89 60.33 3.66 Favored 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 122.493 2.129 . . . . 5.3099999999999996 110.639 165.637 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 4.1 t -91.66 159.77 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 N-CA-C 106.476 -1.676 . . . . 4.7800000000000002 106.476 169.344 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 9.3 m120 70.45 -46.69 0.62 Allowed 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 127.295 2.238 . . . . 4.0300000000000002 112.899 -179.788 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.7 pp -65.42 -32.16 73.64 Favored 'General case' 0 C--N 1.331 -0.216 0 O-C-N 121.661 -0.65 . . . . 4.4299999999999997 110.182 179.563 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 7.8 mtpm? -58.97 -53.23 60.74 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 109.904 -0.406 . . . . 4.71 109.904 174.299 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 16.8 ptm180 -68.94 -26.4 65.05 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 119.778 -0.769 . . . . 5.5899999999999999 111.696 -178.817 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.6 tt -59.62 -49.73 76.64 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 108.566 -0.902 . . . . 3.3100000000000001 108.566 168.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -55.76 -45.82 77.99 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.223 0.609 . . . . 3.8999999999999999 110.344 176.403 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 96.3 t -55.75 -48.76 77.57 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 O-C-N 121.813 -0.554 . . . . 1.78 110.398 174.811 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 55.5 t -55.77 -47.37 79.49 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 O-C-N 121.659 -0.65 . . . . 1.9099999999999999 109.935 176.646 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 72.0 t -54.29 -49.67 61.97 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 CA-C-N 118.783 0.719 . . . . 1.8700000000000001 110.389 176.247 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 73.5 t -56.0 -44.7 79.18 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 O-C-N 121.641 -0.662 . . . . 1.6599999999999999 110.864 177.164 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 54.6 t -59.9 -48.09 89.07 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.168 0 N-CA-C 109.067 -0.716 . . . . 1.6599999999999999 109.067 178.329 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 60.1 t -55.19 -48.92 75.77 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 C-N-CA 122.943 0.497 . . . . 2.1699999999999999 110.32 177.315 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 42.2 t -56.74 -45.76 82.98 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 C-N-CA 123.632 0.773 . . . . 1.8100000000000001 110.601 177.237 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.25 -47.91 83.6 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 123.402 0.681 . . . . 1.8200000000000001 109.405 177.455 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 20.3 t -61.51 -40.88 87.99 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.838 0 O-C-N 121.484 -0.76 . . . . 2.02 110.0 179.481 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 4.1 t -62.0 -45.8 97.9 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.39 0 C-N-CA 123.556 0.742 . . . . 1.75 109.887 175.029 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 1.4 t -57.26 -40.46 73.9 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 CA-C-N 119.437 1.017 . . . . 1.51 111.34 173.329 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.4 t -62.87 -45.3 99.21 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 N-CA-C 108.398 -0.964 . . . . 1.8100000000000001 108.398 177.339 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 10.9 mt -61.22 -41.37 89.33 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 N-CA-C 109.232 -0.655 . . . . 1.72 109.232 178.675 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 32.9 t -62.74 -50.3 80.27 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.277 0 N-CA-C 108.957 -0.757 . . . . 1.77 108.957 179.071 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -52.65 -47.23 58.34 Favored Glycine 0 CA--C 1.53 1.021 0 N-CA-C 111.527 -0.629 . . . . 0.34000000000000002 111.527 173.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -57.01 -49.58 75.35 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 123.224 0.61 . . . . 1.7 110.551 177.583 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 10.4 tp -58.6 -45.63 88.72 Favored 'General case' 0 N--CA 1.441 -0.909 0 C-N-CA 124.351 1.06 . . . . 2.1400000000000001 109.216 178.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 66.4 mt -61.98 -41.78 98.39 Favored 'General case' 0 CA--C 1.533 0.311 0 O-C-N 121.713 -0.617 . . . . 2.6400000000000001 111.017 177.871 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 37.7 ttm -63.1 -37.16 86.11 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 122.918 0.487 . . . . 3.5699999999999998 110.687 175.434 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 103.06 45.49 1.59 Allowed Glycine 0 CA--C 1.528 0.845 0 C-N-CA 125.957 1.741 . . . . 2.4300000000000002 110.614 -177.082 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 94.0 mt . . . . . 0 N--CA 1.447 -0.62 0 C-N-CA 126.472 1.909 . . . . 9.1999999999999993 106.895 173.961 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 3.1 tm? . . . . . 0 N--CA 1.474 0.752 0 N-CA-C 106.123 -1.806 . . . . 24.82 106.123 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 41.6 ptt180 39.83 49.73 2.22 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.442 1.497 . . . . 26.920000000000002 112.929 -171.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -84.11 127.52 66.39 Favored Pre-proline 0 N--CA 1.439 -1.021 0 N-CA-C 106.839 -1.541 . . . . 17.07 106.839 -179.023 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -77.66 -22.71 10.3 Favored 'Trans proline' 0 N--CA 1.459 -0.557 0 C-N-CA 122.636 2.224 . . . . 13.77 112.593 -174.263 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 7.5 t 64.39 41.45 5.77 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-O 122.238 1.018 . . . . 11.119999999999999 110.592 -177.079 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 53.2 t -148.34 69.17 10.47 Favored Pre-proline 0 CA--C 1.532 0.286 0 C-N-CA 123.69 0.796 . . . . 6.8399999999999999 109.682 177.371 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -78.62 60.64 7.7 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 123.297 2.665 . . . . 4.4699999999999998 110.371 -176.464 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 10.6 p -86.32 -134.35 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.529 0.16 0 C-N-CA 124.26 1.024 . . . . 5.8600000000000003 108.483 -179.59 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 32.2 t30 -53.54 -26.42 21.05 Favored 'General case' 0 CA--C 1.532 0.271 0 O-C-N 121.105 -0.997 . . . . 4.8799999999999999 112.022 175.586 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 86.2 mt -53.83 -35.16 61.15 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 123.811 0.844 . . . . 3.9399999999999999 110.478 175.035 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 58.5 tttm -57.95 -49.81 75.52 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 123.164 0.585 . . . . 3.71 109.858 174.002 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 48.6 ttp180 -70.41 -26.72 63.82 Favored 'General case' 0 N--CA 1.442 -0.872 0 O-C-N 121.743 -0.598 . . . . 6.8700000000000001 110.792 179.82 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.4 tt -63.56 -47.53 81.16 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 108.107 -1.072 . . . . 2.9700000000000002 108.107 172.325 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 10.3 tp -55.39 -45.89 76.58 Favored 'General case' 0 N--CA 1.453 -0.293 0 O-C-N 121.81 -0.556 . . . . 3.0899999999999999 111.375 174.579 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 94.3 t -56.15 -49.13 77.67 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 N-CA-C 110.068 -0.345 . . . . 1.6699999999999999 110.068 174.623 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 49.2 t -56.07 -46.5 80.85 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 O-C-N 121.796 -0.565 . . . . 1.76 110.195 177.502 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 53.1 t -54.64 -50.55 58.76 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 CA-C-N 118.952 0.796 . . . . 1.6399999999999999 110.043 176.433 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 78.7 t -55.6 -45.23 78.78 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 O-C-N 121.859 -0.526 . . . . 1.5600000000000001 110.8 177.142 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 61.9 t -60.15 -47.47 91.9 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.136 0 N-CA-C 109.191 -0.67 . . . . 1.52 109.191 178.829 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 55.7 t -55.15 -49.16 74.27 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 C-N-CA 123.487 0.715 . . . . 1.8500000000000001 110.25 177.548 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 46.1 t -57.43 -46.25 85.7 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 C-N-CA 123.246 0.618 . . . . 1.9399999999999999 110.473 177.631 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -59.06 -47.25 85.91 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 123.204 0.602 . . . . 1.55 109.422 177.374 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 14.2 t -61.61 -41.11 89.01 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.821 0 C-N-CA 123.814 0.846 . . . . 1.79 110.003 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 4.1 t -62.24 -47.14 94.48 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 O-C-N 121.541 -0.724 . . . . 1.5700000000000001 109.852 175.172 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 1.4 t -56.11 -39.97 61.74 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.6 0 CA-C-N 119.085 0.857 . . . . 1.6799999999999999 111.349 173.418 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.4 t -64.03 -46.0 95.1 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.203 0 N-CA-C 108.411 -0.959 . . . . 1.6200000000000001 108.411 177.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 10.6 mt -59.95 -43.0 91.34 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 N-CA-C 108.825 -0.806 . . . . 1.73 108.825 178.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 39.2 t -61.71 -54.71 31.05 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 N-CA-C 108.933 -0.766 . . . . 1.5800000000000001 108.933 179.827 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -52.59 -45.17 59.93 Favored Glycine 0 CA--C 1.53 0.985 0 N-CA-C 111.703 -0.559 . . . . 0.32000000000000001 111.703 176.535 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -57.77 -44.78 86.41 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 123.498 0.719 . . . . 1.6399999999999999 110.712 177.274 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 9.7 tp -60.9 -51.97 67.04 Favored 'General case' 0 N--CA 1.439 -0.983 0 C-N-CA 124.014 0.926 . . . . 1.9099999999999999 109.235 177.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 5.5 mp -56.17 -41.36 75.33 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 119.231 0.923 . . . . 3.3399999999999999 112.14 175.546 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 2.1 tmt? -62.22 -43.22 99.31 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 118.093 0.406 . . . . 6.0499999999999998 110.741 176.669 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -173.55 -53.75 0.05 OUTLIER Glycine 0 CA--C 1.528 0.844 0 CA-C-O 119.791 -0.45 . . . . 3.21 112.401 -179.227 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.454 -0.235 0 N-CA-C 105.713 -1.958 . . . . 7.9800000000000004 105.713 -174.622 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 4.2 mm? . . . . . 0 N--CA 1.475 0.786 0 N-CA-C 107.81 -1.181 . . . . 19.809999999999999 107.81 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 37.3 ptt180 -74.05 71.77 1.62 Allowed 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.804 0.841 . . . . 22.73 111.346 -175.336 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 24.7 mm 54.48 70.49 1.66 Allowed Pre-proline 0 CA--C 1.54 0.593 0 C-N-CA 125.506 1.522 . . . . 16.670000000000002 110.517 174.192 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -65.69 -56.75 0.3 Allowed 'Trans proline' 0 N--CA 1.456 -0.722 0 C-N-CA 122.384 2.056 . . . . 13.210000000000001 112.18 -172.118 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 35.5 t -164.84 60.01 0.13 Allowed 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 123.815 0.846 . . . . 7.71 109.093 179.208 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 26.2 p -53.39 102.56 0.32 Allowed Pre-proline 0 CA--C 1.536 0.439 0 C-N-CA 127.85 2.46 . . . . 8.4800000000000004 111.636 -168.492 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -85.12 38.56 0.66 Allowed 'Trans proline' 0 N--CA 1.456 -0.716 0 C-N-CA 123.249 2.632 . . . . 6.3700000000000001 110.724 -171.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 12.4 p -107.75 -133.68 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 N-CA-C 104.271 -2.492 . . . . 5.7199999999999998 104.271 168.171 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 23.7 m120 48.68 -84.16 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 126.115 1.766 . . . . 3.6800000000000002 112.928 164.778 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 96.9 mt -53.64 -43.03 68.42 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 125.697 1.599 . . . . 4.0199999999999996 110.356 176.329 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 4.5 mptp? -57.56 -51.57 68.95 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 109.389 -0.597 . . . . 6.4000000000000004 109.389 175.472 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? -67.44 -26.67 66.51 Favored 'General case' 0 N--CA 1.453 -0.312 0 O-C-N 122.227 -0.295 . . . . 8.3200000000000003 111.675 -178.002 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 63.2 tp -65.47 -49.39 69.27 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 108.6 -0.889 . . . . 3.3300000000000001 108.6 173.5 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 1.6 tt -58.42 -46.13 87.07 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-O 120.984 0.421 . . . . 3.6600000000000001 110.469 178.498 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 71.4 t -55.8 -49.39 74.93 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 N-CA-C 109.863 -0.421 . . . . 1.96 109.863 174.684 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 25.5 t -57.0 -45.61 83.86 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.365 0 CA-C-O 118.505 -0.759 . . . . 1.96 110.252 178.514 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 49.3 t -54.2 -52.11 41.06 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 CA-C-N 119.693 1.133 . . . . 1.8899999999999999 110.008 177.277 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 85.1 t -57.41 -47.18 85.3 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 O-C-N 121.949 -0.469 . . . . 1.76 111.004 178.67 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 57.3 t -60.66 -45.35 97.64 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 N-CA-C 109.219 -0.66 . . . . 1.6599999999999999 109.219 -179.132 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 46.8 t -55.68 -48.79 77.33 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 C-N-CA 124.069 0.948 . . . . 1.8500000000000001 110.099 177.076 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 44.2 t -57.88 -47.71 85.63 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 CA-C-N 118.779 0.718 . . . . 1.6599999999999999 110.601 177.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -59.23 -46.65 87.89 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 109.551 -0.537 . . . . 1.8999999999999999 109.551 178.327 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.5 t -62.55 -39.36 84.25 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.923 0 C-N-CA 124.442 1.097 . . . . 1.74 110.04 -179.682 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 3.4 t -63.23 -48.92 85.26 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.391 0 CA-C-N 118.963 0.801 . . . . 1.78 109.569 175.285 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 1.3 t -53.99 -41.84 51.57 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 CA-C-N 118.881 0.764 . . . . 1.77 111.286 173.242 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.4 t -65.43 -44.45 94.39 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.266 0 N-CA-C 108.667 -0.864 . . . . 1.9399999999999999 108.667 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 12.3 mt -59.34 -44.29 92.06 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.57 0 N-CA-C 108.379 -0.971 . . . . 1.6100000000000001 108.379 178.117 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 39.2 t -64.36 -52.95 49.03 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 N-CA-C 109.568 -0.53 . . . . 1.6499999999999999 109.568 -177.159 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -55.22 -48.24 69.81 Favored Glycine 0 CA--C 1.529 0.934 0 N-CA-C 111.512 -0.635 . . . . 0.33000000000000002 111.512 175.846 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -55.56 -44.98 77.35 Favored 'General case' 0 N--CA 1.454 -0.226 0 O-C-N 122.15 -0.618 . . . . 1.77 110.592 177.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 11.9 tp -62.92 -53.9 46.92 Favored 'General case' 0 N--CA 1.437 -1.102 0 C-N-CA 123.613 0.765 . . . . 1.95 109.045 179.187 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . 0.305 3.1 pp -65.34 -33.82 76.87 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 119.375 0.989 . . . . 4.2800000000000002 112.568 -175.121 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 73.2 mtm -70.71 -43.19 69.49 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 118.071 0.396 . . . . 4.3700000000000001 111.263 174.518 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -70.45 -42.63 64.0 Favored Glycine 0 CA--C 1.528 0.888 0 CA-C-O 119.367 -0.685 . . . . 2.4700000000000002 112.554 -175.354 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . 0.371 0.0 OUTLIER . . . . . 0 N--CA 1.446 -0.642 0 C-N-CA 127.934 2.494 . . . . 8.8800000000000008 115.321 -168.144 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.534 0.358 0 N-CA-C 108.69 -0.856 . . . . 2.9199999999999999 108.69 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 10.2 tp -55.23 -45.58 75.97 Favored 'General case' 0 N--CA 1.453 -0.309 0 O-C-N 121.873 -0.517 . . . . 2.1299999999999999 111.149 176.081 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 89.7 t -55.12 -48.82 75.72 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 O-C-N 122.199 -0.313 . . . . 0.40000000000000002 110.156 174.544 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 55.3 t -56.54 -46.79 82.58 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 CA-C-N 118.612 0.642 . . . . 0.58999999999999997 110.182 177.119 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 72.3 t -54.52 -50.46 58.32 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 CA-C-N 118.771 0.714 . . . . 0.75 110.451 175.972 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 73.0 t -56.27 -44.34 79.25 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 O-C-N 121.636 -0.665 . . . . 0.5 110.843 177.537 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 46.4 t -60.04 -48.11 89.21 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.177 0 N-CA-C 108.904 -0.776 . . . . 0.42999999999999999 108.904 178.262 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 41.9 t -54.02 -50.19 55.64 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 C-N-CA 123.203 0.601 . . . . 0.58999999999999997 110.486 176.779 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 46.9 t -56.96 -46.69 83.98 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 C-N-CA 123.4 0.68 . . . . 0.59999999999999998 110.79 177.57 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -59.38 -46.93 87.31 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 123.352 0.661 . . . . 0.38 109.39 177.951 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 13.7 t -61.32 -40.76 87.24 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.795 0 C-N-CA 123.881 0.873 . . . . 0.40000000000000002 109.951 179.291 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 3.2 t -62.0 -47.64 92.24 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.359 0 O-C-N 121.56 -0.713 . . . . 0.41999999999999998 110.028 174.804 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 1.4 t -55.36 -40.66 58.28 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 CA-C-N 119.115 0.87 . . . . 0.32000000000000001 111.407 173.262 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.4 t -63.9 -46.11 95.09 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.235 0 N-CA-C 108.349 -0.982 . . . . 0.29999999999999999 108.349 178.363 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 10.8 mt -59.34 -42.61 87.93 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 N-CA-C 108.92 -0.771 . . . . 0.40000000000000002 108.92 178.629 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 39.6 t -63.37 -52.79 53.76 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 N-CA-C 109.423 -0.584 . . . . 0.33000000000000002 109.423 -179.673 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -52.27 -47.27 56.2 Favored Glycine 0 CA--C 1.53 1.009 0 N-CA-C 111.527 -0.629 . . . . 0.37 111.527 175.363 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -56.88 -49.83 74.33 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 123.446 0.698 . . . . 0.67000000000000004 110.46 178.231 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 11.2 tp -59.46 -44.63 92.93 Favored 'General case' 0 N--CA 1.44 -0.939 0 C-N-CA 123.776 0.83 . . . . 0.67000000000000004 109.465 178.409 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 85.3 mt . . . . . 0 CA--C 1.533 0.302 0 O-C-N 121.431 -0.793 . . . . 1.6799999999999999 111.23 178.01 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.8 tm? . . . . . 0 N--CA 1.451 -0.4 0 N-CA-C 107.839 -1.171 . . . . 2.4900000000000002 107.839 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -55.48 -45.89 76.95 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-O 120.835 0.35 . . . . 2.4300000000000002 110.639 176.831 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 64.4 t -56.15 -49.94 73.25 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 O-C-N 121.946 -0.471 . . . . 0.46999999999999997 109.77 174.911 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 38.1 t -55.77 -45.79 79.58 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 CA-C-N 118.404 0.547 . . . . 0.44 110.322 177.447 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 54.2 t -55.72 -51.17 62.11 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.375 0 CA-C-N 119.158 0.89 . . . . 0.45000000000000001 110.314 177.113 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 73.3 t -56.22 -45.18 80.98 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 O-C-N 121.791 -0.568 . . . . 0.35999999999999999 110.903 177.341 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 54.8 t -60.87 -46.4 96.41 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 N-CA-C 109.152 -0.684 . . . . 0.34999999999999998 109.152 179.504 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 47.8 t -55.19 -49.01 75.62 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 C-N-CA 123.481 0.712 . . . . 0.44 110.278 176.693 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 46.2 t -57.08 -46.85 84.46 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 O-C-N 121.815 -0.553 . . . . 0.40000000000000002 110.635 177.244 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.13 -47.35 83.59 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 123.265 0.626 . . . . 0.40999999999999998 109.524 177.135 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 11.7 t -62.38 -40.8 89.31 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.814 0 C-N-CA 124.033 0.933 . . . . 0.37 109.939 -179.093 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 5.1 t -62.63 -47.98 90.37 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.411 0 O-C-N 121.649 -0.657 . . . . 0.35999999999999999 109.654 175.273 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 1.5 t -55.09 -40.35 54.32 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.585 0 CA-C-N 119.051 0.842 . . . . 0.32000000000000001 111.144 173.453 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.4 t -65.32 -45.48 93.3 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.249 0 N-CA-C 108.687 -0.857 . . . . 0.33000000000000002 108.687 179.025 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 11.2 mt -59.85 -44.55 94.44 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.525 0 N-CA-C 108.566 -0.902 . . . . 0.37 108.566 178.82 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 38.8 t -63.97 -51.77 65.02 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 N-CA-C 109.371 -0.603 . . . . 0.39000000000000001 109.371 -177.49 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -54.0 -49.81 57.51 Favored Glycine 0 CA--C 1.528 0.868 0 N-CA-C 111.063 -0.815 . . . . 0.29999999999999999 111.063 175.028 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -56.01 -41.9 75.61 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 123.305 0.642 . . . . 0.56999999999999995 111.313 179.465 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 10.7 tp -61.2 -58.09 9.75 Favored 'General case' 0 N--CA 1.439 -0.987 0 N-CA-C 108.338 -0.986 . . . . 0.76000000000000001 108.338 174.054 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 75.6 mt . . . . . 0 CA--C 1.53 0.207 0 C-N-CA 123.823 0.849 . . . . 1.6699999999999999 112.497 -173.981 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.1 tt . . . . . 0 N--CA 1.453 -0.301 0 N-CA-C 108.09 -1.078 . . . . 2.0 108.09 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 11.0 tp -54.41 -46.0 73.06 Favored 'General case' 0 N--CA 1.454 -0.255 0 O-C-N 121.922 -0.486 . . . . 2.1200000000000001 111.245 174.804 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 79.9 t -57.81 -47.64 85.57 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 O-C-N 122.16 -0.337 . . . . 0.41999999999999998 110.241 174.74 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 49.6 t -55.68 -44.83 78.38 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 O-C-N 121.718 -0.614 . . . . 0.48999999999999999 110.218 176.371 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 68.7 t -56.35 -49.33 77.36 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 CA-C-N 119.203 0.911 . . . . 0.5 110.472 175.86 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 76.4 t -55.24 -45.15 77.47 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 O-C-N 121.564 -0.71 . . . . 0.37 110.704 176.151 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 70.1 t -60.17 -46.19 94.92 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.191 0 N-CA-C 109.163 -0.68 . . . . 0.34999999999999998 109.163 177.689 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 41.1 t -54.7 -48.58 72.14 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 C-N-CA 123.471 0.709 . . . . 0.48999999999999999 110.572 177.084 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 53.9 t -56.47 -46.97 82.4 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 CA-C-N 118.673 0.669 . . . . 0.44 110.598 177.12 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -59.08 -47.29 85.81 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 109.514 -0.551 . . . . 0.31 109.514 177.104 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 15.9 t -61.67 -38.49 80.46 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.878 0 C-N-CA 124.145 0.978 . . . . 0.39000000000000001 110.179 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 2.9 t -62.64 -49.45 83.72 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.334 0 C-N-CA 123.616 0.767 . . . . 0.5 109.562 174.417 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 1.3 t -54.25 -41.49 52.37 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 CA-C-N 119.207 0.912 . . . . 0.39000000000000001 111.384 173.369 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.4 t -64.33 -44.76 97.29 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 N-CA-C 108.706 -0.85 . . . . 0.32000000000000001 108.706 179.013 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 11.3 mt -59.85 -43.04 91.08 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 N-CA-C 108.627 -0.879 . . . . 0.5 108.627 178.259 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 39.5 t -61.71 -57.57 11.5 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 N-CA-C 108.809 -0.812 . . . . 0.42999999999999999 108.809 -179.273 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -53.01 -45.18 62.27 Favored Glycine 0 CA--C 1.533 1.18 0 C-N-CA 120.972 -0.632 . . . . 0.47999999999999998 111.936 176.565 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -60.55 -32.73 71.78 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 124.135 0.974 . . . . 1.0 111.868 179.243 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 13.2 tp -70.12 -60.33 2.35 Favored 'General case' 0 N--CA 1.435 -1.209 0 N-CA-C 107.49 -1.3 . . . . 0.79000000000000004 107.49 172.519 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 5.3 mp . . . . . 0 C--N 1.341 0.237 0 N-CA-C 113.412 0.893 . . . . 2.5499999999999998 113.412 -171.928 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.3 tt . . . . . 0 N--CA 1.455 -0.209 0 N-CA-C 108.275 -1.009 . . . . 2.0499999999999998 108.275 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 10.8 tp -56.51 -45.97 80.78 Favored 'General case' 0 N--CA 1.454 -0.272 0 O-C-N 121.868 -0.52 . . . . 2.27 111.477 176.279 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 99.4 t -56.65 -48.03 81.35 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 N-CA-C 109.777 -0.453 . . . . 0.53000000000000003 109.777 174.956 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 44.3 t -56.47 -45.76 82.01 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.291 0 CA-C-O 118.65 -0.691 . . . . 0.78000000000000003 110.058 177.969 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 55.9 t -54.25 -51.41 48.2 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 CA-C-N 119.572 1.078 . . . . 0.90000000000000002 110.467 176.422 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 97.8 t -57.29 -45.78 85.08 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 O-C-N 121.547 -0.721 . . . . 0.80000000000000004 111.011 177.354 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 53.7 t -59.92 -42.74 90.36 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 N-CA-C 109.382 -0.599 . . . . 0.81999999999999995 109.382 179.341 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 30.1 t -54.5 -47.42 71.18 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 C-N-CA 123.711 0.804 . . . . 1.22 110.377 177.3 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 72.8 t -59.1 -46.41 91.93 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 CA-C-N 118.829 0.741 . . . . 0.94999999999999996 110.395 178.178 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -58.93 -46.1 88.77 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 123.216 0.606 . . . . 0.64000000000000001 109.856 177.167 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.4 t -62.54 -40.51 88.52 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.898 0 C-N-CA 124.559 1.144 . . . . 0.90000000000000002 109.84 -179.486 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 5.0 t -62.51 -48.79 86.57 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.402 0 CA-C-N 118.776 0.716 . . . . 0.91000000000000003 109.65 175.042 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 1.4 t -54.58 -39.88 47.93 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 CA-C-N 118.734 0.697 . . . . 0.56000000000000005 111.38 173.611 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.4 t -66.45 -45.01 90.18 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 N-CA-C 108.891 -0.781 . . . . 0.55000000000000004 108.891 179.131 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 11.8 mt -59.01 -44.99 92.5 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 N-CA-C 108.334 -0.987 . . . . 0.81000000000000005 108.334 178.568 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 42.7 t -64.24 -53.46 43.11 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 N-CA-C 109.48 -0.563 . . . . 0.53000000000000003 109.48 -177.857 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -54.71 -44.31 80.05 Favored Glycine 0 CA--C 1.527 0.844 0 N-CA-C 111.568 -0.613 . . . . 0.62 111.568 176.998 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -60.98 -45.02 96.5 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 117.686 0.743 . . . . 0.72999999999999998 111.013 178.122 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 9.7 tp -56.93 -53.45 57.89 Favored 'General case' 0 N--CA 1.441 -0.917 0 N-CA-C 108.303 -0.999 . . . . 0.94999999999999996 108.303 175.99 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 85.5 mt . . . . . 0 CA--C 1.533 0.291 0 C-N-CA 122.804 0.442 . . . . 1.9099999999999999 111.789 -177.837 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 9.3 tt . . . . . 0 N--CA 1.455 -0.213 0 N-CA-C 108.895 -0.78 . . . . 2.4100000000000001 108.895 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 10.5 tp -56.61 -46.07 81.1 Favored 'General case' 0 N--CA 1.453 -0.295 0 O-C-N 122.228 -0.295 . . . . 2.23 111.476 176.881 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 72.7 t -54.26 -50.16 58.14 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 N-CA-C 109.75 -0.463 . . . . 0.93999999999999995 109.75 174.336 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 40.6 t -58.49 -46.37 89.75 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.224 0 CA-C-O 118.681 -0.676 . . . . 0.69999999999999996 110.454 179.452 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 53.1 t -53.37 -53.33 24.76 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 CA-C-N 119.394 0.997 . . . . 0.63 109.93 176.946 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 69.8 t -58.1 -46.07 88.3 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 O-C-N 122.036 -0.415 . . . . 0.29999999999999999 110.974 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 48.5 t -61.44 -46.86 95.71 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 N-CA-C 109.008 -0.738 . . . . 0.34999999999999998 109.008 -178.959 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 43.1 t -54.14 -49.94 58.47 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 C-N-CA 123.566 0.746 . . . . 0.47999999999999998 110.038 176.414 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 44.4 t -58.28 -48.13 85.68 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 CA-C-N 118.71 0.687 . . . . 0.39000000000000001 110.864 179.166 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -59.09 -47.2 86.13 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 109.379 -0.6 . . . . 0.5 109.379 178.829 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 15.5 t -62.63 -39.59 85.21 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.985 0 C-N-CA 124.037 0.935 . . . . 0.41999999999999998 109.929 -179.264 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 3.8 t -63.83 -47.52 90.47 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.482 0 CA-C-N 118.871 0.76 . . . . 0.35999999999999999 109.6 175.863 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 1.4 t -54.76 -41.6 57.46 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.602 0 CA-C-N 119.061 0.846 . . . . 0.35999999999999999 111.225 173.207 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.4 t -65.09 -46.33 91.57 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.171 0 N-CA-C 108.648 -0.871 . . . . 0.46000000000000002 108.648 179.746 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 13.1 mt -59.82 -43.52 92.01 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 N-CA-C 108.421 -0.955 . . . . 0.47999999999999998 108.421 179.792 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 27.3 t -62.99 -54.87 28.02 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 N-CA-C 109.061 -0.718 . . . . 0.35999999999999999 109.061 -178.685 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -52.33 -45.96 57.86 Favored Glycine 0 CA--C 1.529 0.961 0 N-CA-C 111.541 -0.624 . . . . 0.32000000000000001 111.541 176.14 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -61.87 -41.96 98.49 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 122.959 0.504 . . . . 0.45000000000000001 111.54 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 11.6 tp -63.56 -46.28 86.62 Favored 'General case' 0 N--CA 1.44 -0.928 0 N-CA-C 108.669 -0.863 . . . . 0.72999999999999998 108.669 176.23 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 82.8 mt . . . . . 0 CA--C 1.53 0.204 0 O-C-N 122.061 -0.399 . . . . 1.95 111.182 -178.12 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.1 tm? . . . . . 0 CA--C 1.527 0.071 0 N-CA-C 109.005 -0.739 . . . . 2.7400000000000002 109.005 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 1.7 tt -57.61 -46.28 84.3 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-O 121.283 0.563 . . . . 2.6400000000000001 110.225 176.754 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 48.0 t -58.19 -46.13 88.66 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 N-CA-C 109.618 -0.512 . . . . 0.40999999999999998 109.618 176.501 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 68.6 t -57.01 -46.44 84.1 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 CA-C-O 118.515 -0.755 . . . . 0.78000000000000003 109.766 176.79 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 54.5 t -55.36 -50.35 65.98 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 CA-C-N 119.803 1.183 . . . . 0.88 110.144 177.317 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 81.1 t -56.14 -46.58 81.11 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 O-C-N 121.841 -0.537 . . . . 0.48999999999999999 110.929 177.389 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 54.3 t -60.37 -45.53 96.45 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 N-CA-C 109.212 -0.662 . . . . 0.52000000000000002 109.212 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 51.0 t -55.15 -49.7 69.94 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 C-N-CA 123.674 0.79 . . . . 0.89000000000000001 110.052 176.908 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 49.0 t -57.86 -47.21 86.77 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 CA-C-N 118.501 0.591 . . . . 0.71999999999999997 110.553 178.552 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -58.63 -47.13 85.42 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 123.123 0.569 . . . . 0.38 109.466 177.79 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 11.9 t -62.77 -39.72 85.93 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.898 0 C-N-CA 124.238 1.015 . . . . 0.63 109.96 -178.874 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 5.6 t -63.29 -48.49 87.15 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 CA-C-N 118.77 0.714 . . . . 0.68000000000000005 109.687 175.205 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 1.4 t -54.28 -41.1 50.72 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 CA-C-N 118.844 0.747 . . . . 0.42999999999999999 111.232 173.195 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.4 t -65.81 -45.08 92.52 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.278 0 N-CA-C 108.646 -0.872 . . . . 0.40999999999999998 108.646 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 11.6 mt -58.96 -45.35 92.1 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.603 0 N-CA-C 108.191 -1.04 . . . . 0.67000000000000004 108.191 178.489 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 38.4 t -63.77 -52.99 50.16 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 N-CA-C 109.697 -0.483 . . . . 0.34000000000000002 109.697 -176.745 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -54.9 -48.55 66.28 Favored Glycine 0 CA--C 1.528 0.849 0 N-CA-C 111.354 -0.698 . . . . 0.38 111.354 175.814 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -57.1 -41.21 78.49 Favored 'General case' 0 N--CA 1.455 -0.225 0 O-C-N 122.105 -0.644 . . . . 0.62 111.211 178.935 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 12.6 tp -66.73 -52.41 44.73 Favored 'General case' 0 N--CA 1.438 -1.069 0 C-N-CA 123.886 0.874 . . . . 0.59999999999999998 109.11 178.756 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . 0.298 3.6 pp . . . . . 0 CA--C 1.532 0.254 0 CA-C-N 119.11 0.868 . . . . 3.04 112.685 -175.285 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 9.9 tt . . . . . 0 N--CA 1.45 -0.451 0 N-CA-C 108.413 -0.958 . . . . 1.98 108.413 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 10.9 tp -56.04 -45.85 79.08 Favored 'General case' 0 N--CA 1.454 -0.239 0 O-C-N 122.223 -0.298 . . . . 1.8600000000000001 111.232 174.972 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 93.5 t -56.66 -49.75 76.74 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 N-CA-C 110.185 -0.302 . . . . 0.40999999999999998 110.185 174.567 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 54.8 t -55.29 -46.0 77.98 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 O-C-N 121.87 -0.519 . . . . 0.57999999999999996 110.039 177.166 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 54.3 t -56.17 -47.87 80.09 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 CA-C-N 118.833 0.742 . . . . 0.58999999999999997 110.222 177.084 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 76.0 t -54.9 -45.37 75.45 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 CA-C-N 118.683 0.674 . . . . 0.56999999999999995 110.78 175.13 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 87.2 t -60.23 -47.3 92.76 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.182 0 N-CA-C 109.28 -0.637 . . . . 0.48999999999999999 109.28 178.579 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 53.1 t -55.12 -49.09 74.73 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 C-N-CA 123.48 0.712 . . . . 0.54000000000000004 110.406 177.531 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 41.8 t -56.98 -46.23 83.94 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 C-N-CA 123.485 0.714 . . . . 0.52000000000000002 110.22 177.3 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -58.59 -47.4 84.43 Favored 'General case' 0 N--CA 1.45 -0.425 0 N-CA-C 109.363 -0.606 . . . . 0.67000000000000004 109.363 177.148 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.7 t -62.12 -41.3 90.69 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.829 0 O-C-N 121.316 -0.865 . . . . 0.53000000000000003 110.045 -179.482 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 4.3 t -62.91 -47.11 94.38 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 O-C-N 121.512 -0.742 . . . . 0.40999999999999998 109.83 175.694 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 2.1 t -56.86 -37.69 55.21 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.707 0 CA-C-N 118.812 0.733 . . . . 0.46999999999999997 110.957 173.945 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.4 t -66.64 -46.9 84.87 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.245 0 N-CA-C 108.447 -0.946 . . . . 0.47999999999999998 108.447 178.034 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 10.7 mt -58.28 -45.89 89.08 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 N-CA-C 108.569 -0.9 . . . . 0.44 108.569 179.283 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 43.6 t -65.65 -50.95 68.22 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 N-CA-C 109.382 -0.599 . . . . 0.41999999999999998 109.382 -176.723 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -53.08 -49.0 57.47 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 111.101 -0.799 . . . . 0.42999999999999999 111.101 176.06 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -57.54 -47.86 80.86 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.507 0.723 . . . . 0.68999999999999995 110.643 178.273 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 10.8 tp -59.04 -46.94 86.95 Favored 'General case' 0 N--CA 1.441 -0.908 0 C-N-CA 123.679 0.792 . . . . 0.71999999999999997 109.695 178.188 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . 0.307 0.1 OUTLIER . . . . . 0 CA--C 1.54 0.56 0 O-C-N 121.592 -0.692 . . . . 3.2000000000000002 110.732 -178.555 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 9.1 tt . . . . . 0 C--O 1.224 -0.262 0 N-CA-C 108.972 -0.751 . . . . 1.8899999999999999 108.972 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 10.7 tp -52.84 -45.55 67.38 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-O 121.031 0.443 . . . . 1.9399999999999999 111.464 171.448 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 39.7 t -61.65 -44.28 98.43 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 N-CA-C 109.511 -0.551 . . . . 0.70999999999999996 109.511 176.778 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 90.3 t -55.53 -46.86 79.12 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 O-C-N 121.999 -0.438 . . . . 0.68000000000000005 110.051 175.026 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 67.3 t -56.06 -49.14 77.31 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 CA-C-N 118.808 0.731 . . . . 0.60999999999999999 109.809 176.974 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 75.1 t -56.36 -44.49 80.04 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 O-C-N 121.827 -0.546 . . . . 0.40000000000000002 111.013 177.114 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 56.0 t -61.03 -47.79 92.0 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.139 0 O-C-N 121.661 -0.65 . . . . 0.46000000000000002 109.26 178.797 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 54.7 t -54.78 -48.98 72.56 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 C-N-CA 123.312 0.645 . . . . 0.70999999999999996 110.199 176.805 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 38.1 t -57.13 -46.4 84.56 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 C-N-CA 123.568 0.747 . . . . 0.55000000000000004 110.544 177.445 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -59.01 -48.08 82.87 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 123.424 0.69 . . . . 0.42999999999999999 109.361 177.802 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 16.1 t -61.87 -40.98 89.02 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.848 0 O-C-N 121.387 -0.82 . . . . 0.60999999999999999 109.954 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 4.2 t -62.91 -45.89 97.71 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.507 0 O-C-N 121.543 -0.723 . . . . 0.66000000000000003 109.84 175.491 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 1.6 t -56.42 -40.26 66.22 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.631 0 CA-C-N 119.296 0.953 . . . . 0.44 110.927 173.556 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.4 t -63.57 -48.42 86.94 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 N-CA-C 108.345 -0.983 . . . . 0.40999999999999998 108.345 177.779 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 11.2 mt -59.43 -42.46 87.75 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 N-CA-C 109.053 -0.721 . . . . 0.68999999999999995 109.053 -179.725 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 32.4 t -65.06 -50.37 74.86 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 N-CA-C 109.162 -0.681 . . . . 0.46000000000000002 109.162 -178.477 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -52.1 -46.39 56.28 Favored Glycine 0 CA--C 1.53 0.981 0 N-CA-C 111.463 -0.655 . . . . 0.32000000000000001 111.463 173.641 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -59.24 -51.15 71.23 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 121.256 0.55 . . . . 0.72999999999999998 110.587 178.972 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 9.2 tp -54.53 -46.6 73.58 Favored 'General case' 0 N--CA 1.443 -0.817 0 C-N-CA 123.973 0.909 . . . . 0.76000000000000001 109.594 175.798 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 64.7 mt . . . . . 0 CA--C 1.53 0.19 0 O-C-N 121.808 -0.557 . . . . 1.8500000000000001 111.536 -178.789 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 68.9 tp . . . . . 0 N--CA 1.454 -0.275 0 N-CA-C 108.553 -0.906 . . . . 2.1899999999999999 108.553 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -57.58 -46.09 84.44 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-O 120.91 0.386 . . . . 2.2000000000000002 110.151 177.567 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 75.7 t -55.56 -49.32 74.44 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 O-C-N 121.967 -0.458 . . . . 0.41999999999999998 110.234 173.869 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 32.4 t -56.12 -46.04 80.88 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.204 0 CA-C-O 118.896 -0.573 . . . . 0.46999999999999997 110.089 178.348 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 55.1 t -54.92 -51.91 48.52 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.426 0 CA-C-N 119.273 0.942 . . . . 0.48999999999999999 109.924 177.073 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 70.8 t -56.24 -45.76 81.2 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 O-C-N 121.908 -0.495 . . . . 0.38 110.922 177.709 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 52.7 t -60.47 -46.22 95.66 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.309 0 N-CA-C 109.083 -0.71 . . . . 0.37 109.083 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 48.7 t -55.48 -49.5 72.94 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 C-N-CA 123.605 0.762 . . . . 0.46000000000000002 110.119 176.889 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 52.3 t -58.05 -46.98 87.93 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 CA-C-N 118.465 0.575 . . . . 0.47999999999999998 110.619 178.051 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -59.06 -46.83 87.25 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 123.382 0.673 . . . . 0.47999999999999998 109.488 178.017 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 10.6 t -62.08 -40.6 88.04 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.855 0 C-N-CA 124.353 1.061 . . . . 0.35999999999999999 109.909 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 3.5 t -62.32 -48.03 90.29 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.404 0 CA-C-N 118.696 0.68 . . . . 0.35999999999999999 109.685 175.048 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 1.4 t -55.59 -40.63 60.43 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 O-C-N 121.375 -0.828 . . . . 0.38 111.329 173.655 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.4 t -64.63 -44.86 96.69 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.215 0 N-CA-C 108.541 -0.911 . . . . 0.34999999999999998 108.541 178.599 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 11.5 mt -60.01 -43.67 93.06 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 N-CA-C 108.607 -0.886 . . . . 0.34000000000000002 108.607 178.473 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 39.6 t -62.95 -53.83 41.58 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 N-CA-C 109.262 -0.644 . . . . 0.28999999999999998 109.262 -178.823 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -53.19 -47.11 61.86 Favored Glycine 0 CA--C 1.53 1.006 0 N-CA-C 111.572 -0.611 . . . . 0.28000000000000003 111.572 175.432 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -60.34 -40.16 89.68 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 123.503 0.721 . . . . 0.56000000000000005 111.204 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 11.1 tp -63.42 -52.88 59.68 Favored 'General case' 0 N--CA 1.439 -0.991 0 N-CA-C 108.175 -1.046 . . . . 0.62 108.175 174.607 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 79.0 mt . . . . . 0 CA--C 1.531 0.216 0 C-N-CA 123.423 0.689 . . . . 1.6000000000000001 111.981 -177.054 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 59.9 tp . . . . . 0 N--CA 1.45 -0.453 0 N-CA-C 108.358 -0.979 . . . . 2.1699999999999999 108.358 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 10.9 tp -55.58 -46.02 77.29 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 117.9 0.318 . . . . 2.1000000000000001 111.186 176.394 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 75.2 t -55.18 -51.38 55.77 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 N-CA-C 110.221 -0.289 . . . . 0.58999999999999997 110.221 174.809 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 50.6 t -56.01 -46.03 80.5 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 O-C-N 121.725 -0.61 . . . . 0.81999999999999995 110.339 177.336 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 55.0 t -55.68 -47.03 79.65 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 CA-C-N 118.766 0.712 . . . . 0.78000000000000003 110.179 177.824 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 70.6 t -55.44 -45.49 78.29 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 CA-C-N 118.834 0.743 . . . . 0.53000000000000003 110.75 175.718 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 86.8 t -60.47 -47.75 91.32 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 N-CA-C 109.385 -0.598 . . . . 0.66000000000000003 109.385 178.676 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 64.0 t -54.81 -48.61 73.33 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 C-N-CA 123.395 0.678 . . . . 0.88 110.495 177.454 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 39.8 t -57.34 -45.71 85.26 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 C-N-CA 123.574 0.749 . . . . 0.66000000000000003 110.248 177.447 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.6 -47.66 83.56 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 109.469 -0.567 . . . . 0.53000000000000003 109.469 177.075 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 16.6 t -61.93 -41.95 92.84 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.774 0 O-C-N 121.42 -0.8 . . . . 0.62 110.103 -179.588 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 5.9 t -62.24 -46.06 97.31 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 O-C-N 121.565 -0.71 . . . . 0.70999999999999996 109.869 175.616 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 1.6 t -56.79 -39.48 64.57 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.644 0 CA-C-N 119.152 0.887 . . . . 0.5 110.931 173.804 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.4 t -64.25 -46.97 91.82 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.188 0 N-CA-C 108.509 -0.923 . . . . 0.45000000000000001 108.509 177.814 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 10.2 mt -59.5 -44.11 92.22 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 N-CA-C 108.951 -0.759 . . . . 0.58999999999999997 108.951 179.328 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 39.5 t -64.51 -49.74 79.23 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 N-CA-C 109.164 -0.68 . . . . 0.52000000000000002 109.164 -177.543 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -51.37 -52.78 31.0 Favored Glycine 0 CA--C 1.527 0.81 0 N-CA-C 110.619 -0.992 . . . . 0.53000000000000003 110.619 173.479 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -55.18 -43.98 74.85 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 122.966 0.506 . . . . 0.68000000000000005 111.176 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 10.7 tp -62.11 -46.51 88.73 Favored 'General case' 0 N--CA 1.442 -0.848 0 C-N-CA 124.012 0.925 . . . . 0.91000000000000003 109.617 176.327 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 65.5 mt . . . . . 0 CA--C 1.531 0.22 0 CA-C-N 118.287 0.494 . . . . 1.9299999999999999 111.532 -178.102 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 9.5 tt . . . . . 0 N--CA 1.454 -0.247 0 N-CA-C 108.346 -0.983 . . . . 2.0899999999999999 108.346 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 1.3 tt -56.23 -46.22 79.63 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-O 121.017 0.437 . . . . 2.1499999999999999 110.4 175.313 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 84.6 t -56.53 -48.01 81.0 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 O-C-N 121.835 -0.541 . . . . 0.40000000000000002 110.308 175.391 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 41.5 t -56.19 -45.99 81.1 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.185 0 O-C-N 121.758 -0.589 . . . . 0.5 109.885 177.11 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 54.0 t -54.89 -50.13 64.51 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 CA-C-N 119.29 0.95 . . . . 0.46999999999999997 110.207 176.376 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 73.0 t -56.2 -45.87 81.12 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 O-C-N 121.743 -0.598 . . . . 0.34000000000000002 111.007 177.32 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 56.7 t -60.2 -47.32 92.59 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 N-CA-C 109.176 -0.676 . . . . 0.40000000000000002 109.176 179.509 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 51.0 t -54.81 -49.34 70.06 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 C-N-CA 123.591 0.756 . . . . 0.46000000000000002 110.109 177.233 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 42.8 t -57.54 -46.68 86.13 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 O-C-N 121.817 -0.552 . . . . 0.38 110.528 177.82 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -58.5 -47.51 83.85 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 123.248 0.619 . . . . 0.40999999999999998 109.491 177.72 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 14.4 t -62.29 -41.18 90.57 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.842 0 C-N-CA 123.868 0.867 . . . . 0.38 109.958 -179.399 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 5.2 t -62.69 -47.16 94.22 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.49 0 O-C-N 121.605 -0.685 . . . . 0.34000000000000002 109.766 175.652 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 1.6 t -56.01 -39.7 59.35 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.643 0 CA-C-N 118.949 0.795 . . . . 0.28999999999999998 111.211 173.62 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.4 t -65.09 -45.84 93.05 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.191 0 N-CA-C 108.517 -0.919 . . . . 0.31 108.517 178.357 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 11.3 mt -59.93 -43.85 93.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 N-CA-C 108.729 -0.841 . . . . 0.35999999999999999 108.729 179.104 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 39.7 t -64.14 -51.4 69.34 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 N-CA-C 109.301 -0.629 . . . . 0.28000000000000003 109.301 -178.242 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -53.13 -49.6 55.19 Favored Glycine 0 CA--C 1.528 0.87 0 N-CA-C 110.905 -0.878 . . . . 0.28000000000000003 110.905 175.231 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -56.98 -45.43 82.92 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 123.049 0.539 . . . . 0.47999999999999998 111.079 178.857 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 10.0 tp -58.79 -50.01 75.54 Favored 'General case' 0 N--CA 1.442 -0.853 0 C-N-CA 124.004 0.922 . . . . 0.59999999999999998 109.221 176.696 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 72.9 mt . . . . . 0 CA--C 1.532 0.269 0 CA-C-N 118.033 0.379 . . . . 1.6499999999999999 111.115 -178.996 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.1 tm? . . . . . 0 N--CA 1.455 -0.197 0 N-CA-C 108.348 -0.982 . . . . 2.3599999999999999 108.348 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 1.3 tt -57.81 -46.11 85.14 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-O 121.032 0.444 . . . . 2.1400000000000001 110.314 177.028 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 58.4 t -57.44 -48.09 83.51 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 O-C-N 122.022 -0.424 . . . . 0.42999999999999999 109.869 176.315 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 48.2 t -56.47 -45.89 82.05 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.232 0 CA-C-O 118.871 -0.585 . . . . 0.47999999999999998 110.074 176.824 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 48.3 t -55.31 -50.47 64.68 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 CA-C-N 119.379 0.99 . . . . 0.51000000000000001 110.182 176.528 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 71.3 t -55.84 -46.17 79.95 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 O-C-N 121.812 -0.555 . . . . 0.34000000000000002 110.834 177.732 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 56.0 t -60.41 -47.01 94.32 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.227 0 N-CA-C 109.196 -0.668 . . . . 0.39000000000000001 109.196 179.508 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 47.7 t -55.36 -48.43 76.85 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 C-N-CA 123.708 0.803 . . . . 0.5 110.358 177.322 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 44.5 t -57.75 -46.97 86.86 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 CA-C-N 118.603 0.638 . . . . 0.40999999999999998 110.417 177.602 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -59.1 -47.27 85.86 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 109.456 -0.572 . . . . 0.42999999999999999 109.456 177.681 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 15.5 t -61.89 -39.48 83.7 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.886 0 C-N-CA 124.007 0.923 . . . . 0.42999999999999999 110.095 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 3.3 t -62.63 -48.2 89.33 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.38 0 C-N-CA 123.419 0.688 . . . . 0.41999999999999998 109.691 174.918 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 1.4 t -55.12 -41.07 57.93 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 CA-C-N 119.176 0.898 . . . . 0.37 111.415 173.216 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.4 t -63.97 -45.33 97.1 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.198 0 N-CA-C 108.549 -0.908 . . . . 0.34000000000000002 108.549 178.566 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 11.8 mt -60.09 -42.01 88.45 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 N-CA-C 108.719 -0.845 . . . . 0.41999999999999998 108.719 178.722 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 40.4 t -62.62 -55.7 22.18 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 N-CA-C 109.074 -0.713 . . . . 0.40999999999999998 109.074 179.486 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -52.47 -45.41 59.07 Favored Glycine 0 CA--C 1.531 1.089 0 N-CA-C 111.719 -0.553 . . . . 0.29999999999999999 111.719 177.11 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -56.46 -47.57 78.87 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 123.427 0.691 . . . . 0.46999999999999997 110.566 175.874 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 8.5 tp -58.18 -49.96 75.2 Favored 'General case' 0 N--CA 1.441 -0.899 0 C-N-CA 123.947 0.899 . . . . 0.56999999999999995 109.142 178.699 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 5.5 mp . . . . . 0 CA--C 1.534 0.365 0 CA-C-N 119.27 0.941 . . . . 2.0099999999999998 112.142 174.389 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 37.4 tp . . . . . 0 N--CA 1.454 -0.238 0 N-CA-C 108.778 -0.823 . . . . 2.1600000000000001 108.778 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 1.6 tt -56.8 -46.25 81.7 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-O 121.132 0.491 . . . . 2.46 110.3 176.218 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 40.6 t -59.0 -47.02 91.25 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 N-CA-C 109.412 -0.588 . . . . 0.45000000000000001 109.412 176.949 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 57.4 t -56.66 -46.15 82.81 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.219 0 CA-C-O 118.821 -0.609 . . . . 0.60999999999999999 110.104 176.754 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 54.1 t -55.93 -50.57 68.33 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.441 0 CA-C-N 119.35 0.977 . . . . 0.70999999999999996 109.773 177.506 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 77.3 t -56.23 -46.36 81.38 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 O-C-N 121.987 -0.446 . . . . 0.45000000000000001 110.889 177.81 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 54.7 t -60.94 -46.87 95.7 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 N-CA-C 109.104 -0.702 . . . . 0.34999999999999998 109.104 -179.576 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 48.5 t -54.62 -49.79 64.53 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.426 0 C-N-CA 123.421 0.688 . . . . 0.55000000000000004 110.179 176.755 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 46.2 t -58.63 -46.85 90.07 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.425 0 CA-C-N 118.395 0.543 . . . . 0.44 110.588 179.014 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -59.39 -47.36 85.73 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 109.296 -0.631 . . . . 0.34999999999999998 109.296 178.318 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.8 t -62.06 -40.05 86.01 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.9 0 C-N-CA 123.977 0.911 . . . . 0.38 109.997 -179.814 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 3.5 t -62.99 -47.98 90.2 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.412 0 CA-C-N 118.702 0.683 . . . . 0.39000000000000001 109.83 175.248 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 1.5 t -55.27 -40.63 57.3 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 CA-C-N 118.98 0.809 . . . . 0.31 111.048 173.851 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.4 t -65.67 -45.96 90.6 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 N-CA-C 108.674 -0.862 . . . . 0.28999999999999998 108.674 179.215 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 12.3 mt -58.86 -44.57 90.89 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 N-CA-C 108.282 -1.007 . . . . 0.38 108.282 179.133 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 39.3 t -64.1 -54.46 31.14 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 N-CA-C 109.511 -0.552 . . . . 0.34999999999999998 109.511 -177.457 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -55.18 -47.48 73.98 Favored Glycine 0 CA--C 1.529 0.939 0 N-CA-C 111.439 -0.665 . . . . 0.28999999999999998 111.439 177.349 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -57.72 -42.59 84.13 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 123.317 0.647 . . . . 0.52000000000000002 111.282 178.281 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 11.6 tp -63.08 -53.06 59.57 Favored 'General case' 0 N--CA 1.439 -1.009 0 N-CA-C 108.291 -1.003 . . . . 0.77000000000000002 108.291 177.257 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 84.3 mt . . . . . 0 CA--C 1.533 0.296 0 CA-C-N 118.361 0.528 . . . . 1.99 111.41 -177.825 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.4 tm? . . . . . 0 CA--C 1.531 0.236 0 N-CA-C 108.894 -0.78 . . . . 2.2999999999999998 108.894 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -56.09 -46.0 79.21 Favored 'General case' 0 CA--C 1.533 0.3 0 O-C-N 121.891 -0.506 . . . . 2.1000000000000001 110.251 174.886 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 85.3 t -56.16 -48.43 79.25 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 O-C-N 121.814 -0.554 . . . . 0.37 110.136 174.734 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 44.7 t -54.78 -47.05 74.82 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 CA-C-N 118.617 0.644 . . . . 0.46999999999999997 109.822 176.293 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 50.3 t -55.02 -48.44 75.83 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 CA-C-N 119.028 0.831 . . . . 0.54000000000000004 110.754 176.167 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 70.6 t -55.42 -44.99 78.03 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 O-C-N 121.447 -0.783 . . . . 0.37 110.71 175.385 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 87.0 t -60.4 -46.18 95.54 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.22 0 N-CA-C 109.073 -0.714 . . . . 0.38 109.073 178.362 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 72.4 t -55.02 -49.5 70.97 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 C-N-CA 123.218 0.607 . . . . 0.46000000000000002 110.069 177.09 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 46.5 t -56.93 -47.85 82.53 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 O-C-N 121.798 -0.564 . . . . 0.38 110.671 177.848 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -58.34 -47.57 83.36 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 123.23 0.612 . . . . 0.34999999999999998 109.354 177.732 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 14.2 t -62.61 -39.62 85.31 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.92 0 C-N-CA 124.162 0.985 . . . . 0.35999999999999999 110.066 -179.209 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 3.6 t -63.44 -48.25 87.99 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 CA-C-N 118.742 0.701 . . . . 0.37 109.56 175.472 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 1.5 t -55.43 -40.5 58.23 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.617 0 CA-C-N 118.909 0.777 . . . . 0.29999999999999999 110.953 173.845 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.4 t -66.17 -45.06 91.19 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.237 0 N-CA-C 108.746 -0.835 . . . . 0.28000000000000003 108.746 179.319 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 12.5 mt -59.05 -44.86 92.35 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.576 0 N-CA-C 108.285 -1.005 . . . . 0.35999999999999999 108.285 178.598 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 40.2 t -63.73 -55.4 22.74 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 N-CA-C 109.347 -0.612 . . . . 0.28000000000000003 109.347 -177.672 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -53.34 -47.51 61.95 Favored Glycine 0 CA--C 1.529 0.941 0 N-CA-C 111.428 -0.669 . . . . 0.32000000000000001 111.428 176.904 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -57.89 -43.41 86.1 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 123.323 0.649 . . . . 0.47999999999999998 111.142 178.6 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 13.5 tp -67.04 -45.28 77.93 Favored 'General case' 0 N--CA 1.439 -1.008 0 C-N-CA 123.698 0.799 . . . . 0.65000000000000002 109.156 178.969 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 84.1 mt . . . . . 0 CA--C 1.533 0.311 0 CA-C-N 119.087 0.858 . . . . 1.6499999999999999 110.562 176.692 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.452 -0.36 0 N-CA-C 108.16 -1.052 . . . . 2.6600000000000001 108.16 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 10.6 tp -55.33 -45.83 76.38 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 122.648 0.379 . . . . 1.8700000000000001 111.259 175.882 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 74.0 t -54.97 -50.15 65.06 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 N-CA-C 109.989 -0.375 . . . . 0.5 109.989 174.441 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 42.2 t -56.54 -47.33 82.12 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 CA-C-N 118.43 0.559 . . . . 0.45000000000000001 110.185 178.083 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 61.5 t -54.55 -51.18 52.74 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 CA-C-N 119.032 0.833 . . . . 0.46999999999999997 110.268 177.149 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 60.7 t -56.52 -44.87 81.65 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 O-C-N 121.819 -0.55 . . . . 0.35999999999999999 110.825 177.943 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 53.8 t -60.83 -47.4 93.46 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.267 0 N-CA-C 109.033 -0.729 . . . . 0.35999999999999999 109.033 179.27 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 55.4 t -54.27 -50.29 57.31 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 C-N-CA 123.32 0.648 . . . . 0.5 110.148 176.761 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 43.1 t -57.73 -46.97 86.8 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 C-N-CA 123.052 0.541 . . . . 0.51000000000000001 110.811 178.495 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -59.34 -46.99 87.08 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 123.382 0.673 . . . . 0.40000000000000002 109.328 178.123 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 15.5 t -61.89 -40.73 88.14 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.882 0 C-N-CA 124.077 0.951 . . . . 0.34999999999999998 109.898 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 4.1 t -62.24 -47.79 91.42 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.396 0 O-C-N 121.554 -0.716 . . . . 0.39000000000000001 109.78 174.969 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 1.4 t -55.86 -39.87 58.93 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 CA-C-N 119.137 0.88 . . . . 0.39000000000000001 111.459 173.587 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.4 t -64.74 -45.09 96.21 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 N-CA-C 108.492 -0.929 . . . . 0.29999999999999999 108.492 178.111 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 11.3 mt -60.14 -42.85 91.52 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 N-CA-C 108.725 -0.843 . . . . 0.34999999999999998 108.725 178.674 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 40.5 t -63.1 -52.67 56.04 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 N-CA-C 109.294 -0.632 . . . . 0.27000000000000002 109.294 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -53.07 -46.49 61.69 Favored Glycine 0 CA--C 1.529 0.968 0 N-CA-C 111.551 -0.62 . . . . 0.32000000000000001 111.551 175.858 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -57.47 -49.12 77.29 Favored 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 123.409 0.684 . . . . 0.55000000000000004 110.406 177.476 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 10.3 tp -58.88 -46.17 88.44 Favored 'General case' 0 N--CA 1.44 -0.935 0 C-N-CA 123.739 0.816 . . . . 0.55000000000000004 109.206 178.95 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 84.9 mt . . . . . 0 CA--C 1.533 0.314 0 O-C-N 121.792 -0.568 . . . . 1.6299999999999999 111.169 178.737 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 47.8 tp . . . . . 0 N--CA 1.454 -0.233 0 N-CA-C 109.233 -0.654 . . . . 2.2599999999999998 109.233 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -57.53 -46.13 84.23 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-O 121.26 0.553 . . . . 2.2999999999999998 110.231 175.372 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 43.6 t -60.46 -45.15 97.3 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 N-CA-C 109.384 -0.599 . . . . 0.64000000000000001 109.384 176.571 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 72.2 t -56.32 -45.82 81.53 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.217 0 CA-C-O 118.876 -0.583 . . . . 0.55000000000000004 110.132 175.987 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 55.5 t -56.44 -48.98 79.21 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 CA-C-N 119.504 1.047 . . . . 0.56000000000000005 110.102 177.125 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 69.9 t -55.76 -45.75 79.51 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 O-C-N 121.786 -0.571 . . . . 0.39000000000000001 110.905 176.449 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 53.2 t -60.23 -46.87 94.13 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.18 0 N-CA-C 109.248 -0.649 . . . . 0.34000000000000002 109.248 178.841 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 48.9 t -54.48 -49.42 65.81 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 C-N-CA 123.7 0.8 . . . . 0.55000000000000004 110.118 177.145 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 42.2 t -57.01 -47.19 83.93 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 CA-C-N 118.435 0.561 . . . . 0.51000000000000001 110.537 177.744 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.19 -47.44 83.43 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 123.053 0.541 . . . . 0.37 109.553 177.546 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 16.0 t -62.94 -40.4 88.78 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.893 0 C-N-CA 123.909 0.884 . . . . 0.39000000000000001 110.049 -178.886 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 7.5 t -63.55 -47.13 92.9 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.48 0 O-C-N 121.542 -0.724 . . . . 0.41999999999999998 109.503 175.841 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 1.4 t -54.69 -41.37 55.62 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.579 0 CA-C-N 119.107 0.867 . . . . 0.35999999999999999 111.212 172.805 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.4 t -64.51 -45.7 94.9 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.19 0 N-CA-C 108.627 -0.879 . . . . 0.34000000000000002 108.627 179.249 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 11.1 mt -59.89 -43.99 93.35 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 N-CA-C 108.75 -0.833 . . . . 0.40999999999999998 108.75 178.689 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 37.4 t -64.89 -49.74 78.43 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.266 0 N-CA-C 109.535 -0.543 . . . . 0.34000000000000002 109.535 -176.814 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -55.77 -50.33 61.5 Favored Glycine 0 CA--C 1.528 0.897 0 N-CA-C 111.128 -0.789 . . . . 0.41999999999999998 111.128 174.229 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -55.15 -42.3 72.92 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 117.325 0.563 . . . . 0.56999999999999995 111.048 178.835 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 10.2 tp -59.87 -62.36 1.93 Allowed 'General case' 0 N--CA 1.439 -1.023 0 N-CA-C 108.512 -0.921 . . . . 0.65000000000000002 108.512 175.052 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . 0.269 2.9 pp . . . . . 0 N--CA 1.465 0.319 0 CA-C-N 119.223 0.92 . . . . 2.9199999999999999 113.267 -170.357 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.9 tt . . . . . 0 CA--C 1.534 0.358 0 N-CA-C 108.288 -1.005 . . . . 2.1299999999999999 108.288 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.24 -46.06 79.75 Favored 'General case' 0 CA--C 1.535 0.396 0 O-C-N 121.927 -0.483 . . . . 2.71 110.369 176.062 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 89.2 t -55.89 -47.24 80.05 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 O-C-N 121.58 -0.7 . . . . 0.51000000000000001 110.591 174.655 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 51.1 t -56.27 -45.96 81.36 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.19 0 O-C-N 121.507 -0.745 . . . . 0.46999999999999997 109.892 176.997 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 73.0 t -53.74 -50.0 54.06 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 CA-C-N 119.246 0.93 . . . . 0.51000000000000001 110.483 174.689 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 93.2 t -55.5 -45.1 78.38 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 O-C-N 121.696 -0.627 . . . . 0.34999999999999998 111.085 176.692 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 73.8 t -60.42 -46.17 95.61 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.159 0 O-C-N 121.597 -0.689 . . . . 0.33000000000000002 109.25 178.77 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 53.0 t -55.84 -48.01 78.84 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 C-N-CA 123.407 0.683 . . . . 0.46000000000000002 110.36 177.271 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 47.0 t -56.5 -46.45 82.32 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 O-C-N 121.765 -0.585 . . . . 0.37 110.524 176.4 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -58.92 -46.69 87.35 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 123.076 0.55 . . . . 0.33000000000000002 109.63 176.974 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 13.5 t -61.62 -40.59 87.17 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.839 0 O-C-N 121.255 -0.903 . . . . 0.38 110.063 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 5.4 t -62.08 -47.95 90.77 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.416 0 O-C-N 121.511 -0.743 . . . . 0.37 109.841 174.808 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 1.4 t -54.94 -40.76 54.74 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 CA-C-N 119.088 0.858 . . . . 0.31 111.493 173.065 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.4 t -63.88 -45.24 97.54 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.179 0 N-CA-C 108.472 -0.936 . . . . 0.33000000000000002 108.472 178.535 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 10.1 mt -59.42 -43.74 91.11 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 N-CA-C 108.831 -0.803 . . . . 0.45000000000000001 108.831 177.987 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 40.9 t -63.36 -52.37 59.2 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 N-CA-C 109.489 -0.56 . . . . 0.40999999999999998 109.489 -178.444 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -52.74 -50.46 49.46 Favored Glycine 0 CA--C 1.528 0.871 0 N-CA-C 111.007 -0.837 . . . . 0.27000000000000002 111.007 174.916 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -55.24 -44.67 75.7 Favored 'General case' 0 CA--C 1.53 0.182 0 O-C-N 122.284 -0.539 . . . . 0.44 111.075 179.198 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 11.0 tp -61.26 -50.64 72.22 Favored 'General case' 0 N--CA 1.442 -0.869 0 C-N-CA 123.599 0.76 . . . . 0.58999999999999997 108.959 176.935 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 73.7 mt . . . . . 0 CA--C 1.532 0.265 0 CA-C-N 118.264 0.484 . . . . 1.6100000000000001 111.642 -179.148 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.6 tt . . . . . 0 CA--C 1.534 0.354 0 N-CA-C 108.566 -0.902 . . . . 2.0600000000000001 108.566 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -55.76 -45.82 77.99 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.223 0.609 . . . . 2.8799999999999999 110.344 176.403 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 96.3 t -55.75 -48.76 77.57 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 O-C-N 121.813 -0.554 . . . . 0.37 110.398 174.811 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 55.5 t -55.77 -47.37 79.49 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 O-C-N 121.659 -0.65 . . . . 0.69999999999999996 109.935 176.646 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 72.0 t -54.29 -49.67 61.97 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 CA-C-N 118.783 0.719 . . . . 0.83999999999999997 110.389 176.247 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 73.5 t -56.0 -44.7 79.18 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 O-C-N 121.641 -0.662 . . . . 0.48999999999999999 110.864 177.164 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 54.6 t -59.9 -48.09 89.07 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.168 0 N-CA-C 109.067 -0.716 . . . . 0.46999999999999997 109.067 178.329 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 60.1 t -55.19 -48.92 75.77 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 C-N-CA 122.943 0.497 . . . . 0.87 110.32 177.315 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 42.2 t -56.74 -45.76 82.98 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 C-N-CA 123.632 0.773 . . . . 0.66000000000000003 110.601 177.237 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.25 -47.91 83.6 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 123.402 0.681 . . . . 0.41999999999999998 109.405 177.455 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 20.3 t -61.51 -40.88 87.99 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.838 0 O-C-N 121.484 -0.76 . . . . 0.60999999999999999 110.0 179.481 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 4.1 t -62.0 -45.8 97.9 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.39 0 C-N-CA 123.556 0.742 . . . . 0.58999999999999997 109.887 175.029 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 1.4 t -57.26 -40.46 73.9 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 CA-C-N 119.437 1.017 . . . . 0.37 111.34 173.329 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.4 t -62.87 -45.3 99.21 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 N-CA-C 108.398 -0.964 . . . . 0.40999999999999998 108.398 177.339 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 10.9 mt -61.22 -41.37 89.33 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 N-CA-C 109.232 -0.655 . . . . 0.53000000000000003 109.232 178.675 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 32.9 t -62.74 -50.3 80.27 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.277 0 N-CA-C 108.957 -0.757 . . . . 0.46000000000000002 108.957 179.071 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -52.65 -47.23 58.34 Favored Glycine 0 CA--C 1.53 1.021 0 N-CA-C 111.527 -0.629 . . . . 0.32000000000000001 111.527 173.896 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -57.01 -49.58 75.35 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 123.224 0.61 . . . . 0.73999999999999999 110.551 177.583 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 10.4 tp -58.6 -45.63 88.72 Favored 'General case' 0 N--CA 1.441 -0.909 0 C-N-CA 124.351 1.06 . . . . 0.93000000000000005 109.216 178.984 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 66.4 mt . . . . . 0 CA--C 1.533 0.311 0 O-C-N 121.713 -0.617 . . . . 1.77 111.017 177.871 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.4 tt . . . . . 0 N--CA 1.452 -0.336 0 N-CA-C 108.107 -1.072 . . . . 1.97 108.107 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 10.3 tp -55.39 -45.89 76.58 Favored 'General case' 0 N--CA 1.453 -0.293 0 O-C-N 121.81 -0.556 . . . . 2.0 111.375 174.579 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 94.3 t -56.15 -49.13 77.67 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 N-CA-C 110.068 -0.345 . . . . 0.37 110.068 174.623 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 49.2 t -56.07 -46.5 80.85 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 O-C-N 121.796 -0.565 . . . . 0.53000000000000003 110.195 177.502 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 53.1 t -54.64 -50.55 58.76 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 CA-C-N 118.952 0.796 . . . . 0.55000000000000004 110.043 176.433 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 78.7 t -55.6 -45.23 78.78 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 O-C-N 121.859 -0.526 . . . . 0.34000000000000002 110.8 177.142 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 61.9 t -60.15 -47.47 91.9 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.136 0 N-CA-C 109.191 -0.67 . . . . 0.34999999999999998 109.191 178.829 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 55.7 t -55.15 -49.16 74.27 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 C-N-CA 123.487 0.715 . . . . 0.57999999999999996 110.25 177.548 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 46.1 t -57.43 -46.25 85.7 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 C-N-CA 123.246 0.618 . . . . 0.5 110.473 177.631 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -59.06 -47.25 85.91 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 123.204 0.602 . . . . 0.31 109.422 177.374 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 14.2 t -61.61 -41.11 89.01 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.821 0 C-N-CA 123.814 0.846 . . . . 0.39000000000000001 110.003 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 4.1 t -62.24 -47.14 94.48 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 O-C-N 121.541 -0.724 . . . . 0.42999999999999999 109.852 175.172 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 1.4 t -56.11 -39.97 61.74 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.6 0 CA-C-N 119.085 0.857 . . . . 0.33000000000000002 111.349 173.418 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.4 t -64.03 -46.0 95.1 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.203 0 N-CA-C 108.411 -0.959 . . . . 0.28999999999999998 108.411 177.966 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 10.6 mt -59.95 -43.0 91.34 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 N-CA-C 108.825 -0.806 . . . . 0.40000000000000002 108.825 178.927 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 39.2 t -61.71 -54.71 31.05 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 N-CA-C 108.933 -0.766 . . . . 0.29999999999999999 108.933 179.827 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -52.59 -45.17 59.93 Favored Glycine 0 CA--C 1.53 0.985 0 N-CA-C 111.703 -0.559 . . . . 0.32000000000000001 111.703 176.535 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -57.77 -44.78 86.41 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 123.498 0.719 . . . . 0.52000000000000002 110.712 177.274 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 9.7 tp -60.9 -51.97 67.04 Favored 'General case' 0 N--CA 1.439 -0.983 0 C-N-CA 124.014 0.926 . . . . 0.63 109.235 177.861 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 5.5 mp . . . . . 0 CA--C 1.533 0.303 0 CA-C-N 119.231 0.923 . . . . 2.0899999999999999 112.14 175.546 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 63.2 tp . . . . . 0 N--CA 1.451 -0.395 0 N-CA-C 108.6 -0.889 . . . . 2.2999999999999998 108.6 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 1.6 tt -58.42 -46.13 87.07 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-O 120.984 0.421 . . . . 2.5499999999999998 110.469 178.498 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 71.4 t -55.8 -49.39 74.93 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 N-CA-C 109.863 -0.421 . . . . 0.54000000000000004 109.863 174.684 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 25.5 t -57.0 -45.61 83.86 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.365 0 CA-C-O 118.505 -0.759 . . . . 0.70999999999999996 110.252 178.514 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 49.3 t -54.2 -52.11 41.06 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 CA-C-N 119.693 1.133 . . . . 0.72999999999999998 110.008 177.277 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 85.1 t -57.41 -47.18 85.3 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 O-C-N 121.949 -0.469 . . . . 0.42999999999999999 111.004 178.67 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 57.3 t -60.66 -45.35 97.64 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 N-CA-C 109.219 -0.66 . . . . 0.45000000000000001 109.219 -179.132 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 46.8 t -55.68 -48.79 77.33 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 C-N-CA 124.069 0.948 . . . . 0.58999999999999997 110.099 177.076 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 44.2 t -57.88 -47.71 85.63 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 CA-C-N 118.779 0.718 . . . . 0.52000000000000002 110.601 177.961 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -59.23 -46.65 87.89 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 109.551 -0.537 . . . . 0.55000000000000004 109.551 178.327 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.5 t -62.55 -39.36 84.25 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.923 0 C-N-CA 124.442 1.097 . . . . 0.48999999999999999 110.04 -179.682 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 3.4 t -63.23 -48.92 85.26 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.391 0 CA-C-N 118.963 0.801 . . . . 0.45000000000000001 109.569 175.285 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 1.3 t -53.99 -41.84 51.57 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 CA-C-N 118.881 0.764 . . . . 0.41999999999999998 111.286 173.242 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.4 t -65.43 -44.45 94.39 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.266 0 N-CA-C 108.667 -0.864 . . . . 0.44 108.667 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 12.3 mt -59.34 -44.29 92.06 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.57 0 N-CA-C 108.379 -0.971 . . . . 0.45000000000000001 108.379 178.117 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 39.2 t -64.36 -52.95 49.03 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 N-CA-C 109.568 -0.53 . . . . 0.37 109.568 -177.159 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -55.22 -48.24 69.81 Favored Glycine 0 CA--C 1.529 0.934 0 N-CA-C 111.512 -0.635 . . . . 0.31 111.512 175.846 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -55.56 -44.98 77.35 Favored 'General case' 0 N--CA 1.454 -0.226 0 O-C-N 122.15 -0.618 . . . . 0.57999999999999996 110.592 177.913 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 11.9 tp -62.92 -53.9 46.92 Favored 'General case' 0 N--CA 1.437 -1.102 0 C-N-CA 123.613 0.765 . . . . 0.85999999999999999 109.045 179.187 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . 0.305 3.1 pp . . . . . 0 CA--C 1.531 0.239 0 CA-C-N 119.375 0.989 . . . . 3.0800000000000001 112.568 -175.121 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 3.9 mm? . . . . . 0 N--CA 1.474 0.758 0 N-CA-C 105.083 -2.192 . . . . 18.390000000000001 105.083 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 7.5 ptm180 48.49 -176.25 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.969 1.707 . . . . 17.27 112.846 -169.477 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 47.8 pt -74.27 140.07 76.0 Favored Pre-proline 0 N--CA 1.448 -0.545 0 N-CA-C 106.811 -1.551 . . . . 14.029999999999999 106.811 163.332 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -64.65 -66.28 0.05 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.007 0 C-N-CA 121.653 1.569 . . . . 8.7400000000000002 109.951 -176.323 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 48.6 t -163.72 63.77 0.16 Allowed 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 106.276 -1.75 . . . . 9.6699999999999999 106.276 -179.253 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 46.0 t 88.24 134.59 0.04 OUTLIER Pre-proline 0 CA--C 1.533 0.315 0 C-N-CA 128.587 2.755 . . . . 8.9700000000000006 108.351 -164.381 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -61.47 136.44 63.44 Favored 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 121.667 1.578 . . . . 5.8399999999999999 110.894 177.782 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.4 t -80.72 -133.25 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 C-N-CA 125.69 1.596 . . . . 5.0999999999999996 108.608 -178.843 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 14.7 p-10 -46.45 -27.78 1.19 Allowed 'General case' 0 CA--C 1.539 0.534 0 O-C-N 120.858 -1.151 . . . . 4.4199999999999999 113.409 174.27 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -54.03 -35.32 61.84 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 123.882 0.873 . . . . 3.1099999999999999 110.182 174.624 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 55.4 tptt -58.29 -54.2 49.73 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 123.098 0.559 . . . . 4.6299999999999999 109.785 175.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 38.1 ptt180 -69.52 -26.37 64.49 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 119.567 -0.853 . . . . 6.1600000000000001 111.339 -177.515 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -59.04 -51.0 71.96 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 108.69 -0.856 . . . . 2.9199999999999999 108.69 168.615 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 10.2 tp -55.23 -45.58 75.97 Favored 'General case' 0 N--CA 1.453 -0.309 0 O-C-N 121.873 -0.517 . . . . 2.1299999999999999 111.149 176.081 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 89.7 t -55.12 -48.82 75.72 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 O-C-N 122.199 -0.313 . . . . 0.40000000000000002 110.156 174.544 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 55.3 t -56.54 -46.79 82.58 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 CA-C-N 118.612 0.642 . . . . 0.58999999999999997 110.182 177.119 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 72.3 t -54.52 -50.46 58.32 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 CA-C-N 118.771 0.714 . . . . 0.75 110.451 175.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 73.0 t -56.27 -44.34 79.25 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 O-C-N 121.636 -0.665 . . . . 0.5 110.843 177.537 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 46.4 t -60.04 -48.11 89.21 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.177 0 N-CA-C 108.904 -0.776 . . . . 0.42999999999999999 108.904 178.262 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 41.9 t -54.02 -50.19 55.64 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 C-N-CA 123.203 0.601 . . . . 0.58999999999999997 110.486 176.779 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 46.9 t -56.96 -46.69 83.98 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 C-N-CA 123.4 0.68 . . . . 0.59999999999999998 110.79 177.57 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -59.38 -46.93 87.31 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 123.352 0.661 . . . . 0.38 109.39 177.951 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 13.7 t -61.32 -40.76 87.24 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.795 0 C-N-CA 123.881 0.873 . . . . 0.40000000000000002 109.951 179.291 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 3.2 t -62.0 -47.64 92.24 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.359 0 O-C-N 121.56 -0.713 . . . . 0.41999999999999998 110.028 174.804 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 1.4 t -55.36 -40.66 58.28 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 CA-C-N 119.115 0.87 . . . . 0.32000000000000001 111.407 173.262 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.4 t -63.9 -46.11 95.09 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.235 0 N-CA-C 108.349 -0.982 . . . . 0.29999999999999999 108.349 178.363 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 10.8 mt -59.34 -42.61 87.93 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 N-CA-C 108.92 -0.771 . . . . 0.40000000000000002 108.92 178.629 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 39.6 t -63.37 -52.79 53.76 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 N-CA-C 109.423 -0.584 . . . . 0.33000000000000002 109.423 -179.673 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -52.27 -47.27 56.2 Favored Glycine 0 CA--C 1.53 1.009 0 N-CA-C 111.527 -0.629 . . . . 0.37 111.527 175.363 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -56.88 -49.83 74.33 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 123.446 0.698 . . . . 0.67000000000000004 110.46 178.231 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 11.2 tp -59.46 -44.63 92.93 Favored 'General case' 0 N--CA 1.44 -0.939 0 C-N-CA 123.776 0.83 . . . . 0.67000000000000004 109.465 178.409 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 85.3 mt -61.3 -39.78 91.71 Favored 'General case' 0 CA--C 1.533 0.302 0 O-C-N 121.431 -0.793 . . . . 1.6799999999999999 111.23 178.01 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 16.9 tpt -63.65 -44.38 94.02 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 118.145 0.43 . . . . 4.8499999999999996 110.354 173.804 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -179.9 -67.6 0.07 OUTLIER Glycine 0 CA--C 1.528 0.864 0 N-CA-C 111.022 -0.831 . . . . 3.52 111.022 176.247 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 3.1 mm? . . . . . 0 N--CA 1.447 -0.589 0 N-CA-C 104.108 -2.553 . . . . 6.29 104.108 175.317 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.473 0.692 0 CA-C-O 118.198 -0.906 . . . . 16.670000000000002 108.575 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 62.8 ttm-85 -153.83 91.47 1.46 Allowed 'General case' 0 N--CA 1.455 -0.183 0 N-CA-C 107.608 -1.256 . . . . 16.469999999999999 107.608 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 42.9 mm -117.37 82.09 14.56 Favored Pre-proline 0 CA--C 1.538 0.512 0 C-N-CA 124.344 1.058 . . . . 11.960000000000001 108.689 -175.015 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -79.39 -38.41 0.41 Allowed 'Trans proline' 0 N--CA 1.456 -0.705 0 C-N-CA 122.59 2.193 . . . . 8.0299999999999994 111.001 179.496 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 96.8 m 64.37 19.68 11.88 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 125.637 1.575 . . . . 8.3900000000000006 111.298 -177.345 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 11.6 t -53.84 -55.08 39.54 Favored Pre-proline 0 CA--C 1.537 0.462 0 C-N-CA 124.226 1.01 . . . . 7.6799999999999997 112.642 -174.665 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -79.07 7.45 4.36 Favored 'Trans proline' 0 CA--C 1.539 0.773 0 C-N-CA 121.776 1.65 . . . . 4.0599999999999996 113.121 177.502 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.4 t -107.16 -133.33 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 C-N-CA 125.493 1.517 . . . . 3.0800000000000001 107.747 -174.546 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 53.2 p-10 -42.23 -39.57 2.11 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.951 1.3 . . . . 4.3200000000000003 114.161 179.322 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -57.95 -49.14 77.81 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 119.243 0.929 . . . . 3.0699999999999998 109.569 174.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 3.3 tmtm? -59.79 -48.19 82.67 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 108.804 -0.813 . . . . 4.0599999999999996 108.804 177.033 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 39.9 ttt-85 -66.46 -26.86 67.4 Favored 'General case' 0 N--CA 1.448 -0.529 0 O-C-N 122.171 -0.331 . . . . 5.3399999999999999 111.673 -176.107 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -67.57 -50.35 58.87 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 107.839 -1.171 . . . . 2.4900000000000002 107.839 173.177 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -55.48 -45.89 76.95 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-O 120.835 0.35 . . . . 2.4300000000000002 110.639 176.831 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 64.4 t -56.15 -49.94 73.25 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 O-C-N 121.946 -0.471 . . . . 0.46999999999999997 109.77 174.911 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 38.1 t -55.77 -45.79 79.58 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 CA-C-N 118.404 0.547 . . . . 0.44 110.322 177.447 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 54.2 t -55.72 -51.17 62.11 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.375 0 CA-C-N 119.158 0.89 . . . . 0.45000000000000001 110.314 177.113 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 73.3 t -56.22 -45.18 80.98 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 O-C-N 121.791 -0.568 . . . . 0.35999999999999999 110.903 177.341 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 54.8 t -60.87 -46.4 96.41 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 N-CA-C 109.152 -0.684 . . . . 0.34999999999999998 109.152 179.504 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 47.8 t -55.19 -49.01 75.62 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 C-N-CA 123.481 0.712 . . . . 0.44 110.278 176.693 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 46.2 t -57.08 -46.85 84.46 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 O-C-N 121.815 -0.553 . . . . 0.40000000000000002 110.635 177.244 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.13 -47.35 83.59 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 123.265 0.626 . . . . 0.40999999999999998 109.524 177.135 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 11.7 t -62.38 -40.8 89.31 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.814 0 C-N-CA 124.033 0.933 . . . . 0.37 109.939 -179.093 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 5.1 t -62.63 -47.98 90.37 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.411 0 O-C-N 121.649 -0.657 . . . . 0.35999999999999999 109.654 175.273 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 1.5 t -55.09 -40.35 54.32 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.585 0 CA-C-N 119.051 0.842 . . . . 0.32000000000000001 111.144 173.453 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.4 t -65.32 -45.48 93.3 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.249 0 N-CA-C 108.687 -0.857 . . . . 0.33000000000000002 108.687 179.025 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 11.2 mt -59.85 -44.55 94.44 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.525 0 N-CA-C 108.566 -0.902 . . . . 0.37 108.566 178.82 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 38.8 t -63.97 -51.77 65.02 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 N-CA-C 109.371 -0.603 . . . . 0.39000000000000001 109.371 -177.49 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -54.0 -49.81 57.51 Favored Glycine 0 CA--C 1.528 0.868 0 N-CA-C 111.063 -0.815 . . . . 0.29999999999999999 111.063 175.028 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -56.01 -41.9 75.61 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 123.305 0.642 . . . . 0.56999999999999995 111.313 179.465 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 10.7 tp -61.2 -58.09 9.75 Favored 'General case' 0 N--CA 1.439 -0.987 0 N-CA-C 108.338 -0.986 . . . . 0.76000000000000001 108.338 174.054 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 75.6 mt -56.5 -36.7 69.46 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 123.823 0.849 . . . . 1.6699999999999999 112.497 -173.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 50.7 mtt -57.67 -29.7 64.84 Favored 'General case' 0 CA--C 1.535 0.382 0 O-C-N 121.914 -0.491 . . . . 3.8799999999999999 111.422 175.684 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -90.56 -68.23 1.2 Allowed Glycine 0 CA--C 1.529 0.962 0 C-N-CA 124.226 0.917 . . . . 4.21 111.134 173.143 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 3.6 mm? . . . . . 0 N--CA 1.451 -0.377 0 C-N-CA 126.054 1.742 . . . . 8.5099999999999998 107.226 -174.686 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.472 0.663 0 CA-C-O 117.381 -1.295 . . . . 18.93 108.65 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . 0.252 0.0 OUTLIER 38.66 98.84 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 127.646 2.378 . . . . 17.329999999999998 115.215 -175.937 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 16.8 mm 33.94 73.26 0.6 Allowed Pre-proline 0 CA--C 1.543 0.695 0 C-N-CA 125.569 1.547 . . . . 14.16 113.108 159.625 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -75.54 157.99 40.28 Favored 'Trans proline' 0 N--CA 1.452 -0.917 0 C-N-CA 122.561 2.174 . . . . 9.9000000000000004 109.268 174.895 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 20.7 p -152.52 15.79 0.6 Allowed 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 112.624 0.602 . . . . 8.3499999999999996 112.624 178.255 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 52.1 t -121.9 97.26 46.25 Favored Pre-proline 0 CA--C 1.532 0.265 0 C-N-CA 123.528 0.731 . . . . 7.7400000000000002 109.629 -178.206 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -79.98 57.22 6.4 Favored 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 122.872 2.381 . . . . 3.7799999999999998 110.893 -175.188 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 10.4 p -96.13 -136.05 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 N-CA-C 106.17 -1.789 . . . . 4.9199999999999999 106.17 163.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 51.68 -88.97 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 126.178 1.791 . . . . 4.3099999999999996 112.087 169.174 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 6.2 tt -53.97 -45.18 71.3 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 125.465 1.506 . . . . 3.3100000000000001 108.529 175.223 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 50.4 tttp -59.04 -42.7 90.88 Favored 'General case' 0 CA--C 1.534 0.355 0 O-C-N 121.756 -0.59 . . . . 3.8100000000000001 110.403 176.937 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.58 -26.88 64.68 Favored 'General case' 0 N--CA 1.452 -0.326 0 O-C-N 121.759 -0.588 . . . . 6.6600000000000001 110.636 179.096 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.1 tt -64.87 -48.23 75.01 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 108.09 -1.078 . . . . 2.0 108.09 171.649 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 11.0 tp -54.41 -46.0 73.06 Favored 'General case' 0 N--CA 1.454 -0.255 0 O-C-N 121.922 -0.486 . . . . 2.1200000000000001 111.245 174.804 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 79.9 t -57.81 -47.64 85.57 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 O-C-N 122.16 -0.337 . . . . 0.41999999999999998 110.241 174.74 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 49.6 t -55.68 -44.83 78.38 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 O-C-N 121.718 -0.614 . . . . 0.48999999999999999 110.218 176.371 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 68.7 t -56.35 -49.33 77.36 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 CA-C-N 119.203 0.911 . . . . 0.5 110.472 175.86 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 76.4 t -55.24 -45.15 77.47 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 O-C-N 121.564 -0.71 . . . . 0.37 110.704 176.151 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 70.1 t -60.17 -46.19 94.92 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.191 0 N-CA-C 109.163 -0.68 . . . . 0.34999999999999998 109.163 177.689 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 41.1 t -54.7 -48.58 72.14 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 C-N-CA 123.471 0.709 . . . . 0.48999999999999999 110.572 177.084 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 53.9 t -56.47 -46.97 82.4 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 CA-C-N 118.673 0.669 . . . . 0.44 110.598 177.12 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -59.08 -47.29 85.81 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 109.514 -0.551 . . . . 0.31 109.514 177.104 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 15.9 t -61.67 -38.49 80.46 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.878 0 C-N-CA 124.145 0.978 . . . . 0.39000000000000001 110.179 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 2.9 t -62.64 -49.45 83.72 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.334 0 C-N-CA 123.616 0.767 . . . . 0.5 109.562 174.417 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 1.3 t -54.25 -41.49 52.37 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 CA-C-N 119.207 0.912 . . . . 0.39000000000000001 111.384 173.369 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.4 t -64.33 -44.76 97.29 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 N-CA-C 108.706 -0.85 . . . . 0.32000000000000001 108.706 179.013 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 11.3 mt -59.85 -43.04 91.08 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 N-CA-C 108.627 -0.879 . . . . 0.5 108.627 178.259 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 39.5 t -61.71 -57.57 11.5 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 N-CA-C 108.809 -0.812 . . . . 0.42999999999999999 108.809 -179.273 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -53.01 -45.18 62.27 Favored Glycine 0 CA--C 1.533 1.18 0 C-N-CA 120.972 -0.632 . . . . 0.47999999999999998 111.936 176.565 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -60.55 -32.73 71.78 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 124.135 0.974 . . . . 1.0 111.868 179.243 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 13.2 tp -70.12 -60.33 2.35 Favored 'General case' 0 N--CA 1.435 -1.209 0 N-CA-C 107.49 -1.3 . . . . 0.79000000000000004 107.49 172.519 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 5.3 mp -57.65 -35.49 70.59 Favored 'General case' 0 C--N 1.341 0.237 0 N-CA-C 113.412 0.893 . . . . 2.5499999999999998 113.412 -171.928 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 28.1 ptm -61.05 -25.58 67.02 Favored 'General case' 0 CA--C 1.537 0.457 0 O-C-N 121.459 -0.775 . . . . 3.8799999999999999 111.941 176.233 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -91.01 -61.97 1.25 Allowed Glycine 0 CA--C 1.528 0.874 0 C-N-CA 124.625 1.107 . . . . 3.6000000000000001 111.002 175.353 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 76.1 mt . . . . . 0 N--CA 1.446 -0.649 0 C-N-CA 125.767 1.627 . . . . 7.96 107.705 -173.167 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 10.7 mp . . . . . 0 N--CA 1.475 0.812 0 N-CA-C 106.219 -1.771 . . . . 18.530000000000001 106.219 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 55.8 mmm-85 -146.67 80.79 1.55 Allowed 'General case' 0 C--O 1.224 -0.248 0 C-N-CA 124.108 0.963 . . . . 22.859999999999999 108.593 177.875 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 3.8 mp 47.18 73.29 1.02 Allowed Pre-proline 0 CA--C 1.544 0.728 0 C-N-CA 125.007 1.323 . . . . 17.32 111.51 173.655 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -66.37 -25.43 49.08 Favored 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 122.261 1.974 . . . . 12.300000000000001 112.327 -177.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER 66.16 14.52 9.68 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 126.181 1.792 . . . . 12.470000000000001 112.847 172.206 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 48.7 m -83.82 -54.12 0.52 Allowed Pre-proline 0 CA--C 1.535 0.395 0 C-N-CA 124.937 1.295 . . . . 8.0800000000000001 112.644 -174.212 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -70.21 -36.81 8.98 Favored 'Trans proline' 0 N--CA 1.459 -0.513 0 C-N-CA 121.319 1.346 . . . . 5.2800000000000002 110.315 172.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 5.6 t -60.33 156.05 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 N-CA-C 107.648 -1.241 . . . . 4.5599999999999996 107.648 167.183 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 29.5 m-80 72.12 -46.69 0.65 Allowed 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 125.85 1.66 . . . . 4.1699999999999999 111.916 -176.41 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -66.76 -47.97 70.56 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 108.419 -0.956 . . . . 4.6900000000000004 108.419 175.079 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -57.78 -40.77 80.6 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-O 121.216 0.531 . . . . 3.7200000000000002 110.163 174.411 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 43.0 ttt85 -67.28 -26.41 66.53 Favored 'General case' 0 N--CA 1.44 -0.931 0 O-C-N 122.116 -0.365 . . . . 6.2300000000000004 111.592 179.246 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.3 tt -60.07 -48.75 80.4 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 108.275 -1.009 . . . . 2.0499999999999998 108.275 173.89 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 10.8 tp -56.51 -45.97 80.78 Favored 'General case' 0 N--CA 1.454 -0.272 0 O-C-N 121.868 -0.52 . . . . 2.27 111.477 176.279 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 99.4 t -56.65 -48.03 81.35 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 N-CA-C 109.777 -0.453 . . . . 0.53000000000000003 109.777 174.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 44.3 t -56.47 -45.76 82.01 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.291 0 CA-C-O 118.65 -0.691 . . . . 0.78000000000000003 110.058 177.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 55.9 t -54.25 -51.41 48.2 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 CA-C-N 119.572 1.078 . . . . 0.90000000000000002 110.467 176.422 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 97.8 t -57.29 -45.78 85.08 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 O-C-N 121.547 -0.721 . . . . 0.80000000000000004 111.011 177.354 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 53.7 t -59.92 -42.74 90.36 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 N-CA-C 109.382 -0.599 . . . . 0.81999999999999995 109.382 179.341 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 30.1 t -54.5 -47.42 71.18 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 C-N-CA 123.711 0.804 . . . . 1.22 110.377 177.3 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 72.8 t -59.1 -46.41 91.93 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 CA-C-N 118.829 0.741 . . . . 0.94999999999999996 110.395 178.178 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -58.93 -46.1 88.77 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 123.216 0.606 . . . . 0.64000000000000001 109.856 177.167 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.4 t -62.54 -40.51 88.52 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.898 0 C-N-CA 124.559 1.144 . . . . 0.90000000000000002 109.84 -179.486 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 5.0 t -62.51 -48.79 86.57 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.402 0 CA-C-N 118.776 0.716 . . . . 0.91000000000000003 109.65 175.042 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 1.4 t -54.58 -39.88 47.93 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 CA-C-N 118.734 0.697 . . . . 0.56000000000000005 111.38 173.611 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.4 t -66.45 -45.01 90.18 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 N-CA-C 108.891 -0.781 . . . . 0.55000000000000004 108.891 179.131 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 11.8 mt -59.01 -44.99 92.5 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 N-CA-C 108.334 -0.987 . . . . 0.81000000000000005 108.334 178.568 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 42.7 t -64.24 -53.46 43.11 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 N-CA-C 109.48 -0.563 . . . . 0.53000000000000003 109.48 -177.857 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -54.71 -44.31 80.05 Favored Glycine 0 CA--C 1.527 0.844 0 N-CA-C 111.568 -0.613 . . . . 0.62 111.568 176.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -60.98 -45.02 96.5 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 117.686 0.743 . . . . 0.72999999999999998 111.013 178.122 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 9.7 tp -56.93 -53.45 57.89 Favored 'General case' 0 N--CA 1.441 -0.917 0 N-CA-C 108.303 -0.999 . . . . 0.94999999999999996 108.303 175.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 85.5 mt -61.18 -37.64 83.64 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 122.804 0.442 . . . . 1.9099999999999999 111.789 -177.837 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 47.4 ttm -60.51 -34.45 74.11 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.067 0.547 . . . . 3.2200000000000002 110.13 174.032 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -69.85 -66.23 2.29 Favored Glycine 0 CA--C 1.529 0.913 0 N-CA-C 110.967 -0.853 . . . . 2.8999999999999999 110.967 172.629 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 3.4 pp . . . . . 0 N--CA 1.436 -1.145 0 C-N-CA 125.601 1.56 . . . . 7.7699999999999996 110.181 -169.38 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 65.2 mt . . . . . 0 N--CA 1.475 0.811 0 N-CA-C 107.918 -1.141 . . . . 17.98 107.918 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 55.0 ttt85 -161.89 156.93 23.18 Favored 'General case' 0 N--CA 1.455 -0.182 0 N-CA-C 106.749 -1.574 . . . . 15.130000000000001 106.749 178.789 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 64.7 mt -73.92 126.63 89.26 Favored Pre-proline 0 CA--C 1.538 0.499 0 N-CA-C 106.758 -1.571 . . . . 12.06 106.758 169.565 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -75.21 177.65 8.34 Favored 'Trans proline' 0 N--CA 1.454 -0.822 0 C-N-CA 122.679 2.252 . . . . 10.210000000000001 110.423 -178.655 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 78.6 m 64.2 48.18 2.99 Favored 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 124.254 1.022 . . . . 10.77 109.781 176.78 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 40.3 t -109.2 87.43 4.89 Favored Pre-proline 0 CA--C 1.535 0.388 0 C-N-CA 124.523 1.129 . . . . 5.3799999999999999 110.516 -178.49 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -77.26 63.88 7.83 Favored 'Trans proline' 0 CA--C 1.535 0.562 0 C-N-CA 123.386 2.724 . . . . 3.4500000000000002 111.518 -174.549 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 12.7 p -80.27 -133.63 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 C-N-CA 125.109 1.364 . . . . 4.3899999999999997 109.788 179.745 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 66.9 m-80 -55.51 -21.36 16.35 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.096 0.958 . . . . 3.1000000000000001 113.562 -174.075 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.7 pp -54.37 -29.31 48.07 Favored 'General case' 0 CA--C 1.536 0.418 0 O-C-N 121.3 -0.875 . . . . 4.1900000000000004 111.133 171.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 3.0 ttmp? -57.7 -56.55 20.52 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 123.685 0.794 . . . . 4.9900000000000002 109.409 172.424 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 7.4 ptp180 -67.83 -26.59 66.13 Favored 'General case' 0 C--N 1.34 0.169 0 C-N-CA 120.318 -0.553 . . . . 5.8499999999999996 111.144 -178.027 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 9.3 tt -62.45 -50.86 69.77 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 108.895 -0.78 . . . . 2.4100000000000001 108.895 173.072 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 10.5 tp -56.61 -46.07 81.1 Favored 'General case' 0 N--CA 1.453 -0.295 0 O-C-N 122.228 -0.295 . . . . 2.23 111.476 176.881 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 72.7 t -54.26 -50.16 58.14 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 N-CA-C 109.75 -0.463 . . . . 0.93999999999999995 109.75 174.336 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 40.6 t -58.49 -46.37 89.75 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.224 0 CA-C-O 118.681 -0.676 . . . . 0.69999999999999996 110.454 179.452 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 53.1 t -53.37 -53.33 24.76 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 CA-C-N 119.394 0.997 . . . . 0.63 109.93 176.946 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 69.8 t -58.1 -46.07 88.3 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 O-C-N 122.036 -0.415 . . . . 0.29999999999999999 110.974 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 48.5 t -61.44 -46.86 95.71 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 N-CA-C 109.008 -0.738 . . . . 0.34999999999999998 109.008 -178.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 43.1 t -54.14 -49.94 58.47 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 C-N-CA 123.566 0.746 . . . . 0.47999999999999998 110.038 176.414 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 44.4 t -58.28 -48.13 85.68 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 CA-C-N 118.71 0.687 . . . . 0.39000000000000001 110.864 179.166 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -59.09 -47.2 86.13 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 109.379 -0.6 . . . . 0.5 109.379 178.829 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 15.5 t -62.63 -39.59 85.21 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.985 0 C-N-CA 124.037 0.935 . . . . 0.41999999999999998 109.929 -179.264 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 3.8 t -63.83 -47.52 90.47 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.482 0 CA-C-N 118.871 0.76 . . . . 0.35999999999999999 109.6 175.863 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 1.4 t -54.76 -41.6 57.46 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.602 0 CA-C-N 119.061 0.846 . . . . 0.35999999999999999 111.225 173.207 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.4 t -65.09 -46.33 91.57 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.171 0 N-CA-C 108.648 -0.871 . . . . 0.46000000000000002 108.648 179.746 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 13.1 mt -59.82 -43.52 92.01 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 N-CA-C 108.421 -0.955 . . . . 0.47999999999999998 108.421 179.792 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 27.3 t -62.99 -54.87 28.02 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 N-CA-C 109.061 -0.718 . . . . 0.35999999999999999 109.061 -178.685 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -52.33 -45.96 57.86 Favored Glycine 0 CA--C 1.529 0.961 0 N-CA-C 111.541 -0.624 . . . . 0.32000000000000001 111.541 176.14 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -61.87 -41.96 98.49 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 122.959 0.504 . . . . 0.45000000000000001 111.54 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 11.6 tp -63.56 -46.28 86.62 Favored 'General case' 0 N--CA 1.44 -0.928 0 N-CA-C 108.669 -0.863 . . . . 0.72999999999999998 108.669 176.23 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 82.8 mt -62.7 -47.52 83.27 Favored 'General case' 0 CA--C 1.53 0.204 0 O-C-N 122.061 -0.399 . . . . 1.95 111.182 -178.12 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 14.0 ptt? -66.79 -36.8 83.23 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 118.3 0.5 . . . . 4.04 110.394 177.946 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.17 76.32 1.22 Allowed Glycine 0 C--N 1.338 0.66 0 N-CA-C 109.984 -1.246 . . . . 3.3399999999999999 109.984 -178.608 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.536 0.414 0 CA-C-O 117.82 -1.086 . . . . 7.7599999999999998 111.384 161.342 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 68.5 tp . . . . . 0 N--CA 1.475 0.777 0 N-CA-C 108.688 -0.856 . . . . 16.239999999999998 108.688 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 30.1 ptt180 -79.59 64.26 4.41 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 118.472 0.578 . . . . 17.030000000000001 111.979 -173.407 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 16.0 mm 41.51 71.92 1.21 Allowed Pre-proline 0 CA--C 1.543 0.709 0 C-N-CA 125.933 1.693 . . . . 12.16 112.388 167.203 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -62.94 115.49 2.98 Favored 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 122.148 1.899 . . . . 9.0299999999999994 110.186 -178.613 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 23.6 p -125.87 34.72 4.83 Favored 'General case' 0 CA--C 1.529 0.135 0 C-N-CA 126.042 1.737 . . . . 6.9900000000000002 109.114 -172.168 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 46.2 t 57.83 72.04 0.96 Allowed Pre-proline 0 CA--C 1.535 0.399 0 C-N-CA 124.914 1.285 . . . . 7.5899999999999999 109.771 -167.261 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_endo -80.11 -176.8 3.4 Favored 'Trans proline' 0 N--CA 1.45 -1.048 0 C-N-CA 122.788 2.326 . . . . 6.1500000000000004 111.428 -173.504 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.9 p -52.1 155.49 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 CA-C-O 122.876 1.322 . . . . 5.1600000000000001 111.064 170.771 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 13.7 t30 68.16 -46.37 0.52 Allowed 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 127.371 2.268 . . . . 4.3300000000000001 112.96 -172.499 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.4 tt -63.57 -54.49 35.27 Favored 'General case' 0 N--CA 1.446 -0.631 0 N-CA-C 107.86 -1.163 . . . . 3.1499999999999999 107.86 174.555 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 33.4 ttmt -57.26 -44.83 84.26 Favored 'General case' 0 N--CA 1.453 -0.288 0 O-C-N 121.989 -0.444 . . . . 4.6799999999999997 110.308 176.717 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 1.2 ptt85 -65.22 -26.21 68.03 Favored 'General case' 0 C--O 1.224 -0.245 0 CA-C-O 119.521 -0.276 . . . . 6.5499999999999998 111.49 -178.311 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -58.76 -44.21 90.53 Favored 'General case' 0 C--N 1.333 -0.11 0 N-CA-C 109.005 -0.739 . . . . 2.7400000000000002 109.005 179.129 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 1.7 tt -57.61 -46.28 84.3 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-O 121.283 0.563 . . . . 2.6400000000000001 110.225 176.754 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 48.0 t -58.19 -46.13 88.66 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 N-CA-C 109.618 -0.512 . . . . 0.40999999999999998 109.618 176.501 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 68.6 t -57.01 -46.44 84.1 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 CA-C-O 118.515 -0.755 . . . . 0.78000000000000003 109.766 176.79 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 54.5 t -55.36 -50.35 65.98 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 CA-C-N 119.803 1.183 . . . . 0.88 110.144 177.317 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 81.1 t -56.14 -46.58 81.11 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 O-C-N 121.841 -0.537 . . . . 0.48999999999999999 110.929 177.389 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 54.3 t -60.37 -45.53 96.45 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 N-CA-C 109.212 -0.662 . . . . 0.52000000000000002 109.212 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 51.0 t -55.15 -49.7 69.94 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 C-N-CA 123.674 0.79 . . . . 0.89000000000000001 110.052 176.908 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 49.0 t -57.86 -47.21 86.77 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 CA-C-N 118.501 0.591 . . . . 0.71999999999999997 110.553 178.552 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -58.63 -47.13 85.42 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 123.123 0.569 . . . . 0.38 109.466 177.79 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 11.9 t -62.77 -39.72 85.93 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.898 0 C-N-CA 124.238 1.015 . . . . 0.63 109.96 -178.874 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 5.6 t -63.29 -48.49 87.15 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 CA-C-N 118.77 0.714 . . . . 0.68000000000000005 109.687 175.205 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 1.4 t -54.28 -41.1 50.72 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 CA-C-N 118.844 0.747 . . . . 0.42999999999999999 111.232 173.195 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.4 t -65.81 -45.08 92.52 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.278 0 N-CA-C 108.646 -0.872 . . . . 0.40999999999999998 108.646 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 11.6 mt -58.96 -45.35 92.1 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.603 0 N-CA-C 108.191 -1.04 . . . . 0.67000000000000004 108.191 178.489 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 38.4 t -63.77 -52.99 50.16 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 N-CA-C 109.697 -0.483 . . . . 0.34000000000000002 109.697 -176.745 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -54.9 -48.55 66.28 Favored Glycine 0 CA--C 1.528 0.849 0 N-CA-C 111.354 -0.698 . . . . 0.38 111.354 175.814 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -57.1 -41.21 78.49 Favored 'General case' 0 N--CA 1.455 -0.225 0 O-C-N 122.105 -0.644 . . . . 0.62 111.211 178.935 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 12.6 tp -66.73 -52.41 44.73 Favored 'General case' 0 N--CA 1.438 -1.069 0 C-N-CA 123.886 0.874 . . . . 0.59999999999999998 109.11 178.756 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . 0.298 3.6 pp -68.27 -34.29 75.91 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 119.11 0.868 . . . . 3.04 112.685 -175.285 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 73.7 mtm -68.03 -42.98 79.8 Favored 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 110.004 -0.369 . . . . 3.4300000000000002 110.004 171.394 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 94.4 72.48 1.17 Allowed Glycine 0 CA--C 1.524 0.6 0 N-CA-C 109.598 -1.401 . . . . 3.48 109.598 -178.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 2.3 pt? . . . . . 0 CA--C 1.533 0.325 0 CA-C-O 118.296 -0.859 . . . . 8.4499999999999993 111.483 168.954 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 1.7 tm? . . . . . 0 N--CA 1.474 0.775 0 N-CA-C 107.835 -1.172 . . . . 18.219999999999999 107.835 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.18 68.6 0.87 Allowed 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.817 1.247 . . . . 17.52 108.581 179.591 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.7 mp -104.47 105.3 49.34 Favored Pre-proline 0 CA--C 1.533 0.31 0 N-CA-C 105.915 -1.883 . . . . 12.880000000000001 105.915 171.88 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -78.23 -53.9 0.06 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.879 0 C-N-CA 121.833 1.689 . . . . 8.6199999999999992 109.717 175.332 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 25.5 p -156.97 23.89 0.32 Allowed 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 124.43 1.092 . . . . 6.8899999999999997 111.127 -172.263 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 29.5 t -53.81 -51.62 75.05 Favored Pre-proline 0 CA--C 1.54 0.574 0 N-CA-C 113.837 1.051 . . . . 7.2800000000000002 113.837 -172.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -71.85 75.92 2.09 Favored 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 122.044 1.829 . . . . 3.8399999999999999 110.301 176.5 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 10.1 p -95.36 -135.36 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 C-N-CA 125.401 1.48 . . . . 4.9699999999999998 109.897 -176.227 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -54.05 -34.37 59.86 Favored 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 124.331 1.052 . . . . 3.75 110.642 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 10.0 tt -54.47 -39.12 67.16 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 124.027 0.931 . . . . 4.04 109.906 177.787 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 28.1 tptp -63.67 -42.87 97.99 Favored 'General case' 0 N--CA 1.451 -0.4 0 O-C-N 121.936 -0.478 . . . . 4.0599999999999996 109.879 179.472 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 10.6 mpt_? -74.11 -26.77 60.54 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 109.884 -0.413 . . . . 9.5399999999999991 109.884 -178.877 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 9.9 tt -64.18 -45.36 88.71 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 108.413 -0.958 . . . . 1.98 108.413 172.222 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 10.9 tp -56.04 -45.85 79.08 Favored 'General case' 0 N--CA 1.454 -0.239 0 O-C-N 122.223 -0.298 . . . . 1.8600000000000001 111.232 174.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 93.5 t -56.66 -49.75 76.74 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 N-CA-C 110.185 -0.302 . . . . 0.40999999999999998 110.185 174.567 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 54.8 t -55.29 -46.0 77.98 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 O-C-N 121.87 -0.519 . . . . 0.57999999999999996 110.039 177.166 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 54.3 t -56.17 -47.87 80.09 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 CA-C-N 118.833 0.742 . . . . 0.58999999999999997 110.222 177.084 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 76.0 t -54.9 -45.37 75.45 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 CA-C-N 118.683 0.674 . . . . 0.56999999999999995 110.78 175.13 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 87.2 t -60.23 -47.3 92.76 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.182 0 N-CA-C 109.28 -0.637 . . . . 0.48999999999999999 109.28 178.579 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 53.1 t -55.12 -49.09 74.73 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 C-N-CA 123.48 0.712 . . . . 0.54000000000000004 110.406 177.531 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 41.8 t -56.98 -46.23 83.94 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 C-N-CA 123.485 0.714 . . . . 0.52000000000000002 110.22 177.3 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -58.59 -47.4 84.43 Favored 'General case' 0 N--CA 1.45 -0.425 0 N-CA-C 109.363 -0.606 . . . . 0.67000000000000004 109.363 177.148 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.7 t -62.12 -41.3 90.69 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.829 0 O-C-N 121.316 -0.865 . . . . 0.53000000000000003 110.045 -179.482 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 4.3 t -62.91 -47.11 94.38 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 O-C-N 121.512 -0.742 . . . . 0.40999999999999998 109.83 175.694 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 2.1 t -56.86 -37.69 55.21 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.707 0 CA-C-N 118.812 0.733 . . . . 0.46999999999999997 110.957 173.945 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.4 t -66.64 -46.9 84.87 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.245 0 N-CA-C 108.447 -0.946 . . . . 0.47999999999999998 108.447 178.034 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 10.7 mt -58.28 -45.89 89.08 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 N-CA-C 108.569 -0.9 . . . . 0.44 108.569 179.283 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 43.6 t -65.65 -50.95 68.22 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 N-CA-C 109.382 -0.599 . . . . 0.41999999999999998 109.382 -176.723 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -53.08 -49.0 57.47 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 111.101 -0.799 . . . . 0.42999999999999999 111.101 176.06 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -57.54 -47.86 80.86 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.507 0.723 . . . . 0.68999999999999995 110.643 178.273 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 10.8 tp -59.04 -46.94 86.95 Favored 'General case' 0 N--CA 1.441 -0.908 0 C-N-CA 123.679 0.792 . . . . 0.71999999999999997 109.695 178.188 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . 0.307 0.1 OUTLIER -66.67 -40.25 88.51 Favored 'General case' 0 CA--C 1.54 0.56 0 O-C-N 121.592 -0.692 . . . . 3.2000000000000002 110.732 -178.555 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 28.1 ttt -63.98 -37.24 86.71 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 123.954 0.902 . . . . 3.5699999999999998 110.688 176.366 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 86.34 59.09 1.87 Allowed Glycine 0 CA--C 1.524 0.639 0 N-CA-C 108.358 -1.897 . . . . 3.1200000000000001 108.358 -168.697 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.45 -0.444 0 N-CA-C 105.602 -1.999 . . . . 8.9399999999999995 105.602 178.427 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.473 0.692 0 CA-C-O 119.211 -0.423 . . . . 20.510000000000002 109.92 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 90.2 mmt-85 -145.18 171.71 14.15 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 105.377 -2.083 . . . . 20.359999999999999 105.377 165.109 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.5 pp -73.79 145.04 83.71 Favored Pre-proline 0 CA--C 1.535 0.401 0 N-CA-C 109.568 -0.53 . . . . 14.16 109.568 -178.611 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_endo -73.27 141.06 31.59 Favored 'Trans proline' 0 N--CA 1.453 -0.909 0 C-N-CA 122.628 2.219 . . . . 11.01 110.031 179.231 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -155.93 54.35 0.59 Allowed 'General case' 0 C--O 1.226 -0.177 0 N-CA-C 107.699 -1.223 . . . . 9.0999999999999996 107.699 176.557 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 10.1 t -54.17 -53.39 59.31 Favored Pre-proline 0 CA--C 1.541 0.601 0 N-CA-C 113.62 0.97 . . . . 6.3099999999999996 113.62 -177.062 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -77.99 54.97 5.11 Favored 'Trans proline' 0 CA--C 1.54 0.779 0 C-N-CA 122.229 1.953 . . . . 4.1600000000000001 112.577 -174.372 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.5 t -59.83 149.0 7.13 Favored 'Isoleucine or valine' 0 C--N 1.339 0.126 0 N-CA-C 108.039 -1.097 . . . . 3.3500000000000001 108.039 171.53 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 40.2 m-80 63.5 -46.3 0.24 Allowed 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 127.026 2.13 . . . . 3.1400000000000001 113.744 -170.884 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 86.9 mt -64.12 -47.36 80.31 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 119.411 1.005 . . . . 3.1099999999999999 109.482 -177.01 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 2.2 tmtm? -60.82 -37.01 80.54 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.491 -0.322 . . . . 4.0300000000000002 110.777 -174.813 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.05 -26.56 26.93 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 122.847 0.459 . . . . 6.7000000000000002 111.918 177.768 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 9.1 tt -60.52 -39.71 88.82 Favored 'General case' 0 C--O 1.224 -0.262 0 N-CA-C 108.972 -0.751 . . . . 1.8899999999999999 108.972 172.844 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 10.7 tp -52.84 -45.55 67.38 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-O 121.031 0.443 . . . . 1.9399999999999999 111.464 171.448 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 39.7 t -61.65 -44.28 98.43 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 N-CA-C 109.511 -0.551 . . . . 0.70999999999999996 109.511 176.778 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 90.3 t -55.53 -46.86 79.12 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 O-C-N 121.999 -0.438 . . . . 0.68000000000000005 110.051 175.026 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 67.3 t -56.06 -49.14 77.31 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 CA-C-N 118.808 0.731 . . . . 0.60999999999999999 109.809 176.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 75.1 t -56.36 -44.49 80.04 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 O-C-N 121.827 -0.546 . . . . 0.40000000000000002 111.013 177.114 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 56.0 t -61.03 -47.79 92.0 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.139 0 O-C-N 121.661 -0.65 . . . . 0.46000000000000002 109.26 178.797 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 54.7 t -54.78 -48.98 72.56 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 C-N-CA 123.312 0.645 . . . . 0.70999999999999996 110.199 176.805 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 38.1 t -57.13 -46.4 84.56 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 C-N-CA 123.568 0.747 . . . . 0.55000000000000004 110.544 177.445 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -59.01 -48.08 82.87 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 123.424 0.69 . . . . 0.42999999999999999 109.361 177.802 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 16.1 t -61.87 -40.98 89.02 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.848 0 O-C-N 121.387 -0.82 . . . . 0.60999999999999999 109.954 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 4.2 t -62.91 -45.89 97.71 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.507 0 O-C-N 121.543 -0.723 . . . . 0.66000000000000003 109.84 175.491 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 1.6 t -56.42 -40.26 66.22 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.631 0 CA-C-N 119.296 0.953 . . . . 0.44 110.927 173.556 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.4 t -63.57 -48.42 86.94 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 N-CA-C 108.345 -0.983 . . . . 0.40999999999999998 108.345 177.779 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 11.2 mt -59.43 -42.46 87.75 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 N-CA-C 109.053 -0.721 . . . . 0.68999999999999995 109.053 -179.725 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 32.4 t -65.06 -50.37 74.86 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 N-CA-C 109.162 -0.681 . . . . 0.46000000000000002 109.162 -178.477 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -52.1 -46.39 56.28 Favored Glycine 0 CA--C 1.53 0.981 0 N-CA-C 111.463 -0.655 . . . . 0.32000000000000001 111.463 173.641 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -59.24 -51.15 71.23 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 121.256 0.55 . . . . 0.72999999999999998 110.587 178.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 9.2 tp -54.53 -46.6 73.58 Favored 'General case' 0 N--CA 1.443 -0.817 0 C-N-CA 123.973 0.909 . . . . 0.76000000000000001 109.594 175.798 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 64.7 mt -63.17 -45.33 92.36 Favored 'General case' 0 CA--C 1.53 0.19 0 O-C-N 121.808 -0.557 . . . . 1.8500000000000001 111.536 -178.789 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 18.8 ptt? -65.99 -35.92 81.89 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 118.837 0.744 . . . . 4.3300000000000001 110.524 178.398 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 173.02 -47.67 0.16 Allowed Glycine 0 CA--C 1.526 0.756 0 CA-C-N 117.836 0.289 . . . . 3.23 112.513 174.075 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 3.2 tm? . . . . . 0 N--CA 1.45 -0.427 0 N-CA-C 104.58 -2.378 . . . . 7.21 104.58 -175.188 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 4.3 mm? . . . . . 0 N--CA 1.475 0.791 0 N-CA-C 106.706 -1.59 . . . . 21.280000000000001 106.706 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.18 55.33 0.76 Allowed 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 107.991 -1.115 . . . . 17.239999999999998 107.991 -179.215 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 41.3 pt -73.85 148.0 86.85 Favored Pre-proline 0 CA--C 1.538 0.499 0 C-N-CA 123.325 0.65 . . . . 13.199999999999999 111.219 -169.322 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_endo -63.26 -71.0 0.03 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.75 0 C-N-CA 122.376 2.05 . . . . 8.9499999999999993 111.597 -173.548 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 32.0 p -158.15 44.83 0.32 Allowed 'General case' 0 C--N 1.332 -0.173 0 C-N-CA 124.024 0.93 . . . . 6.79 109.52 -167.209 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 38.0 t 62.0 88.09 0.12 Allowed Pre-proline 0 CA--C 1.535 0.397 0 C-N-CA 124.606 1.162 . . . . 8.3499999999999996 110.139 -169.345 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -73.57 74.38 3.25 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 123.312 2.675 . . . . 3.7200000000000002 110.856 -173.277 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.8 p -55.79 153.95 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 CA-C-O 122.693 1.235 . . . . 3.6899999999999999 110.847 174.792 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 35.5 t30 64.8 -46.58 0.33 Allowed 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 127.769 2.427 . . . . 3.8799999999999999 113.218 -168.469 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -66.4 -48.33 70.43 Favored 'General case' 0 N--CA 1.453 -0.325 0 C-N-CA 123.588 0.755 . . . . 3.9399999999999999 109.061 -178.76 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 9.4 tmtt? -57.63 -51.45 69.46 Favored 'General case' 0 C--O 1.233 0.192 0 N-CA-C 108.57 -0.9 . . . . 4.5800000000000001 108.57 -179.726 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 10.4 ptm180 -69.77 -26.33 64.24 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 120.026 -0.67 . . . . 5.4100000000000001 112.469 -177.507 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 68.9 tp -63.64 -48.4 77.41 Favored 'General case' 0 N--CA 1.454 -0.275 0 N-CA-C 108.553 -0.906 . . . . 2.1899999999999999 108.553 172.548 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -57.58 -46.09 84.44 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-O 120.91 0.386 . . . . 2.2000000000000002 110.151 177.567 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 75.7 t -55.56 -49.32 74.44 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 O-C-N 121.967 -0.458 . . . . 0.41999999999999998 110.234 173.869 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 32.4 t -56.12 -46.04 80.88 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.204 0 CA-C-O 118.896 -0.573 . . . . 0.46999999999999997 110.089 178.348 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 55.1 t -54.92 -51.91 48.52 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.426 0 CA-C-N 119.273 0.942 . . . . 0.48999999999999999 109.924 177.073 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 70.8 t -56.24 -45.76 81.2 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 O-C-N 121.908 -0.495 . . . . 0.38 110.922 177.709 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 52.7 t -60.47 -46.22 95.66 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.309 0 N-CA-C 109.083 -0.71 . . . . 0.37 109.083 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 48.7 t -55.48 -49.5 72.94 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 C-N-CA 123.605 0.762 . . . . 0.46000000000000002 110.119 176.889 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 52.3 t -58.05 -46.98 87.93 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 CA-C-N 118.465 0.575 . . . . 0.47999999999999998 110.619 178.051 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -59.06 -46.83 87.25 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 123.382 0.673 . . . . 0.47999999999999998 109.488 178.017 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 10.6 t -62.08 -40.6 88.04 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.855 0 C-N-CA 124.353 1.061 . . . . 0.35999999999999999 109.909 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 3.5 t -62.32 -48.03 90.29 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.404 0 CA-C-N 118.696 0.68 . . . . 0.35999999999999999 109.685 175.048 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 1.4 t -55.59 -40.63 60.43 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 O-C-N 121.375 -0.828 . . . . 0.38 111.329 173.655 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.4 t -64.63 -44.86 96.69 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.215 0 N-CA-C 108.541 -0.911 . . . . 0.34999999999999998 108.541 178.599 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 11.5 mt -60.01 -43.67 93.06 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 N-CA-C 108.607 -0.886 . . . . 0.34000000000000002 108.607 178.473 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 39.6 t -62.95 -53.83 41.58 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 N-CA-C 109.262 -0.644 . . . . 0.28999999999999998 109.262 -178.823 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -53.19 -47.11 61.86 Favored Glycine 0 CA--C 1.53 1.006 0 N-CA-C 111.572 -0.611 . . . . 0.28000000000000003 111.572 175.432 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -60.34 -40.16 89.68 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 123.503 0.721 . . . . 0.56000000000000005 111.204 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 11.1 tp -63.42 -52.88 59.68 Favored 'General case' 0 N--CA 1.439 -0.991 0 N-CA-C 108.175 -1.046 . . . . 0.62 108.175 174.607 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 79.0 mt -55.91 -42.18 75.67 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 123.423 0.689 . . . . 1.6000000000000001 111.981 -177.054 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 17.6 ptp -77.35 -13.68 59.88 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 112.371 0.508 . . . . 3.3500000000000001 112.371 176.893 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -101.25 -40.94 2.69 Favored Glycine 0 CA--C 1.527 0.821 0 C-N-CA 124.356 0.979 . . . . 2.3999999999999999 113.512 -166.282 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.6 pt? . . . . . 0 CA--C 1.532 0.276 0 CA-C-O 117.588 -1.196 . . . . 8.5600000000000005 112.304 -176.192 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 3.0 pp . . . . . 0 N--CA 1.476 0.831 0 CA-C-O 117.824 -1.084 . . . . 16.170000000000002 108.635 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -157.65 60.52 0.48 Allowed 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 119.05 0.841 . . . . 17.449999999999999 110.285 -179.522 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 41.1 mm -116.99 89.41 29.76 Favored Pre-proline 0 CA--C 1.538 0.485 0 N-CA-C 108.027 -1.101 . . . . 12.630000000000001 108.027 -178.77 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -78.0 70.14 7.18 Favored 'Trans proline' 0 N--CA 1.455 -0.736 0 C-N-CA 122.639 2.226 . . . . 9.6999999999999993 110.295 -174.312 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.8 m -145.91 47.98 1.24 Allowed 'General case' 0 N--CA 1.463 0.192 0 C-N-CA 124.172 0.989 . . . . 7.3200000000000003 109.074 179.394 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 7.9 t -59.53 -57.78 24.37 Favored Pre-proline 0 CA--C 1.541 0.627 0 CA-C-O 118.429 -0.796 . . . . 7.4900000000000002 112.447 173.62 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_endo -78.67 62.21 8.24 Favored 'Trans proline' 0 CA--C 1.537 0.664 0 C-N-CA 122.382 2.055 . . . . 3.8500000000000001 111.215 -178.164 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 12.1 p -86.21 -133.56 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 C-N-CA 125.502 1.521 . . . . 4.8300000000000001 108.66 175.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 7.4 m120 -35.21 -40.87 0.15 Allowed 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 126.818 2.047 . . . . 3.54 114.024 179.325 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -54.02 -40.84 67.39 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 125.159 1.383 . . . . 3.9399999999999999 110.13 -178.582 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 82.7 tttt -57.9 -53.22 60.64 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 123.193 0.597 . . . . 3.6499999999999999 109.447 176.802 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 66.3 ttt-85 -67.95 -26.89 66.18 Favored 'General case' 0 N--CA 1.442 -0.832 0 O-C-N 121.914 -0.491 . . . . 5.0 111.376 -177.799 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 59.9 tp -65.43 -49.01 70.79 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 108.358 -0.979 . . . . 2.1699999999999999 108.358 173.218 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 10.9 tp -55.58 -46.02 77.29 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 117.9 0.318 . . . . 2.1000000000000001 111.186 176.394 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 75.2 t -55.18 -51.38 55.77 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 N-CA-C 110.221 -0.289 . . . . 0.58999999999999997 110.221 174.809 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 50.6 t -56.01 -46.03 80.5 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 O-C-N 121.725 -0.61 . . . . 0.81999999999999995 110.339 177.336 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 55.0 t -55.68 -47.03 79.65 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 CA-C-N 118.766 0.712 . . . . 0.78000000000000003 110.179 177.824 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 70.6 t -55.44 -45.49 78.29 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 CA-C-N 118.834 0.743 . . . . 0.53000000000000003 110.75 175.718 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 86.8 t -60.47 -47.75 91.32 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 N-CA-C 109.385 -0.598 . . . . 0.66000000000000003 109.385 178.676 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 64.0 t -54.81 -48.61 73.33 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 C-N-CA 123.395 0.678 . . . . 0.88 110.495 177.454 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 39.8 t -57.34 -45.71 85.26 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 C-N-CA 123.574 0.749 . . . . 0.66000000000000003 110.248 177.447 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.6 -47.66 83.56 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 109.469 -0.567 . . . . 0.53000000000000003 109.469 177.075 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 16.6 t -61.93 -41.95 92.84 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.774 0 O-C-N 121.42 -0.8 . . . . 0.62 110.103 -179.588 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 5.9 t -62.24 -46.06 97.31 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 O-C-N 121.565 -0.71 . . . . 0.70999999999999996 109.869 175.616 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 1.6 t -56.79 -39.48 64.57 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.644 0 CA-C-N 119.152 0.887 . . . . 0.5 110.931 173.804 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.4 t -64.25 -46.97 91.82 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.188 0 N-CA-C 108.509 -0.923 . . . . 0.45000000000000001 108.509 177.814 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 10.2 mt -59.5 -44.11 92.22 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 N-CA-C 108.951 -0.759 . . . . 0.58999999999999997 108.951 179.328 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 39.5 t -64.51 -49.74 79.23 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 N-CA-C 109.164 -0.68 . . . . 0.52000000000000002 109.164 -177.543 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -51.37 -52.78 31.0 Favored Glycine 0 CA--C 1.527 0.81 0 N-CA-C 110.619 -0.992 . . . . 0.53000000000000003 110.619 173.479 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -55.18 -43.98 74.85 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 122.966 0.506 . . . . 0.68000000000000005 111.176 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 10.7 tp -62.11 -46.51 88.73 Favored 'General case' 0 N--CA 1.442 -0.848 0 C-N-CA 124.012 0.925 . . . . 0.91000000000000003 109.617 176.327 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 65.5 mt -62.23 -50.26 72.45 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 118.287 0.494 . . . . 1.9299999999999999 111.532 -178.102 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 4.9 mpp? -63.48 -39.71 95.19 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 118.494 0.588 . . . . 4.1699999999999999 110.606 174.706 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 90.06 56.33 1.84 Allowed Glycine 0 CA--C 1.525 0.663 0 N-CA-C 109.164 -1.574 . . . . 2.6499999999999999 109.164 -173.827 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 19.8 tp . . . . . 0 CA--C 1.534 0.331 0 C-N-CA 126.219 1.808 . . . . 8.0600000000000005 110.089 -172.621 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 1.2 pt? . . . . . 0 N--CA 1.478 0.967 0 N-CA-C 113.104 0.779 . . . . 18.91 113.104 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -77.86 66.53 3.54 Favored 'General case' 0 CA--C 1.538 0.485 0 O-C-N 121.135 -0.978 . . . . 18.109999999999999 111.272 -176.777 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 55.8 mt -114.58 90.6 22.09 Favored Pre-proline 0 CA--C 1.54 0.573 0 C-N-CA 124.926 1.291 . . . . 13.33 108.765 -174.398 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -73.61 75.76 2.96 Favored 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 122.909 2.406 . . . . 9.9600000000000009 110.089 -179.1 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 31.5 p -113.41 30.21 7.4 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 125.681 1.592 . . . . 8.25 111.021 -176.972 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 26.1 m -53.12 104.12 0.41 Allowed Pre-proline 0 CA--C 1.532 0.28 0 C-N-CA 127.083 2.153 . . . . 7.6699999999999999 109.722 -168.848 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -84.95 67.66 6.14 Favored 'Trans proline' 0 N--CA 1.45 -1.037 0 C-N-CA 123.111 2.541 . . . . 3.9399999999999999 109.678 -166.575 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.2 t -79.62 -133.83 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 C-N-CA 123.671 0.789 . . . . 3.1200000000000001 109.933 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -62.64 -11.78 19.2 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 114.459 1.281 . . . . 4.5700000000000003 114.459 -160.423 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -55.17 -48.25 74.03 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 119.489 1.04 . . . . 3.3700000000000001 108.868 166.77 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 23.0 tptm -58.67 -47.4 84.6 Favored 'General case' 0 N--CA 1.451 -0.383 0 O-C-N 121.71 -0.619 . . . . 3.2799999999999998 109.577 175.878 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 35.1 mtp-105 -65.58 -26.49 67.87 Favored 'General case' 0 C--O 1.224 -0.243 0 N-CA-C 111.982 0.364 . . . . 4.7599999999999998 111.982 -178.249 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 9.5 tt -63.45 -47.8 80.36 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 108.346 -0.983 . . . . 2.0899999999999999 108.346 173.334 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 1.3 tt -56.23 -46.22 79.63 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-O 121.017 0.437 . . . . 2.1499999999999999 110.4 175.313 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 84.6 t -56.53 -48.01 81.0 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 O-C-N 121.835 -0.541 . . . . 0.40000000000000002 110.308 175.391 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 41.5 t -56.19 -45.99 81.1 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.185 0 O-C-N 121.758 -0.589 . . . . 0.5 109.885 177.11 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 54.0 t -54.89 -50.13 64.51 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 CA-C-N 119.29 0.95 . . . . 0.46999999999999997 110.207 176.376 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 73.0 t -56.2 -45.87 81.12 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 O-C-N 121.743 -0.598 . . . . 0.34000000000000002 111.007 177.32 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 56.7 t -60.2 -47.32 92.59 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 N-CA-C 109.176 -0.676 . . . . 0.40000000000000002 109.176 179.509 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 51.0 t -54.81 -49.34 70.06 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 C-N-CA 123.591 0.756 . . . . 0.46000000000000002 110.109 177.233 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 42.8 t -57.54 -46.68 86.13 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 O-C-N 121.817 -0.552 . . . . 0.38 110.528 177.82 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -58.5 -47.51 83.85 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 123.248 0.619 . . . . 0.40999999999999998 109.491 177.72 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 14.4 t -62.29 -41.18 90.57 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.842 0 C-N-CA 123.868 0.867 . . . . 0.38 109.958 -179.399 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 5.2 t -62.69 -47.16 94.22 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.49 0 O-C-N 121.605 -0.685 . . . . 0.34000000000000002 109.766 175.652 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 1.6 t -56.01 -39.7 59.35 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.643 0 CA-C-N 118.949 0.795 . . . . 0.28999999999999998 111.211 173.62 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.4 t -65.09 -45.84 93.05 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.191 0 N-CA-C 108.517 -0.919 . . . . 0.31 108.517 178.357 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 11.3 mt -59.93 -43.85 93.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 N-CA-C 108.729 -0.841 . . . . 0.35999999999999999 108.729 179.104 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 39.7 t -64.14 -51.4 69.34 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 N-CA-C 109.301 -0.629 . . . . 0.28000000000000003 109.301 -178.242 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -53.13 -49.6 55.19 Favored Glycine 0 CA--C 1.528 0.87 0 N-CA-C 110.905 -0.878 . . . . 0.28000000000000003 110.905 175.231 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -56.98 -45.43 82.92 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 123.049 0.539 . . . . 0.47999999999999998 111.079 178.857 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 10.0 tp -58.79 -50.01 75.54 Favored 'General case' 0 N--CA 1.442 -0.853 0 C-N-CA 124.004 0.922 . . . . 0.59999999999999998 109.221 176.696 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 72.9 mt -61.27 -41.49 97.03 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 118.033 0.379 . . . . 1.6499999999999999 111.115 -178.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 75.3 mtp -64.08 -49.68 71.32 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 123.36 0.664 . . . . 2.8599999999999999 110.676 177.976 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 140.45 88.26 0.14 Allowed Glycine 0 CA--C 1.523 0.588 0 N-CA-C 108.888 -1.685 . . . . 3.3999999999999999 108.888 -172.875 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.6 pp . . . . . 0 CA--C 1.534 0.355 0 CA-C-O 117.907 -1.044 . . . . 6.8099999999999996 111.102 168.9 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.473 0.724 0 CA-C-O 117.95 -1.024 . . . . 24.260000000000002 108.342 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 2.2 ptt85 -159.31 58.74 0.4 Allowed 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 118.746 0.703 . . . . 20.32 109.992 175.868 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -74.33 150.0 87.07 Favored Pre-proline 0 CA--C 1.538 0.488 0 C-N-CA 123.514 0.725 . . . . 15.789999999999999 109.352 175.26 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -67.18 -35.11 25.91 Favored 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 122.383 2.056 . . . . 11.9 111.982 -178.312 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 9.1 t 64.71 47.96 2.65 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-O 122.393 1.092 . . . . 10.19 110.322 176.46 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 32.8 t -149.79 -65.37 0.02 OUTLIER Pre-proline 0 CA--C 1.534 0.359 0 CA-C-N 114.966 -1.015 . . . . 6.04 111.594 177.62 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -73.43 67.83 4.41 Favored 'Trans proline' 0 CA--C 1.538 0.695 0 C-N-CA 122.471 2.114 . . . . 3.6000000000000001 110.62 175.092 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 20.1 t -120.58 163.19 18.42 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.187 0 C-N-CA 126.21 1.804 . . . . 3.3799999999999999 106.942 176.974 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 58.0 t30 70.11 -45.88 0.59 Allowed 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 126.638 1.975 . . . . 3.04 113.74 -179.755 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 8.7 tt -66.6 -50.2 63.83 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 124.293 1.037 . . . . 3.25 109.088 170.542 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.06 -38.42 79.38 Favored 'General case' 0 CA--C 1.531 0.238 0 O-C-N 121.489 -0.757 . . . . 3.3500000000000001 111.106 -169.336 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 40.1 ptt85 -65.5 -25.95 67.7 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 116.303 -0.408 . . . . 6.9800000000000004 111.952 178.922 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -62.13 -45.85 91.63 Favored 'General case' 0 N--CA 1.455 -0.197 0 N-CA-C 108.348 -0.982 . . . . 2.3599999999999999 108.348 178.269 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 1.3 tt -57.81 -46.11 85.14 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-O 121.032 0.444 . . . . 2.1400000000000001 110.314 177.028 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 58.4 t -57.44 -48.09 83.51 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 O-C-N 122.022 -0.424 . . . . 0.42999999999999999 109.869 176.315 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 48.2 t -56.47 -45.89 82.05 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.232 0 CA-C-O 118.871 -0.585 . . . . 0.47999999999999998 110.074 176.824 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 48.3 t -55.31 -50.47 64.68 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 CA-C-N 119.379 0.99 . . . . 0.51000000000000001 110.182 176.528 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 71.3 t -55.84 -46.17 79.95 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 O-C-N 121.812 -0.555 . . . . 0.34000000000000002 110.834 177.732 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 56.0 t -60.41 -47.01 94.32 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.227 0 N-CA-C 109.196 -0.668 . . . . 0.39000000000000001 109.196 179.508 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 47.7 t -55.36 -48.43 76.85 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 C-N-CA 123.708 0.803 . . . . 0.5 110.358 177.322 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 44.5 t -57.75 -46.97 86.86 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 CA-C-N 118.603 0.638 . . . . 0.40999999999999998 110.417 177.602 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -59.1 -47.27 85.86 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 109.456 -0.572 . . . . 0.42999999999999999 109.456 177.681 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 15.5 t -61.89 -39.48 83.7 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.886 0 C-N-CA 124.007 0.923 . . . . 0.42999999999999999 110.095 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 3.3 t -62.63 -48.2 89.33 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.38 0 C-N-CA 123.419 0.688 . . . . 0.41999999999999998 109.691 174.918 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 1.4 t -55.12 -41.07 57.93 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 CA-C-N 119.176 0.898 . . . . 0.37 111.415 173.216 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.4 t -63.97 -45.33 97.1 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.198 0 N-CA-C 108.549 -0.908 . . . . 0.34000000000000002 108.549 178.566 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 11.8 mt -60.09 -42.01 88.45 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 N-CA-C 108.719 -0.845 . . . . 0.41999999999999998 108.719 178.722 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 40.4 t -62.62 -55.7 22.18 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 N-CA-C 109.074 -0.713 . . . . 0.40999999999999998 109.074 179.486 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -52.47 -45.41 59.07 Favored Glycine 0 CA--C 1.531 1.089 0 N-CA-C 111.719 -0.553 . . . . 0.29999999999999999 111.719 177.11 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -56.46 -47.57 78.87 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 123.427 0.691 . . . . 0.46999999999999997 110.566 175.874 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 8.5 tp -58.18 -49.96 75.2 Favored 'General case' 0 N--CA 1.441 -0.899 0 C-N-CA 123.947 0.899 . . . . 0.56999999999999995 109.142 178.699 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 5.5 mp -56.01 -44.45 78.7 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 119.27 0.941 . . . . 2.0099999999999998 112.142 174.389 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 43.8 tpp -64.57 -32.09 73.58 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 118.253 0.479 . . . . 3.5699999999999998 111.557 178.329 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 99.37 44.94 2.25 Favored Glycine 0 CA--C 1.528 0.9 0 C-N-CA 125.797 1.665 . . . . 3.0899999999999999 111.007 -177.782 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 5.3 mp . . . . . 0 N--CA 1.449 -0.52 0 N-CA-C 106.315 -1.735 . . . . 8.5500000000000007 106.315 170.519 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 2.8 tm? . . . . . 0 N--CA 1.474 0.742 0 N-CA-C 105.708 -1.96 . . . . 21.059999999999999 105.708 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 80.5 mtp180 -129.86 147.0 51.58 Favored 'General case' 0 N--CA 1.457 -0.116 0 N-CA-C 106.784 -1.562 . . . . 21.739999999999998 106.784 175.601 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 11.1 pt -118.69 71.36 10.07 Favored Pre-proline 0 CA--C 1.538 0.489 0 C-N-CA 124.951 1.3 . . . . 15.67 110.385 -173.806 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -66.12 132.24 29.28 Favored 'Trans proline' 0 N--CA 1.452 -0.936 0 C-N-CA 121.237 1.292 . . . . 11.5 109.026 175.037 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 15.8 p -103.7 15.45 28.79 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 123.726 0.81 . . . . 9.4900000000000002 110.89 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 84.1 m -112.14 85.2 6.48 Favored Pre-proline 0 N--CA 1.455 -0.217 0 C-N-CA 125.082 1.353 . . . . 7.9900000000000002 108.584 -175.496 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -66.65 -47.41 2.85 Favored 'Trans proline' 0 N--CA 1.454 -0.838 0 C-N-CA 121.423 1.415 . . . . 4.5800000000000001 109.342 172.789 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 14.3 t -62.02 158.07 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 N-CA-C 108.336 -0.987 . . . . 3.3900000000000001 108.336 169.678 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 67.1 m-80 69.5 -35.4 0.31 Allowed 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 125.883 1.673 . . . . 3.75 114.084 -173.447 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 10.8 mp -82.41 -44.41 16.11 Favored 'General case' 0 CA--C 1.528 0.103 0 CA-C-N 118.818 0.735 . . . . 4.3799999999999999 110.483 171.2 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.06 -33.81 73.9 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 119.793 1.179 . . . . 5.3899999999999997 110.922 -173.571 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 25.0 ptt180 -64.15 -26.24 68.44 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 112.133 0.42 . . . . 7.3700000000000001 112.133 176.122 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 37.4 tp -63.52 -43.3 97.57 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 108.778 -0.823 . . . . 2.1600000000000001 108.778 -174.811 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 1.6 tt -56.8 -46.25 81.7 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-O 121.132 0.491 . . . . 2.46 110.3 176.218 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 40.6 t -59.0 -47.02 91.25 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 N-CA-C 109.412 -0.588 . . . . 0.45000000000000001 109.412 176.949 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 57.4 t -56.66 -46.15 82.81 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.219 0 CA-C-O 118.821 -0.609 . . . . 0.60999999999999999 110.104 176.754 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 54.1 t -55.93 -50.57 68.33 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.441 0 CA-C-N 119.35 0.977 . . . . 0.70999999999999996 109.773 177.506 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 77.3 t -56.23 -46.36 81.38 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 O-C-N 121.987 -0.446 . . . . 0.45000000000000001 110.889 177.81 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 54.7 t -60.94 -46.87 95.7 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 N-CA-C 109.104 -0.702 . . . . 0.34999999999999998 109.104 -179.576 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 48.5 t -54.62 -49.79 64.53 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.426 0 C-N-CA 123.421 0.688 . . . . 0.55000000000000004 110.179 176.755 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 46.2 t -58.63 -46.85 90.07 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.425 0 CA-C-N 118.395 0.543 . . . . 0.44 110.588 179.014 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -59.39 -47.36 85.73 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 109.296 -0.631 . . . . 0.34999999999999998 109.296 178.318 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.8 t -62.06 -40.05 86.01 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.9 0 C-N-CA 123.977 0.911 . . . . 0.38 109.997 -179.814 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 3.5 t -62.99 -47.98 90.2 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.412 0 CA-C-N 118.702 0.683 . . . . 0.39000000000000001 109.83 175.248 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 1.5 t -55.27 -40.63 57.3 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 CA-C-N 118.98 0.809 . . . . 0.31 111.048 173.851 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.4 t -65.67 -45.96 90.6 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 N-CA-C 108.674 -0.862 . . . . 0.28999999999999998 108.674 179.215 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 12.3 mt -58.86 -44.57 90.89 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 N-CA-C 108.282 -1.007 . . . . 0.38 108.282 179.133 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 39.3 t -64.1 -54.46 31.14 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 N-CA-C 109.511 -0.552 . . . . 0.34999999999999998 109.511 -177.457 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -55.18 -47.48 73.98 Favored Glycine 0 CA--C 1.529 0.939 0 N-CA-C 111.439 -0.665 . . . . 0.28999999999999998 111.439 177.349 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -57.72 -42.59 84.13 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 123.317 0.647 . . . . 0.52000000000000002 111.282 178.281 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 11.6 tp -63.08 -53.06 59.57 Favored 'General case' 0 N--CA 1.439 -1.009 0 N-CA-C 108.291 -1.003 . . . . 0.77000000000000002 108.291 177.257 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 84.3 mt -58.13 -38.13 75.93 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 118.361 0.528 . . . . 1.99 111.41 -177.825 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 38.2 ttm -83.68 6.8 19.67 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 123.557 0.743 . . . . 3.6299999999999999 111.901 177.428 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -121.95 -61.12 0.22 Allowed Glycine 0 CA--C 1.528 0.852 0 C-N-CA 125.151 1.358 . . . . 2.4900000000000002 112.497 -170.161 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 85.0 mt . . . . . 0 N--CA 1.447 -0.596 0 C-N-CA 125.069 1.348 . . . . 7.0 107.816 -170.271 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 11.1 mp . . . . . 0 N--CA 1.476 0.853 0 N-CA-C 106.691 -1.596 . . . . 20.879999999999999 106.691 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 3.2 mpt_? -120.13 158.93 25.87 Favored 'General case' 0 CA--C 1.53 0.204 0 N-CA-C 105.81 -1.922 . . . . 25.16 105.81 161.417 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 24.6 mm 50.07 68.72 3.17 Favored Pre-proline 0 CA--C 1.541 0.614 0 C-N-CA 124.831 1.252 . . . . 17.57 110.938 -178.157 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -75.04 64.72 6.1 Favored 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 123.109 2.539 . . . . 13.68 109.5 176.565 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.3 m -158.48 57.23 0.45 Allowed 'General case' 0 C--O 1.227 -0.086 0 C-N-CA 126.149 1.78 . . . . 12.41 106.375 -174.548 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 46.8 t 56.07 71.69 1.16 Allowed Pre-proline 0 CA--C 1.536 0.439 0 C-N-CA 124.77 1.228 . . . . 5.8600000000000003 111.585 178.786 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -75.78 70.17 5.9 Favored 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 123.22 2.613 . . . . 4.0999999999999996 112.145 -170.486 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 8.5 p -115.37 -133.27 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 C-N-CA 126.061 1.744 . . . . 3.79 109.739 177.365 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 20.0 p-10 -39.45 -45.88 1.59 Allowed 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.781 1.232 . . . . 4.6500000000000004 112.614 176.154 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 89.3 mt -58.06 -39.85 79.51 Favored 'General case' 0 C--O 1.227 -0.113 0 C-N-CA 124.135 0.974 . . . . 2.79 110.266 178.81 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.26 -51.27 64.43 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 123.371 0.669 . . . . 4.75 109.354 -179.725 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 14.5 ptm180 -68.45 -26.42 65.5 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 119.223 -0.991 . . . . 4.8300000000000001 111.869 179.532 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -63.46 -47.34 82.23 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 108.894 -0.78 . . . . 2.2999999999999998 108.894 171.206 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -56.09 -46.0 79.21 Favored 'General case' 0 CA--C 1.533 0.3 0 O-C-N 121.891 -0.506 . . . . 2.1000000000000001 110.251 174.886 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 85.3 t -56.16 -48.43 79.25 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 O-C-N 121.814 -0.554 . . . . 0.37 110.136 174.734 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 44.7 t -54.78 -47.05 74.82 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 CA-C-N 118.617 0.644 . . . . 0.46999999999999997 109.822 176.293 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 50.3 t -55.02 -48.44 75.83 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 CA-C-N 119.028 0.831 . . . . 0.54000000000000004 110.754 176.167 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 70.6 t -55.42 -44.99 78.03 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 O-C-N 121.447 -0.783 . . . . 0.37 110.71 175.385 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 87.0 t -60.4 -46.18 95.54 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.22 0 N-CA-C 109.073 -0.714 . . . . 0.38 109.073 178.362 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 72.4 t -55.02 -49.5 70.97 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 C-N-CA 123.218 0.607 . . . . 0.46000000000000002 110.069 177.09 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 46.5 t -56.93 -47.85 82.53 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 O-C-N 121.798 -0.564 . . . . 0.38 110.671 177.848 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -58.34 -47.57 83.36 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 123.23 0.612 . . . . 0.34999999999999998 109.354 177.732 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 14.2 t -62.61 -39.62 85.31 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.92 0 C-N-CA 124.162 0.985 . . . . 0.35999999999999999 110.066 -179.209 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 3.6 t -63.44 -48.25 87.99 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 CA-C-N 118.742 0.701 . . . . 0.37 109.56 175.472 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 1.5 t -55.43 -40.5 58.23 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.617 0 CA-C-N 118.909 0.777 . . . . 0.29999999999999999 110.953 173.845 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.4 t -66.17 -45.06 91.19 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.237 0 N-CA-C 108.746 -0.835 . . . . 0.28000000000000003 108.746 179.319 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 12.5 mt -59.05 -44.86 92.35 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.576 0 N-CA-C 108.285 -1.005 . . . . 0.35999999999999999 108.285 178.598 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 40.2 t -63.73 -55.4 22.74 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 N-CA-C 109.347 -0.612 . . . . 0.28000000000000003 109.347 -177.672 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -53.34 -47.51 61.95 Favored Glycine 0 CA--C 1.529 0.941 0 N-CA-C 111.428 -0.669 . . . . 0.32000000000000001 111.428 176.904 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -57.89 -43.41 86.1 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 123.323 0.649 . . . . 0.47999999999999998 111.142 178.6 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 13.5 tp -67.04 -45.28 77.93 Favored 'General case' 0 N--CA 1.439 -1.008 0 C-N-CA 123.698 0.799 . . . . 0.65000000000000002 109.156 178.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 84.1 mt -58.03 -42.09 84.61 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 119.087 0.858 . . . . 1.6499999999999999 110.562 176.692 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 27.6 ttt -69.46 -42.03 75.42 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 123.041 0.536 . . . . 3.8399999999999999 111.779 178.8 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -126.11 50.89 0.86 Allowed Glycine 0 CA--C 1.526 0.759 0 C-N-CA 125.794 1.664 . . . . 3.1600000000000001 111.663 -168.181 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 66.2 mt . . . . . 0 CA--C 1.532 0.265 0 C-N-CA 125.613 1.565 . . . . 8.6600000000000001 110.743 166.531 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.473 0.689 0 N-CA-C 107.168 -1.419 . . . . 18.370000000000001 107.168 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 65.21 175.21 0.21 Allowed 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 106.943 -1.502 . . . . 21.300000000000001 106.943 -158.138 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.43 ' N ' HD12 ' A' ' 3' ' ' ILE . 2.2 mp 54.2 78.55 0.38 Allowed Pre-proline 0 CA--C 1.543 0.688 0 C-N-CA 124.665 1.186 . . . . 16.800000000000001 109.564 -176.62 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -76.53 67.09 7.24 Favored 'Trans proline' 0 N--CA 1.456 -0.709 0 C-N-CA 122.931 2.421 . . . . 14.75 109.908 -177.855 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 23.7 t -104.25 28.43 6.86 Favored 'General case' 0 C--O 1.224 -0.27 0 C-N-CA 125.215 1.406 . . . . 11.640000000000001 109.246 -178.577 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 13.2 t -55.52 -49.79 90.61 Favored Pre-proline 0 CA--C 1.543 0.689 0 N-CA-C 114.178 1.177 . . . . 7.0899999999999999 114.178 173.544 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -79.26 65.38 8.87 Favored 'Trans proline' 0 CA--C 1.537 0.658 0 C-N-CA 122.015 1.81 . . . . 5.9800000000000004 112.912 -165.933 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.1 t -93.92 -133.66 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 C-N-CA 124.076 0.95 . . . . 3.8500000000000001 109.928 177.887 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -68.19 31.44 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 127.102 2.161 . . . . 3.1299999999999999 115.792 -167.261 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -114.36 -57.7 2.24 Favored 'General case' 0 N--CA 1.444 -0.736 0 C-N-CA 126.728 2.011 . . . . 3.4700000000000002 105.634 159.462 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 3.6 tmtm? -57.63 -52.1 66.81 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 123.302 0.641 . . . . 4.1900000000000004 109.642 175.888 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 26.8 mmm180 -64.92 -26.42 68.3 Favored 'General case' 0 N--CA 1.452 -0.328 0 O-C-N 122.288 -0.258 . . . . 6.9299999999999997 111.301 179.698 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.63 -51.02 64.81 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 108.16 -1.052 . . . . 2.6600000000000001 108.16 173.098 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 10.6 tp -55.33 -45.83 76.38 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 122.648 0.379 . . . . 1.8700000000000001 111.259 175.882 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 74.0 t -54.97 -50.15 65.06 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 N-CA-C 109.989 -0.375 . . . . 0.5 109.989 174.441 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 42.2 t -56.54 -47.33 82.12 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 CA-C-N 118.43 0.559 . . . . 0.45000000000000001 110.185 178.083 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 61.5 t -54.55 -51.18 52.74 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 CA-C-N 119.032 0.833 . . . . 0.46999999999999997 110.268 177.149 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 60.7 t -56.52 -44.87 81.65 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 O-C-N 121.819 -0.55 . . . . 0.35999999999999999 110.825 177.943 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 53.8 t -60.83 -47.4 93.46 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.267 0 N-CA-C 109.033 -0.729 . . . . 0.35999999999999999 109.033 179.27 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 55.4 t -54.27 -50.29 57.31 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 C-N-CA 123.32 0.648 . . . . 0.5 110.148 176.761 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 43.1 t -57.73 -46.97 86.8 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 C-N-CA 123.052 0.541 . . . . 0.51000000000000001 110.811 178.495 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -59.34 -46.99 87.08 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 123.382 0.673 . . . . 0.40000000000000002 109.328 178.123 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 15.5 t -61.89 -40.73 88.14 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.882 0 C-N-CA 124.077 0.951 . . . . 0.34999999999999998 109.898 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 4.1 t -62.24 -47.79 91.42 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.396 0 O-C-N 121.554 -0.716 . . . . 0.39000000000000001 109.78 174.969 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 1.4 t -55.86 -39.87 58.93 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 CA-C-N 119.137 0.88 . . . . 0.39000000000000001 111.459 173.587 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.4 t -64.74 -45.09 96.21 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 N-CA-C 108.492 -0.929 . . . . 0.29999999999999999 108.492 178.111 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 11.3 mt -60.14 -42.85 91.52 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 N-CA-C 108.725 -0.843 . . . . 0.34999999999999998 108.725 178.674 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 40.5 t -63.1 -52.67 56.04 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 N-CA-C 109.294 -0.632 . . . . 0.27000000000000002 109.294 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -53.07 -46.49 61.69 Favored Glycine 0 CA--C 1.529 0.968 0 N-CA-C 111.551 -0.62 . . . . 0.32000000000000001 111.551 175.858 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -57.47 -49.12 77.29 Favored 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 123.409 0.684 . . . . 0.55000000000000004 110.406 177.476 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 10.3 tp -58.88 -46.17 88.44 Favored 'General case' 0 N--CA 1.44 -0.935 0 C-N-CA 123.739 0.816 . . . . 0.55000000000000004 109.206 178.95 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 84.9 mt -61.7 -42.54 99.08 Favored 'General case' 0 CA--C 1.533 0.314 0 O-C-N 121.792 -0.568 . . . . 1.6299999999999999 111.169 178.737 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 47.9 tpp -63.73 -38.61 91.74 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 123.073 0.549 . . . . 3.7000000000000002 110.825 176.312 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 101.85 57.36 0.82 Allowed Glycine 0 CA--C 1.527 0.806 0 C-N-CA 125.709 1.623 . . . . 3.0499999999999998 109.604 -173.027 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 60.5 tp . . . . . 0 N--CA 1.45 -0.437 0 C-N-CA 126.118 1.767 . . . . 8.9900000000000002 106.396 178.235 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 1.3 pt? . . . . . 0 N--CA 1.481 1.105 0 N-CA-C 114.052 1.13 . . . . 23.780000000000001 114.052 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 96.3 mtm-85 -152.02 171.25 18.13 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 105.09 -2.189 . . . . 23.100000000000001 105.09 172.681 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.9 mp 46.9 74.31 0.83 Allowed Pre-proline 0 CA--C 1.542 0.64 0 C-N-CA 125.429 1.492 . . . . 15.539999999999999 111.851 -179.316 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -75.12 -151.81 0.04 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.856 0 C-N-CA 122.237 1.958 . . . . 12.02 108.0 164.673 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 17.4 p -103.57 26.49 8.42 Favored 'General case' 0 N--CA 1.464 0.243 0 O-C-N 120.937 -1.102 . . . . 11.49 109.489 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 33.5 t -144.61 92.13 6.03 Favored Pre-proline 0 CA--C 1.531 0.219 0 C-N-CA 125.39 1.476 . . . . 7.8300000000000001 108.556 175.153 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -72.23 -31.87 11.26 Favored 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 122.411 2.074 . . . . 5.2800000000000002 110.942 179.626 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.4 t -58.9 151.23 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.23 0 N-CA-C 108.368 -0.975 . . . . 3.0 108.368 174.168 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 69.2 m-20 68.36 -46.35 0.53 Allowed 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 126.493 1.917 . . . . 3.4300000000000002 112.585 -172.813 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -63.14 -41.61 99.32 Favored 'General case' 0 C--N 1.332 -0.162 0 C-N-CA 123.618 0.767 . . . . 4.1100000000000003 109.438 176.556 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 2.5 tmtp? -55.27 -47.52 75.36 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 108.928 -0.768 . . . . 3.0899999999999999 108.928 172.25 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.8 -26.6 66.16 Favored 'General case' 0 CA--C 1.533 0.307 0 O-C-N 122.1 -0.375 . . . . 6.1100000000000003 111.378 -178.56 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 47.8 tp -61.45 -39.06 89.46 Favored 'General case' 0 C--N 1.33 -0.251 0 O-C-N 121.534 -0.728 . . . . 2.2599999999999998 109.233 178.066 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -57.53 -46.13 84.23 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-O 121.26 0.553 . . . . 2.2999999999999998 110.231 175.372 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 43.6 t -60.46 -45.15 97.3 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 N-CA-C 109.384 -0.599 . . . . 0.64000000000000001 109.384 176.571 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 72.2 t -56.32 -45.82 81.53 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.217 0 CA-C-O 118.876 -0.583 . . . . 0.55000000000000004 110.132 175.987 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 55.5 t -56.44 -48.98 79.21 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 CA-C-N 119.504 1.047 . . . . 0.56000000000000005 110.102 177.125 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 69.9 t -55.76 -45.75 79.51 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 O-C-N 121.786 -0.571 . . . . 0.39000000000000001 110.905 176.449 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 53.2 t -60.23 -46.87 94.13 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.18 0 N-CA-C 109.248 -0.649 . . . . 0.34000000000000002 109.248 178.841 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 48.9 t -54.48 -49.42 65.81 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 C-N-CA 123.7 0.8 . . . . 0.55000000000000004 110.118 177.145 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 42.2 t -57.01 -47.19 83.93 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 CA-C-N 118.435 0.561 . . . . 0.51000000000000001 110.537 177.744 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.19 -47.44 83.43 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 123.053 0.541 . . . . 0.37 109.553 177.546 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 16.0 t -62.94 -40.4 88.78 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.893 0 C-N-CA 123.909 0.884 . . . . 0.39000000000000001 110.049 -178.886 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 7.5 t -63.55 -47.13 92.9 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.48 0 O-C-N 121.542 -0.724 . . . . 0.41999999999999998 109.503 175.841 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 1.4 t -54.69 -41.37 55.62 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.579 0 CA-C-N 119.107 0.867 . . . . 0.35999999999999999 111.212 172.805 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.4 t -64.51 -45.7 94.9 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.19 0 N-CA-C 108.627 -0.879 . . . . 0.34000000000000002 108.627 179.249 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 11.1 mt -59.89 -43.99 93.35 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 N-CA-C 108.75 -0.833 . . . . 0.40999999999999998 108.75 178.689 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 37.4 t -64.89 -49.74 78.43 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.266 0 N-CA-C 109.535 -0.543 . . . . 0.34000000000000002 109.535 -176.814 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -55.77 -50.33 61.5 Favored Glycine 0 CA--C 1.528 0.897 0 N-CA-C 111.128 -0.789 . . . . 0.41999999999999998 111.128 174.229 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -55.15 -42.3 72.92 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 117.325 0.563 . . . . 0.56999999999999995 111.048 178.835 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 10.2 tp -59.87 -62.36 1.93 Allowed 'General case' 0 N--CA 1.439 -1.023 0 N-CA-C 108.512 -0.921 . . . . 0.65000000000000002 108.512 175.052 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . 0.269 2.9 pp -65.7 -27.92 68.69 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 119.223 0.92 . . . . 2.9199999999999999 113.267 -170.357 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 60.8 mtt -61.49 -32.31 72.33 Favored 'General case' 0 CA--C 1.534 0.333 0 O-C-N 121.919 -0.488 . . . . 3.8599999999999999 110.923 171.037 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -83.75 -65.73 1.54 Allowed Glycine 0 CA--C 1.528 0.884 0 N-CA-C 111.074 -0.811 . . . . 3.54 111.074 176.946 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 2.2 pt? . . . . . 0 N--CA 1.432 -1.329 0 C-N-CA 125.749 1.619 . . . . 7.8399999999999999 110.114 -166.216 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 67.3 mt . . . . . 0 N--CA 1.474 0.757 0 N-CA-C 106.84 -1.541 . . . . 20.629999999999999 106.84 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 58.0 ttt180 -150.3 129.59 12.85 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 107.629 -1.248 . . . . 17.25 107.629 -179.346 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -74.2 145.28 82.93 Favored Pre-proline 0 N--CA 1.45 -0.449 0 N-CA-C 109.604 -0.517 . . . . 13.15 109.604 176.847 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -77.15 60.35 6.9 Favored 'Trans proline' 0 N--CA 1.457 -0.67 0 C-N-CA 123.237 2.625 . . . . 12.109999999999999 109.903 178.405 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -170.1 58.83 0.04 OUTLIER 'General case' 0 CA--C 1.529 0.166 0 N-CA-C 107.618 -1.252 . . . . 9.7400000000000002 107.618 -174.756 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 44.8 t -160.58 101.7 1.34 Allowed Pre-proline 0 CA--C 1.532 0.286 0 CA-C-O 118.599 -0.715 . . . . 5.7699999999999996 110.214 -177.67 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -82.54 -5.4 11.7 Favored 'Trans proline' 0 CA--C 1.536 0.606 0 C-N-CA 123.308 2.672 . . . . 3.5699999999999998 112.437 178.447 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 9.5 t -60.61 153.34 4.92 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 N-CA-C 108.455 -0.942 . . . . 3.29 108.455 -179.517 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . 0.368 17.1 p30 59.69 -45.87 0.08 Allowed 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 127.367 2.267 . . . . 3.6499999999999999 115.031 -166.401 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 7.9 mp -57.12 -39.08 74.43 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 119.498 1.044 . . . . 3.8700000000000001 110.443 175.331 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 3.2 tmtp? -57.76 -51.14 70.79 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 108.526 -0.916 . . . . 3.1400000000000001 108.526 178.712 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 7.5 ptm180 -70.39 -25.83 63.42 Favored 'General case' 0 C--O 1.224 -0.245 0 C-N-CA 119.907 -0.717 . . . . 5.1500000000000004 112.204 -179.627 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.9 tt -57.28 -49.68 75.3 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 108.288 -1.005 . . . . 2.1299999999999999 108.288 169.703 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.24 -46.06 79.75 Favored 'General case' 0 CA--C 1.535 0.396 0 O-C-N 121.927 -0.483 . . . . 2.71 110.369 176.062 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 89.2 t -55.89 -47.24 80.05 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 O-C-N 121.58 -0.7 . . . . 0.51000000000000001 110.591 174.655 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 51.1 t -56.27 -45.96 81.36 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.19 0 O-C-N 121.507 -0.745 . . . . 0.46999999999999997 109.892 176.997 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 73.0 t -53.74 -50.0 54.06 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 CA-C-N 119.246 0.93 . . . . 0.51000000000000001 110.483 174.689 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 93.2 t -55.5 -45.1 78.38 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 O-C-N 121.696 -0.627 . . . . 0.34999999999999998 111.085 176.692 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 73.8 t -60.42 -46.17 95.61 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.159 0 O-C-N 121.597 -0.689 . . . . 0.33000000000000002 109.25 178.77 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 53.0 t -55.84 -48.01 78.84 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 C-N-CA 123.407 0.683 . . . . 0.46000000000000002 110.36 177.271 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 47.0 t -56.5 -46.45 82.32 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 O-C-N 121.765 -0.585 . . . . 0.37 110.524 176.4 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -58.92 -46.69 87.35 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 123.076 0.55 . . . . 0.33000000000000002 109.63 176.974 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 13.5 t -61.62 -40.59 87.17 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.839 0 O-C-N 121.255 -0.903 . . . . 0.38 110.063 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 5.4 t -62.08 -47.95 90.77 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.416 0 O-C-N 121.511 -0.743 . . . . 0.37 109.841 174.808 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 1.4 t -54.94 -40.76 54.74 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 CA-C-N 119.088 0.858 . . . . 0.31 111.493 173.065 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.4 t -63.88 -45.24 97.54 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.179 0 N-CA-C 108.472 -0.936 . . . . 0.33000000000000002 108.472 178.535 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 10.1 mt -59.42 -43.74 91.11 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 N-CA-C 108.831 -0.803 . . . . 0.45000000000000001 108.831 177.987 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 40.9 t -63.36 -52.37 59.2 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 N-CA-C 109.489 -0.56 . . . . 0.40999999999999998 109.489 -178.444 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -52.74 -50.46 49.46 Favored Glycine 0 CA--C 1.528 0.871 0 N-CA-C 111.007 -0.837 . . . . 0.27000000000000002 111.007 174.916 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -55.24 -44.67 75.7 Favored 'General case' 0 CA--C 1.53 0.182 0 O-C-N 122.284 -0.539 . . . . 0.44 111.075 179.198 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 11.0 tp -61.26 -50.64 72.22 Favored 'General case' 0 N--CA 1.442 -0.869 0 C-N-CA 123.599 0.76 . . . . 0.58999999999999997 108.959 176.935 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 73.7 mt -57.59 -41.97 82.25 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 118.264 0.484 . . . . 1.6100000000000001 111.642 -179.148 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -71.06 -35.62 71.97 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 122.441 0.296 . . . . 4.4699999999999998 111.314 176.234 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -80.46 -34.33 29.05 Favored Glycine 0 CA--C 1.53 0.978 0 CA-C-O 118.893 -0.948 . . . . 2.5600000000000001 113.987 -171.071 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 4.4 pp . . . . . 0 CA--C 1.531 0.214 0 CA-C-N 117.973 0.886 . . . . 9.0299999999999994 112.595 -175.323 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 63.2 tp . . . . . 0 N--CA 1.474 0.76 0 N-CA-C 106.728 -1.582 . . . . 16.140000000000001 106.728 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 22.5 ptt-85 -157.02 175.7 13.74 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 106.945 -1.502 . . . . 18.5 106.945 171.058 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 15.4 mt 64.56 126.38 0.02 OUTLIER Pre-proline 0 CA--C 1.543 0.674 0 C-N-CA 127.349 2.26 . . . . 12.970000000000001 112.16 179.686 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -77.96 57.21 6.01 Favored 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 122.622 2.215 . . . . 10.93 111.137 -178.78 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 27.3 t -129.52 46.4 2.65 Favored 'General case' 0 CA--C 1.529 0.135 0 CA-C-O 122.954 1.359 . . . . 7.8300000000000001 107.439 174.03 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 28.6 t -158.93 -57.41 0.02 OUTLIER Pre-proline 0 CA--C 1.532 0.277 0 C-N-CA 126.398 1.879 . . . . 6.9000000000000004 109.083 -179.572 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -72.89 60.33 3.66 Favored 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 122.493 2.129 . . . . 4.6100000000000003 110.639 165.637 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 4.1 t -91.66 159.77 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 N-CA-C 106.476 -1.676 . . . . 4.0499999999999998 106.476 169.344 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 9.3 m120 70.45 -46.69 0.62 Allowed 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 127.295 2.238 . . . . 4.0 112.899 -179.788 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.7 pp -65.42 -32.16 73.64 Favored 'General case' 0 C--N 1.331 -0.216 0 O-C-N 121.661 -0.65 . . . . 3.5600000000000001 110.182 179.563 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 7.8 mtpm? -58.97 -53.23 60.74 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 109.904 -0.406 . . . . 3.4300000000000002 109.904 174.299 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 16.8 ptm180 -68.94 -26.4 65.05 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 119.778 -0.769 . . . . 4.6100000000000003 111.696 -178.817 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.6 tt -59.62 -49.73 76.64 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 108.566 -0.902 . . . . 2.0600000000000001 108.566 168.904 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -55.76 -45.82 77.99 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.223 0.609 . . . . 2.8799999999999999 110.344 176.403 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 96.3 t -55.75 -48.76 77.57 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 O-C-N 121.813 -0.554 . . . . 0.37 110.398 174.811 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 55.5 t -55.77 -47.37 79.49 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 O-C-N 121.659 -0.65 . . . . 0.69999999999999996 109.935 176.646 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 72.0 t -54.29 -49.67 61.97 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 CA-C-N 118.783 0.719 . . . . 0.83999999999999997 110.389 176.247 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 73.5 t -56.0 -44.7 79.18 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 O-C-N 121.641 -0.662 . . . . 0.48999999999999999 110.864 177.164 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 54.6 t -59.9 -48.09 89.07 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.168 0 N-CA-C 109.067 -0.716 . . . . 0.46999999999999997 109.067 178.329 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 60.1 t -55.19 -48.92 75.77 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 C-N-CA 122.943 0.497 . . . . 0.87 110.32 177.315 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 42.2 t -56.74 -45.76 82.98 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 C-N-CA 123.632 0.773 . . . . 0.66000000000000003 110.601 177.237 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.25 -47.91 83.6 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 123.402 0.681 . . . . 0.41999999999999998 109.405 177.455 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 20.3 t -61.51 -40.88 87.99 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.838 0 O-C-N 121.484 -0.76 . . . . 0.60999999999999999 110.0 179.481 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 4.1 t -62.0 -45.8 97.9 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.39 0 C-N-CA 123.556 0.742 . . . . 0.58999999999999997 109.887 175.029 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 1.4 t -57.26 -40.46 73.9 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 CA-C-N 119.437 1.017 . . . . 0.37 111.34 173.329 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.4 t -62.87 -45.3 99.21 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 N-CA-C 108.398 -0.964 . . . . 0.40999999999999998 108.398 177.339 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 10.9 mt -61.22 -41.37 89.33 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 N-CA-C 109.232 -0.655 . . . . 0.53000000000000003 109.232 178.675 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 32.9 t -62.74 -50.3 80.27 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.277 0 N-CA-C 108.957 -0.757 . . . . 0.46000000000000002 108.957 179.071 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -52.65 -47.23 58.34 Favored Glycine 0 CA--C 1.53 1.021 0 N-CA-C 111.527 -0.629 . . . . 0.32000000000000001 111.527 173.896 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -57.01 -49.58 75.35 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 123.224 0.61 . . . . 0.73999999999999999 110.551 177.583 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 10.4 tp -58.6 -45.63 88.72 Favored 'General case' 0 N--CA 1.441 -0.909 0 C-N-CA 124.351 1.06 . . . . 0.93000000000000005 109.216 178.984 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 66.4 mt -61.98 -41.78 98.39 Favored 'General case' 0 CA--C 1.533 0.311 0 O-C-N 121.713 -0.617 . . . . 1.77 111.017 177.871 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 37.7 ttm -63.1 -37.16 86.11 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 122.918 0.487 . . . . 2.7799999999999998 110.687 175.434 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 103.06 45.49 1.59 Allowed Glycine 0 CA--C 1.528 0.845 0 C-N-CA 125.957 1.741 . . . . 2.4300000000000002 110.614 -177.082 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 94.0 mt . . . . . 0 N--CA 1.447 -0.62 0 C-N-CA 126.472 1.909 . . . . 8.3200000000000003 106.895 173.961 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 3.1 tm? . . . . . 0 N--CA 1.474 0.752 0 N-CA-C 106.123 -1.806 . . . . 23.719999999999999 106.123 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 41.6 ptt180 39.83 49.73 2.22 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.442 1.497 . . . . 25.93 112.929 -171.915 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -84.11 127.52 66.39 Favored Pre-proline 0 N--CA 1.439 -1.021 0 N-CA-C 106.839 -1.541 . . . . 16.52 106.839 -179.023 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -77.66 -22.71 10.3 Favored 'Trans proline' 0 N--CA 1.459 -0.557 0 C-N-CA 122.636 2.224 . . . . 12.52 112.593 -174.263 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 7.5 t 64.39 41.45 5.77 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-O 122.238 1.018 . . . . 10.23 110.592 -177.079 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 53.2 t -148.34 69.17 10.47 Favored Pre-proline 0 CA--C 1.532 0.286 0 C-N-CA 123.69 0.796 . . . . 6.1900000000000004 109.682 177.371 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -78.62 60.64 7.7 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 123.297 2.665 . . . . 4.0199999999999996 110.371 -176.464 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 10.6 p -86.32 -134.35 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.529 0.16 0 C-N-CA 124.26 1.024 . . . . 4.8700000000000001 108.483 -179.59 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 32.2 t30 -53.54 -26.42 21.05 Favored 'General case' 0 CA--C 1.532 0.271 0 O-C-N 121.105 -0.997 . . . . 3.5899999999999999 112.022 175.586 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 86.2 mt -53.83 -35.16 61.15 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 123.811 0.844 . . . . 3.0699999999999998 110.478 175.035 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 58.5 tttm -57.95 -49.81 75.52 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 123.164 0.585 . . . . 3.1099999999999999 109.858 174.002 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 48.6 ttp180 -70.41 -26.72 63.82 Favored 'General case' 0 N--CA 1.442 -0.872 0 O-C-N 121.743 -0.598 . . . . 5.7699999999999996 110.792 179.82 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.4 tt -63.56 -47.53 81.16 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 108.107 -1.072 . . . . 1.97 108.107 172.325 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 10.3 tp -55.39 -45.89 76.58 Favored 'General case' 0 N--CA 1.453 -0.293 0 O-C-N 121.81 -0.556 . . . . 2.0 111.375 174.579 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 94.3 t -56.15 -49.13 77.67 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 N-CA-C 110.068 -0.345 . . . . 0.37 110.068 174.623 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 49.2 t -56.07 -46.5 80.85 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 O-C-N 121.796 -0.565 . . . . 0.53000000000000003 110.195 177.502 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 53.1 t -54.64 -50.55 58.76 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 CA-C-N 118.952 0.796 . . . . 0.55000000000000004 110.043 176.433 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 78.7 t -55.6 -45.23 78.78 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 O-C-N 121.859 -0.526 . . . . 0.34000000000000002 110.8 177.142 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 61.9 t -60.15 -47.47 91.9 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.136 0 N-CA-C 109.191 -0.67 . . . . 0.34999999999999998 109.191 178.829 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 55.7 t -55.15 -49.16 74.27 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 C-N-CA 123.487 0.715 . . . . 0.57999999999999996 110.25 177.548 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 46.1 t -57.43 -46.25 85.7 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 C-N-CA 123.246 0.618 . . . . 0.5 110.473 177.631 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -59.06 -47.25 85.91 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 123.204 0.602 . . . . 0.31 109.422 177.374 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 14.2 t -61.61 -41.11 89.01 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.821 0 C-N-CA 123.814 0.846 . . . . 0.39000000000000001 110.003 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 4.1 t -62.24 -47.14 94.48 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 O-C-N 121.541 -0.724 . . . . 0.42999999999999999 109.852 175.172 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 1.4 t -56.11 -39.97 61.74 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.6 0 CA-C-N 119.085 0.857 . . . . 0.33000000000000002 111.349 173.418 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.4 t -64.03 -46.0 95.1 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.203 0 N-CA-C 108.411 -0.959 . . . . 0.28999999999999998 108.411 177.966 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 10.6 mt -59.95 -43.0 91.34 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 N-CA-C 108.825 -0.806 . . . . 0.40000000000000002 108.825 178.927 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 39.2 t -61.71 -54.71 31.05 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 N-CA-C 108.933 -0.766 . . . . 0.29999999999999999 108.933 179.827 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -52.59 -45.17 59.93 Favored Glycine 0 CA--C 1.53 0.985 0 N-CA-C 111.703 -0.559 . . . . 0.32000000000000001 111.703 176.535 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -57.77 -44.78 86.41 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 123.498 0.719 . . . . 0.52000000000000002 110.712 177.274 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 9.7 tp -60.9 -51.97 67.04 Favored 'General case' 0 N--CA 1.439 -0.983 0 C-N-CA 124.014 0.926 . . . . 0.63 109.235 177.861 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 5.5 mp -56.17 -41.36 75.33 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 119.231 0.923 . . . . 2.0899999999999999 112.14 175.546 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 2.1 tmt? -62.22 -43.22 99.31 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 118.093 0.406 . . . . 5.0300000000000002 110.741 176.669 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -173.55 -53.75 0.05 OUTLIER Glycine 0 CA--C 1.528 0.844 0 CA-C-O 119.791 -0.45 . . . . 3.21 112.401 -179.227 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.454 -0.235 0 N-CA-C 105.713 -1.958 . . . . 7.0999999999999996 105.713 -174.622 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 4.2 mm? . . . . . 0 N--CA 1.475 0.786 0 N-CA-C 107.81 -1.181 . . . . 18.890000000000001 107.81 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 37.3 ptt180 -74.05 71.77 1.62 Allowed 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.804 0.841 . . . . 21.780000000000001 111.346 -175.336 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 24.7 mm 54.48 70.49 1.66 Allowed Pre-proline 0 CA--C 1.54 0.593 0 C-N-CA 125.506 1.522 . . . . 15.85 110.517 174.192 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -65.69 -56.75 0.3 Allowed 'Trans proline' 0 N--CA 1.456 -0.722 0 C-N-CA 122.384 2.056 . . . . 11.949999999999999 112.18 -172.118 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 35.5 t -164.84 60.01 0.13 Allowed 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 123.815 0.846 . . . . 7.5499999999999998 109.093 179.208 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 26.2 p -53.39 102.56 0.32 Allowed Pre-proline 0 CA--C 1.536 0.439 0 C-N-CA 127.85 2.46 . . . . 7.6100000000000003 111.636 -168.492 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -85.12 38.56 0.66 Allowed 'Trans proline' 0 N--CA 1.456 -0.716 0 C-N-CA 123.249 2.632 . . . . 5.5599999999999996 110.724 -171.878 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 12.4 p -107.75 -133.68 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 N-CA-C 104.271 -2.492 . . . . 5.0300000000000002 104.271 168.171 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 23.7 m120 48.68 -84.16 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 126.115 1.766 . . . . 3.3399999999999999 112.928 164.778 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 96.9 mt -53.64 -43.03 68.42 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 125.697 1.599 . . . . 3.1200000000000001 110.356 176.329 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 4.5 mptp? -57.56 -51.57 68.95 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 109.389 -0.597 . . . . 5.0800000000000001 109.389 175.472 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? -67.44 -26.67 66.51 Favored 'General case' 0 N--CA 1.453 -0.312 0 O-C-N 122.227 -0.295 . . . . 7.2199999999999998 111.675 -178.002 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 63.2 tp -65.47 -49.39 69.27 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 108.6 -0.889 . . . . 2.2999999999999998 108.6 173.5 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 1.6 tt -58.42 -46.13 87.07 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-O 120.984 0.421 . . . . 2.5499999999999998 110.469 178.498 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 71.4 t -55.8 -49.39 74.93 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 N-CA-C 109.863 -0.421 . . . . 0.54000000000000004 109.863 174.684 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 25.5 t -57.0 -45.61 83.86 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.365 0 CA-C-O 118.505 -0.759 . . . . 0.70999999999999996 110.252 178.514 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 49.3 t -54.2 -52.11 41.06 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 CA-C-N 119.693 1.133 . . . . 0.72999999999999998 110.008 177.277 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 85.1 t -57.41 -47.18 85.3 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 O-C-N 121.949 -0.469 . . . . 0.42999999999999999 111.004 178.67 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 57.3 t -60.66 -45.35 97.64 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 N-CA-C 109.219 -0.66 . . . . 0.45000000000000001 109.219 -179.132 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 46.8 t -55.68 -48.79 77.33 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 C-N-CA 124.069 0.948 . . . . 0.58999999999999997 110.099 177.076 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 44.2 t -57.88 -47.71 85.63 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 CA-C-N 118.779 0.718 . . . . 0.52000000000000002 110.601 177.961 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -59.23 -46.65 87.89 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 109.551 -0.537 . . . . 0.55000000000000004 109.551 178.327 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.5 t -62.55 -39.36 84.25 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.923 0 C-N-CA 124.442 1.097 . . . . 0.48999999999999999 110.04 -179.682 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 3.4 t -63.23 -48.92 85.26 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.391 0 CA-C-N 118.963 0.801 . . . . 0.45000000000000001 109.569 175.285 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 1.3 t -53.99 -41.84 51.57 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 CA-C-N 118.881 0.764 . . . . 0.41999999999999998 111.286 173.242 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.4 t -65.43 -44.45 94.39 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.266 0 N-CA-C 108.667 -0.864 . . . . 0.44 108.667 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 12.3 mt -59.34 -44.29 92.06 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.57 0 N-CA-C 108.379 -0.971 . . . . 0.45000000000000001 108.379 178.117 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 39.2 t -64.36 -52.95 49.03 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 N-CA-C 109.568 -0.53 . . . . 0.37 109.568 -177.159 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -55.22 -48.24 69.81 Favored Glycine 0 CA--C 1.529 0.934 0 N-CA-C 111.512 -0.635 . . . . 0.31 111.512 175.846 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -55.56 -44.98 77.35 Favored 'General case' 0 N--CA 1.454 -0.226 0 O-C-N 122.15 -0.618 . . . . 0.57999999999999996 110.592 177.913 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 11.9 tp -62.92 -53.9 46.92 Favored 'General case' 0 N--CA 1.437 -1.102 0 C-N-CA 123.613 0.765 . . . . 0.85999999999999999 109.045 179.187 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . 0.305 3.1 pp -65.34 -33.82 76.87 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 119.375 0.989 . . . . 3.0800000000000001 112.568 -175.121 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 73.2 mtm -70.71 -43.19 69.49 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 118.071 0.396 . . . . 3.4100000000000001 111.263 174.518 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -70.45 -42.63 64.0 Favored Glycine 0 CA--C 1.528 0.888 0 CA-C-O 119.367 -0.685 . . . . 2.3900000000000001 112.554 -175.354 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . 0.371 0.0 OUTLIER . . . . . 0 N--CA 1.446 -0.642 0 C-N-CA 127.934 2.494 . . . . 7.8799999999999999 115.321 -168.144 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.534 0.358 0 N-CA-C 108.69 -0.856 . . . . 2.9199999999999999 108.69 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 10.2 tp -55.23 -45.58 75.97 Favored 'General case' 0 N--CA 1.453 -0.309 0 O-C-N 121.873 -0.517 . . . . 2.1299999999999999 111.149 176.081 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 89.7 t -55.12 -48.82 75.72 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 O-C-N 122.199 -0.313 . . . . 0.40000000000000002 110.156 174.544 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 55.3 t -56.54 -46.79 82.58 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 CA-C-N 118.612 0.642 . . . . 0.58999999999999997 110.182 177.119 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 72.3 t -54.52 -50.46 58.32 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 CA-C-N 118.771 0.714 . . . . 0.75 110.451 175.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 73.0 t -56.27 -44.34 79.25 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 O-C-N 121.636 -0.665 . . . . 0.5 110.843 177.537 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 46.4 t -60.04 -48.11 89.21 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.177 0 N-CA-C 108.904 -0.776 . . . . 0.42999999999999999 108.904 178.262 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 41.9 t -54.02 -50.19 55.64 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 C-N-CA 123.203 0.601 . . . . 0.58999999999999997 110.486 176.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 46.9 t -56.96 -46.69 83.98 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 C-N-CA 123.4 0.68 . . . . 0.59999999999999998 110.79 177.57 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -59.38 -46.93 87.31 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 123.352 0.661 . . . . 0.38 109.39 177.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 13.7 t -61.32 -40.76 87.24 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.795 0 C-N-CA 123.881 0.873 . . . . 0.40000000000000002 109.951 179.291 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 3.2 t -62.0 -47.64 92.24 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.359 0 O-C-N 121.56 -0.713 . . . . 0.41999999999999998 110.028 174.804 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 1.4 t -55.36 -40.66 58.28 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 CA-C-N 119.115 0.87 . . . . 0.32000000000000001 111.407 173.262 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.4 t -63.9 -46.11 95.09 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.235 0 N-CA-C 108.349 -0.982 . . . . 0.29999999999999999 108.349 178.363 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 10.8 mt -59.34 -42.61 87.93 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 N-CA-C 108.92 -0.771 . . . . 0.40000000000000002 108.92 178.629 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 39.6 t -63.37 -52.79 53.76 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 N-CA-C 109.423 -0.584 . . . . 0.33000000000000002 109.423 -179.673 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -52.27 -47.27 56.2 Favored Glycine 0 CA--C 1.53 1.009 0 N-CA-C 111.527 -0.629 . . . . 0.37 111.527 175.363 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -56.88 -49.83 74.33 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 123.446 0.698 . . . . 0.67000000000000004 110.46 178.231 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 11.2 tp -59.46 -44.63 92.93 Favored 'General case' 0 N--CA 1.44 -0.939 0 C-N-CA 123.776 0.83 . . . . 0.67000000000000004 109.465 178.409 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 85.3 mt . . . . . 0 CA--C 1.533 0.302 0 O-C-N 121.431 -0.793 . . . . 1.6799999999999999 111.23 178.01 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.8 tm? . . . . . 0 N--CA 1.451 -0.4 0 N-CA-C 107.839 -1.171 . . . . 2.4900000000000002 107.839 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -55.48 -45.89 76.95 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-O 120.835 0.35 . . . . 2.4300000000000002 110.639 176.831 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 64.4 t -56.15 -49.94 73.25 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 O-C-N 121.946 -0.471 . . . . 0.46999999999999997 109.77 174.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 38.1 t -55.77 -45.79 79.58 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 CA-C-N 118.404 0.547 . . . . 0.44 110.322 177.447 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 54.2 t -55.72 -51.17 62.11 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.375 0 CA-C-N 119.158 0.89 . . . . 0.45000000000000001 110.314 177.113 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 73.3 t -56.22 -45.18 80.98 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 O-C-N 121.791 -0.568 . . . . 0.35999999999999999 110.903 177.341 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 54.8 t -60.87 -46.4 96.41 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 N-CA-C 109.152 -0.684 . . . . 0.34999999999999998 109.152 179.504 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 47.8 t -55.19 -49.01 75.62 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 C-N-CA 123.481 0.712 . . . . 0.44 110.278 176.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 46.2 t -57.08 -46.85 84.46 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 O-C-N 121.815 -0.553 . . . . 0.40000000000000002 110.635 177.244 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.13 -47.35 83.59 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 123.265 0.626 . . . . 0.40999999999999998 109.524 177.135 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 11.7 t -62.38 -40.8 89.31 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.814 0 C-N-CA 124.033 0.933 . . . . 0.37 109.939 -179.093 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 5.1 t -62.63 -47.98 90.37 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.411 0 O-C-N 121.649 -0.657 . . . . 0.35999999999999999 109.654 175.273 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 1.5 t -55.09 -40.35 54.32 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.585 0 CA-C-N 119.051 0.842 . . . . 0.32000000000000001 111.144 173.453 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.4 t -65.32 -45.48 93.3 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.249 0 N-CA-C 108.687 -0.857 . . . . 0.33000000000000002 108.687 179.025 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 11.2 mt -59.85 -44.55 94.44 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.525 0 N-CA-C 108.566 -0.902 . . . . 0.37 108.566 178.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 38.8 t -63.97 -51.77 65.02 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 N-CA-C 109.371 -0.603 . . . . 0.39000000000000001 109.371 -177.49 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -54.0 -49.81 57.51 Favored Glycine 0 CA--C 1.528 0.868 0 N-CA-C 111.063 -0.815 . . . . 0.29999999999999999 111.063 175.028 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -56.01 -41.9 75.61 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 123.305 0.642 . . . . 0.56999999999999995 111.313 179.465 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 10.7 tp -61.2 -58.09 9.75 Favored 'General case' 0 N--CA 1.439 -0.987 0 N-CA-C 108.338 -0.986 . . . . 0.76000000000000001 108.338 174.054 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 75.6 mt . . . . . 0 CA--C 1.53 0.207 0 C-N-CA 123.823 0.849 . . . . 1.6699999999999999 112.497 -173.981 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.1 tt . . . . . 0 N--CA 1.453 -0.301 0 N-CA-C 108.09 -1.078 . . . . 2.0 108.09 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 11.0 tp -54.41 -46.0 73.06 Favored 'General case' 0 N--CA 1.454 -0.255 0 O-C-N 121.922 -0.486 . . . . 2.1200000000000001 111.245 174.804 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 79.9 t -57.81 -47.64 85.57 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 O-C-N 122.16 -0.337 . . . . 0.41999999999999998 110.241 174.74 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 49.6 t -55.68 -44.83 78.38 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 O-C-N 121.718 -0.614 . . . . 0.48999999999999999 110.218 176.371 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 68.7 t -56.35 -49.33 77.36 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 CA-C-N 119.203 0.911 . . . . 0.5 110.472 175.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 76.4 t -55.24 -45.15 77.47 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 O-C-N 121.564 -0.71 . . . . 0.37 110.704 176.151 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 70.1 t -60.17 -46.19 94.92 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.191 0 N-CA-C 109.163 -0.68 . . . . 0.34999999999999998 109.163 177.689 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 41.1 t -54.7 -48.58 72.14 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 C-N-CA 123.471 0.709 . . . . 0.48999999999999999 110.572 177.084 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 53.9 t -56.47 -46.97 82.4 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 CA-C-N 118.673 0.669 . . . . 0.44 110.598 177.12 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -59.08 -47.29 85.81 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 109.514 -0.551 . . . . 0.31 109.514 177.104 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 15.9 t -61.67 -38.49 80.46 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.878 0 C-N-CA 124.145 0.978 . . . . 0.39000000000000001 110.179 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 2.9 t -62.64 -49.45 83.72 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.334 0 C-N-CA 123.616 0.767 . . . . 0.5 109.562 174.417 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 1.3 t -54.25 -41.49 52.37 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 CA-C-N 119.207 0.912 . . . . 0.39000000000000001 111.384 173.369 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.4 t -64.33 -44.76 97.29 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 N-CA-C 108.706 -0.85 . . . . 0.32000000000000001 108.706 179.013 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 11.3 mt -59.85 -43.04 91.08 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 N-CA-C 108.627 -0.879 . . . . 0.5 108.627 178.259 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 39.5 t -61.71 -57.57 11.5 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 N-CA-C 108.809 -0.812 . . . . 0.42999999999999999 108.809 -179.273 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -53.01 -45.18 62.27 Favored Glycine 0 CA--C 1.533 1.18 0 C-N-CA 120.972 -0.632 . . . . 0.47999999999999998 111.936 176.565 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -60.55 -32.73 71.78 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 124.135 0.974 . . . . 1.0 111.868 179.243 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 13.2 tp -70.12 -60.33 2.35 Favored 'General case' 0 N--CA 1.435 -1.209 0 N-CA-C 107.49 -1.3 . . . . 0.79000000000000004 107.49 172.519 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 5.3 mp . . . . . 0 C--N 1.341 0.237 0 N-CA-C 113.412 0.893 . . . . 2.5499999999999998 113.412 -171.928 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.3 tt . . . . . 0 N--CA 1.455 -0.209 0 N-CA-C 108.275 -1.009 . . . . 2.0499999999999998 108.275 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 10.8 tp -56.51 -45.97 80.78 Favored 'General case' 0 N--CA 1.454 -0.272 0 O-C-N 121.868 -0.52 . . . . 2.27 111.477 176.279 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 99.4 t -56.65 -48.03 81.35 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 N-CA-C 109.777 -0.453 . . . . 0.53000000000000003 109.777 174.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 44.3 t -56.47 -45.76 82.01 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.291 0 CA-C-O 118.65 -0.691 . . . . 0.78000000000000003 110.058 177.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 55.9 t -54.25 -51.41 48.2 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 CA-C-N 119.572 1.078 . . . . 0.90000000000000002 110.467 176.422 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 97.8 t -57.29 -45.78 85.08 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 O-C-N 121.547 -0.721 . . . . 0.80000000000000004 111.011 177.354 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 53.7 t -59.92 -42.74 90.36 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 N-CA-C 109.382 -0.599 . . . . 0.81999999999999995 109.382 179.341 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 30.1 t -54.5 -47.42 71.18 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 C-N-CA 123.711 0.804 . . . . 1.22 110.377 177.3 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 72.8 t -59.1 -46.41 91.93 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 CA-C-N 118.829 0.741 . . . . 0.94999999999999996 110.395 178.178 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -58.93 -46.1 88.77 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 123.216 0.606 . . . . 0.64000000000000001 109.856 177.167 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.4 t -62.54 -40.51 88.52 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.898 0 C-N-CA 124.559 1.144 . . . . 0.90000000000000002 109.84 -179.486 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 5.0 t -62.51 -48.79 86.57 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.402 0 CA-C-N 118.776 0.716 . . . . 0.91000000000000003 109.65 175.042 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 1.4 t -54.58 -39.88 47.93 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 CA-C-N 118.734 0.697 . . . . 0.56000000000000005 111.38 173.611 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.4 t -66.45 -45.01 90.18 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 N-CA-C 108.891 -0.781 . . . . 0.55000000000000004 108.891 179.131 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 11.8 mt -59.01 -44.99 92.5 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 N-CA-C 108.334 -0.987 . . . . 0.81000000000000005 108.334 178.568 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 42.7 t -64.24 -53.46 43.11 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 N-CA-C 109.48 -0.563 . . . . 0.53000000000000003 109.48 -177.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -54.71 -44.31 80.05 Favored Glycine 0 CA--C 1.527 0.844 0 N-CA-C 111.568 -0.613 . . . . 0.62 111.568 176.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -60.98 -45.02 96.5 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 117.686 0.743 . . . . 0.72999999999999998 111.013 178.122 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 9.7 tp -56.93 -53.45 57.89 Favored 'General case' 0 N--CA 1.441 -0.917 0 N-CA-C 108.303 -0.999 . . . . 0.94999999999999996 108.303 175.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 85.5 mt . . . . . 0 CA--C 1.533 0.291 0 C-N-CA 122.804 0.442 . . . . 1.9099999999999999 111.789 -177.837 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 9.3 tt . . . . . 0 N--CA 1.455 -0.213 0 N-CA-C 108.895 -0.78 . . . . 2.4100000000000001 108.895 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 10.5 tp -56.61 -46.07 81.1 Favored 'General case' 0 N--CA 1.453 -0.295 0 O-C-N 122.228 -0.295 . . . . 2.23 111.476 176.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 72.7 t -54.26 -50.16 58.14 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 N-CA-C 109.75 -0.463 . . . . 0.93999999999999995 109.75 174.336 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 40.6 t -58.49 -46.37 89.75 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.224 0 CA-C-O 118.681 -0.676 . . . . 0.69999999999999996 110.454 179.452 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 53.1 t -53.37 -53.33 24.76 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 CA-C-N 119.394 0.997 . . . . 0.63 109.93 176.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 69.8 t -58.1 -46.07 88.3 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 O-C-N 122.036 -0.415 . . . . 0.29999999999999999 110.974 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 48.5 t -61.44 -46.86 95.71 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 N-CA-C 109.008 -0.738 . . . . 0.34999999999999998 109.008 -178.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 43.1 t -54.14 -49.94 58.47 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 C-N-CA 123.566 0.746 . . . . 0.47999999999999998 110.038 176.414 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 44.4 t -58.28 -48.13 85.68 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 CA-C-N 118.71 0.687 . . . . 0.39000000000000001 110.864 179.166 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -59.09 -47.2 86.13 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 109.379 -0.6 . . . . 0.5 109.379 178.829 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 15.5 t -62.63 -39.59 85.21 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.985 0 C-N-CA 124.037 0.935 . . . . 0.41999999999999998 109.929 -179.264 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 3.8 t -63.83 -47.52 90.47 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.482 0 CA-C-N 118.871 0.76 . . . . 0.35999999999999999 109.6 175.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 1.4 t -54.76 -41.6 57.46 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.602 0 CA-C-N 119.061 0.846 . . . . 0.35999999999999999 111.225 173.207 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.4 t -65.09 -46.33 91.57 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.171 0 N-CA-C 108.648 -0.871 . . . . 0.46000000000000002 108.648 179.746 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 13.1 mt -59.82 -43.52 92.01 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 N-CA-C 108.421 -0.955 . . . . 0.47999999999999998 108.421 179.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 27.3 t -62.99 -54.87 28.02 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 N-CA-C 109.061 -0.718 . . . . 0.35999999999999999 109.061 -178.685 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -52.33 -45.96 57.86 Favored Glycine 0 CA--C 1.529 0.961 0 N-CA-C 111.541 -0.624 . . . . 0.32000000000000001 111.541 176.14 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -61.87 -41.96 98.49 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 122.959 0.504 . . . . 0.45000000000000001 111.54 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 11.6 tp -63.56 -46.28 86.62 Favored 'General case' 0 N--CA 1.44 -0.928 0 N-CA-C 108.669 -0.863 . . . . 0.72999999999999998 108.669 176.23 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 82.8 mt . . . . . 0 CA--C 1.53 0.204 0 O-C-N 122.061 -0.399 . . . . 1.95 111.182 -178.12 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.1 tm? . . . . . 0 CA--C 1.527 0.071 0 N-CA-C 109.005 -0.739 . . . . 2.7400000000000002 109.005 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 1.7 tt -57.61 -46.28 84.3 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-O 121.283 0.563 . . . . 2.6400000000000001 110.225 176.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 48.0 t -58.19 -46.13 88.66 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 N-CA-C 109.618 -0.512 . . . . 0.40999999999999998 109.618 176.501 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 68.6 t -57.01 -46.44 84.1 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 CA-C-O 118.515 -0.755 . . . . 0.78000000000000003 109.766 176.79 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 54.5 t -55.36 -50.35 65.98 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 CA-C-N 119.803 1.183 . . . . 0.88 110.144 177.317 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 81.1 t -56.14 -46.58 81.11 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 O-C-N 121.841 -0.537 . . . . 0.48999999999999999 110.929 177.389 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 54.3 t -60.37 -45.53 96.45 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 N-CA-C 109.212 -0.662 . . . . 0.52000000000000002 109.212 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 51.0 t -55.15 -49.7 69.94 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 C-N-CA 123.674 0.79 . . . . 0.89000000000000001 110.052 176.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 49.0 t -57.86 -47.21 86.77 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 CA-C-N 118.501 0.591 . . . . 0.71999999999999997 110.553 178.552 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -58.63 -47.13 85.42 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 123.123 0.569 . . . . 0.38 109.466 177.79 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 11.9 t -62.77 -39.72 85.93 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.898 0 C-N-CA 124.238 1.015 . . . . 0.63 109.96 -178.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 5.6 t -63.29 -48.49 87.15 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 CA-C-N 118.77 0.714 . . . . 0.68000000000000005 109.687 175.205 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 1.4 t -54.28 -41.1 50.72 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 CA-C-N 118.844 0.747 . . . . 0.42999999999999999 111.232 173.195 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.4 t -65.81 -45.08 92.52 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.278 0 N-CA-C 108.646 -0.872 . . . . 0.40999999999999998 108.646 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 11.6 mt -58.96 -45.35 92.1 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.603 0 N-CA-C 108.191 -1.04 . . . . 0.67000000000000004 108.191 178.489 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 38.4 t -63.77 -52.99 50.16 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 N-CA-C 109.697 -0.483 . . . . 0.34000000000000002 109.697 -176.745 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -54.9 -48.55 66.28 Favored Glycine 0 CA--C 1.528 0.849 0 N-CA-C 111.354 -0.698 . . . . 0.38 111.354 175.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -57.1 -41.21 78.49 Favored 'General case' 0 N--CA 1.455 -0.225 0 O-C-N 122.105 -0.644 . . . . 0.62 111.211 178.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 12.6 tp -66.73 -52.41 44.73 Favored 'General case' 0 N--CA 1.438 -1.069 0 C-N-CA 123.886 0.874 . . . . 0.59999999999999998 109.11 178.756 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . 0.298 3.6 pp . . . . . 0 CA--C 1.532 0.254 0 CA-C-N 119.11 0.868 . . . . 3.04 112.685 -175.285 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 9.9 tt . . . . . 0 N--CA 1.45 -0.451 0 N-CA-C 108.413 -0.958 . . . . 1.98 108.413 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 10.9 tp -56.04 -45.85 79.08 Favored 'General case' 0 N--CA 1.454 -0.239 0 O-C-N 122.223 -0.298 . . . . 1.8600000000000001 111.232 174.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 93.5 t -56.66 -49.75 76.74 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 N-CA-C 110.185 -0.302 . . . . 0.40999999999999998 110.185 174.567 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 54.8 t -55.29 -46.0 77.98 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 O-C-N 121.87 -0.519 . . . . 0.57999999999999996 110.039 177.166 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 54.3 t -56.17 -47.87 80.09 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 CA-C-N 118.833 0.742 . . . . 0.58999999999999997 110.222 177.084 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 76.0 t -54.9 -45.37 75.45 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 CA-C-N 118.683 0.674 . . . . 0.56999999999999995 110.78 175.13 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 87.2 t -60.23 -47.3 92.76 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.182 0 N-CA-C 109.28 -0.637 . . . . 0.48999999999999999 109.28 178.579 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 53.1 t -55.12 -49.09 74.73 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 C-N-CA 123.48 0.712 . . . . 0.54000000000000004 110.406 177.531 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 41.8 t -56.98 -46.23 83.94 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 C-N-CA 123.485 0.714 . . . . 0.52000000000000002 110.22 177.3 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -58.59 -47.4 84.43 Favored 'General case' 0 N--CA 1.45 -0.425 0 N-CA-C 109.363 -0.606 . . . . 0.67000000000000004 109.363 177.148 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.7 t -62.12 -41.3 90.69 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.829 0 O-C-N 121.316 -0.865 . . . . 0.53000000000000003 110.045 -179.482 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 4.3 t -62.91 -47.11 94.38 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 O-C-N 121.512 -0.742 . . . . 0.40999999999999998 109.83 175.694 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 2.1 t -56.86 -37.69 55.21 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.707 0 CA-C-N 118.812 0.733 . . . . 0.46999999999999997 110.957 173.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.4 t -66.64 -46.9 84.87 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.245 0 N-CA-C 108.447 -0.946 . . . . 0.47999999999999998 108.447 178.034 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 10.7 mt -58.28 -45.89 89.08 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 N-CA-C 108.569 -0.9 . . . . 0.44 108.569 179.283 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 43.6 t -65.65 -50.95 68.22 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 N-CA-C 109.382 -0.599 . . . . 0.41999999999999998 109.382 -176.723 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -53.08 -49.0 57.47 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 111.101 -0.799 . . . . 0.42999999999999999 111.101 176.06 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -57.54 -47.86 80.86 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.507 0.723 . . . . 0.68999999999999995 110.643 178.273 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 10.8 tp -59.04 -46.94 86.95 Favored 'General case' 0 N--CA 1.441 -0.908 0 C-N-CA 123.679 0.792 . . . . 0.71999999999999997 109.695 178.188 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . 0.307 0.1 OUTLIER . . . . . 0 CA--C 1.54 0.56 0 O-C-N 121.592 -0.692 . . . . 3.2000000000000002 110.732 -178.555 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 9.1 tt . . . . . 0 C--O 1.224 -0.262 0 N-CA-C 108.972 -0.751 . . . . 1.8899999999999999 108.972 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 10.7 tp -52.84 -45.55 67.38 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-O 121.031 0.443 . . . . 1.9399999999999999 111.464 171.448 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 39.7 t -61.65 -44.28 98.43 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 N-CA-C 109.511 -0.551 . . . . 0.70999999999999996 109.511 176.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 90.3 t -55.53 -46.86 79.12 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 O-C-N 121.999 -0.438 . . . . 0.68000000000000005 110.051 175.026 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 67.3 t -56.06 -49.14 77.31 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 CA-C-N 118.808 0.731 . . . . 0.60999999999999999 109.809 176.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 75.1 t -56.36 -44.49 80.04 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 O-C-N 121.827 -0.546 . . . . 0.40000000000000002 111.013 177.114 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 56.0 t -61.03 -47.79 92.0 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.139 0 O-C-N 121.661 -0.65 . . . . 0.46000000000000002 109.26 178.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 54.7 t -54.78 -48.98 72.56 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 C-N-CA 123.312 0.645 . . . . 0.70999999999999996 110.199 176.805 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 38.1 t -57.13 -46.4 84.56 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 C-N-CA 123.568 0.747 . . . . 0.55000000000000004 110.544 177.445 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -59.01 -48.08 82.87 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 123.424 0.69 . . . . 0.42999999999999999 109.361 177.802 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 16.1 t -61.87 -40.98 89.02 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.848 0 O-C-N 121.387 -0.82 . . . . 0.60999999999999999 109.954 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 4.2 t -62.91 -45.89 97.71 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.507 0 O-C-N 121.543 -0.723 . . . . 0.66000000000000003 109.84 175.491 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 1.6 t -56.42 -40.26 66.22 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.631 0 CA-C-N 119.296 0.953 . . . . 0.44 110.927 173.556 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.4 t -63.57 -48.42 86.94 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 N-CA-C 108.345 -0.983 . . . . 0.40999999999999998 108.345 177.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 11.2 mt -59.43 -42.46 87.75 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 N-CA-C 109.053 -0.721 . . . . 0.68999999999999995 109.053 -179.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 32.4 t -65.06 -50.37 74.86 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 N-CA-C 109.162 -0.681 . . . . 0.46000000000000002 109.162 -178.477 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -52.1 -46.39 56.28 Favored Glycine 0 CA--C 1.53 0.981 0 N-CA-C 111.463 -0.655 . . . . 0.32000000000000001 111.463 173.641 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -59.24 -51.15 71.23 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 121.256 0.55 . . . . 0.72999999999999998 110.587 178.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 9.2 tp -54.53 -46.6 73.58 Favored 'General case' 0 N--CA 1.443 -0.817 0 C-N-CA 123.973 0.909 . . . . 0.76000000000000001 109.594 175.798 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 64.7 mt . . . . . 0 CA--C 1.53 0.19 0 O-C-N 121.808 -0.557 . . . . 1.8500000000000001 111.536 -178.789 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 68.9 tp . . . . . 0 N--CA 1.454 -0.275 0 N-CA-C 108.553 -0.906 . . . . 2.1899999999999999 108.553 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -57.58 -46.09 84.44 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-O 120.91 0.386 . . . . 2.2000000000000002 110.151 177.567 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 75.7 t -55.56 -49.32 74.44 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 O-C-N 121.967 -0.458 . . . . 0.41999999999999998 110.234 173.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 32.4 t -56.12 -46.04 80.88 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.204 0 CA-C-O 118.896 -0.573 . . . . 0.46999999999999997 110.089 178.348 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 55.1 t -54.92 -51.91 48.52 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.426 0 CA-C-N 119.273 0.942 . . . . 0.48999999999999999 109.924 177.073 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 70.8 t -56.24 -45.76 81.2 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 O-C-N 121.908 -0.495 . . . . 0.38 110.922 177.709 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 52.7 t -60.47 -46.22 95.66 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.309 0 N-CA-C 109.083 -0.71 . . . . 0.37 109.083 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 48.7 t -55.48 -49.5 72.94 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 C-N-CA 123.605 0.762 . . . . 0.46000000000000002 110.119 176.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 52.3 t -58.05 -46.98 87.93 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 CA-C-N 118.465 0.575 . . . . 0.47999999999999998 110.619 178.051 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -59.06 -46.83 87.25 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 123.382 0.673 . . . . 0.47999999999999998 109.488 178.017 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 10.6 t -62.08 -40.6 88.04 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.855 0 C-N-CA 124.353 1.061 . . . . 0.35999999999999999 109.909 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 3.5 t -62.32 -48.03 90.29 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.404 0 CA-C-N 118.696 0.68 . . . . 0.35999999999999999 109.685 175.048 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 1.4 t -55.59 -40.63 60.43 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 O-C-N 121.375 -0.828 . . . . 0.38 111.329 173.655 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.4 t -64.63 -44.86 96.69 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.215 0 N-CA-C 108.541 -0.911 . . . . 0.34999999999999998 108.541 178.599 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 11.5 mt -60.01 -43.67 93.06 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 N-CA-C 108.607 -0.886 . . . . 0.34000000000000002 108.607 178.473 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 39.6 t -62.95 -53.83 41.58 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 N-CA-C 109.262 -0.644 . . . . 0.28999999999999998 109.262 -178.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -53.19 -47.11 61.86 Favored Glycine 0 CA--C 1.53 1.006 0 N-CA-C 111.572 -0.611 . . . . 0.28000000000000003 111.572 175.432 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -60.34 -40.16 89.68 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 123.503 0.721 . . . . 0.56000000000000005 111.204 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 11.1 tp -63.42 -52.88 59.68 Favored 'General case' 0 N--CA 1.439 -0.991 0 N-CA-C 108.175 -1.046 . . . . 0.62 108.175 174.607 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 79.0 mt . . . . . 0 CA--C 1.531 0.216 0 C-N-CA 123.423 0.689 . . . . 1.6000000000000001 111.981 -177.054 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 59.9 tp . . . . . 0 N--CA 1.45 -0.453 0 N-CA-C 108.358 -0.979 . . . . 2.1699999999999999 108.358 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 10.9 tp -55.58 -46.02 77.29 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 117.9 0.318 . . . . 2.1000000000000001 111.186 176.394 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 75.2 t -55.18 -51.38 55.77 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 N-CA-C 110.221 -0.289 . . . . 0.58999999999999997 110.221 174.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 50.6 t -56.01 -46.03 80.5 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 O-C-N 121.725 -0.61 . . . . 0.81999999999999995 110.339 177.336 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 55.0 t -55.68 -47.03 79.65 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 CA-C-N 118.766 0.712 . . . . 0.78000000000000003 110.179 177.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 70.6 t -55.44 -45.49 78.29 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 CA-C-N 118.834 0.743 . . . . 0.53000000000000003 110.75 175.718 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 86.8 t -60.47 -47.75 91.32 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 N-CA-C 109.385 -0.598 . . . . 0.66000000000000003 109.385 178.676 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 64.0 t -54.81 -48.61 73.33 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 C-N-CA 123.395 0.678 . . . . 0.88 110.495 177.454 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 39.8 t -57.34 -45.71 85.26 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 C-N-CA 123.574 0.749 . . . . 0.66000000000000003 110.248 177.447 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.6 -47.66 83.56 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 109.469 -0.567 . . . . 0.53000000000000003 109.469 177.075 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 16.6 t -61.93 -41.95 92.84 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.774 0 O-C-N 121.42 -0.8 . . . . 0.62 110.103 -179.588 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 5.9 t -62.24 -46.06 97.31 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 O-C-N 121.565 -0.71 . . . . 0.70999999999999996 109.869 175.616 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 1.6 t -56.79 -39.48 64.57 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.644 0 CA-C-N 119.152 0.887 . . . . 0.5 110.931 173.804 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.4 t -64.25 -46.97 91.82 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.188 0 N-CA-C 108.509 -0.923 . . . . 0.45000000000000001 108.509 177.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 10.2 mt -59.5 -44.11 92.22 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 N-CA-C 108.951 -0.759 . . . . 0.58999999999999997 108.951 179.328 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 39.5 t -64.51 -49.74 79.23 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 N-CA-C 109.164 -0.68 . . . . 0.52000000000000002 109.164 -177.543 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -51.37 -52.78 31.0 Favored Glycine 0 CA--C 1.527 0.81 0 N-CA-C 110.619 -0.992 . . . . 0.53000000000000003 110.619 173.479 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -55.18 -43.98 74.85 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 122.966 0.506 . . . . 0.68000000000000005 111.176 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 10.7 tp -62.11 -46.51 88.73 Favored 'General case' 0 N--CA 1.442 -0.848 0 C-N-CA 124.012 0.925 . . . . 0.91000000000000003 109.617 176.327 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 65.5 mt . . . . . 0 CA--C 1.531 0.22 0 CA-C-N 118.287 0.494 . . . . 1.9299999999999999 111.532 -178.102 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 9.5 tt . . . . . 0 N--CA 1.454 -0.247 0 N-CA-C 108.346 -0.983 . . . . 2.0899999999999999 108.346 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 1.3 tt -56.23 -46.22 79.63 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-O 121.017 0.437 . . . . 2.1499999999999999 110.4 175.313 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 84.6 t -56.53 -48.01 81.0 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 O-C-N 121.835 -0.541 . . . . 0.40000000000000002 110.308 175.391 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 41.5 t -56.19 -45.99 81.1 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.185 0 O-C-N 121.758 -0.589 . . . . 0.5 109.885 177.11 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 54.0 t -54.89 -50.13 64.51 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 CA-C-N 119.29 0.95 . . . . 0.46999999999999997 110.207 176.376 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 73.0 t -56.2 -45.87 81.12 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 O-C-N 121.743 -0.598 . . . . 0.34000000000000002 111.007 177.32 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 56.7 t -60.2 -47.32 92.59 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 N-CA-C 109.176 -0.676 . . . . 0.40000000000000002 109.176 179.509 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 51.0 t -54.81 -49.34 70.06 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 C-N-CA 123.591 0.756 . . . . 0.46000000000000002 110.109 177.233 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 42.8 t -57.54 -46.68 86.13 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 O-C-N 121.817 -0.552 . . . . 0.38 110.528 177.82 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -58.5 -47.51 83.85 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 123.248 0.619 . . . . 0.40999999999999998 109.491 177.72 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 14.4 t -62.29 -41.18 90.57 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.842 0 C-N-CA 123.868 0.867 . . . . 0.38 109.958 -179.399 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 5.2 t -62.69 -47.16 94.22 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.49 0 O-C-N 121.605 -0.685 . . . . 0.34000000000000002 109.766 175.652 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 1.6 t -56.01 -39.7 59.35 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.643 0 CA-C-N 118.949 0.795 . . . . 0.28999999999999998 111.211 173.62 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.4 t -65.09 -45.84 93.05 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.191 0 N-CA-C 108.517 -0.919 . . . . 0.31 108.517 178.357 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 11.3 mt -59.93 -43.85 93.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 N-CA-C 108.729 -0.841 . . . . 0.35999999999999999 108.729 179.104 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 39.7 t -64.14 -51.4 69.34 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 N-CA-C 109.301 -0.629 . . . . 0.28000000000000003 109.301 -178.242 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -53.13 -49.6 55.19 Favored Glycine 0 CA--C 1.528 0.87 0 N-CA-C 110.905 -0.878 . . . . 0.28000000000000003 110.905 175.231 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -56.98 -45.43 82.92 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 123.049 0.539 . . . . 0.47999999999999998 111.079 178.857 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 10.0 tp -58.79 -50.01 75.54 Favored 'General case' 0 N--CA 1.442 -0.853 0 C-N-CA 124.004 0.922 . . . . 0.59999999999999998 109.221 176.696 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 72.9 mt . . . . . 0 CA--C 1.532 0.269 0 CA-C-N 118.033 0.379 . . . . 1.6499999999999999 111.115 -178.996 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.1 tm? . . . . . 0 N--CA 1.455 -0.197 0 N-CA-C 108.348 -0.982 . . . . 2.3599999999999999 108.348 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 1.3 tt -57.81 -46.11 85.14 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-O 121.032 0.444 . . . . 2.1400000000000001 110.314 177.028 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 58.4 t -57.44 -48.09 83.51 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 O-C-N 122.022 -0.424 . . . . 0.42999999999999999 109.869 176.315 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 48.2 t -56.47 -45.89 82.05 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.232 0 CA-C-O 118.871 -0.585 . . . . 0.47999999999999998 110.074 176.824 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 48.3 t -55.31 -50.47 64.68 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 CA-C-N 119.379 0.99 . . . . 0.51000000000000001 110.182 176.528 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 71.3 t -55.84 -46.17 79.95 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 O-C-N 121.812 -0.555 . . . . 0.34000000000000002 110.834 177.732 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 56.0 t -60.41 -47.01 94.32 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.227 0 N-CA-C 109.196 -0.668 . . . . 0.39000000000000001 109.196 179.508 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 47.7 t -55.36 -48.43 76.85 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 C-N-CA 123.708 0.803 . . . . 0.5 110.358 177.322 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 44.5 t -57.75 -46.97 86.86 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 CA-C-N 118.603 0.638 . . . . 0.40999999999999998 110.417 177.602 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -59.1 -47.27 85.86 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 109.456 -0.572 . . . . 0.42999999999999999 109.456 177.681 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 15.5 t -61.89 -39.48 83.7 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.886 0 C-N-CA 124.007 0.923 . . . . 0.42999999999999999 110.095 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 3.3 t -62.63 -48.2 89.33 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.38 0 C-N-CA 123.419 0.688 . . . . 0.41999999999999998 109.691 174.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 1.4 t -55.12 -41.07 57.93 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 CA-C-N 119.176 0.898 . . . . 0.37 111.415 173.216 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.4 t -63.97 -45.33 97.1 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.198 0 N-CA-C 108.549 -0.908 . . . . 0.34000000000000002 108.549 178.566 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 11.8 mt -60.09 -42.01 88.45 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 N-CA-C 108.719 -0.845 . . . . 0.41999999999999998 108.719 178.722 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 40.4 t -62.62 -55.7 22.18 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 N-CA-C 109.074 -0.713 . . . . 0.40999999999999998 109.074 179.486 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -52.47 -45.41 59.07 Favored Glycine 0 CA--C 1.531 1.089 0 N-CA-C 111.719 -0.553 . . . . 0.29999999999999999 111.719 177.11 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -56.46 -47.57 78.87 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 123.427 0.691 . . . . 0.46999999999999997 110.566 175.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 8.5 tp -58.18 -49.96 75.2 Favored 'General case' 0 N--CA 1.441 -0.899 0 C-N-CA 123.947 0.899 . . . . 0.56999999999999995 109.142 178.699 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 5.5 mp . . . . . 0 CA--C 1.534 0.365 0 CA-C-N 119.27 0.941 . . . . 2.0099999999999998 112.142 174.389 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 37.4 tp . . . . . 0 N--CA 1.454 -0.238 0 N-CA-C 108.778 -0.823 . . . . 2.1600000000000001 108.778 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 1.6 tt -56.8 -46.25 81.7 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-O 121.132 0.491 . . . . 2.46 110.3 176.218 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 40.6 t -59.0 -47.02 91.25 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 N-CA-C 109.412 -0.588 . . . . 0.45000000000000001 109.412 176.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 57.4 t -56.66 -46.15 82.81 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.219 0 CA-C-O 118.821 -0.609 . . . . 0.60999999999999999 110.104 176.754 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 54.1 t -55.93 -50.57 68.33 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.441 0 CA-C-N 119.35 0.977 . . . . 0.70999999999999996 109.773 177.506 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 77.3 t -56.23 -46.36 81.38 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 O-C-N 121.987 -0.446 . . . . 0.45000000000000001 110.889 177.81 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 54.7 t -60.94 -46.87 95.7 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 N-CA-C 109.104 -0.702 . . . . 0.34999999999999998 109.104 -179.576 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 48.5 t -54.62 -49.79 64.53 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.426 0 C-N-CA 123.421 0.688 . . . . 0.55000000000000004 110.179 176.755 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 46.2 t -58.63 -46.85 90.07 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.425 0 CA-C-N 118.395 0.543 . . . . 0.44 110.588 179.014 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -59.39 -47.36 85.73 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 109.296 -0.631 . . . . 0.34999999999999998 109.296 178.318 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.8 t -62.06 -40.05 86.01 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.9 0 C-N-CA 123.977 0.911 . . . . 0.38 109.997 -179.814 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 3.5 t -62.99 -47.98 90.2 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.412 0 CA-C-N 118.702 0.683 . . . . 0.39000000000000001 109.83 175.248 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 1.5 t -55.27 -40.63 57.3 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 CA-C-N 118.98 0.809 . . . . 0.31 111.048 173.851 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.4 t -65.67 -45.96 90.6 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 N-CA-C 108.674 -0.862 . . . . 0.28999999999999998 108.674 179.215 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 12.3 mt -58.86 -44.57 90.89 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 N-CA-C 108.282 -1.007 . . . . 0.38 108.282 179.133 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 39.3 t -64.1 -54.46 31.14 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 N-CA-C 109.511 -0.552 . . . . 0.34999999999999998 109.511 -177.457 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -55.18 -47.48 73.98 Favored Glycine 0 CA--C 1.529 0.939 0 N-CA-C 111.439 -0.665 . . . . 0.28999999999999998 111.439 177.349 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -57.72 -42.59 84.13 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 123.317 0.647 . . . . 0.52000000000000002 111.282 178.281 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 11.6 tp -63.08 -53.06 59.57 Favored 'General case' 0 N--CA 1.439 -1.009 0 N-CA-C 108.291 -1.003 . . . . 0.77000000000000002 108.291 177.257 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 84.3 mt . . . . . 0 CA--C 1.533 0.296 0 CA-C-N 118.361 0.528 . . . . 1.99 111.41 -177.825 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.4 tm? . . . . . 0 CA--C 1.531 0.236 0 N-CA-C 108.894 -0.78 . . . . 2.2999999999999998 108.894 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -56.09 -46.0 79.21 Favored 'General case' 0 CA--C 1.533 0.3 0 O-C-N 121.891 -0.506 . . . . 2.1000000000000001 110.251 174.886 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 85.3 t -56.16 -48.43 79.25 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 O-C-N 121.814 -0.554 . . . . 0.37 110.136 174.734 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 44.7 t -54.78 -47.05 74.82 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 CA-C-N 118.617 0.644 . . . . 0.46999999999999997 109.822 176.293 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 50.3 t -55.02 -48.44 75.83 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 CA-C-N 119.028 0.831 . . . . 0.54000000000000004 110.754 176.167 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 70.6 t -55.42 -44.99 78.03 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 O-C-N 121.447 -0.783 . . . . 0.37 110.71 175.385 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 87.0 t -60.4 -46.18 95.54 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.22 0 N-CA-C 109.073 -0.714 . . . . 0.38 109.073 178.362 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 72.4 t -55.02 -49.5 70.97 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 C-N-CA 123.218 0.607 . . . . 0.46000000000000002 110.069 177.09 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 46.5 t -56.93 -47.85 82.53 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 O-C-N 121.798 -0.564 . . . . 0.38 110.671 177.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -58.34 -47.57 83.36 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 123.23 0.612 . . . . 0.34999999999999998 109.354 177.732 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 14.2 t -62.61 -39.62 85.31 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.92 0 C-N-CA 124.162 0.985 . . . . 0.35999999999999999 110.066 -179.209 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 3.6 t -63.44 -48.25 87.99 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 CA-C-N 118.742 0.701 . . . . 0.37 109.56 175.472 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 1.5 t -55.43 -40.5 58.23 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.617 0 CA-C-N 118.909 0.777 . . . . 0.29999999999999999 110.953 173.845 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.4 t -66.17 -45.06 91.19 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.237 0 N-CA-C 108.746 -0.835 . . . . 0.28000000000000003 108.746 179.319 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 12.5 mt -59.05 -44.86 92.35 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.576 0 N-CA-C 108.285 -1.005 . . . . 0.35999999999999999 108.285 178.598 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 40.2 t -63.73 -55.4 22.74 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 N-CA-C 109.347 -0.612 . . . . 0.28000000000000003 109.347 -177.672 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -53.34 -47.51 61.95 Favored Glycine 0 CA--C 1.529 0.941 0 N-CA-C 111.428 -0.669 . . . . 0.32000000000000001 111.428 176.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -57.89 -43.41 86.1 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 123.323 0.649 . . . . 0.47999999999999998 111.142 178.6 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 13.5 tp -67.04 -45.28 77.93 Favored 'General case' 0 N--CA 1.439 -1.008 0 C-N-CA 123.698 0.799 . . . . 0.65000000000000002 109.156 178.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 84.1 mt . . . . . 0 CA--C 1.533 0.311 0 CA-C-N 119.087 0.858 . . . . 1.6499999999999999 110.562 176.692 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.452 -0.36 0 N-CA-C 108.16 -1.052 . . . . 2.6600000000000001 108.16 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 10.6 tp -55.33 -45.83 76.38 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 122.648 0.379 . . . . 1.8700000000000001 111.259 175.882 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 74.0 t -54.97 -50.15 65.06 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 N-CA-C 109.989 -0.375 . . . . 0.5 109.989 174.441 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 42.2 t -56.54 -47.33 82.12 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 CA-C-N 118.43 0.559 . . . . 0.45000000000000001 110.185 178.083 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 61.5 t -54.55 -51.18 52.74 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 CA-C-N 119.032 0.833 . . . . 0.46999999999999997 110.268 177.149 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 60.7 t -56.52 -44.87 81.65 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 O-C-N 121.819 -0.55 . . . . 0.35999999999999999 110.825 177.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 53.8 t -60.83 -47.4 93.46 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.267 0 N-CA-C 109.033 -0.729 . . . . 0.35999999999999999 109.033 179.27 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 55.4 t -54.27 -50.29 57.31 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 C-N-CA 123.32 0.648 . . . . 0.5 110.148 176.761 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 43.1 t -57.73 -46.97 86.8 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 C-N-CA 123.052 0.541 . . . . 0.51000000000000001 110.811 178.495 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -59.34 -46.99 87.08 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 123.382 0.673 . . . . 0.40000000000000002 109.328 178.123 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 15.5 t -61.89 -40.73 88.14 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.882 0 C-N-CA 124.077 0.951 . . . . 0.34999999999999998 109.898 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 4.1 t -62.24 -47.79 91.42 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.396 0 O-C-N 121.554 -0.716 . . . . 0.39000000000000001 109.78 174.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 1.4 t -55.86 -39.87 58.93 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 CA-C-N 119.137 0.88 . . . . 0.39000000000000001 111.459 173.587 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.4 t -64.74 -45.09 96.21 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 N-CA-C 108.492 -0.929 . . . . 0.29999999999999999 108.492 178.111 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 11.3 mt -60.14 -42.85 91.52 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 N-CA-C 108.725 -0.843 . . . . 0.34999999999999998 108.725 178.674 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 40.5 t -63.1 -52.67 56.04 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 N-CA-C 109.294 -0.632 . . . . 0.27000000000000002 109.294 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -53.07 -46.49 61.69 Favored Glycine 0 CA--C 1.529 0.968 0 N-CA-C 111.551 -0.62 . . . . 0.32000000000000001 111.551 175.858 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -57.47 -49.12 77.29 Favored 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 123.409 0.684 . . . . 0.55000000000000004 110.406 177.476 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 10.3 tp -58.88 -46.17 88.44 Favored 'General case' 0 N--CA 1.44 -0.935 0 C-N-CA 123.739 0.816 . . . . 0.55000000000000004 109.206 178.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 84.9 mt . . . . . 0 CA--C 1.533 0.314 0 O-C-N 121.792 -0.568 . . . . 1.6299999999999999 111.169 178.737 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 47.8 tp . . . . . 0 N--CA 1.454 -0.233 0 N-CA-C 109.233 -0.654 . . . . 2.2599999999999998 109.233 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -57.53 -46.13 84.23 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-O 121.26 0.553 . . . . 2.2999999999999998 110.231 175.372 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 43.6 t -60.46 -45.15 97.3 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 N-CA-C 109.384 -0.599 . . . . 0.64000000000000001 109.384 176.571 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 72.2 t -56.32 -45.82 81.53 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.217 0 CA-C-O 118.876 -0.583 . . . . 0.55000000000000004 110.132 175.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 55.5 t -56.44 -48.98 79.21 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 CA-C-N 119.504 1.047 . . . . 0.56000000000000005 110.102 177.125 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 69.9 t -55.76 -45.75 79.51 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 O-C-N 121.786 -0.571 . . . . 0.39000000000000001 110.905 176.449 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 53.2 t -60.23 -46.87 94.13 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.18 0 N-CA-C 109.248 -0.649 . . . . 0.34000000000000002 109.248 178.841 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 48.9 t -54.48 -49.42 65.81 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 C-N-CA 123.7 0.8 . . . . 0.55000000000000004 110.118 177.145 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 42.2 t -57.01 -47.19 83.93 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 CA-C-N 118.435 0.561 . . . . 0.51000000000000001 110.537 177.744 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.19 -47.44 83.43 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 123.053 0.541 . . . . 0.37 109.553 177.546 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 16.0 t -62.94 -40.4 88.78 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.893 0 C-N-CA 123.909 0.884 . . . . 0.39000000000000001 110.049 -178.886 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 7.5 t -63.55 -47.13 92.9 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.48 0 O-C-N 121.542 -0.724 . . . . 0.41999999999999998 109.503 175.841 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 1.4 t -54.69 -41.37 55.62 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.579 0 CA-C-N 119.107 0.867 . . . . 0.35999999999999999 111.212 172.805 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.4 t -64.51 -45.7 94.9 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.19 0 N-CA-C 108.627 -0.879 . . . . 0.34000000000000002 108.627 179.249 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 11.1 mt -59.89 -43.99 93.35 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 N-CA-C 108.75 -0.833 . . . . 0.40999999999999998 108.75 178.689 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 37.4 t -64.89 -49.74 78.43 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.266 0 N-CA-C 109.535 -0.543 . . . . 0.34000000000000002 109.535 -176.814 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -55.77 -50.33 61.5 Favored Glycine 0 CA--C 1.528 0.897 0 N-CA-C 111.128 -0.789 . . . . 0.41999999999999998 111.128 174.229 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -55.15 -42.3 72.92 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 117.325 0.563 . . . . 0.56999999999999995 111.048 178.835 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 10.2 tp -59.87 -62.36 1.93 Allowed 'General case' 0 N--CA 1.439 -1.023 0 N-CA-C 108.512 -0.921 . . . . 0.65000000000000002 108.512 175.052 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . 0.269 2.9 pp . . . . . 0 N--CA 1.465 0.319 0 CA-C-N 119.223 0.92 . . . . 2.9199999999999999 113.267 -170.357 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.9 tt . . . . . 0 CA--C 1.534 0.358 0 N-CA-C 108.288 -1.005 . . . . 2.1299999999999999 108.288 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.24 -46.06 79.75 Favored 'General case' 0 CA--C 1.535 0.396 0 O-C-N 121.927 -0.483 . . . . 2.71 110.369 176.062 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 89.2 t -55.89 -47.24 80.05 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 O-C-N 121.58 -0.7 . . . . 0.51000000000000001 110.591 174.655 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 51.1 t -56.27 -45.96 81.36 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.19 0 O-C-N 121.507 -0.745 . . . . 0.46999999999999997 109.892 176.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 73.0 t -53.74 -50.0 54.06 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 CA-C-N 119.246 0.93 . . . . 0.51000000000000001 110.483 174.689 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 93.2 t -55.5 -45.1 78.38 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 O-C-N 121.696 -0.627 . . . . 0.34999999999999998 111.085 176.692 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 73.8 t -60.42 -46.17 95.61 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.159 0 O-C-N 121.597 -0.689 . . . . 0.33000000000000002 109.25 178.77 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 53.0 t -55.84 -48.01 78.84 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 C-N-CA 123.407 0.683 . . . . 0.46000000000000002 110.36 177.271 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 47.0 t -56.5 -46.45 82.32 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 O-C-N 121.765 -0.585 . . . . 0.37 110.524 176.4 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -58.92 -46.69 87.35 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 123.076 0.55 . . . . 0.33000000000000002 109.63 176.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 13.5 t -61.62 -40.59 87.17 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.839 0 O-C-N 121.255 -0.903 . . . . 0.38 110.063 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 5.4 t -62.08 -47.95 90.77 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.416 0 O-C-N 121.511 -0.743 . . . . 0.37 109.841 174.808 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 1.4 t -54.94 -40.76 54.74 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 CA-C-N 119.088 0.858 . . . . 0.31 111.493 173.065 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.4 t -63.88 -45.24 97.54 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.179 0 N-CA-C 108.472 -0.936 . . . . 0.33000000000000002 108.472 178.535 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 10.1 mt -59.42 -43.74 91.11 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 N-CA-C 108.831 -0.803 . . . . 0.45000000000000001 108.831 177.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 40.9 t -63.36 -52.37 59.2 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 N-CA-C 109.489 -0.56 . . . . 0.40999999999999998 109.489 -178.444 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -52.74 -50.46 49.46 Favored Glycine 0 CA--C 1.528 0.871 0 N-CA-C 111.007 -0.837 . . . . 0.27000000000000002 111.007 174.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -55.24 -44.67 75.7 Favored 'General case' 0 CA--C 1.53 0.182 0 O-C-N 122.284 -0.539 . . . . 0.44 111.075 179.198 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 11.0 tp -61.26 -50.64 72.22 Favored 'General case' 0 N--CA 1.442 -0.869 0 C-N-CA 123.599 0.76 . . . . 0.58999999999999997 108.959 176.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 73.7 mt . . . . . 0 CA--C 1.532 0.265 0 CA-C-N 118.264 0.484 . . . . 1.6100000000000001 111.642 -179.148 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.6 tt . . . . . 0 CA--C 1.534 0.354 0 N-CA-C 108.566 -0.902 . . . . 2.0600000000000001 108.566 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -55.76 -45.82 77.99 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.223 0.609 . . . . 2.8799999999999999 110.344 176.403 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 96.3 t -55.75 -48.76 77.57 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 O-C-N 121.813 -0.554 . . . . 0.37 110.398 174.811 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 55.5 t -55.77 -47.37 79.49 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 O-C-N 121.659 -0.65 . . . . 0.69999999999999996 109.935 176.646 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 72.0 t -54.29 -49.67 61.97 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 CA-C-N 118.783 0.719 . . . . 0.83999999999999997 110.389 176.247 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 73.5 t -56.0 -44.7 79.18 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 O-C-N 121.641 -0.662 . . . . 0.48999999999999999 110.864 177.164 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 54.6 t -59.9 -48.09 89.07 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.168 0 N-CA-C 109.067 -0.716 . . . . 0.46999999999999997 109.067 178.329 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 60.1 t -55.19 -48.92 75.77 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 C-N-CA 122.943 0.497 . . . . 0.87 110.32 177.315 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 42.2 t -56.74 -45.76 82.98 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 C-N-CA 123.632 0.773 . . . . 0.66000000000000003 110.601 177.237 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.25 -47.91 83.6 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 123.402 0.681 . . . . 0.41999999999999998 109.405 177.455 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 20.3 t -61.51 -40.88 87.99 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.838 0 O-C-N 121.484 -0.76 . . . . 0.60999999999999999 110.0 179.481 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 4.1 t -62.0 -45.8 97.9 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.39 0 C-N-CA 123.556 0.742 . . . . 0.58999999999999997 109.887 175.029 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 1.4 t -57.26 -40.46 73.9 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 CA-C-N 119.437 1.017 . . . . 0.37 111.34 173.329 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.4 t -62.87 -45.3 99.21 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 N-CA-C 108.398 -0.964 . . . . 0.40999999999999998 108.398 177.339 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 10.9 mt -61.22 -41.37 89.33 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 N-CA-C 109.232 -0.655 . . . . 0.53000000000000003 109.232 178.675 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 32.9 t -62.74 -50.3 80.27 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.277 0 N-CA-C 108.957 -0.757 . . . . 0.46000000000000002 108.957 179.071 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -52.65 -47.23 58.34 Favored Glycine 0 CA--C 1.53 1.021 0 N-CA-C 111.527 -0.629 . . . . 0.32000000000000001 111.527 173.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -57.01 -49.58 75.35 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 123.224 0.61 . . . . 0.73999999999999999 110.551 177.583 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 10.4 tp -58.6 -45.63 88.72 Favored 'General case' 0 N--CA 1.441 -0.909 0 C-N-CA 124.351 1.06 . . . . 0.93000000000000005 109.216 178.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 66.4 mt . . . . . 0 CA--C 1.533 0.311 0 O-C-N 121.713 -0.617 . . . . 1.77 111.017 177.871 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.4 tt . . . . . 0 N--CA 1.452 -0.336 0 N-CA-C 108.107 -1.072 . . . . 1.97 108.107 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 10.3 tp -55.39 -45.89 76.58 Favored 'General case' 0 N--CA 1.453 -0.293 0 O-C-N 121.81 -0.556 . . . . 2.0 111.375 174.579 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 94.3 t -56.15 -49.13 77.67 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 N-CA-C 110.068 -0.345 . . . . 0.37 110.068 174.623 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 49.2 t -56.07 -46.5 80.85 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 O-C-N 121.796 -0.565 . . . . 0.53000000000000003 110.195 177.502 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 53.1 t -54.64 -50.55 58.76 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 CA-C-N 118.952 0.796 . . . . 0.55000000000000004 110.043 176.433 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 78.7 t -55.6 -45.23 78.78 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 O-C-N 121.859 -0.526 . . . . 0.34000000000000002 110.8 177.142 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 61.9 t -60.15 -47.47 91.9 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.136 0 N-CA-C 109.191 -0.67 . . . . 0.34999999999999998 109.191 178.829 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 55.7 t -55.15 -49.16 74.27 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 C-N-CA 123.487 0.715 . . . . 0.57999999999999996 110.25 177.548 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 46.1 t -57.43 -46.25 85.7 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 C-N-CA 123.246 0.618 . . . . 0.5 110.473 177.631 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -59.06 -47.25 85.91 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 123.204 0.602 . . . . 0.31 109.422 177.374 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 14.2 t -61.61 -41.11 89.01 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.821 0 C-N-CA 123.814 0.846 . . . . 0.39000000000000001 110.003 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 4.1 t -62.24 -47.14 94.48 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 O-C-N 121.541 -0.724 . . . . 0.42999999999999999 109.852 175.172 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 1.4 t -56.11 -39.97 61.74 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.6 0 CA-C-N 119.085 0.857 . . . . 0.33000000000000002 111.349 173.418 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.4 t -64.03 -46.0 95.1 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.203 0 N-CA-C 108.411 -0.959 . . . . 0.28999999999999998 108.411 177.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 10.6 mt -59.95 -43.0 91.34 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 N-CA-C 108.825 -0.806 . . . . 0.40000000000000002 108.825 178.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 39.2 t -61.71 -54.71 31.05 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 N-CA-C 108.933 -0.766 . . . . 0.29999999999999999 108.933 179.827 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -52.59 -45.17 59.93 Favored Glycine 0 CA--C 1.53 0.985 0 N-CA-C 111.703 -0.559 . . . . 0.32000000000000001 111.703 176.535 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -57.77 -44.78 86.41 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 123.498 0.719 . . . . 0.52000000000000002 110.712 177.274 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 9.7 tp -60.9 -51.97 67.04 Favored 'General case' 0 N--CA 1.439 -0.983 0 C-N-CA 124.014 0.926 . . . . 0.63 109.235 177.861 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 5.5 mp . . . . . 0 CA--C 1.533 0.303 0 CA-C-N 119.231 0.923 . . . . 2.0899999999999999 112.14 175.546 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 63.2 tp . . . . . 0 N--CA 1.451 -0.395 0 N-CA-C 108.6 -0.889 . . . . 2.2999999999999998 108.6 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 1.6 tt -58.42 -46.13 87.07 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-O 120.984 0.421 . . . . 2.5499999999999998 110.469 178.498 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 71.4 t -55.8 -49.39 74.93 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 N-CA-C 109.863 -0.421 . . . . 0.54000000000000004 109.863 174.684 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 25.5 t -57.0 -45.61 83.86 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.365 0 CA-C-O 118.505 -0.759 . . . . 0.70999999999999996 110.252 178.514 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 49.3 t -54.2 -52.11 41.06 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 CA-C-N 119.693 1.133 . . . . 0.72999999999999998 110.008 177.277 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 85.1 t -57.41 -47.18 85.3 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 O-C-N 121.949 -0.469 . . . . 0.42999999999999999 111.004 178.67 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 57.3 t -60.66 -45.35 97.64 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 N-CA-C 109.219 -0.66 . . . . 0.45000000000000001 109.219 -179.132 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 46.8 t -55.68 -48.79 77.33 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 C-N-CA 124.069 0.948 . . . . 0.58999999999999997 110.099 177.076 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 44.2 t -57.88 -47.71 85.63 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 CA-C-N 118.779 0.718 . . . . 0.52000000000000002 110.601 177.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -59.23 -46.65 87.89 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 109.551 -0.537 . . . . 0.55000000000000004 109.551 178.327 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.5 t -62.55 -39.36 84.25 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.923 0 C-N-CA 124.442 1.097 . . . . 0.48999999999999999 110.04 -179.682 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 3.4 t -63.23 -48.92 85.26 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.391 0 CA-C-N 118.963 0.801 . . . . 0.45000000000000001 109.569 175.285 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 1.3 t -53.99 -41.84 51.57 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 CA-C-N 118.881 0.764 . . . . 0.41999999999999998 111.286 173.242 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.4 t -65.43 -44.45 94.39 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.266 0 N-CA-C 108.667 -0.864 . . . . 0.44 108.667 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 12.3 mt -59.34 -44.29 92.06 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.57 0 N-CA-C 108.379 -0.971 . . . . 0.45000000000000001 108.379 178.117 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 39.2 t -64.36 -52.95 49.03 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 N-CA-C 109.568 -0.53 . . . . 0.37 109.568 -177.159 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -55.22 -48.24 69.81 Favored Glycine 0 CA--C 1.529 0.934 0 N-CA-C 111.512 -0.635 . . . . 0.31 111.512 175.846 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -55.56 -44.98 77.35 Favored 'General case' 0 N--CA 1.454 -0.226 0 O-C-N 122.15 -0.618 . . . . 0.57999999999999996 110.592 177.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 11.9 tp -62.92 -53.9 46.92 Favored 'General case' 0 N--CA 1.437 -1.102 0 C-N-CA 123.613 0.765 . . . . 0.85999999999999999 109.045 179.187 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . 0.305 3.1 pp . . . . . 0 CA--C 1.531 0.239 0 CA-C-N 119.375 0.989 . . . . 3.0800000000000001 112.568 -175.121 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 3.9 mm? . . . . . 0 N--CA 1.474 0.758 0 N-CA-C 105.083 -2.192 . . . . 18.390000000000001 105.083 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 7.5 ptm180 48.49 -176.25 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.969 1.707 . . . . 17.27 112.846 -169.477 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 47.8 pt -74.27 140.07 76.0 Favored Pre-proline 0 N--CA 1.448 -0.545 0 N-CA-C 106.811 -1.551 . . . . 14.029999999999999 106.811 163.332 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -64.65 -66.28 0.05 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.007 0 C-N-CA 121.653 1.569 . . . . 8.7400000000000002 109.951 -176.323 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 48.6 t -163.72 63.77 0.16 Allowed 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 106.276 -1.75 . . . . 9.6699999999999999 106.276 -179.253 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 46.0 t 88.24 134.59 0.04 OUTLIER Pre-proline 0 CA--C 1.533 0.315 0 C-N-CA 128.587 2.755 . . . . 8.9700000000000006 108.351 -164.381 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -61.47 136.44 63.44 Favored 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 121.667 1.578 . . . . 5.8399999999999999 110.894 177.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.4 t -80.72 -133.25 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 C-N-CA 125.69 1.596 . . . . 5.0999999999999996 108.608 -178.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 14.7 p-10 -46.45 -27.78 1.19 Allowed 'General case' 0 CA--C 1.539 0.534 0 O-C-N 120.858 -1.151 . . . . 4.4199999999999999 113.409 174.27 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -54.03 -35.32 61.84 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 123.882 0.873 . . . . 3.1099999999999999 110.182 174.624 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 55.4 tptt -58.29 -54.2 49.73 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 123.098 0.559 . . . . 4.6299999999999999 109.785 175.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 38.1 ptt180 -69.52 -26.37 64.49 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 119.567 -0.853 . . . . 6.1600000000000001 111.339 -177.515 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -59.04 -51.0 71.96 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 108.69 -0.856 . . . . 2.9199999999999999 108.69 168.615 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 10.2 tp -55.23 -45.58 75.97 Favored 'General case' 0 N--CA 1.453 -0.309 0 O-C-N 121.873 -0.517 . . . . 2.1299999999999999 111.149 176.081 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 89.7 t -55.12 -48.82 75.72 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 O-C-N 122.199 -0.313 . . . . 0.40000000000000002 110.156 174.544 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 55.3 t -56.54 -46.79 82.58 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 CA-C-N 118.612 0.642 . . . . 0.58999999999999997 110.182 177.119 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 72.3 t -54.52 -50.46 58.32 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 CA-C-N 118.771 0.714 . . . . 0.75 110.451 175.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 73.0 t -56.27 -44.34 79.25 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 O-C-N 121.636 -0.665 . . . . 0.5 110.843 177.537 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 46.4 t -60.04 -48.11 89.21 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.177 0 N-CA-C 108.904 -0.776 . . . . 0.42999999999999999 108.904 178.262 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 41.9 t -54.02 -50.19 55.64 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 C-N-CA 123.203 0.601 . . . . 0.58999999999999997 110.486 176.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 46.9 t -56.96 -46.69 83.98 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 C-N-CA 123.4 0.68 . . . . 0.59999999999999998 110.79 177.57 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -59.38 -46.93 87.31 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 123.352 0.661 . . . . 0.38 109.39 177.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 13.7 t -61.32 -40.76 87.24 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.795 0 C-N-CA 123.881 0.873 . . . . 0.40000000000000002 109.951 179.291 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 3.2 t -62.0 -47.64 92.24 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.359 0 O-C-N 121.56 -0.713 . . . . 0.41999999999999998 110.028 174.804 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 1.4 t -55.36 -40.66 58.28 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 CA-C-N 119.115 0.87 . . . . 0.32000000000000001 111.407 173.262 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.4 t -63.9 -46.11 95.09 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.235 0 N-CA-C 108.349 -0.982 . . . . 0.29999999999999999 108.349 178.363 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 10.8 mt -59.34 -42.61 87.93 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 N-CA-C 108.92 -0.771 . . . . 0.40000000000000002 108.92 178.629 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 39.6 t -63.37 -52.79 53.76 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 N-CA-C 109.423 -0.584 . . . . 0.33000000000000002 109.423 -179.673 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -52.27 -47.27 56.2 Favored Glycine 0 CA--C 1.53 1.009 0 N-CA-C 111.527 -0.629 . . . . 0.37 111.527 175.363 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -56.88 -49.83 74.33 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 123.446 0.698 . . . . 0.67000000000000004 110.46 178.231 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 11.2 tp -59.46 -44.63 92.93 Favored 'General case' 0 N--CA 1.44 -0.939 0 C-N-CA 123.776 0.83 . . . . 0.67000000000000004 109.465 178.409 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 85.3 mt -61.3 -39.78 91.71 Favored 'General case' 0 CA--C 1.533 0.302 0 O-C-N 121.431 -0.793 . . . . 1.6799999999999999 111.23 178.01 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 16.9 tpt -63.65 -44.38 94.02 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 118.145 0.43 . . . . 4.8499999999999996 110.354 173.804 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -179.9 -67.6 0.07 OUTLIER Glycine 0 CA--C 1.528 0.864 0 N-CA-C 111.022 -0.831 . . . . 3.52 111.022 176.247 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 3.1 mm? . . . . . 0 N--CA 1.447 -0.589 0 N-CA-C 104.108 -2.553 . . . . 6.29 104.108 175.317 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.473 0.692 0 CA-C-O 118.198 -0.906 . . . . 16.670000000000002 108.575 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 62.8 ttm-85 -153.83 91.47 1.46 Allowed 'General case' 0 N--CA 1.455 -0.183 0 N-CA-C 107.608 -1.256 . . . . 16.469999999999999 107.608 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 42.9 mm -117.37 82.09 14.56 Favored Pre-proline 0 CA--C 1.538 0.512 0 C-N-CA 124.344 1.058 . . . . 11.960000000000001 108.689 -175.015 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -79.39 -38.41 0.41 Allowed 'Trans proline' 0 N--CA 1.456 -0.705 0 C-N-CA 122.59 2.193 . . . . 8.0299999999999994 111.001 179.496 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 96.8 m 64.37 19.68 11.88 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 125.637 1.575 . . . . 8.3900000000000006 111.298 -177.345 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 11.6 t -53.84 -55.08 39.54 Favored Pre-proline 0 CA--C 1.537 0.462 0 C-N-CA 124.226 1.01 . . . . 7.6799999999999997 112.642 -174.665 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -79.07 7.45 4.36 Favored 'Trans proline' 0 CA--C 1.539 0.773 0 C-N-CA 121.776 1.65 . . . . 4.0599999999999996 113.121 177.502 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.4 t -107.16 -133.33 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 C-N-CA 125.493 1.517 . . . . 3.0800000000000001 107.747 -174.546 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 53.2 p-10 -42.23 -39.57 2.11 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.951 1.3 . . . . 4.3200000000000003 114.161 179.322 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -57.95 -49.14 77.81 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 119.243 0.929 . . . . 3.0699999999999998 109.569 174.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 3.3 tmtm? -59.79 -48.19 82.67 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 108.804 -0.813 . . . . 4.0599999999999996 108.804 177.033 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 39.9 ttt-85 -66.46 -26.86 67.4 Favored 'General case' 0 N--CA 1.448 -0.529 0 O-C-N 122.171 -0.331 . . . . 5.3399999999999999 111.673 -176.107 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -67.57 -50.35 58.87 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 107.839 -1.171 . . . . 2.4900000000000002 107.839 173.177 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -55.48 -45.89 76.95 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-O 120.835 0.35 . . . . 2.4300000000000002 110.639 176.831 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 64.4 t -56.15 -49.94 73.25 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 O-C-N 121.946 -0.471 . . . . 0.46999999999999997 109.77 174.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 38.1 t -55.77 -45.79 79.58 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 CA-C-N 118.404 0.547 . . . . 0.44 110.322 177.447 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 54.2 t -55.72 -51.17 62.11 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.375 0 CA-C-N 119.158 0.89 . . . . 0.45000000000000001 110.314 177.113 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 73.3 t -56.22 -45.18 80.98 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 O-C-N 121.791 -0.568 . . . . 0.35999999999999999 110.903 177.341 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 54.8 t -60.87 -46.4 96.41 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 N-CA-C 109.152 -0.684 . . . . 0.34999999999999998 109.152 179.504 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 47.8 t -55.19 -49.01 75.62 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 C-N-CA 123.481 0.712 . . . . 0.44 110.278 176.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 46.2 t -57.08 -46.85 84.46 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 O-C-N 121.815 -0.553 . . . . 0.40000000000000002 110.635 177.244 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.13 -47.35 83.59 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 123.265 0.626 . . . . 0.40999999999999998 109.524 177.135 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 11.7 t -62.38 -40.8 89.31 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.814 0 C-N-CA 124.033 0.933 . . . . 0.37 109.939 -179.093 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 5.1 t -62.63 -47.98 90.37 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.411 0 O-C-N 121.649 -0.657 . . . . 0.35999999999999999 109.654 175.273 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 1.5 t -55.09 -40.35 54.32 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.585 0 CA-C-N 119.051 0.842 . . . . 0.32000000000000001 111.144 173.453 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.4 t -65.32 -45.48 93.3 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.249 0 N-CA-C 108.687 -0.857 . . . . 0.33000000000000002 108.687 179.025 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 11.2 mt -59.85 -44.55 94.44 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.525 0 N-CA-C 108.566 -0.902 . . . . 0.37 108.566 178.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 38.8 t -63.97 -51.77 65.02 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 N-CA-C 109.371 -0.603 . . . . 0.39000000000000001 109.371 -177.49 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -54.0 -49.81 57.51 Favored Glycine 0 CA--C 1.528 0.868 0 N-CA-C 111.063 -0.815 . . . . 0.29999999999999999 111.063 175.028 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -56.01 -41.9 75.61 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 123.305 0.642 . . . . 0.56999999999999995 111.313 179.465 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 10.7 tp -61.2 -58.09 9.75 Favored 'General case' 0 N--CA 1.439 -0.987 0 N-CA-C 108.338 -0.986 . . . . 0.76000000000000001 108.338 174.054 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 75.6 mt -56.5 -36.7 69.46 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 123.823 0.849 . . . . 1.6699999999999999 112.497 -173.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 50.7 mtt -57.67 -29.7 64.84 Favored 'General case' 0 CA--C 1.535 0.382 0 O-C-N 121.914 -0.491 . . . . 3.8799999999999999 111.422 175.684 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -90.56 -68.23 1.2 Allowed Glycine 0 CA--C 1.529 0.962 0 C-N-CA 124.226 0.917 . . . . 4.21 111.134 173.143 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 3.6 mm? . . . . . 0 N--CA 1.451 -0.377 0 C-N-CA 126.054 1.742 . . . . 8.5099999999999998 107.226 -174.686 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.472 0.663 0 CA-C-O 117.381 -1.295 . . . . 18.93 108.65 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . 0.252 0.0 OUTLIER 38.66 98.84 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 127.646 2.378 . . . . 17.329999999999998 115.215 -175.937 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 16.8 mm 33.94 73.26 0.6 Allowed Pre-proline 0 CA--C 1.543 0.695 0 C-N-CA 125.569 1.547 . . . . 14.16 113.108 159.625 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -75.54 157.99 40.28 Favored 'Trans proline' 0 N--CA 1.452 -0.917 0 C-N-CA 122.561 2.174 . . . . 9.9000000000000004 109.268 174.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 20.7 p -152.52 15.79 0.6 Allowed 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 112.624 0.602 . . . . 8.3499999999999996 112.624 178.255 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 52.1 t -121.9 97.26 46.25 Favored Pre-proline 0 CA--C 1.532 0.265 0 C-N-CA 123.528 0.731 . . . . 7.7400000000000002 109.629 -178.206 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -79.98 57.22 6.4 Favored 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 122.872 2.381 . . . . 3.7799999999999998 110.893 -175.188 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 10.4 p -96.13 -136.05 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 N-CA-C 106.17 -1.789 . . . . 4.9199999999999999 106.17 163.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 51.68 -88.97 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 126.178 1.791 . . . . 4.3099999999999996 112.087 169.174 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 6.2 tt -53.97 -45.18 71.3 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 125.465 1.506 . . . . 3.3100000000000001 108.529 175.223 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 50.4 tttp -59.04 -42.7 90.88 Favored 'General case' 0 CA--C 1.534 0.355 0 O-C-N 121.756 -0.59 . . . . 3.8100000000000001 110.403 176.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.58 -26.88 64.68 Favored 'General case' 0 N--CA 1.452 -0.326 0 O-C-N 121.759 -0.588 . . . . 6.6600000000000001 110.636 179.096 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.1 tt -64.87 -48.23 75.01 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 108.09 -1.078 . . . . 2.0 108.09 171.649 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 11.0 tp -54.41 -46.0 73.06 Favored 'General case' 0 N--CA 1.454 -0.255 0 O-C-N 121.922 -0.486 . . . . 2.1200000000000001 111.245 174.804 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 79.9 t -57.81 -47.64 85.57 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 O-C-N 122.16 -0.337 . . . . 0.41999999999999998 110.241 174.74 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 49.6 t -55.68 -44.83 78.38 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 O-C-N 121.718 -0.614 . . . . 0.48999999999999999 110.218 176.371 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 68.7 t -56.35 -49.33 77.36 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 CA-C-N 119.203 0.911 . . . . 0.5 110.472 175.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 76.4 t -55.24 -45.15 77.47 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 O-C-N 121.564 -0.71 . . . . 0.37 110.704 176.151 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 70.1 t -60.17 -46.19 94.92 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.191 0 N-CA-C 109.163 -0.68 . . . . 0.34999999999999998 109.163 177.689 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 41.1 t -54.7 -48.58 72.14 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 C-N-CA 123.471 0.709 . . . . 0.48999999999999999 110.572 177.084 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 53.9 t -56.47 -46.97 82.4 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 CA-C-N 118.673 0.669 . . . . 0.44 110.598 177.12 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -59.08 -47.29 85.81 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 109.514 -0.551 . . . . 0.31 109.514 177.104 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 15.9 t -61.67 -38.49 80.46 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.878 0 C-N-CA 124.145 0.978 . . . . 0.39000000000000001 110.179 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 2.9 t -62.64 -49.45 83.72 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.334 0 C-N-CA 123.616 0.767 . . . . 0.5 109.562 174.417 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 1.3 t -54.25 -41.49 52.37 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 CA-C-N 119.207 0.912 . . . . 0.39000000000000001 111.384 173.369 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.4 t -64.33 -44.76 97.29 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 N-CA-C 108.706 -0.85 . . . . 0.32000000000000001 108.706 179.013 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 11.3 mt -59.85 -43.04 91.08 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 N-CA-C 108.627 -0.879 . . . . 0.5 108.627 178.259 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 39.5 t -61.71 -57.57 11.5 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 N-CA-C 108.809 -0.812 . . . . 0.42999999999999999 108.809 -179.273 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -53.01 -45.18 62.27 Favored Glycine 0 CA--C 1.533 1.18 0 C-N-CA 120.972 -0.632 . . . . 0.47999999999999998 111.936 176.565 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -60.55 -32.73 71.78 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 124.135 0.974 . . . . 1.0 111.868 179.243 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 13.2 tp -70.12 -60.33 2.35 Favored 'General case' 0 N--CA 1.435 -1.209 0 N-CA-C 107.49 -1.3 . . . . 0.79000000000000004 107.49 172.519 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 5.3 mp -57.65 -35.49 70.59 Favored 'General case' 0 C--N 1.341 0.237 0 N-CA-C 113.412 0.893 . . . . 2.5499999999999998 113.412 -171.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 28.1 ptm -61.05 -25.58 67.02 Favored 'General case' 0 CA--C 1.537 0.457 0 O-C-N 121.459 -0.775 . . . . 3.8799999999999999 111.941 176.233 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -91.01 -61.97 1.25 Allowed Glycine 0 CA--C 1.528 0.874 0 C-N-CA 124.625 1.107 . . . . 3.6000000000000001 111.002 175.353 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 76.1 mt . . . . . 0 N--CA 1.446 -0.649 0 C-N-CA 125.767 1.627 . . . . 7.96 107.705 -173.167 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 10.7 mp . . . . . 0 N--CA 1.475 0.812 0 N-CA-C 106.219 -1.771 . . . . 18.530000000000001 106.219 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 55.8 mmm-85 -146.67 80.79 1.55 Allowed 'General case' 0 C--O 1.224 -0.248 0 C-N-CA 124.108 0.963 . . . . 22.859999999999999 108.593 177.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 3.8 mp 47.18 73.29 1.02 Allowed Pre-proline 0 CA--C 1.544 0.728 0 C-N-CA 125.007 1.323 . . . . 17.32 111.51 173.655 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -66.37 -25.43 49.08 Favored 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 122.261 1.974 . . . . 12.300000000000001 112.327 -177.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER 66.16 14.52 9.68 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 126.181 1.792 . . . . 12.470000000000001 112.847 172.206 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 48.7 m -83.82 -54.12 0.52 Allowed Pre-proline 0 CA--C 1.535 0.395 0 C-N-CA 124.937 1.295 . . . . 8.0800000000000001 112.644 -174.212 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -70.21 -36.81 8.98 Favored 'Trans proline' 0 N--CA 1.459 -0.513 0 C-N-CA 121.319 1.346 . . . . 5.2800000000000002 110.315 172.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 5.6 t -60.33 156.05 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 N-CA-C 107.648 -1.241 . . . . 4.5599999999999996 107.648 167.183 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 29.5 m-80 72.12 -46.69 0.65 Allowed 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 125.85 1.66 . . . . 4.1699999999999999 111.916 -176.41 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -66.76 -47.97 70.56 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 108.419 -0.956 . . . . 4.6900000000000004 108.419 175.079 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -57.78 -40.77 80.6 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-O 121.216 0.531 . . . . 3.7200000000000002 110.163 174.411 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 43.0 ttt85 -67.28 -26.41 66.53 Favored 'General case' 0 N--CA 1.44 -0.931 0 O-C-N 122.116 -0.365 . . . . 6.2300000000000004 111.592 179.246 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.3 tt -60.07 -48.75 80.4 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 108.275 -1.009 . . . . 2.0499999999999998 108.275 173.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 10.8 tp -56.51 -45.97 80.78 Favored 'General case' 0 N--CA 1.454 -0.272 0 O-C-N 121.868 -0.52 . . . . 2.27 111.477 176.279 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 99.4 t -56.65 -48.03 81.35 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 N-CA-C 109.777 -0.453 . . . . 0.53000000000000003 109.777 174.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 44.3 t -56.47 -45.76 82.01 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.291 0 CA-C-O 118.65 -0.691 . . . . 0.78000000000000003 110.058 177.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 55.9 t -54.25 -51.41 48.2 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 CA-C-N 119.572 1.078 . . . . 0.90000000000000002 110.467 176.422 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 97.8 t -57.29 -45.78 85.08 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 O-C-N 121.547 -0.721 . . . . 0.80000000000000004 111.011 177.354 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 53.7 t -59.92 -42.74 90.36 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 N-CA-C 109.382 -0.599 . . . . 0.81999999999999995 109.382 179.341 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 30.1 t -54.5 -47.42 71.18 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 C-N-CA 123.711 0.804 . . . . 1.22 110.377 177.3 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 72.8 t -59.1 -46.41 91.93 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 CA-C-N 118.829 0.741 . . . . 0.94999999999999996 110.395 178.178 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -58.93 -46.1 88.77 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 123.216 0.606 . . . . 0.64000000000000001 109.856 177.167 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.4 t -62.54 -40.51 88.52 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.898 0 C-N-CA 124.559 1.144 . . . . 0.90000000000000002 109.84 -179.486 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 5.0 t -62.51 -48.79 86.57 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.402 0 CA-C-N 118.776 0.716 . . . . 0.91000000000000003 109.65 175.042 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 1.4 t -54.58 -39.88 47.93 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 CA-C-N 118.734 0.697 . . . . 0.56000000000000005 111.38 173.611 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.4 t -66.45 -45.01 90.18 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 N-CA-C 108.891 -0.781 . . . . 0.55000000000000004 108.891 179.131 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 11.8 mt -59.01 -44.99 92.5 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 N-CA-C 108.334 -0.987 . . . . 0.81000000000000005 108.334 178.568 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 42.7 t -64.24 -53.46 43.11 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 N-CA-C 109.48 -0.563 . . . . 0.53000000000000003 109.48 -177.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -54.71 -44.31 80.05 Favored Glycine 0 CA--C 1.527 0.844 0 N-CA-C 111.568 -0.613 . . . . 0.62 111.568 176.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -60.98 -45.02 96.5 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 117.686 0.743 . . . . 0.72999999999999998 111.013 178.122 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 9.7 tp -56.93 -53.45 57.89 Favored 'General case' 0 N--CA 1.441 -0.917 0 N-CA-C 108.303 -0.999 . . . . 0.94999999999999996 108.303 175.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 85.5 mt -61.18 -37.64 83.64 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 122.804 0.442 . . . . 1.9099999999999999 111.789 -177.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 47.4 ttm -60.51 -34.45 74.11 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.067 0.547 . . . . 3.2200000000000002 110.13 174.032 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -69.85 -66.23 2.29 Favored Glycine 0 CA--C 1.529 0.913 0 N-CA-C 110.967 -0.853 . . . . 2.8999999999999999 110.967 172.629 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 3.4 pp . . . . . 0 N--CA 1.436 -1.145 0 C-N-CA 125.601 1.56 . . . . 7.7699999999999996 110.181 -169.38 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 65.2 mt . . . . . 0 N--CA 1.475 0.811 0 N-CA-C 107.918 -1.141 . . . . 17.98 107.918 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 55.0 ttt85 -161.89 156.93 23.18 Favored 'General case' 0 N--CA 1.455 -0.182 0 N-CA-C 106.749 -1.574 . . . . 15.130000000000001 106.749 178.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 64.7 mt -73.92 126.63 89.26 Favored Pre-proline 0 CA--C 1.538 0.499 0 N-CA-C 106.758 -1.571 . . . . 12.06 106.758 169.565 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -75.21 177.65 8.34 Favored 'Trans proline' 0 N--CA 1.454 -0.822 0 C-N-CA 122.679 2.252 . . . . 10.210000000000001 110.423 -178.655 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 78.6 m 64.2 48.18 2.99 Favored 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 124.254 1.022 . . . . 10.77 109.781 176.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 40.3 t -109.2 87.43 4.89 Favored Pre-proline 0 CA--C 1.535 0.388 0 C-N-CA 124.523 1.129 . . . . 5.3799999999999999 110.516 -178.49 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -77.26 63.88 7.83 Favored 'Trans proline' 0 CA--C 1.535 0.562 0 C-N-CA 123.386 2.724 . . . . 3.4500000000000002 111.518 -174.549 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 12.7 p -80.27 -133.63 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 C-N-CA 125.109 1.364 . . . . 4.3899999999999997 109.788 179.745 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 66.9 m-80 -55.51 -21.36 16.35 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.096 0.958 . . . . 3.1000000000000001 113.562 -174.075 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.7 pp -54.37 -29.31 48.07 Favored 'General case' 0 CA--C 1.536 0.418 0 O-C-N 121.3 -0.875 . . . . 4.1900000000000004 111.133 171.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 3.0 ttmp? -57.7 -56.55 20.52 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 123.685 0.794 . . . . 4.9900000000000002 109.409 172.424 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 7.4 ptp180 -67.83 -26.59 66.13 Favored 'General case' 0 C--N 1.34 0.169 0 C-N-CA 120.318 -0.553 . . . . 5.8499999999999996 111.144 -178.027 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 9.3 tt -62.45 -50.86 69.77 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 108.895 -0.78 . . . . 2.4100000000000001 108.895 173.072 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 10.5 tp -56.61 -46.07 81.1 Favored 'General case' 0 N--CA 1.453 -0.295 0 O-C-N 122.228 -0.295 . . . . 2.23 111.476 176.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 72.7 t -54.26 -50.16 58.14 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 N-CA-C 109.75 -0.463 . . . . 0.93999999999999995 109.75 174.336 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 40.6 t -58.49 -46.37 89.75 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.224 0 CA-C-O 118.681 -0.676 . . . . 0.69999999999999996 110.454 179.452 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 53.1 t -53.37 -53.33 24.76 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 CA-C-N 119.394 0.997 . . . . 0.63 109.93 176.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 69.8 t -58.1 -46.07 88.3 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 O-C-N 122.036 -0.415 . . . . 0.29999999999999999 110.974 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 48.5 t -61.44 -46.86 95.71 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 N-CA-C 109.008 -0.738 . . . . 0.34999999999999998 109.008 -178.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 43.1 t -54.14 -49.94 58.47 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 C-N-CA 123.566 0.746 . . . . 0.47999999999999998 110.038 176.414 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 44.4 t -58.28 -48.13 85.68 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 CA-C-N 118.71 0.687 . . . . 0.39000000000000001 110.864 179.166 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -59.09 -47.2 86.13 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 109.379 -0.6 . . . . 0.5 109.379 178.829 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 15.5 t -62.63 -39.59 85.21 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.985 0 C-N-CA 124.037 0.935 . . . . 0.41999999999999998 109.929 -179.264 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 3.8 t -63.83 -47.52 90.47 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.482 0 CA-C-N 118.871 0.76 . . . . 0.35999999999999999 109.6 175.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 1.4 t -54.76 -41.6 57.46 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.602 0 CA-C-N 119.061 0.846 . . . . 0.35999999999999999 111.225 173.207 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.4 t -65.09 -46.33 91.57 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.171 0 N-CA-C 108.648 -0.871 . . . . 0.46000000000000002 108.648 179.746 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 13.1 mt -59.82 -43.52 92.01 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 N-CA-C 108.421 -0.955 . . . . 0.47999999999999998 108.421 179.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 27.3 t -62.99 -54.87 28.02 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 N-CA-C 109.061 -0.718 . . . . 0.35999999999999999 109.061 -178.685 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -52.33 -45.96 57.86 Favored Glycine 0 CA--C 1.529 0.961 0 N-CA-C 111.541 -0.624 . . . . 0.32000000000000001 111.541 176.14 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -61.87 -41.96 98.49 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 122.959 0.504 . . . . 0.45000000000000001 111.54 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 11.6 tp -63.56 -46.28 86.62 Favored 'General case' 0 N--CA 1.44 -0.928 0 N-CA-C 108.669 -0.863 . . . . 0.72999999999999998 108.669 176.23 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 82.8 mt -62.7 -47.52 83.27 Favored 'General case' 0 CA--C 1.53 0.204 0 O-C-N 122.061 -0.399 . . . . 1.95 111.182 -178.12 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 14.0 ptt? -66.79 -36.8 83.23 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 118.3 0.5 . . . . 4.04 110.394 177.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.17 76.32 1.22 Allowed Glycine 0 C--N 1.338 0.66 0 N-CA-C 109.984 -1.246 . . . . 3.3399999999999999 109.984 -178.608 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.536 0.414 0 CA-C-O 117.82 -1.086 . . . . 7.7599999999999998 111.384 161.342 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 68.5 tp . . . . . 0 N--CA 1.475 0.777 0 N-CA-C 108.688 -0.856 . . . . 16.239999999999998 108.688 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 30.1 ptt180 -79.59 64.26 4.41 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 118.472 0.578 . . . . 17.030000000000001 111.979 -173.407 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 16.0 mm 41.51 71.92 1.21 Allowed Pre-proline 0 CA--C 1.543 0.709 0 C-N-CA 125.933 1.693 . . . . 12.16 112.388 167.203 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -62.94 115.49 2.98 Favored 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 122.148 1.899 . . . . 9.0299999999999994 110.186 -178.613 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 23.6 p -125.87 34.72 4.83 Favored 'General case' 0 CA--C 1.529 0.135 0 C-N-CA 126.042 1.737 . . . . 6.9900000000000002 109.114 -172.168 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 46.2 t 57.83 72.04 0.96 Allowed Pre-proline 0 CA--C 1.535 0.399 0 C-N-CA 124.914 1.285 . . . . 7.5899999999999999 109.771 -167.261 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_endo -80.11 -176.8 3.4 Favored 'Trans proline' 0 N--CA 1.45 -1.048 0 C-N-CA 122.788 2.326 . . . . 6.1500000000000004 111.428 -173.504 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.9 p -52.1 155.49 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 CA-C-O 122.876 1.322 . . . . 5.1600000000000001 111.064 170.771 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 13.7 t30 68.16 -46.37 0.52 Allowed 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 127.371 2.268 . . . . 4.3300000000000001 112.96 -172.499 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.4 tt -63.57 -54.49 35.27 Favored 'General case' 0 N--CA 1.446 -0.631 0 N-CA-C 107.86 -1.163 . . . . 3.1499999999999999 107.86 174.555 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 33.4 ttmt -57.26 -44.83 84.26 Favored 'General case' 0 N--CA 1.453 -0.288 0 O-C-N 121.989 -0.444 . . . . 4.6799999999999997 110.308 176.717 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 1.2 ptt85 -65.22 -26.21 68.03 Favored 'General case' 0 C--O 1.224 -0.245 0 CA-C-O 119.521 -0.276 . . . . 6.5499999999999998 111.49 -178.311 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -58.76 -44.21 90.53 Favored 'General case' 0 C--N 1.333 -0.11 0 N-CA-C 109.005 -0.739 . . . . 2.7400000000000002 109.005 179.129 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 1.7 tt -57.61 -46.28 84.3 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-O 121.283 0.563 . . . . 2.6400000000000001 110.225 176.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 48.0 t -58.19 -46.13 88.66 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 N-CA-C 109.618 -0.512 . . . . 0.40999999999999998 109.618 176.501 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 68.6 t -57.01 -46.44 84.1 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 CA-C-O 118.515 -0.755 . . . . 0.78000000000000003 109.766 176.79 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 54.5 t -55.36 -50.35 65.98 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 CA-C-N 119.803 1.183 . . . . 0.88 110.144 177.317 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 81.1 t -56.14 -46.58 81.11 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 O-C-N 121.841 -0.537 . . . . 0.48999999999999999 110.929 177.389 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 54.3 t -60.37 -45.53 96.45 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 N-CA-C 109.212 -0.662 . . . . 0.52000000000000002 109.212 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 51.0 t -55.15 -49.7 69.94 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 C-N-CA 123.674 0.79 . . . . 0.89000000000000001 110.052 176.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 49.0 t -57.86 -47.21 86.77 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 CA-C-N 118.501 0.591 . . . . 0.71999999999999997 110.553 178.552 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -58.63 -47.13 85.42 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 123.123 0.569 . . . . 0.38 109.466 177.79 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 11.9 t -62.77 -39.72 85.93 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.898 0 C-N-CA 124.238 1.015 . . . . 0.63 109.96 -178.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 5.6 t -63.29 -48.49 87.15 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 CA-C-N 118.77 0.714 . . . . 0.68000000000000005 109.687 175.205 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 1.4 t -54.28 -41.1 50.72 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 CA-C-N 118.844 0.747 . . . . 0.42999999999999999 111.232 173.195 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.4 t -65.81 -45.08 92.52 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.278 0 N-CA-C 108.646 -0.872 . . . . 0.40999999999999998 108.646 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 11.6 mt -58.96 -45.35 92.1 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.603 0 N-CA-C 108.191 -1.04 . . . . 0.67000000000000004 108.191 178.489 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 38.4 t -63.77 -52.99 50.16 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 N-CA-C 109.697 -0.483 . . . . 0.34000000000000002 109.697 -176.745 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -54.9 -48.55 66.28 Favored Glycine 0 CA--C 1.528 0.849 0 N-CA-C 111.354 -0.698 . . . . 0.38 111.354 175.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -57.1 -41.21 78.49 Favored 'General case' 0 N--CA 1.455 -0.225 0 O-C-N 122.105 -0.644 . . . . 0.62 111.211 178.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 12.6 tp -66.73 -52.41 44.73 Favored 'General case' 0 N--CA 1.438 -1.069 0 C-N-CA 123.886 0.874 . . . . 0.59999999999999998 109.11 178.756 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . 0.298 3.6 pp -68.27 -34.29 75.91 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 119.11 0.868 . . . . 3.04 112.685 -175.285 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 73.7 mtm -68.03 -42.98 79.8 Favored 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 110.004 -0.369 . . . . 3.4300000000000002 110.004 171.394 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 94.4 72.48 1.17 Allowed Glycine 0 CA--C 1.524 0.6 0 N-CA-C 109.598 -1.401 . . . . 3.48 109.598 -178.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 2.3 pt? . . . . . 0 CA--C 1.533 0.325 0 CA-C-O 118.296 -0.859 . . . . 8.4499999999999993 111.483 168.954 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 1.7 tm? . . . . . 0 N--CA 1.474 0.775 0 N-CA-C 107.835 -1.172 . . . . 18.219999999999999 107.835 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.18 68.6 0.87 Allowed 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.817 1.247 . . . . 17.52 108.581 179.591 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.7 mp -104.47 105.3 49.34 Favored Pre-proline 0 CA--C 1.533 0.31 0 N-CA-C 105.915 -1.883 . . . . 12.880000000000001 105.915 171.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -78.23 -53.9 0.06 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.879 0 C-N-CA 121.833 1.689 . . . . 8.6199999999999992 109.717 175.332 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 25.5 p -156.97 23.89 0.32 Allowed 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 124.43 1.092 . . . . 6.8899999999999997 111.127 -172.263 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 29.5 t -53.81 -51.62 75.05 Favored Pre-proline 0 CA--C 1.54 0.574 0 N-CA-C 113.837 1.051 . . . . 7.2800000000000002 113.837 -172.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -71.85 75.92 2.09 Favored 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 122.044 1.829 . . . . 3.8399999999999999 110.301 176.5 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 10.1 p -95.36 -135.36 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 C-N-CA 125.401 1.48 . . . . 4.9699999999999998 109.897 -176.227 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -54.05 -34.37 59.86 Favored 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 124.331 1.052 . . . . 3.75 110.642 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 10.0 tt -54.47 -39.12 67.16 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 124.027 0.931 . . . . 4.04 109.906 177.787 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 28.1 tptp -63.67 -42.87 97.99 Favored 'General case' 0 N--CA 1.451 -0.4 0 O-C-N 121.936 -0.478 . . . . 4.0599999999999996 109.879 179.472 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 10.6 mpt_? -74.11 -26.77 60.54 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 109.884 -0.413 . . . . 9.5399999999999991 109.884 -178.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 9.9 tt -64.18 -45.36 88.71 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 108.413 -0.958 . . . . 1.98 108.413 172.222 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 10.9 tp -56.04 -45.85 79.08 Favored 'General case' 0 N--CA 1.454 -0.239 0 O-C-N 122.223 -0.298 . . . . 1.8600000000000001 111.232 174.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 93.5 t -56.66 -49.75 76.74 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 N-CA-C 110.185 -0.302 . . . . 0.40999999999999998 110.185 174.567 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 54.8 t -55.29 -46.0 77.98 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 O-C-N 121.87 -0.519 . . . . 0.57999999999999996 110.039 177.166 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 54.3 t -56.17 -47.87 80.09 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 CA-C-N 118.833 0.742 . . . . 0.58999999999999997 110.222 177.084 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 76.0 t -54.9 -45.37 75.45 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 CA-C-N 118.683 0.674 . . . . 0.56999999999999995 110.78 175.13 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 87.2 t -60.23 -47.3 92.76 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.182 0 N-CA-C 109.28 -0.637 . . . . 0.48999999999999999 109.28 178.579 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 53.1 t -55.12 -49.09 74.73 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 C-N-CA 123.48 0.712 . . . . 0.54000000000000004 110.406 177.531 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 41.8 t -56.98 -46.23 83.94 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 C-N-CA 123.485 0.714 . . . . 0.52000000000000002 110.22 177.3 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -58.59 -47.4 84.43 Favored 'General case' 0 N--CA 1.45 -0.425 0 N-CA-C 109.363 -0.606 . . . . 0.67000000000000004 109.363 177.148 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.7 t -62.12 -41.3 90.69 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.829 0 O-C-N 121.316 -0.865 . . . . 0.53000000000000003 110.045 -179.482 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 4.3 t -62.91 -47.11 94.38 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 O-C-N 121.512 -0.742 . . . . 0.40999999999999998 109.83 175.694 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 2.1 t -56.86 -37.69 55.21 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.707 0 CA-C-N 118.812 0.733 . . . . 0.46999999999999997 110.957 173.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.4 t -66.64 -46.9 84.87 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.245 0 N-CA-C 108.447 -0.946 . . . . 0.47999999999999998 108.447 178.034 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 10.7 mt -58.28 -45.89 89.08 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 N-CA-C 108.569 -0.9 . . . . 0.44 108.569 179.283 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 43.6 t -65.65 -50.95 68.22 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 N-CA-C 109.382 -0.599 . . . . 0.41999999999999998 109.382 -176.723 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -53.08 -49.0 57.47 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 111.101 -0.799 . . . . 0.42999999999999999 111.101 176.06 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -57.54 -47.86 80.86 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.507 0.723 . . . . 0.68999999999999995 110.643 178.273 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 10.8 tp -59.04 -46.94 86.95 Favored 'General case' 0 N--CA 1.441 -0.908 0 C-N-CA 123.679 0.792 . . . . 0.71999999999999997 109.695 178.188 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . 0.307 0.1 OUTLIER -66.67 -40.25 88.51 Favored 'General case' 0 CA--C 1.54 0.56 0 O-C-N 121.592 -0.692 . . . . 3.2000000000000002 110.732 -178.555 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 28.1 ttt -63.98 -37.24 86.71 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 123.954 0.902 . . . . 3.5699999999999998 110.688 176.366 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 86.34 59.09 1.87 Allowed Glycine 0 CA--C 1.524 0.639 0 N-CA-C 108.358 -1.897 . . . . 3.1200000000000001 108.358 -168.697 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.45 -0.444 0 N-CA-C 105.602 -1.999 . . . . 8.9399999999999995 105.602 178.427 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.473 0.692 0 CA-C-O 119.211 -0.423 . . . . 20.510000000000002 109.92 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 90.2 mmt-85 -145.18 171.71 14.15 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 105.377 -2.083 . . . . 20.359999999999999 105.377 165.109 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.5 pp -73.79 145.04 83.71 Favored Pre-proline 0 CA--C 1.535 0.401 0 N-CA-C 109.568 -0.53 . . . . 14.16 109.568 -178.611 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_endo -73.27 141.06 31.59 Favored 'Trans proline' 0 N--CA 1.453 -0.909 0 C-N-CA 122.628 2.219 . . . . 11.01 110.031 179.231 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -155.93 54.35 0.59 Allowed 'General case' 0 C--O 1.226 -0.177 0 N-CA-C 107.699 -1.223 . . . . 9.0999999999999996 107.699 176.557 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 10.1 t -54.17 -53.39 59.31 Favored Pre-proline 0 CA--C 1.541 0.601 0 N-CA-C 113.62 0.97 . . . . 6.3099999999999996 113.62 -177.062 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -77.99 54.97 5.11 Favored 'Trans proline' 0 CA--C 1.54 0.779 0 C-N-CA 122.229 1.953 . . . . 4.1600000000000001 112.577 -174.372 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.5 t -59.83 149.0 7.13 Favored 'Isoleucine or valine' 0 C--N 1.339 0.126 0 N-CA-C 108.039 -1.097 . . . . 3.3500000000000001 108.039 171.53 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 40.2 m-80 63.5 -46.3 0.24 Allowed 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 127.026 2.13 . . . . 3.1400000000000001 113.744 -170.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 86.9 mt -64.12 -47.36 80.31 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 119.411 1.005 . . . . 3.1099999999999999 109.482 -177.01 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 2.2 tmtm? -60.82 -37.01 80.54 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.491 -0.322 . . . . 4.0300000000000002 110.777 -174.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.05 -26.56 26.93 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 122.847 0.459 . . . . 6.7000000000000002 111.918 177.768 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 9.1 tt -60.52 -39.71 88.82 Favored 'General case' 0 C--O 1.224 -0.262 0 N-CA-C 108.972 -0.751 . . . . 1.8899999999999999 108.972 172.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 10.7 tp -52.84 -45.55 67.38 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-O 121.031 0.443 . . . . 1.9399999999999999 111.464 171.448 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 39.7 t -61.65 -44.28 98.43 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 N-CA-C 109.511 -0.551 . . . . 0.70999999999999996 109.511 176.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 90.3 t -55.53 -46.86 79.12 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 O-C-N 121.999 -0.438 . . . . 0.68000000000000005 110.051 175.026 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 67.3 t -56.06 -49.14 77.31 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 CA-C-N 118.808 0.731 . . . . 0.60999999999999999 109.809 176.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 75.1 t -56.36 -44.49 80.04 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 O-C-N 121.827 -0.546 . . . . 0.40000000000000002 111.013 177.114 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 56.0 t -61.03 -47.79 92.0 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.139 0 O-C-N 121.661 -0.65 . . . . 0.46000000000000002 109.26 178.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 54.7 t -54.78 -48.98 72.56 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 C-N-CA 123.312 0.645 . . . . 0.70999999999999996 110.199 176.805 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 38.1 t -57.13 -46.4 84.56 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 C-N-CA 123.568 0.747 . . . . 0.55000000000000004 110.544 177.445 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -59.01 -48.08 82.87 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 123.424 0.69 . . . . 0.42999999999999999 109.361 177.802 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 16.1 t -61.87 -40.98 89.02 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.848 0 O-C-N 121.387 -0.82 . . . . 0.60999999999999999 109.954 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 4.2 t -62.91 -45.89 97.71 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.507 0 O-C-N 121.543 -0.723 . . . . 0.66000000000000003 109.84 175.491 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 1.6 t -56.42 -40.26 66.22 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.631 0 CA-C-N 119.296 0.953 . . . . 0.44 110.927 173.556 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.4 t -63.57 -48.42 86.94 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 N-CA-C 108.345 -0.983 . . . . 0.40999999999999998 108.345 177.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 11.2 mt -59.43 -42.46 87.75 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 N-CA-C 109.053 -0.721 . . . . 0.68999999999999995 109.053 -179.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 32.4 t -65.06 -50.37 74.86 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 N-CA-C 109.162 -0.681 . . . . 0.46000000000000002 109.162 -178.477 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -52.1 -46.39 56.28 Favored Glycine 0 CA--C 1.53 0.981 0 N-CA-C 111.463 -0.655 . . . . 0.32000000000000001 111.463 173.641 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -59.24 -51.15 71.23 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 121.256 0.55 . . . . 0.72999999999999998 110.587 178.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 9.2 tp -54.53 -46.6 73.58 Favored 'General case' 0 N--CA 1.443 -0.817 0 C-N-CA 123.973 0.909 . . . . 0.76000000000000001 109.594 175.798 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 64.7 mt -63.17 -45.33 92.36 Favored 'General case' 0 CA--C 1.53 0.19 0 O-C-N 121.808 -0.557 . . . . 1.8500000000000001 111.536 -178.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 18.8 ptt? -65.99 -35.92 81.89 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 118.837 0.744 . . . . 4.3300000000000001 110.524 178.398 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 173.02 -47.67 0.16 Allowed Glycine 0 CA--C 1.526 0.756 0 CA-C-N 117.836 0.289 . . . . 3.23 112.513 174.075 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 3.2 tm? . . . . . 0 N--CA 1.45 -0.427 0 N-CA-C 104.58 -2.378 . . . . 7.21 104.58 -175.188 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 4.3 mm? . . . . . 0 N--CA 1.475 0.791 0 N-CA-C 106.706 -1.59 . . . . 21.280000000000001 106.706 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.18 55.33 0.76 Allowed 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 107.991 -1.115 . . . . 17.239999999999998 107.991 -179.215 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 41.3 pt -73.85 148.0 86.85 Favored Pre-proline 0 CA--C 1.538 0.499 0 C-N-CA 123.325 0.65 . . . . 13.199999999999999 111.219 -169.322 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_endo -63.26 -71.0 0.03 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.75 0 C-N-CA 122.376 2.05 . . . . 8.9499999999999993 111.597 -173.548 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 32.0 p -158.15 44.83 0.32 Allowed 'General case' 0 C--N 1.332 -0.173 0 C-N-CA 124.024 0.93 . . . . 6.79 109.52 -167.209 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 38.0 t 62.0 88.09 0.12 Allowed Pre-proline 0 CA--C 1.535 0.397 0 C-N-CA 124.606 1.162 . . . . 8.3499999999999996 110.139 -169.345 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -73.57 74.38 3.25 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 123.312 2.675 . . . . 3.7200000000000002 110.856 -173.277 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.8 p -55.79 153.95 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 CA-C-O 122.693 1.235 . . . . 3.6899999999999999 110.847 174.792 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 35.5 t30 64.8 -46.58 0.33 Allowed 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 127.769 2.427 . . . . 3.8799999999999999 113.218 -168.469 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -66.4 -48.33 70.43 Favored 'General case' 0 N--CA 1.453 -0.325 0 C-N-CA 123.588 0.755 . . . . 3.9399999999999999 109.061 -178.76 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 9.4 tmtt? -57.63 -51.45 69.46 Favored 'General case' 0 C--O 1.233 0.192 0 N-CA-C 108.57 -0.9 . . . . 4.5800000000000001 108.57 -179.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 10.4 ptm180 -69.77 -26.33 64.24 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 120.026 -0.67 . . . . 5.4100000000000001 112.469 -177.507 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 68.9 tp -63.64 -48.4 77.41 Favored 'General case' 0 N--CA 1.454 -0.275 0 N-CA-C 108.553 -0.906 . . . . 2.1899999999999999 108.553 172.548 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -57.58 -46.09 84.44 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-O 120.91 0.386 . . . . 2.2000000000000002 110.151 177.567 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 75.7 t -55.56 -49.32 74.44 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 O-C-N 121.967 -0.458 . . . . 0.41999999999999998 110.234 173.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 32.4 t -56.12 -46.04 80.88 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.204 0 CA-C-O 118.896 -0.573 . . . . 0.46999999999999997 110.089 178.348 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 55.1 t -54.92 -51.91 48.52 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.426 0 CA-C-N 119.273 0.942 . . . . 0.48999999999999999 109.924 177.073 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 70.8 t -56.24 -45.76 81.2 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 O-C-N 121.908 -0.495 . . . . 0.38 110.922 177.709 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 52.7 t -60.47 -46.22 95.66 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.309 0 N-CA-C 109.083 -0.71 . . . . 0.37 109.083 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 48.7 t -55.48 -49.5 72.94 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 C-N-CA 123.605 0.762 . . . . 0.46000000000000002 110.119 176.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 52.3 t -58.05 -46.98 87.93 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 CA-C-N 118.465 0.575 . . . . 0.47999999999999998 110.619 178.051 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -59.06 -46.83 87.25 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 123.382 0.673 . . . . 0.47999999999999998 109.488 178.017 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 10.6 t -62.08 -40.6 88.04 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.855 0 C-N-CA 124.353 1.061 . . . . 0.35999999999999999 109.909 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 3.5 t -62.32 -48.03 90.29 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.404 0 CA-C-N 118.696 0.68 . . . . 0.35999999999999999 109.685 175.048 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 1.4 t -55.59 -40.63 60.43 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 O-C-N 121.375 -0.828 . . . . 0.38 111.329 173.655 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.4 t -64.63 -44.86 96.69 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.215 0 N-CA-C 108.541 -0.911 . . . . 0.34999999999999998 108.541 178.599 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 11.5 mt -60.01 -43.67 93.06 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 N-CA-C 108.607 -0.886 . . . . 0.34000000000000002 108.607 178.473 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 39.6 t -62.95 -53.83 41.58 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 N-CA-C 109.262 -0.644 . . . . 0.28999999999999998 109.262 -178.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -53.19 -47.11 61.86 Favored Glycine 0 CA--C 1.53 1.006 0 N-CA-C 111.572 -0.611 . . . . 0.28000000000000003 111.572 175.432 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -60.34 -40.16 89.68 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 123.503 0.721 . . . . 0.56000000000000005 111.204 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 11.1 tp -63.42 -52.88 59.68 Favored 'General case' 0 N--CA 1.439 -0.991 0 N-CA-C 108.175 -1.046 . . . . 0.62 108.175 174.607 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 79.0 mt -55.91 -42.18 75.67 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 123.423 0.689 . . . . 1.6000000000000001 111.981 -177.054 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 17.6 ptp -77.35 -13.68 59.88 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 112.371 0.508 . . . . 3.3500000000000001 112.371 176.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -101.25 -40.94 2.69 Favored Glycine 0 CA--C 1.527 0.821 0 C-N-CA 124.356 0.979 . . . . 2.3999999999999999 113.512 -166.282 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.6 pt? . . . . . 0 CA--C 1.532 0.276 0 CA-C-O 117.588 -1.196 . . . . 8.5600000000000005 112.304 -176.192 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 3.0 pp . . . . . 0 N--CA 1.476 0.831 0 CA-C-O 117.824 -1.084 . . . . 16.170000000000002 108.635 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -157.65 60.52 0.48 Allowed 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 119.05 0.841 . . . . 17.449999999999999 110.285 -179.522 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 41.1 mm -116.99 89.41 29.76 Favored Pre-proline 0 CA--C 1.538 0.485 0 N-CA-C 108.027 -1.101 . . . . 12.630000000000001 108.027 -178.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -78.0 70.14 7.18 Favored 'Trans proline' 0 N--CA 1.455 -0.736 0 C-N-CA 122.639 2.226 . . . . 9.6999999999999993 110.295 -174.312 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.8 m -145.91 47.98 1.24 Allowed 'General case' 0 N--CA 1.463 0.192 0 C-N-CA 124.172 0.989 . . . . 7.3200000000000003 109.074 179.394 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 7.9 t -59.53 -57.78 24.37 Favored Pre-proline 0 CA--C 1.541 0.627 0 CA-C-O 118.429 -0.796 . . . . 7.4900000000000002 112.447 173.62 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_endo -78.67 62.21 8.24 Favored 'Trans proline' 0 CA--C 1.537 0.664 0 C-N-CA 122.382 2.055 . . . . 3.8500000000000001 111.215 -178.164 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 12.1 p -86.21 -133.56 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 C-N-CA 125.502 1.521 . . . . 4.8300000000000001 108.66 175.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 7.4 m120 -35.21 -40.87 0.15 Allowed 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 126.818 2.047 . . . . 3.54 114.024 179.325 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -54.02 -40.84 67.39 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 125.159 1.383 . . . . 3.9399999999999999 110.13 -178.582 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 82.7 tttt -57.9 -53.22 60.64 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 123.193 0.597 . . . . 3.6499999999999999 109.447 176.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 66.3 ttt-85 -67.95 -26.89 66.18 Favored 'General case' 0 N--CA 1.442 -0.832 0 O-C-N 121.914 -0.491 . . . . 5.0 111.376 -177.799 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 59.9 tp -65.43 -49.01 70.79 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 108.358 -0.979 . . . . 2.1699999999999999 108.358 173.218 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 10.9 tp -55.58 -46.02 77.29 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 117.9 0.318 . . . . 2.1000000000000001 111.186 176.394 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 75.2 t -55.18 -51.38 55.77 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 N-CA-C 110.221 -0.289 . . . . 0.58999999999999997 110.221 174.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 50.6 t -56.01 -46.03 80.5 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 O-C-N 121.725 -0.61 . . . . 0.81999999999999995 110.339 177.336 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 55.0 t -55.68 -47.03 79.65 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 CA-C-N 118.766 0.712 . . . . 0.78000000000000003 110.179 177.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 70.6 t -55.44 -45.49 78.29 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 CA-C-N 118.834 0.743 . . . . 0.53000000000000003 110.75 175.718 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 86.8 t -60.47 -47.75 91.32 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 N-CA-C 109.385 -0.598 . . . . 0.66000000000000003 109.385 178.676 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 64.0 t -54.81 -48.61 73.33 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 C-N-CA 123.395 0.678 . . . . 0.88 110.495 177.454 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 39.8 t -57.34 -45.71 85.26 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 C-N-CA 123.574 0.749 . . . . 0.66000000000000003 110.248 177.447 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.6 -47.66 83.56 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 109.469 -0.567 . . . . 0.53000000000000003 109.469 177.075 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 16.6 t -61.93 -41.95 92.84 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.774 0 O-C-N 121.42 -0.8 . . . . 0.62 110.103 -179.588 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 5.9 t -62.24 -46.06 97.31 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 O-C-N 121.565 -0.71 . . . . 0.70999999999999996 109.869 175.616 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 1.6 t -56.79 -39.48 64.57 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.644 0 CA-C-N 119.152 0.887 . . . . 0.5 110.931 173.804 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.4 t -64.25 -46.97 91.82 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.188 0 N-CA-C 108.509 -0.923 . . . . 0.45000000000000001 108.509 177.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 10.2 mt -59.5 -44.11 92.22 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 N-CA-C 108.951 -0.759 . . . . 0.58999999999999997 108.951 179.328 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 39.5 t -64.51 -49.74 79.23 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 N-CA-C 109.164 -0.68 . . . . 0.52000000000000002 109.164 -177.543 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -51.37 -52.78 31.0 Favored Glycine 0 CA--C 1.527 0.81 0 N-CA-C 110.619 -0.992 . . . . 0.53000000000000003 110.619 173.479 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -55.18 -43.98 74.85 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 122.966 0.506 . . . . 0.68000000000000005 111.176 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 10.7 tp -62.11 -46.51 88.73 Favored 'General case' 0 N--CA 1.442 -0.848 0 C-N-CA 124.012 0.925 . . . . 0.91000000000000003 109.617 176.327 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 65.5 mt -62.23 -50.26 72.45 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 118.287 0.494 . . . . 1.9299999999999999 111.532 -178.102 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 4.9 mpp? -63.48 -39.71 95.19 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 118.494 0.588 . . . . 4.1699999999999999 110.606 174.706 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 90.06 56.33 1.84 Allowed Glycine 0 CA--C 1.525 0.663 0 N-CA-C 109.164 -1.574 . . . . 2.6499999999999999 109.164 -173.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 19.8 tp . . . . . 0 CA--C 1.534 0.331 0 C-N-CA 126.219 1.808 . . . . 8.0600000000000005 110.089 -172.621 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 1.2 pt? . . . . . 0 N--CA 1.478 0.967 0 N-CA-C 113.104 0.779 . . . . 18.91 113.104 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -77.86 66.53 3.54 Favored 'General case' 0 CA--C 1.538 0.485 0 O-C-N 121.135 -0.978 . . . . 18.109999999999999 111.272 -176.777 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 55.8 mt -114.58 90.6 22.09 Favored Pre-proline 0 CA--C 1.54 0.573 0 C-N-CA 124.926 1.291 . . . . 13.33 108.765 -174.398 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -73.61 75.76 2.96 Favored 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 122.909 2.406 . . . . 9.9600000000000009 110.089 -179.1 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 31.5 p -113.41 30.21 7.4 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 125.681 1.592 . . . . 8.25 111.021 -176.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 26.1 m -53.12 104.12 0.41 Allowed Pre-proline 0 CA--C 1.532 0.28 0 C-N-CA 127.083 2.153 . . . . 7.6699999999999999 109.722 -168.848 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -84.95 67.66 6.14 Favored 'Trans proline' 0 N--CA 1.45 -1.037 0 C-N-CA 123.111 2.541 . . . . 3.9399999999999999 109.678 -166.575 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.2 t -79.62 -133.83 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 C-N-CA 123.671 0.789 . . . . 3.1200000000000001 109.933 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -62.64 -11.78 19.2 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 114.459 1.281 . . . . 4.5700000000000003 114.459 -160.423 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -55.17 -48.25 74.03 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 119.489 1.04 . . . . 3.3700000000000001 108.868 166.77 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 23.0 tptm -58.67 -47.4 84.6 Favored 'General case' 0 N--CA 1.451 -0.383 0 O-C-N 121.71 -0.619 . . . . 3.2799999999999998 109.577 175.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 35.1 mtp-105 -65.58 -26.49 67.87 Favored 'General case' 0 C--O 1.224 -0.243 0 N-CA-C 111.982 0.364 . . . . 4.7599999999999998 111.982 -178.249 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 9.5 tt -63.45 -47.8 80.36 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 108.346 -0.983 . . . . 2.0899999999999999 108.346 173.334 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 1.3 tt -56.23 -46.22 79.63 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-O 121.017 0.437 . . . . 2.1499999999999999 110.4 175.313 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 84.6 t -56.53 -48.01 81.0 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 O-C-N 121.835 -0.541 . . . . 0.40000000000000002 110.308 175.391 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 41.5 t -56.19 -45.99 81.1 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.185 0 O-C-N 121.758 -0.589 . . . . 0.5 109.885 177.11 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 54.0 t -54.89 -50.13 64.51 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 CA-C-N 119.29 0.95 . . . . 0.46999999999999997 110.207 176.376 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 73.0 t -56.2 -45.87 81.12 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 O-C-N 121.743 -0.598 . . . . 0.34000000000000002 111.007 177.32 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 56.7 t -60.2 -47.32 92.59 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 N-CA-C 109.176 -0.676 . . . . 0.40000000000000002 109.176 179.509 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 51.0 t -54.81 -49.34 70.06 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 C-N-CA 123.591 0.756 . . . . 0.46000000000000002 110.109 177.233 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 42.8 t -57.54 -46.68 86.13 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 O-C-N 121.817 -0.552 . . . . 0.38 110.528 177.82 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -58.5 -47.51 83.85 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 123.248 0.619 . . . . 0.40999999999999998 109.491 177.72 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 14.4 t -62.29 -41.18 90.57 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.842 0 C-N-CA 123.868 0.867 . . . . 0.38 109.958 -179.399 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 5.2 t -62.69 -47.16 94.22 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.49 0 O-C-N 121.605 -0.685 . . . . 0.34000000000000002 109.766 175.652 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 1.6 t -56.01 -39.7 59.35 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.643 0 CA-C-N 118.949 0.795 . . . . 0.28999999999999998 111.211 173.62 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.4 t -65.09 -45.84 93.05 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.191 0 N-CA-C 108.517 -0.919 . . . . 0.31 108.517 178.357 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 11.3 mt -59.93 -43.85 93.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 N-CA-C 108.729 -0.841 . . . . 0.35999999999999999 108.729 179.104 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 39.7 t -64.14 -51.4 69.34 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 N-CA-C 109.301 -0.629 . . . . 0.28000000000000003 109.301 -178.242 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -53.13 -49.6 55.19 Favored Glycine 0 CA--C 1.528 0.87 0 N-CA-C 110.905 -0.878 . . . . 0.28000000000000003 110.905 175.231 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -56.98 -45.43 82.92 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 123.049 0.539 . . . . 0.47999999999999998 111.079 178.857 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 10.0 tp -58.79 -50.01 75.54 Favored 'General case' 0 N--CA 1.442 -0.853 0 C-N-CA 124.004 0.922 . . . . 0.59999999999999998 109.221 176.696 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 72.9 mt -61.27 -41.49 97.03 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 118.033 0.379 . . . . 1.6499999999999999 111.115 -178.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 75.3 mtp -64.08 -49.68 71.32 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 123.36 0.664 . . . . 2.8599999999999999 110.676 177.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 140.45 88.26 0.14 Allowed Glycine 0 CA--C 1.523 0.588 0 N-CA-C 108.888 -1.685 . . . . 3.3999999999999999 108.888 -172.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.6 pp . . . . . 0 CA--C 1.534 0.355 0 CA-C-O 117.907 -1.044 . . . . 6.8099999999999996 111.102 168.9 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.473 0.724 0 CA-C-O 117.95 -1.024 . . . . 24.260000000000002 108.342 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 2.2 ptt85 -159.31 58.74 0.4 Allowed 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 118.746 0.703 . . . . 20.32 109.992 175.868 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -74.33 150.0 87.07 Favored Pre-proline 0 CA--C 1.538 0.488 0 C-N-CA 123.514 0.725 . . . . 15.789999999999999 109.352 175.26 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -67.18 -35.11 25.91 Favored 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 122.383 2.056 . . . . 11.9 111.982 -178.312 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 9.1 t 64.71 47.96 2.65 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-O 122.393 1.092 . . . . 10.19 110.322 176.46 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 32.8 t -149.79 -65.37 0.02 OUTLIER Pre-proline 0 CA--C 1.534 0.359 0 CA-C-N 114.966 -1.015 . . . . 6.04 111.594 177.62 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -73.43 67.83 4.41 Favored 'Trans proline' 0 CA--C 1.538 0.695 0 C-N-CA 122.471 2.114 . . . . 3.6000000000000001 110.62 175.092 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 20.1 t -120.58 163.19 18.42 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.187 0 C-N-CA 126.21 1.804 . . . . 3.3799999999999999 106.942 176.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 58.0 t30 70.11 -45.88 0.59 Allowed 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 126.638 1.975 . . . . 3.04 113.74 -179.755 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 8.7 tt -66.6 -50.2 63.83 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 124.293 1.037 . . . . 3.25 109.088 170.542 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.06 -38.42 79.38 Favored 'General case' 0 CA--C 1.531 0.238 0 O-C-N 121.489 -0.757 . . . . 3.3500000000000001 111.106 -169.336 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 40.1 ptt85 -65.5 -25.95 67.7 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 116.303 -0.408 . . . . 6.9800000000000004 111.952 178.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -62.13 -45.85 91.63 Favored 'General case' 0 N--CA 1.455 -0.197 0 N-CA-C 108.348 -0.982 . . . . 2.3599999999999999 108.348 178.269 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 1.3 tt -57.81 -46.11 85.14 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-O 121.032 0.444 . . . . 2.1400000000000001 110.314 177.028 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 58.4 t -57.44 -48.09 83.51 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 O-C-N 122.022 -0.424 . . . . 0.42999999999999999 109.869 176.315 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 48.2 t -56.47 -45.89 82.05 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.232 0 CA-C-O 118.871 -0.585 . . . . 0.47999999999999998 110.074 176.824 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 48.3 t -55.31 -50.47 64.68 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 CA-C-N 119.379 0.99 . . . . 0.51000000000000001 110.182 176.528 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 71.3 t -55.84 -46.17 79.95 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 O-C-N 121.812 -0.555 . . . . 0.34000000000000002 110.834 177.732 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 56.0 t -60.41 -47.01 94.32 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.227 0 N-CA-C 109.196 -0.668 . . . . 0.39000000000000001 109.196 179.508 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 47.7 t -55.36 -48.43 76.85 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 C-N-CA 123.708 0.803 . . . . 0.5 110.358 177.322 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 44.5 t -57.75 -46.97 86.86 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 CA-C-N 118.603 0.638 . . . . 0.40999999999999998 110.417 177.602 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -59.1 -47.27 85.86 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 109.456 -0.572 . . . . 0.42999999999999999 109.456 177.681 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 15.5 t -61.89 -39.48 83.7 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.886 0 C-N-CA 124.007 0.923 . . . . 0.42999999999999999 110.095 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 3.3 t -62.63 -48.2 89.33 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.38 0 C-N-CA 123.419 0.688 . . . . 0.41999999999999998 109.691 174.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 1.4 t -55.12 -41.07 57.93 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 CA-C-N 119.176 0.898 . . . . 0.37 111.415 173.216 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.4 t -63.97 -45.33 97.1 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.198 0 N-CA-C 108.549 -0.908 . . . . 0.34000000000000002 108.549 178.566 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 11.8 mt -60.09 -42.01 88.45 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 N-CA-C 108.719 -0.845 . . . . 0.41999999999999998 108.719 178.722 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 40.4 t -62.62 -55.7 22.18 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 N-CA-C 109.074 -0.713 . . . . 0.40999999999999998 109.074 179.486 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -52.47 -45.41 59.07 Favored Glycine 0 CA--C 1.531 1.089 0 N-CA-C 111.719 -0.553 . . . . 0.29999999999999999 111.719 177.11 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -56.46 -47.57 78.87 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 123.427 0.691 . . . . 0.46999999999999997 110.566 175.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 8.5 tp -58.18 -49.96 75.2 Favored 'General case' 0 N--CA 1.441 -0.899 0 C-N-CA 123.947 0.899 . . . . 0.56999999999999995 109.142 178.699 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 5.5 mp -56.01 -44.45 78.7 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 119.27 0.941 . . . . 2.0099999999999998 112.142 174.389 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 43.8 tpp -64.57 -32.09 73.58 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 118.253 0.479 . . . . 3.5699999999999998 111.557 178.329 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 99.37 44.94 2.25 Favored Glycine 0 CA--C 1.528 0.9 0 C-N-CA 125.797 1.665 . . . . 3.0899999999999999 111.007 -177.782 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 5.3 mp . . . . . 0 N--CA 1.449 -0.52 0 N-CA-C 106.315 -1.735 . . . . 8.5500000000000007 106.315 170.519 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 2.8 tm? . . . . . 0 N--CA 1.474 0.742 0 N-CA-C 105.708 -1.96 . . . . 21.059999999999999 105.708 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 80.5 mtp180 -129.86 147.0 51.58 Favored 'General case' 0 N--CA 1.457 -0.116 0 N-CA-C 106.784 -1.562 . . . . 21.739999999999998 106.784 175.601 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 11.1 pt -118.69 71.36 10.07 Favored Pre-proline 0 CA--C 1.538 0.489 0 C-N-CA 124.951 1.3 . . . . 15.67 110.385 -173.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -66.12 132.24 29.28 Favored 'Trans proline' 0 N--CA 1.452 -0.936 0 C-N-CA 121.237 1.292 . . . . 11.5 109.026 175.037 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 15.8 p -103.7 15.45 28.79 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 123.726 0.81 . . . . 9.4900000000000002 110.89 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 84.1 m -112.14 85.2 6.48 Favored Pre-proline 0 N--CA 1.455 -0.217 0 C-N-CA 125.082 1.353 . . . . 7.9900000000000002 108.584 -175.496 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -66.65 -47.41 2.85 Favored 'Trans proline' 0 N--CA 1.454 -0.838 0 C-N-CA 121.423 1.415 . . . . 4.5800000000000001 109.342 172.789 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 14.3 t -62.02 158.07 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 N-CA-C 108.336 -0.987 . . . . 3.3900000000000001 108.336 169.678 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 67.1 m-80 69.5 -35.4 0.31 Allowed 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 125.883 1.673 . . . . 3.75 114.084 -173.447 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 10.8 mp -82.41 -44.41 16.11 Favored 'General case' 0 CA--C 1.528 0.103 0 CA-C-N 118.818 0.735 . . . . 4.3799999999999999 110.483 171.2 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.06 -33.81 73.9 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 119.793 1.179 . . . . 5.3899999999999997 110.922 -173.571 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 25.0 ptt180 -64.15 -26.24 68.44 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 112.133 0.42 . . . . 7.3700000000000001 112.133 176.122 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 37.4 tp -63.52 -43.3 97.57 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 108.778 -0.823 . . . . 2.1600000000000001 108.778 -174.811 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 1.6 tt -56.8 -46.25 81.7 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-O 121.132 0.491 . . . . 2.46 110.3 176.218 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 40.6 t -59.0 -47.02 91.25 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 N-CA-C 109.412 -0.588 . . . . 0.45000000000000001 109.412 176.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 57.4 t -56.66 -46.15 82.81 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.219 0 CA-C-O 118.821 -0.609 . . . . 0.60999999999999999 110.104 176.754 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 54.1 t -55.93 -50.57 68.33 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.441 0 CA-C-N 119.35 0.977 . . . . 0.70999999999999996 109.773 177.506 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 77.3 t -56.23 -46.36 81.38 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 O-C-N 121.987 -0.446 . . . . 0.45000000000000001 110.889 177.81 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 54.7 t -60.94 -46.87 95.7 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 N-CA-C 109.104 -0.702 . . . . 0.34999999999999998 109.104 -179.576 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 48.5 t -54.62 -49.79 64.53 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.426 0 C-N-CA 123.421 0.688 . . . . 0.55000000000000004 110.179 176.755 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 46.2 t -58.63 -46.85 90.07 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.425 0 CA-C-N 118.395 0.543 . . . . 0.44 110.588 179.014 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -59.39 -47.36 85.73 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 109.296 -0.631 . . . . 0.34999999999999998 109.296 178.318 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.8 t -62.06 -40.05 86.01 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.9 0 C-N-CA 123.977 0.911 . . . . 0.38 109.997 -179.814 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 3.5 t -62.99 -47.98 90.2 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.412 0 CA-C-N 118.702 0.683 . . . . 0.39000000000000001 109.83 175.248 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 1.5 t -55.27 -40.63 57.3 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 CA-C-N 118.98 0.809 . . . . 0.31 111.048 173.851 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.4 t -65.67 -45.96 90.6 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 N-CA-C 108.674 -0.862 . . . . 0.28999999999999998 108.674 179.215 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 12.3 mt -58.86 -44.57 90.89 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 N-CA-C 108.282 -1.007 . . . . 0.38 108.282 179.133 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 39.3 t -64.1 -54.46 31.14 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 N-CA-C 109.511 -0.552 . . . . 0.34999999999999998 109.511 -177.457 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -55.18 -47.48 73.98 Favored Glycine 0 CA--C 1.529 0.939 0 N-CA-C 111.439 -0.665 . . . . 0.28999999999999998 111.439 177.349 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -57.72 -42.59 84.13 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 123.317 0.647 . . . . 0.52000000000000002 111.282 178.281 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 11.6 tp -63.08 -53.06 59.57 Favored 'General case' 0 N--CA 1.439 -1.009 0 N-CA-C 108.291 -1.003 . . . . 0.77000000000000002 108.291 177.257 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 84.3 mt -58.13 -38.13 75.93 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 118.361 0.528 . . . . 1.99 111.41 -177.825 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 38.2 ttm -83.68 6.8 19.67 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 123.557 0.743 . . . . 3.6299999999999999 111.901 177.428 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -121.95 -61.12 0.22 Allowed Glycine 0 CA--C 1.528 0.852 0 C-N-CA 125.151 1.358 . . . . 2.4900000000000002 112.497 -170.161 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 85.0 mt . . . . . 0 N--CA 1.447 -0.596 0 C-N-CA 125.069 1.348 . . . . 7.0 107.816 -170.271 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 11.1 mp . . . . . 0 N--CA 1.476 0.853 0 N-CA-C 106.691 -1.596 . . . . 20.879999999999999 106.691 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 3.2 mpt_? -120.13 158.93 25.87 Favored 'General case' 0 CA--C 1.53 0.204 0 N-CA-C 105.81 -1.922 . . . . 25.16 105.81 161.417 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 24.6 mm 50.07 68.72 3.17 Favored Pre-proline 0 CA--C 1.541 0.614 0 C-N-CA 124.831 1.252 . . . . 17.57 110.938 -178.157 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -75.04 64.72 6.1 Favored 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 123.109 2.539 . . . . 13.68 109.5 176.565 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.3 m -158.48 57.23 0.45 Allowed 'General case' 0 C--O 1.227 -0.086 0 C-N-CA 126.149 1.78 . . . . 12.41 106.375 -174.548 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 46.8 t 56.07 71.69 1.16 Allowed Pre-proline 0 CA--C 1.536 0.439 0 C-N-CA 124.77 1.228 . . . . 5.8600000000000003 111.585 178.786 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -75.78 70.17 5.9 Favored 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 123.22 2.613 . . . . 4.0999999999999996 112.145 -170.486 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 8.5 p -115.37 -133.27 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 C-N-CA 126.061 1.744 . . . . 3.79 109.739 177.365 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 20.0 p-10 -39.45 -45.88 1.59 Allowed 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.781 1.232 . . . . 4.6500000000000004 112.614 176.154 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 89.3 mt -58.06 -39.85 79.51 Favored 'General case' 0 C--O 1.227 -0.113 0 C-N-CA 124.135 0.974 . . . . 2.79 110.266 178.81 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.26 -51.27 64.43 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 123.371 0.669 . . . . 4.75 109.354 -179.725 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 14.5 ptm180 -68.45 -26.42 65.5 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 119.223 -0.991 . . . . 4.8300000000000001 111.869 179.532 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -63.46 -47.34 82.23 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 108.894 -0.78 . . . . 2.2999999999999998 108.894 171.206 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -56.09 -46.0 79.21 Favored 'General case' 0 CA--C 1.533 0.3 0 O-C-N 121.891 -0.506 . . . . 2.1000000000000001 110.251 174.886 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 85.3 t -56.16 -48.43 79.25 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 O-C-N 121.814 -0.554 . . . . 0.37 110.136 174.734 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 44.7 t -54.78 -47.05 74.82 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 CA-C-N 118.617 0.644 . . . . 0.46999999999999997 109.822 176.293 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 50.3 t -55.02 -48.44 75.83 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 CA-C-N 119.028 0.831 . . . . 0.54000000000000004 110.754 176.167 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 70.6 t -55.42 -44.99 78.03 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 O-C-N 121.447 -0.783 . . . . 0.37 110.71 175.385 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 87.0 t -60.4 -46.18 95.54 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.22 0 N-CA-C 109.073 -0.714 . . . . 0.38 109.073 178.362 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 72.4 t -55.02 -49.5 70.97 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 C-N-CA 123.218 0.607 . . . . 0.46000000000000002 110.069 177.09 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 46.5 t -56.93 -47.85 82.53 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 O-C-N 121.798 -0.564 . . . . 0.38 110.671 177.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -58.34 -47.57 83.36 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 123.23 0.612 . . . . 0.34999999999999998 109.354 177.732 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 14.2 t -62.61 -39.62 85.31 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.92 0 C-N-CA 124.162 0.985 . . . . 0.35999999999999999 110.066 -179.209 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 3.6 t -63.44 -48.25 87.99 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 CA-C-N 118.742 0.701 . . . . 0.37 109.56 175.472 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 1.5 t -55.43 -40.5 58.23 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.617 0 CA-C-N 118.909 0.777 . . . . 0.29999999999999999 110.953 173.845 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.4 t -66.17 -45.06 91.19 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.237 0 N-CA-C 108.746 -0.835 . . . . 0.28000000000000003 108.746 179.319 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 12.5 mt -59.05 -44.86 92.35 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.576 0 N-CA-C 108.285 -1.005 . . . . 0.35999999999999999 108.285 178.598 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 40.2 t -63.73 -55.4 22.74 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 N-CA-C 109.347 -0.612 . . . . 0.28000000000000003 109.347 -177.672 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -53.34 -47.51 61.95 Favored Glycine 0 CA--C 1.529 0.941 0 N-CA-C 111.428 -0.669 . . . . 0.32000000000000001 111.428 176.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -57.89 -43.41 86.1 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 123.323 0.649 . . . . 0.47999999999999998 111.142 178.6 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 13.5 tp -67.04 -45.28 77.93 Favored 'General case' 0 N--CA 1.439 -1.008 0 C-N-CA 123.698 0.799 . . . . 0.65000000000000002 109.156 178.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 84.1 mt -58.03 -42.09 84.61 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 119.087 0.858 . . . . 1.6499999999999999 110.562 176.692 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 27.6 ttt -69.46 -42.03 75.42 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 123.041 0.536 . . . . 3.8399999999999999 111.779 178.8 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -126.11 50.89 0.86 Allowed Glycine 0 CA--C 1.526 0.759 0 C-N-CA 125.794 1.664 . . . . 3.1600000000000001 111.663 -168.181 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 66.2 mt . . . . . 0 CA--C 1.532 0.265 0 C-N-CA 125.613 1.565 . . . . 8.6600000000000001 110.743 166.531 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.473 0.689 0 N-CA-C 107.168 -1.419 . . . . 18.370000000000001 107.168 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 65.21 175.21 0.21 Allowed 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 106.943 -1.502 . . . . 21.300000000000001 106.943 -158.138 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.43 ' N ' HD12 ' A' ' 3' ' ' ILE . 2.2 mp 54.2 78.55 0.38 Allowed Pre-proline 0 CA--C 1.543 0.688 0 C-N-CA 124.665 1.186 . . . . 16.800000000000001 109.564 -176.62 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -76.53 67.09 7.24 Favored 'Trans proline' 0 N--CA 1.456 -0.709 0 C-N-CA 122.931 2.421 . . . . 14.75 109.908 -177.855 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 23.7 t -104.25 28.43 6.86 Favored 'General case' 0 C--O 1.224 -0.27 0 C-N-CA 125.215 1.406 . . . . 11.640000000000001 109.246 -178.577 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 13.2 t -55.52 -49.79 90.61 Favored Pre-proline 0 CA--C 1.543 0.689 0 N-CA-C 114.178 1.177 . . . . 7.0899999999999999 114.178 173.544 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -79.26 65.38 8.87 Favored 'Trans proline' 0 CA--C 1.537 0.658 0 C-N-CA 122.015 1.81 . . . . 5.9800000000000004 112.912 -165.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.1 t -93.92 -133.66 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 C-N-CA 124.076 0.95 . . . . 3.8500000000000001 109.928 177.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -68.19 31.44 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 127.102 2.161 . . . . 3.1299999999999999 115.792 -167.261 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -114.36 -57.7 2.24 Favored 'General case' 0 N--CA 1.444 -0.736 0 C-N-CA 126.728 2.011 . . . . 3.4700000000000002 105.634 159.462 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 3.6 tmtm? -57.63 -52.1 66.81 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 123.302 0.641 . . . . 4.1900000000000004 109.642 175.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 26.8 mmm180 -64.92 -26.42 68.3 Favored 'General case' 0 N--CA 1.452 -0.328 0 O-C-N 122.288 -0.258 . . . . 6.9299999999999997 111.301 179.698 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.63 -51.02 64.81 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 108.16 -1.052 . . . . 2.6600000000000001 108.16 173.098 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 10.6 tp -55.33 -45.83 76.38 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 122.648 0.379 . . . . 1.8700000000000001 111.259 175.882 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 74.0 t -54.97 -50.15 65.06 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 N-CA-C 109.989 -0.375 . . . . 0.5 109.989 174.441 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 42.2 t -56.54 -47.33 82.12 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 CA-C-N 118.43 0.559 . . . . 0.45000000000000001 110.185 178.083 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 61.5 t -54.55 -51.18 52.74 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 CA-C-N 119.032 0.833 . . . . 0.46999999999999997 110.268 177.149 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 60.7 t -56.52 -44.87 81.65 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 O-C-N 121.819 -0.55 . . . . 0.35999999999999999 110.825 177.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 53.8 t -60.83 -47.4 93.46 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.267 0 N-CA-C 109.033 -0.729 . . . . 0.35999999999999999 109.033 179.27 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 55.4 t -54.27 -50.29 57.31 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 C-N-CA 123.32 0.648 . . . . 0.5 110.148 176.761 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 43.1 t -57.73 -46.97 86.8 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 C-N-CA 123.052 0.541 . . . . 0.51000000000000001 110.811 178.495 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -59.34 -46.99 87.08 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 123.382 0.673 . . . . 0.40000000000000002 109.328 178.123 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 15.5 t -61.89 -40.73 88.14 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.882 0 C-N-CA 124.077 0.951 . . . . 0.34999999999999998 109.898 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 4.1 t -62.24 -47.79 91.42 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.396 0 O-C-N 121.554 -0.716 . . . . 0.39000000000000001 109.78 174.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 1.4 t -55.86 -39.87 58.93 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 CA-C-N 119.137 0.88 . . . . 0.39000000000000001 111.459 173.587 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.4 t -64.74 -45.09 96.21 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 N-CA-C 108.492 -0.929 . . . . 0.29999999999999999 108.492 178.111 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 11.3 mt -60.14 -42.85 91.52 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 N-CA-C 108.725 -0.843 . . . . 0.34999999999999998 108.725 178.674 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 40.5 t -63.1 -52.67 56.04 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 N-CA-C 109.294 -0.632 . . . . 0.27000000000000002 109.294 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -53.07 -46.49 61.69 Favored Glycine 0 CA--C 1.529 0.968 0 N-CA-C 111.551 -0.62 . . . . 0.32000000000000001 111.551 175.858 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -57.47 -49.12 77.29 Favored 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 123.409 0.684 . . . . 0.55000000000000004 110.406 177.476 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 10.3 tp -58.88 -46.17 88.44 Favored 'General case' 0 N--CA 1.44 -0.935 0 C-N-CA 123.739 0.816 . . . . 0.55000000000000004 109.206 178.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 84.9 mt -61.7 -42.54 99.08 Favored 'General case' 0 CA--C 1.533 0.314 0 O-C-N 121.792 -0.568 . . . . 1.6299999999999999 111.169 178.737 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 47.9 tpp -63.73 -38.61 91.74 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 123.073 0.549 . . . . 3.7000000000000002 110.825 176.312 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 101.85 57.36 0.82 Allowed Glycine 0 CA--C 1.527 0.806 0 C-N-CA 125.709 1.623 . . . . 3.0499999999999998 109.604 -173.027 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 60.5 tp . . . . . 0 N--CA 1.45 -0.437 0 C-N-CA 126.118 1.767 . . . . 8.9900000000000002 106.396 178.235 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 1.3 pt? . . . . . 0 N--CA 1.481 1.105 0 N-CA-C 114.052 1.13 . . . . 23.780000000000001 114.052 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 96.3 mtm-85 -152.02 171.25 18.13 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 105.09 -2.189 . . . . 23.100000000000001 105.09 172.681 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.9 mp 46.9 74.31 0.83 Allowed Pre-proline 0 CA--C 1.542 0.64 0 C-N-CA 125.429 1.492 . . . . 15.539999999999999 111.851 -179.316 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -75.12 -151.81 0.04 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.856 0 C-N-CA 122.237 1.958 . . . . 12.02 108.0 164.673 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 17.4 p -103.57 26.49 8.42 Favored 'General case' 0 N--CA 1.464 0.243 0 O-C-N 120.937 -1.102 . . . . 11.49 109.489 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 33.5 t -144.61 92.13 6.03 Favored Pre-proline 0 CA--C 1.531 0.219 0 C-N-CA 125.39 1.476 . . . . 7.8300000000000001 108.556 175.153 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -72.23 -31.87 11.26 Favored 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 122.411 2.074 . . . . 5.2800000000000002 110.942 179.626 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.4 t -58.9 151.23 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.23 0 N-CA-C 108.368 -0.975 . . . . 3.0 108.368 174.168 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 69.2 m-20 68.36 -46.35 0.53 Allowed 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 126.493 1.917 . . . . 3.4300000000000002 112.585 -172.813 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -63.14 -41.61 99.32 Favored 'General case' 0 C--N 1.332 -0.162 0 C-N-CA 123.618 0.767 . . . . 4.1100000000000003 109.438 176.556 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 2.5 tmtp? -55.27 -47.52 75.36 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 108.928 -0.768 . . . . 3.0899999999999999 108.928 172.25 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.8 -26.6 66.16 Favored 'General case' 0 CA--C 1.533 0.307 0 O-C-N 122.1 -0.375 . . . . 6.1100000000000003 111.378 -178.56 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 47.8 tp -61.45 -39.06 89.46 Favored 'General case' 0 C--N 1.33 -0.251 0 O-C-N 121.534 -0.728 . . . . 2.2599999999999998 109.233 178.066 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -57.53 -46.13 84.23 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-O 121.26 0.553 . . . . 2.2999999999999998 110.231 175.372 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 43.6 t -60.46 -45.15 97.3 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 N-CA-C 109.384 -0.599 . . . . 0.64000000000000001 109.384 176.571 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 72.2 t -56.32 -45.82 81.53 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.217 0 CA-C-O 118.876 -0.583 . . . . 0.55000000000000004 110.132 175.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 55.5 t -56.44 -48.98 79.21 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 CA-C-N 119.504 1.047 . . . . 0.56000000000000005 110.102 177.125 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 69.9 t -55.76 -45.75 79.51 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 O-C-N 121.786 -0.571 . . . . 0.39000000000000001 110.905 176.449 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 53.2 t -60.23 -46.87 94.13 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.18 0 N-CA-C 109.248 -0.649 . . . . 0.34000000000000002 109.248 178.841 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 48.9 t -54.48 -49.42 65.81 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 C-N-CA 123.7 0.8 . . . . 0.55000000000000004 110.118 177.145 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 42.2 t -57.01 -47.19 83.93 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 CA-C-N 118.435 0.561 . . . . 0.51000000000000001 110.537 177.744 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.19 -47.44 83.43 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 123.053 0.541 . . . . 0.37 109.553 177.546 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 16.0 t -62.94 -40.4 88.78 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.893 0 C-N-CA 123.909 0.884 . . . . 0.39000000000000001 110.049 -178.886 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 7.5 t -63.55 -47.13 92.9 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.48 0 O-C-N 121.542 -0.724 . . . . 0.41999999999999998 109.503 175.841 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 1.4 t -54.69 -41.37 55.62 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.579 0 CA-C-N 119.107 0.867 . . . . 0.35999999999999999 111.212 172.805 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.4 t -64.51 -45.7 94.9 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.19 0 N-CA-C 108.627 -0.879 . . . . 0.34000000000000002 108.627 179.249 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 11.1 mt -59.89 -43.99 93.35 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 N-CA-C 108.75 -0.833 . . . . 0.40999999999999998 108.75 178.689 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 37.4 t -64.89 -49.74 78.43 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.266 0 N-CA-C 109.535 -0.543 . . . . 0.34000000000000002 109.535 -176.814 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -55.77 -50.33 61.5 Favored Glycine 0 CA--C 1.528 0.897 0 N-CA-C 111.128 -0.789 . . . . 0.41999999999999998 111.128 174.229 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -55.15 -42.3 72.92 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 117.325 0.563 . . . . 0.56999999999999995 111.048 178.835 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 10.2 tp -59.87 -62.36 1.93 Allowed 'General case' 0 N--CA 1.439 -1.023 0 N-CA-C 108.512 -0.921 . . . . 0.65000000000000002 108.512 175.052 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . 0.269 2.9 pp -65.7 -27.92 68.69 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 119.223 0.92 . . . . 2.9199999999999999 113.267 -170.357 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 60.8 mtt -61.49 -32.31 72.33 Favored 'General case' 0 CA--C 1.534 0.333 0 O-C-N 121.919 -0.488 . . . . 3.8599999999999999 110.923 171.037 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -83.75 -65.73 1.54 Allowed Glycine 0 CA--C 1.528 0.884 0 N-CA-C 111.074 -0.811 . . . . 3.54 111.074 176.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 2.2 pt? . . . . . 0 N--CA 1.432 -1.329 0 C-N-CA 125.749 1.619 . . . . 7.8399999999999999 110.114 -166.216 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 67.3 mt . . . . . 0 N--CA 1.474 0.757 0 N-CA-C 106.84 -1.541 . . . . 20.629999999999999 106.84 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 58.0 ttt180 -150.3 129.59 12.85 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 107.629 -1.248 . . . . 17.25 107.629 -179.346 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -74.2 145.28 82.93 Favored Pre-proline 0 N--CA 1.45 -0.449 0 N-CA-C 109.604 -0.517 . . . . 13.15 109.604 176.847 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -77.15 60.35 6.9 Favored 'Trans proline' 0 N--CA 1.457 -0.67 0 C-N-CA 123.237 2.625 . . . . 12.109999999999999 109.903 178.405 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -170.1 58.83 0.04 OUTLIER 'General case' 0 CA--C 1.529 0.166 0 N-CA-C 107.618 -1.252 . . . . 9.7400000000000002 107.618 -174.756 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 44.8 t -160.58 101.7 1.34 Allowed Pre-proline 0 CA--C 1.532 0.286 0 CA-C-O 118.599 -0.715 . . . . 5.7699999999999996 110.214 -177.67 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -82.54 -5.4 11.7 Favored 'Trans proline' 0 CA--C 1.536 0.606 0 C-N-CA 123.308 2.672 . . . . 3.5699999999999998 112.437 178.447 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 9.5 t -60.61 153.34 4.92 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 N-CA-C 108.455 -0.942 . . . . 3.29 108.455 -179.517 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . 0.368 17.1 p30 59.69 -45.87 0.08 Allowed 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 127.367 2.267 . . . . 3.6499999999999999 115.031 -166.401 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 7.9 mp -57.12 -39.08 74.43 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 119.498 1.044 . . . . 3.8700000000000001 110.443 175.331 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 3.2 tmtp? -57.76 -51.14 70.79 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 108.526 -0.916 . . . . 3.1400000000000001 108.526 178.712 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 7.5 ptm180 -70.39 -25.83 63.42 Favored 'General case' 0 C--O 1.224 -0.245 0 C-N-CA 119.907 -0.717 . . . . 5.1500000000000004 112.204 -179.627 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.9 tt -57.28 -49.68 75.3 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 108.288 -1.005 . . . . 2.1299999999999999 108.288 169.703 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.24 -46.06 79.75 Favored 'General case' 0 CA--C 1.535 0.396 0 O-C-N 121.927 -0.483 . . . . 2.71 110.369 176.062 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 89.2 t -55.89 -47.24 80.05 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 O-C-N 121.58 -0.7 . . . . 0.51000000000000001 110.591 174.655 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 51.1 t -56.27 -45.96 81.36 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.19 0 O-C-N 121.507 -0.745 . . . . 0.46999999999999997 109.892 176.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 73.0 t -53.74 -50.0 54.06 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 CA-C-N 119.246 0.93 . . . . 0.51000000000000001 110.483 174.689 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 93.2 t -55.5 -45.1 78.38 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 O-C-N 121.696 -0.627 . . . . 0.34999999999999998 111.085 176.692 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 73.8 t -60.42 -46.17 95.61 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.159 0 O-C-N 121.597 -0.689 . . . . 0.33000000000000002 109.25 178.77 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 53.0 t -55.84 -48.01 78.84 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 C-N-CA 123.407 0.683 . . . . 0.46000000000000002 110.36 177.271 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 47.0 t -56.5 -46.45 82.32 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 O-C-N 121.765 -0.585 . . . . 0.37 110.524 176.4 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -58.92 -46.69 87.35 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 123.076 0.55 . . . . 0.33000000000000002 109.63 176.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 13.5 t -61.62 -40.59 87.17 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.839 0 O-C-N 121.255 -0.903 . . . . 0.38 110.063 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 5.4 t -62.08 -47.95 90.77 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.416 0 O-C-N 121.511 -0.743 . . . . 0.37 109.841 174.808 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 1.4 t -54.94 -40.76 54.74 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 CA-C-N 119.088 0.858 . . . . 0.31 111.493 173.065 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.4 t -63.88 -45.24 97.54 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.179 0 N-CA-C 108.472 -0.936 . . . . 0.33000000000000002 108.472 178.535 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 10.1 mt -59.42 -43.74 91.11 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 N-CA-C 108.831 -0.803 . . . . 0.45000000000000001 108.831 177.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 40.9 t -63.36 -52.37 59.2 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 N-CA-C 109.489 -0.56 . . . . 0.40999999999999998 109.489 -178.444 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -52.74 -50.46 49.46 Favored Glycine 0 CA--C 1.528 0.871 0 N-CA-C 111.007 -0.837 . . . . 0.27000000000000002 111.007 174.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -55.24 -44.67 75.7 Favored 'General case' 0 CA--C 1.53 0.182 0 O-C-N 122.284 -0.539 . . . . 0.44 111.075 179.198 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 11.0 tp -61.26 -50.64 72.22 Favored 'General case' 0 N--CA 1.442 -0.869 0 C-N-CA 123.599 0.76 . . . . 0.58999999999999997 108.959 176.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 73.7 mt -57.59 -41.97 82.25 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 118.264 0.484 . . . . 1.6100000000000001 111.642 -179.148 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -71.06 -35.62 71.97 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 122.441 0.296 . . . . 4.4699999999999998 111.314 176.234 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -80.46 -34.33 29.05 Favored Glycine 0 CA--C 1.53 0.978 0 CA-C-O 118.893 -0.948 . . . . 2.5600000000000001 113.987 -171.071 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 4.4 pp . . . . . 0 CA--C 1.531 0.214 0 CA-C-N 117.973 0.886 . . . . 9.0299999999999994 112.595 -175.323 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 63.2 tp . . . . . 0 N--CA 1.474 0.76 0 N-CA-C 106.728 -1.582 . . . . 16.140000000000001 106.728 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 22.5 ptt-85 -157.02 175.7 13.74 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 106.945 -1.502 . . . . 18.5 106.945 171.058 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 15.4 mt 64.56 126.38 0.02 OUTLIER Pre-proline 0 CA--C 1.543 0.674 0 C-N-CA 127.349 2.26 . . . . 12.970000000000001 112.16 179.686 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -77.96 57.21 6.01 Favored 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 122.622 2.215 . . . . 10.93 111.137 -178.78 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 27.3 t -129.52 46.4 2.65 Favored 'General case' 0 CA--C 1.529 0.135 0 CA-C-O 122.954 1.359 . . . . 7.8300000000000001 107.439 174.03 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 28.6 t -158.93 -57.41 0.02 OUTLIER Pre-proline 0 CA--C 1.532 0.277 0 C-N-CA 126.398 1.879 . . . . 6.9000000000000004 109.083 -179.572 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -72.89 60.33 3.66 Favored 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 122.493 2.129 . . . . 4.6100000000000003 110.639 165.637 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 4.1 t -91.66 159.77 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 N-CA-C 106.476 -1.676 . . . . 4.0499999999999998 106.476 169.344 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 9.3 m120 70.45 -46.69 0.62 Allowed 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 127.295 2.238 . . . . 4.0 112.899 -179.788 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.7 pp -65.42 -32.16 73.64 Favored 'General case' 0 C--N 1.331 -0.216 0 O-C-N 121.661 -0.65 . . . . 3.5600000000000001 110.182 179.563 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 7.8 mtpm? -58.97 -53.23 60.74 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 109.904 -0.406 . . . . 3.4300000000000002 109.904 174.299 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 16.8 ptm180 -68.94 -26.4 65.05 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 119.778 -0.769 . . . . 4.6100000000000003 111.696 -178.817 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.6 tt -59.62 -49.73 76.64 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 108.566 -0.902 . . . . 2.0600000000000001 108.566 168.904 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -55.76 -45.82 77.99 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.223 0.609 . . . . 2.8799999999999999 110.344 176.403 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 96.3 t -55.75 -48.76 77.57 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 O-C-N 121.813 -0.554 . . . . 0.37 110.398 174.811 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 55.5 t -55.77 -47.37 79.49 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 O-C-N 121.659 -0.65 . . . . 0.69999999999999996 109.935 176.646 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 72.0 t -54.29 -49.67 61.97 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 CA-C-N 118.783 0.719 . . . . 0.83999999999999997 110.389 176.247 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 73.5 t -56.0 -44.7 79.18 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 O-C-N 121.641 -0.662 . . . . 0.48999999999999999 110.864 177.164 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 54.6 t -59.9 -48.09 89.07 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.168 0 N-CA-C 109.067 -0.716 . . . . 0.46999999999999997 109.067 178.329 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 60.1 t -55.19 -48.92 75.77 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 C-N-CA 122.943 0.497 . . . . 0.87 110.32 177.315 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 42.2 t -56.74 -45.76 82.98 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 C-N-CA 123.632 0.773 . . . . 0.66000000000000003 110.601 177.237 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.25 -47.91 83.6 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 123.402 0.681 . . . . 0.41999999999999998 109.405 177.455 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 20.3 t -61.51 -40.88 87.99 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.838 0 O-C-N 121.484 -0.76 . . . . 0.60999999999999999 110.0 179.481 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 4.1 t -62.0 -45.8 97.9 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.39 0 C-N-CA 123.556 0.742 . . . . 0.58999999999999997 109.887 175.029 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 1.4 t -57.26 -40.46 73.9 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 CA-C-N 119.437 1.017 . . . . 0.37 111.34 173.329 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.4 t -62.87 -45.3 99.21 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 N-CA-C 108.398 -0.964 . . . . 0.40999999999999998 108.398 177.339 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 10.9 mt -61.22 -41.37 89.33 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 N-CA-C 109.232 -0.655 . . . . 0.53000000000000003 109.232 178.675 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 32.9 t -62.74 -50.3 80.27 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.277 0 N-CA-C 108.957 -0.757 . . . . 0.46000000000000002 108.957 179.071 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -52.65 -47.23 58.34 Favored Glycine 0 CA--C 1.53 1.021 0 N-CA-C 111.527 -0.629 . . . . 0.32000000000000001 111.527 173.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -57.01 -49.58 75.35 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 123.224 0.61 . . . . 0.73999999999999999 110.551 177.583 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 10.4 tp -58.6 -45.63 88.72 Favored 'General case' 0 N--CA 1.441 -0.909 0 C-N-CA 124.351 1.06 . . . . 0.93000000000000005 109.216 178.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 66.4 mt -61.98 -41.78 98.39 Favored 'General case' 0 CA--C 1.533 0.311 0 O-C-N 121.713 -0.617 . . . . 1.77 111.017 177.871 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 37.7 ttm -63.1 -37.16 86.11 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 122.918 0.487 . . . . 2.7799999999999998 110.687 175.434 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 103.06 45.49 1.59 Allowed Glycine 0 CA--C 1.528 0.845 0 C-N-CA 125.957 1.741 . . . . 2.4300000000000002 110.614 -177.082 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 94.0 mt . . . . . 0 N--CA 1.447 -0.62 0 C-N-CA 126.472 1.909 . . . . 8.3200000000000003 106.895 173.961 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 3.1 tm? . . . . . 0 N--CA 1.474 0.752 0 N-CA-C 106.123 -1.806 . . . . 23.719999999999999 106.123 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 41.6 ptt180 39.83 49.73 2.22 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.442 1.497 . . . . 25.93 112.929 -171.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -84.11 127.52 66.39 Favored Pre-proline 0 N--CA 1.439 -1.021 0 N-CA-C 106.839 -1.541 . . . . 16.52 106.839 -179.023 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -77.66 -22.71 10.3 Favored 'Trans proline' 0 N--CA 1.459 -0.557 0 C-N-CA 122.636 2.224 . . . . 12.52 112.593 -174.263 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 7.5 t 64.39 41.45 5.77 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-O 122.238 1.018 . . . . 10.23 110.592 -177.079 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 53.2 t -148.34 69.17 10.47 Favored Pre-proline 0 CA--C 1.532 0.286 0 C-N-CA 123.69 0.796 . . . . 6.1900000000000004 109.682 177.371 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -78.62 60.64 7.7 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 123.297 2.665 . . . . 4.0199999999999996 110.371 -176.464 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 10.6 p -86.32 -134.35 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.529 0.16 0 C-N-CA 124.26 1.024 . . . . 4.8700000000000001 108.483 -179.59 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 32.2 t30 -53.54 -26.42 21.05 Favored 'General case' 0 CA--C 1.532 0.271 0 O-C-N 121.105 -0.997 . . . . 3.5899999999999999 112.022 175.586 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 86.2 mt -53.83 -35.16 61.15 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 123.811 0.844 . . . . 3.0699999999999998 110.478 175.035 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 58.5 tttm -57.95 -49.81 75.52 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 123.164 0.585 . . . . 3.1099999999999999 109.858 174.002 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 48.6 ttp180 -70.41 -26.72 63.82 Favored 'General case' 0 N--CA 1.442 -0.872 0 O-C-N 121.743 -0.598 . . . . 5.7699999999999996 110.792 179.82 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.4 tt -63.56 -47.53 81.16 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 108.107 -1.072 . . . . 1.97 108.107 172.325 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 10.3 tp -55.39 -45.89 76.58 Favored 'General case' 0 N--CA 1.453 -0.293 0 O-C-N 121.81 -0.556 . . . . 2.0 111.375 174.579 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 94.3 t -56.15 -49.13 77.67 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 N-CA-C 110.068 -0.345 . . . . 0.37 110.068 174.623 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 49.2 t -56.07 -46.5 80.85 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 O-C-N 121.796 -0.565 . . . . 0.53000000000000003 110.195 177.502 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 53.1 t -54.64 -50.55 58.76 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 CA-C-N 118.952 0.796 . . . . 0.55000000000000004 110.043 176.433 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 78.7 t -55.6 -45.23 78.78 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 O-C-N 121.859 -0.526 . . . . 0.34000000000000002 110.8 177.142 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 61.9 t -60.15 -47.47 91.9 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.136 0 N-CA-C 109.191 -0.67 . . . . 0.34999999999999998 109.191 178.829 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 55.7 t -55.15 -49.16 74.27 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 C-N-CA 123.487 0.715 . . . . 0.57999999999999996 110.25 177.548 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 46.1 t -57.43 -46.25 85.7 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 C-N-CA 123.246 0.618 . . . . 0.5 110.473 177.631 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -59.06 -47.25 85.91 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 123.204 0.602 . . . . 0.31 109.422 177.374 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 14.2 t -61.61 -41.11 89.01 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.821 0 C-N-CA 123.814 0.846 . . . . 0.39000000000000001 110.003 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 4.1 t -62.24 -47.14 94.48 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 O-C-N 121.541 -0.724 . . . . 0.42999999999999999 109.852 175.172 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 1.4 t -56.11 -39.97 61.74 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.6 0 CA-C-N 119.085 0.857 . . . . 0.33000000000000002 111.349 173.418 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.4 t -64.03 -46.0 95.1 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.203 0 N-CA-C 108.411 -0.959 . . . . 0.28999999999999998 108.411 177.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 10.6 mt -59.95 -43.0 91.34 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 N-CA-C 108.825 -0.806 . . . . 0.40000000000000002 108.825 178.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 39.2 t -61.71 -54.71 31.05 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 N-CA-C 108.933 -0.766 . . . . 0.29999999999999999 108.933 179.827 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -52.59 -45.17 59.93 Favored Glycine 0 CA--C 1.53 0.985 0 N-CA-C 111.703 -0.559 . . . . 0.32000000000000001 111.703 176.535 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -57.77 -44.78 86.41 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 123.498 0.719 . . . . 0.52000000000000002 110.712 177.274 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 9.7 tp -60.9 -51.97 67.04 Favored 'General case' 0 N--CA 1.439 -0.983 0 C-N-CA 124.014 0.926 . . . . 0.63 109.235 177.861 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 5.5 mp -56.17 -41.36 75.33 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 119.231 0.923 . . . . 2.0899999999999999 112.14 175.546 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 2.1 tmt? -62.22 -43.22 99.31 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 118.093 0.406 . . . . 5.0300000000000002 110.741 176.669 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -173.55 -53.75 0.05 OUTLIER Glycine 0 CA--C 1.528 0.844 0 CA-C-O 119.791 -0.45 . . . . 3.21 112.401 -179.227 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.454 -0.235 0 N-CA-C 105.713 -1.958 . . . . 7.0999999999999996 105.713 -174.622 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 4.2 mm? . . . . . 0 N--CA 1.475 0.786 0 N-CA-C 107.81 -1.181 . . . . 18.890000000000001 107.81 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 37.3 ptt180 -74.05 71.77 1.62 Allowed 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.804 0.841 . . . . 21.780000000000001 111.346 -175.336 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 24.7 mm 54.48 70.49 1.66 Allowed Pre-proline 0 CA--C 1.54 0.593 0 C-N-CA 125.506 1.522 . . . . 15.85 110.517 174.192 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -65.69 -56.75 0.3 Allowed 'Trans proline' 0 N--CA 1.456 -0.722 0 C-N-CA 122.384 2.056 . . . . 11.949999999999999 112.18 -172.118 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 35.5 t -164.84 60.01 0.13 Allowed 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 123.815 0.846 . . . . 7.5499999999999998 109.093 179.208 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 26.2 p -53.39 102.56 0.32 Allowed Pre-proline 0 CA--C 1.536 0.439 0 C-N-CA 127.85 2.46 . . . . 7.6100000000000003 111.636 -168.492 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -85.12 38.56 0.66 Allowed 'Trans proline' 0 N--CA 1.456 -0.716 0 C-N-CA 123.249 2.632 . . . . 5.5599999999999996 110.724 -171.878 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 12.4 p -107.75 -133.68 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 N-CA-C 104.271 -2.492 . . . . 5.0300000000000002 104.271 168.171 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 23.7 m120 48.68 -84.16 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 126.115 1.766 . . . . 3.3399999999999999 112.928 164.778 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 96.9 mt -53.64 -43.03 68.42 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 125.697 1.599 . . . . 3.1200000000000001 110.356 176.329 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 4.5 mptp? -57.56 -51.57 68.95 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 109.389 -0.597 . . . . 5.0800000000000001 109.389 175.472 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? -67.44 -26.67 66.51 Favored 'General case' 0 N--CA 1.453 -0.312 0 O-C-N 122.227 -0.295 . . . . 7.2199999999999998 111.675 -178.002 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 63.2 tp -65.47 -49.39 69.27 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 108.6 -0.889 . . . . 2.2999999999999998 108.6 173.5 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 1.6 tt -58.42 -46.13 87.07 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-O 120.984 0.421 . . . . 2.5499999999999998 110.469 178.498 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 71.4 t -55.8 -49.39 74.93 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 N-CA-C 109.863 -0.421 . . . . 0.54000000000000004 109.863 174.684 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 25.5 t -57.0 -45.61 83.86 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.365 0 CA-C-O 118.505 -0.759 . . . . 0.70999999999999996 110.252 178.514 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 49.3 t -54.2 -52.11 41.06 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 CA-C-N 119.693 1.133 . . . . 0.72999999999999998 110.008 177.277 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 85.1 t -57.41 -47.18 85.3 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 O-C-N 121.949 -0.469 . . . . 0.42999999999999999 111.004 178.67 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 57.3 t -60.66 -45.35 97.64 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 N-CA-C 109.219 -0.66 . . . . 0.45000000000000001 109.219 -179.132 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 46.8 t -55.68 -48.79 77.33 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 C-N-CA 124.069 0.948 . . . . 0.58999999999999997 110.099 177.076 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 44.2 t -57.88 -47.71 85.63 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 CA-C-N 118.779 0.718 . . . . 0.52000000000000002 110.601 177.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -59.23 -46.65 87.89 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 109.551 -0.537 . . . . 0.55000000000000004 109.551 178.327 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.5 t -62.55 -39.36 84.25 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.923 0 C-N-CA 124.442 1.097 . . . . 0.48999999999999999 110.04 -179.682 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 3.4 t -63.23 -48.92 85.26 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.391 0 CA-C-N 118.963 0.801 . . . . 0.45000000000000001 109.569 175.285 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 1.3 t -53.99 -41.84 51.57 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 CA-C-N 118.881 0.764 . . . . 0.41999999999999998 111.286 173.242 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.4 t -65.43 -44.45 94.39 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.266 0 N-CA-C 108.667 -0.864 . . . . 0.44 108.667 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 12.3 mt -59.34 -44.29 92.06 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.57 0 N-CA-C 108.379 -0.971 . . . . 0.45000000000000001 108.379 178.117 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 39.2 t -64.36 -52.95 49.03 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 N-CA-C 109.568 -0.53 . . . . 0.37 109.568 -177.159 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -55.22 -48.24 69.81 Favored Glycine 0 CA--C 1.529 0.934 0 N-CA-C 111.512 -0.635 . . . . 0.31 111.512 175.846 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -55.56 -44.98 77.35 Favored 'General case' 0 N--CA 1.454 -0.226 0 O-C-N 122.15 -0.618 . . . . 0.57999999999999996 110.592 177.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 11.9 tp -62.92 -53.9 46.92 Favored 'General case' 0 N--CA 1.437 -1.102 0 C-N-CA 123.613 0.765 . . . . 0.85999999999999999 109.045 179.187 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . 0.305 3.1 pp -65.34 -33.82 76.87 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 119.375 0.989 . . . . 3.0800000000000001 112.568 -175.121 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 73.2 mtm -70.71 -43.19 69.49 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 118.071 0.396 . . . . 3.4100000000000001 111.263 174.518 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -70.45 -42.63 64.0 Favored Glycine 0 CA--C 1.528 0.888 0 CA-C-O 119.367 -0.685 . . . . 2.3900000000000001 112.554 -175.354 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . 0.371 0.0 OUTLIER . . . . . 0 N--CA 1.446 -0.642 0 C-N-CA 127.934 2.494 . . . . 7.8799999999999999 115.321 -168.144 . . . . . . . . 2 2 . 1 stop_ save_